UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): November 8, 2018

 


 

Novelion Therapeutics Inc.

(Exact Name of Registrant as specified in its charter)

 


 

British Columbia, Canada

 

000-17082

 

98-0455702

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

c/o Norton Rose Fulbright

1800 - 510 West Georgia Street, Vancouver, BC V6B 0M3 Canada

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (877) 764-3131

 

N/A

(Former name or former address, if changed since last report.)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o                  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 


 

Item 1.01 Entry Into a Material Definitive Agreement.

 

On November 8, 2018, Aegerion Pharmaceuticals, Inc. (“ Aegerion ”), a wholly-owned subsidiary of Novelion Therapeutics, Inc. (“ Novelion ”), entered into a bridge credit agreement (the “ Bridge Credit Agreement ”) with certain funds managed by Athyrium Capital Management, LP (“ Athyrium ”) and Highbridge Capital Management, LLC (“ Highbridge ”), as lenders (the “ Bridge Lenders ”), and Cantor Fitzgerald Securities, as agent (the “ Bridge Agent ”), under which Aegerion borrowed from the Bridge Lenders new secured first lien term loans in cash in an original aggregate principal amount of $50.0 million (“ New Money Loans ”) and $22.5 million of new secured term loans that were funded, on behalf of Aegerion, to repurchase and retire an equal amount of Aegerion’s 2% convertible notes due August 2019 (the “ Convertible Notes ”), at par, held by certain funds managed by Athyrium and Highbridge (the “ Roll Up Loans ”; together with the New Money Loans, the “ Bridge Loans ”).

 

The Bridge Loans mature on the earliest to occur of (i) certain restructuring or bankruptcy events, (ii) February 15, 2019, unless extended pursuant to the terms and conditions of the Bridge Credit Agreement, in which case, June 30, 2019, and (iii) the acceleration after occurrence of an event of default.  The February 15, 2019 maturity date of the Bridge Loans may be extended, at Aegerion’s option, to June 30, 2019 subject to the satisfaction of all of the following conditions: (A) Aegerion must make such request in writing to the Bridge Agent no later than February 1, 2019; (B) on or before February 15, 2019, Aegerion must have paid to the Bridge Lenders an extension fee in cash equal to 3% of the amount of each Bridge Lender’s then outstanding New Money Loans; (C)  Aegerion must have provided to the Bridge Lenders or their counsel a term sheet setting forth the material terms of a sale (which may include a sale or merger of Novelion and one or more of its subsidiaries (but including Aegerion), or any other transaction having a similar effect or result) of Aegerion or its assets that, in the reasonable opinion of Aegerion, may be acceptable to Aegerion and its board of directors; (D) since the closing date of the Bridge Loans (the “ Closing Date ”), there shall not have been any event or circumstance, either individually or in the aggregate, that has had or would reasonably be expected to have a “material adverse effect” (as defined in the Bridge Credit Agreement), except for (1) matters set forth in any public filings of Novelion prior to the Closing Date, (2) any matters disclosed on the disclosure schedules to the Bridge Credit Agreement and related documentation as of the Closing Date, (iii) such events disclosed in writing to the Bridge Lenders or its financial advisor prior to the Closing Date and (iv) any event or circumstance permitted by the terms of the Bridge Credit Agreement and related documentation; and (E) at the time of the effectiveness of the extension, the representations and warranties of Aegerion and each Guarantor contained in certain sections of the Bridge Credit Agreement and the related documentation shall be true and correct in all material respects (without giving effect to any “materiality,” “material adverse effect” or similar qualifiers) on and as of such date (before and after giving effect to such extension) unless such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date.

 

The New Money Loans will accrue interest at the rate of 11.0% per annum and the Roll Up Loans will accrue interest at the rate of 2.00% per annum.  If an event of default occurs and is continuing, the interest rate on each of the New Money Loans and the Roll Up Loans will increase by 2.00% per annum.  Interest on the New Money Loans and the Roll Up Loans will accrue and compound quarterly in arrears and not be payable in cash until the maturity date or any earlier time that the Bridge Loans become due and payable under the Bridge Credit Agreement.  Aegerion will pay a commitment fee equal to 2.00% of the New Money Loans provided on the Closing Date.  The commitment fee will be paid in kind and be added to the outstanding principal amount of the New Money Loans.  The New Money Loan may be prepaid, in whole or in part, by Aegerion at any time subject to payment of an exit fee (including at maturity) equal to 3.00% of the commitments with respect to New Money Loans provided by the Bridge Lenders on the Closing Date.  The Roll Up Loans may be prepaid, in whole or in part, by Aegerion without premium or penalty, but only to the extent all New Money Loans have been paid in full and such prepayment of the Roll Up Loans is otherwise permitted by the Bridge Intercreditor Agreement (as defined below).

 

2


 

Aegerion’s obligations under the Bridge Credit Agreement are guaranteed by each domestic subsidiary of Aegerion other than Aegerion Securities Corporation, a Massachusetts corporation, as guarantors (the “ Guarantors ”), and secured by a lien on substantially all of the assets of Aegerion and the Guarantors, including a pledge of 65% of Aegerion’s and the Guarantors’ first-tier foreign subsidiaries’ equity interests and substantially all of the intellectual property and related rights in respect of MYALEPT and JUXTAPID, subject to certain contractual limitations (if any) and other exclusions set forth in the Bridge Credit Agreement and related documentation.  The liens on the assets of Aegerion and the Guarantors granted to secure Aegerion’s obligations to the Bridge Lenders with respect to New Money Loans are senior to the liens granted to secure Aegerion’s obligations to Novelion with respect to the Intercompany Loan (as defined below).  The liens on the assets of Aegerion and the Guarantors granted to secure Aegerion’s obligations to the Bridge Lenders with respect to Roll Up Loans are junior to the liens granted to secure Aegerion’s obligations to Novelion with respect to the Intercompany Loan.  Upon consummation of certain restructuring transactions consented to by the Bridge Lenders in their discretion, the liens securing the Roll Up Loans will be terminated and released, and the Roll Up Loans will be treated as unsecured obligations of Aegerion, pari passu with the other obligations of Aegerion with respect to the Convertible Notes.

 

The Bridge Credit Agreement includes affirmative and negative covenants binding on Aegerion and its subsidiaries, including prohibitions on the incurrence of additional indebtedness, granting of liens, certain asset dispositions, investments and restricted payments, in each case, subject to certain exceptions set forth in the Bridge Credit Agreement.  The Bridge Credit Agreement also includes customary events of default for a transaction of this type, and includes (i) a cross-default to the occurrence of any event of default under material indebtedness of Aegerion, including the Convertible Notes or the Intercompany Loan, and (ii) Novelion or any of its subsidiaries being subject to bankruptcy or other insolvency proceedings.  Upon the occurrence of an event of default, the Bridge Lenders may declare all of the outstanding Bridge Loans and other obligations under the Bridge Credit Agreement to be immediately due and payable and exercise all rights and remedies available to the Bridge Lenders under the Bridge Credit Agreement and related documentation.

 

On the Closing Date, in addition to the repurchase and cancellation of certain Convertible Notes with the proceeds of the Roll Up Loans, Aegerion used proceeds of the New Money Loans to repay, at par, in full the term loans outstanding under Aegerion’s Loan and Security Agreement, dated as of March 15, 2018, with affiliates of Broadfin Capital, LLC and Sarissa Capital Management LP (the “ Shareholder Loans ”), in an aggregate principal amount of approximately $21.2 million and to repay, at par, principal of the Intercompany Loan in an amount of $3.5 million.

 

Pursuant to the Bridge Credit Agreement, if Aegerion consummates certain territorial licensing transactions, the first $15.0 million of the net cash proceeds thereof will be retained by Aegerion, with $12.0 million to be used in accordance with a proceeds reinvestment budget provided by Aegerion, and the balance to be used in accordance with a general budget of Aegerion, in each case, subject to certain restrictions.  The net cash proceeds from such licensing transactions in excess of $15.0 million are required to be used by Aegerion to repay New Money Loans and the Intercompany Loan pro rata on a 58% and 42% basis, respectively.

 

In connection with, and as a condition to, Aegerion’s entering into the Bridge Credit Agreement, Novelion, as lender under the existing Amended and Restated Loan Agreement, dated as of March 15, 2018 (the “ Intercompany Loan ”), between Aegerion, as borrower, and Novelion, as lender, consented to Aegerion’s incurrence of the Bridge Loans and the repayment of the Shareholder Loans and entered into an amendment to the Intercompany Loan (the “ Consent and Amendment ”). Novelion also agreed to subordinate the Intercompany Loan to the New Money Loans pursuant to a subordination agreement with the Bridge Lenders and Bridge Agent (the “ Bridge Intercreditor Agreement ”).  Under the terms of the Bridge Intercreditor Agreement, the New Money Loans and the liens securing the New Money Loans are senior to the Intercompany Loan and the liens securing the Intercompany Loan.  The Intercompany Loan is not subordinated to the Roll Up Loans.  Under the terms of the Bridge Intercreditor Agreement, the liens securing the Roll Up Loans rank junior to the liens securing the Intercompany Loan.

 

3


 

Under the terms of the Bridge Credit Agreement and the Bridge Intercreditor Agreement, Aegerion is prohibited from making, and Novelion is prohibited from accepting, certain payments, such as payments in cash to Novelion, including for out-of-pocket costs incurred by Novelion, and services rendered by or on behalf of Novelion, for the benefit of Aegerion, unless such payments are approved by the lenders under the Bridge Credit Agreement (and the intercompany services agreements providing for such services cannot be amended without the prior approval of the lenders under the Bridge Credit Agreement).

 

In consideration for its consent to the Bridge Credit Agreement, Novelion received a consent fee of $138,000, representing 0.50% of the remaining outstanding principal balance of the Intercompany Loan, paid in kind and added to the outstanding principal amount of the Intercompany Loan. Under the terms of the Consent and Amendment, the Intercompany Loan Agreement was amended to, among other things, increase the interest rate on the Intercompany Loan from the current rate of 8.00% per annum to 8.50% per annum, effective as of January 1, 2019, add a guarantor, Aegerion’s wholly-owned subsidiary, Aegerion Holdings, Inc., require a mandatory prepayment from the proceeds of certain territorial licensing transactions (as described above), permit the Bridge Loans to be senior to the Intercompany Loans, require the liens securing the Roll Up Loans be subordinated to the liens securing the Intercompany Loan, modify reporting requirements and other covenants to align with the limitations of the Bridge Credit Agreement, and cross-default with any event of default under the Bridge Loans as well as the Convertible Notes.  Interest on the Intercompany Loan accrues and compounds quarterly in arrears and not be payable in cash until the stated maturity date or any earlier time that the Intercompany Loan becomes due and payable pursuant to the terms thereof.  The stated maturity date of the Intercompany Loan did not change and is July 1, 2019.

 

The foregoing summary is qualified in its entirety by the full text of the transaction agreements, which are attached as Exhibits 10.1, 10.2 and 10.3 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth in Item 1.01 above is incorporated herein by reference.

 

Item 7.01 Regulation FD.

 

A copy of the press release announcing the consummation of the transactions contemplated by the Bridge Credit Agreement and the related transactions described herein, which press release also provides a business update, is furnished with this report as Exhibit 99.1 and a related slide presentation is furnished with this report as Exhibit 99.2.

 

Exhibits 99.1 and 99.2 attached hereto are intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Forward Looking Statements

 

Certain statements in this report and in Exhibits 99.1 and 99.2 constitute “forward-looking statements” within the meaning of applicable laws and regulations and constitute “forward-looking information” within the meaning of applicable Canadian securities laws.  Any statements contained herein or therein which do not describe historical facts, including (among others) statements regarding the Bridge Credit Agreement , the Intercompany Loan, the Bridge Intercreditor Agreement, and territorial licensing transactions, as well as those examples identified under the caption “Forward Looking Statements” in Exhibits 99.1 and 99.2, are forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. Such risks and uncertainties

 

4


 

include, among others, Novelion’s and Aegerion’s ability to meet immediate operational needs and obligations, as well as long-term obligations; the possibility that the restrictions in and other terms of the Bridge Credit Agreement and the related documents could have a negative impact on Novelion’s business and its shareholders (whose interests may not be aligned with those of Aegerion’s holders of Convertible Notes and other lenders); whether Novelion and/or Aegerion will be able to undertake a wholesale recapitalization, which is likely to include a debt for equity swap, and Novelion and/ or Aegerion may be forced to use the protections of the bankruptcy code to effectuate such recapitalization or other alternative; Novelion’s and Aegerion’s ability to identify, pursue and consummate any financial or strategic alternatives; Novelion’s ability to maintain its listing status on Nasdaq; Novelion’s and Aegerion’s ability to continue as a going concern; the risks inherent in the development and commercialization of pharmaceutical products, as well as those identified in Novelion’s filings with the U.S. Securities and Exchange Commission (the “ Commission ”), including under the heading “Risk Factors” in Novelion’s Annual Report on Form 10-K filed on March 16, 2018 and subsequent filings with the Commission (including Novelion’s upcoming Quarterly Report on Form 10-Q and Novelion’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018), available on the Commission’s website at www.sec.gov. Any such risks and uncertainties could materially and adversely affect Novelion’s or Aegerion’s results of operations, cash flows, and ability to continue its operations, which would, in turn, have a significant and adverse impact on Novelion’s stock price. Novelion cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made.  Except as required by law, Novelion undertakes no obligation to update or revise the information contained in this report, whether as a result of new information, future events or circumstances or otherwise.

 

This report and Exhibits 99.1 and 99.2 also contain “forward-looking information” that constitutes “financial outlooks” within the meaning of applicable Canadian securities laws. This information is provided to give investors general guidance on management’s current expectations of certain factors affecting our business, including our financial results. Given the uncertainties, assumptions and risk factors associated with this type of information, including those described above, investors are cautioned that the information may not be an appropriate subject of reliance for other purposes.

 

Item 9.01.                                         Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.

 

Description

10.1

 

Bridge Credit Agreement, dated November 8, 2018

 

 

 

10.2

 

Amendment No. 1 to and Consent under the Amended and Restated Loan and Security Agreement, dated as of November 8, 2018

 

 

 

10.3

 

Subordination Agreement made as of November 8, 2018.

 

 

 

99.1

 

Press Release, dated November 8, 2018 (furnished).

 

 

 

99.2

 

Slide Presentation (furnished).

 

5


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Novelion Therapeutics Inc.

 

 

 

 

 

By:

/s/ Benjamin Harshbarger

 

Name:

Benjamin Harshbarger

 

Title:

General Counsel

 

Date:  November 8, 2018

 

6


Exhibit 10.1

 

THE INDEBTEDNESS AND OTHER OBLIGATIONS OF THE BORROWER UNDER OR EVIDENCED HEREBY WITH RESPECT TO THE ROLL UP LOANS AND THE LIENS AND SECURITY INTERESTS SECURING THE ROLL UP LOANS ARE SUBORDINATED PURSUANT TO THE TERMS AND CONDITIONS OF THE NOVELION SUBORDINATION AGREEMENT

 

 

BRIDGE CREDIT AGREEMENT

 

Dated as of November 8, 2018

 

Among

 

AEGERION PHARMACEUTICALS, INC.,
as Borrower,

 

THE LENDERS PARTY HERETO

 

and

 

CANTOR FITZGERALD SECURITIES,
as Administrative Agent

 

 


 

TABLE OF CONTENTS

 

 

 

 

Page

 

 

 

 

ARTICLE I

 

DEFINITIONS AND ACCOUNTING TERMS

 

 

 

 

Section 1.01

 

Defined Terms

1

Section 1.02

 

Other Interpretive Provisions

23

Section 1.03

 

Accounting Terms

23

Section 1.04

 

References to Agreements, Laws, Etc.

24

Section 1.05

 

Times of Day

24

Section 1.06

 

Timing of Payment or Performance

24

 

 

 

 

ARTICLE II

 

THE COMMITMENTS AND THE LOANS

 

 

 

 

Section 2.01

 

The Commitments and the Loans

24

Section 2.02

 

Prepayments

25

Section 2.03

 

Repayment of Loans

27

Section 2.04

 

Interest

27

Section 2.05

 

Fees

27

Section 2.06

 

Computation of Interest and Fees

28

Section 2.07

 

Evidence of Indebtedness

28

Section 2.08

 

Payments Generally

29

Section 2.09

 

Sharing of Payments

30

Section 2.10

 

Extension Option

30

 

 

 

 

ARTICLE III

 

TAXES, INCREASED COSTS PROTECTION AND ILLEGALITY

 

 

 

 

Section 3.01

 

Taxes

31

Section 3.02

 

Increased Cost and Reduced Return; Capital and Liquidity Requirements

35

Section 3.03

 

Matters Applicable to All Requests for Compensation

36

Section 3.04

 

Mitigation Obligations; Replacement of Lenders under Certain Circumstances

37

Section 3.05

 

Survival

38

 

i


 

ARTICLE IV

 

CONDITIONS PRECEDENT TO LOANS

 

 

 

 

Section 4.01

 

Conditions to Loans

38

 

 

 

 

ARTICLE V

 

REPRESENTATIONS AND WARRANTIES

 

 

 

 

Section 5.01

 

Existence, Qualification and Power; Compliance with Laws

40

Section 5.02

 

Authorization; No Contravention

40

Section 5.03

 

Governmental Authorization; Other Consents

40

Section 5.04

 

Binding Effect

41

Section 5.05

 

No Material Adverse Effect

41

Section 5.06

 

Litigation

41

Section 5.07

 

Ownership of Property; Liens

41

Section 5.08

 

Enforceable Obligations

42

Section 5.09

 

Environmental Compliance

42

Section 5.10

 

Taxes

43

Section 5.11

 

Compliance with ERISA

43

Section 5.12

 

Labor Matters

44

Section 5.13

 

Insurance

44

Section 5.14

 

Subsidiaries; Equity Interests

44

Section 5.15

 

Margin Regulations; Investment Company Act; PATRIOT Act; OFAC and Other Regulations

44

Section 5.16

 

Disclosure

45

Section 5.17

 

Intellectual Property

46

Section 5.18

 

Initial Budget

46

Section 5.19

 

EEA Financial Institution

46

 

 

 

 

ARTICLE VI

 

AFFIRMATIVE COVENANTS

 

 

 

 

Section 6.01

 

Financial Statements

47

Section 6.02

 

Certificates; Reports; Other Information

48

Section 6.03

 

Notice Requirements; Other Information

49

Section 6.04

 

Environmental Matters

50

Section 6.05

 

Maintenance of Existence

52

Section 6.06

 

Maintenance of Properties

52

Section 6.07

 

Maintenance of Insurance

52

Section 6.08

 

Compliance with Laws

53

Section 6.09

 

Books and Records

53

Section 6.10

 

Inspection Rights; Lender Calls

53

Section 6.11

 

Additional Guarantors

53

 

ii


 

Section 6.12

 

Use of Proceeds

54

Section 6.13

 

Anti-Corruption Laws

54

Section 6.14

 

Taxes

54

Section 6.15

 

End of Fiscal Years; Fiscal Quarters

54

Section 6.16

 

ERISA

54

Section 6.17

 

Further Assurances

55

Section 6.18

 

Business

55

 

 

 

 

ARTICLE VII

 

NEGATIVE COVENANTS

 

 

 

 

Section 7.01

 

Liens

56

Section 7.02

 

Investments

58

Section 7.03

 

Indebtedness

59

Section 7.04

 

Fundamental Changes

60

Section 7.05

 

Dispositions

60

Section 7.06

 

Restricted Payments

62

Section 7.07

 

Change in Nature of Business

62

Section 7.08

 

Transactions with Affiliates

62

Section 7.09

 

Prepayments and Modifications of Certain Agreements

63

Section 7.10

 

Negative Pledge

64

Section 7.11

 

Amendments to Organization Documents

64

Section 7.12

 

Use of Proceeds

64

Section 7.13

 

Accounting Changes

64

Section 7.14

 

OFAC

64

Section 7.15

 

Ownership of Subsidiaries

64

Section 7.16

 

Compliance with Budget

65

Section 7.17

 

Compliance With Certain Laws

65

 

 

 

 

ARTICLE VIII

 

EVENTS OF DEFAULT AND REMEDIES

 

 

 

 

Section 8.01

 

Events of Default

66

Section 8.02

 

Remedies Upon Event of Default

69

Section 8.03

 

Application of Funds

70

 

 

 

 

ARTICLE IX

 

ADMINISTRATIVE AGENT AND OTHER AGENTS

 

 

 

 

Section 9.01

 

Appointment and Authorization

71

Section 9.02

 

Delegation of Duties

72

Section 9.03

 

Liability of the Administrative Agent

73

Section 9.04

 

Reliance by the Administrative Agent

73

 

iii


 

Section 9.05

 

Notice of Default

74

Section 9.06

 

Credit Decision; Disclosure of Information by the Administrative Agent

74

Section 9.07

 

Indemnification of the Administrative Agent

75

Section 9.08

 

The Administrative Agent in its Individual Capacity

75

Section 9.09

 

Successor Agents

76

Section 9.10

 

Administrative Agent May File Proofs of Claim

76

Section 9.11

 

Release of Collateral and Guarantee

77

Section 9.12

 

Other Agents; Arrangers and Managers

78

Section 9.13

 

Appointment of Supplemental Administrative Agent

78

 

 

 

 

ARTICLE X

 

MISCELLANEOUS

 

 

 

 

Section 10.01

 

Amendments, Etc.

79

Section 10.02

 

Notices and Other Communications; Facsimile and Electronic Copies

80

Section 10.03

 

No Waiver; Cumulative Remedies

84

Section 10.04

 

Costs and Expenses

85

Section 10.05

 

Indemnification by the Borrower

85

Section 10.06

 

Payments Set Aside

87

Section 10.07

 

Successors and Assigns

87

Section 10.08

 

Confidentiality

91

Section 10.09

 

Setoff

92

Section 10.10

 

Counterparts

92

Section 10.11

 

Integration

92

Section 10.12

 

Survival of Representations and Warranties

93

Section 10.13

 

Severability

93

Section 10.14

 

GOVERNING LAW

93

Section 10.15

 

WAIVER OF RIGHT TO TRIAL BY JURY

94

Section 10.16

 

Binding Effect

94

Section 10.17

 

Lender Action

94

Section 10.18

 

PATRIOT Act

94

Section 10.19

 

No Advisory or Fiduciary Responsibility

94

Section 10.20

 

Acknowledgement and Consent to Bail-In of EEA Financial Institutions

95

Section 10.21

 

Novelion Subordination Agreement

96

 

iv


 

SCHEDULES

 

Schedule 1

-

Closing Checklist

Schedule 2

-

Subsidiary Guarantors

Schedule 1.01

-

Permitted Licensing Transaction

Schedule 2.01

-

Commitments and Roll Up Loans

Schedule 5.01

-

Existence, Qualification and Power; Compliance with Laws

Schedule 5.02

-

Authorizations; No Contravention

Schedule 5.06

-

Litigation

Schedule 5.07(b)

-

Real Property

Schedule 5.09

-

Environmental Compliance

Schedule 5.10

-

Taxes

Schedule 5.14

-

Subsidiaries and Other Equity Investments

Schedule 5.17

-

Intellectual Property, Licenses

Schedule 5.20

-

Material Contracts

Schedule 6.01(e)

 

Budget Updates

Schedule 7.01(b)

-

Existing Liens

Schedule 7.02(c)

-

Existing Investments

Schedule 7.03(b)

-

Surviving Indebtedness

Schedule 10.02

-

Administrative Agent’s Office, Certain Addresses for Notices

 

v


 

EXHIBITS

 

Exhibit A-1

Form of Committed Loan Notice

Exhibit A-2

Form of Prepayment Notice

Exhibit B

Form of Note

Exhibit C

Form of Compliance Certificate

Exhibit D

Form of Assignment and Assumption

Exhibit E

Form of Guarantee and Collateral Agreement

Exhibit F

Form of Officer’s Certificate

Exhibit G

Form of Administrative Questionnaire

 

vi


 

BRIDGE CREDIT AGREEMENT

 

This BRIDGE CREDIT AGREEMENT (this “ Agreement ”) is entered into as of November 8, 2018 among AEGERION PHARMACEUTICALS, INC., a Delaware corporation (the “ Borrower ”), each Lender (as hereinafter defined) from time to time party hereto and CANTOR FITZGERALD SECURITIES, as administrative agent and collateral agent for the Lenders (in such capacities, together with any successor administrative agent and collateral agent, the “ Administrative Agent ”).

 

PRELIMINARY STATEMENTS

 

1.                                       The Borrower has requested that the Lenders make available to the Borrower a senior secured term loan facility in an aggregate amount not to exceed $50,000,000 consisting of new money term loans advanced on the Closing Date, the proceeds of which the Borrower may use for the purposes permitted hereunder, and in partial consideration therefor the Borrower will roll up $22,500,000 of Convertible Notes owed to the Lenders on the Closing Date as Roll Up Loans hereunder pursuant to the terms hereof.

 

2.                                       The Guarantors (as hereinafter defined) have agreed to guarantee the obligations of the Borrower hereunder and the Borrower and the Guarantors have agreed to secure their respective Obligations by granting to the Administrative Agent, for the benefit of the Secured Parties (as hereinafter defined), a lien on substantially all of their respective assets, in accordance with the priorities provided in the Loan Documents (as hereinafter defined).

 

Subject to and upon the terms and conditions set forth herein, the Lenders are willing to make available to the Borrower the senior secured term loan facility provided for herein:

 

ARTICLE I

 

DEFINITIONS AND ACCOUNTING TERMS

 

Section 1.01                              Defined Terms .  As used in this Agreement, the following terms shall have the meanings set forth below:

 

Accounting Changes ” means changes in accounting principles required by the promulgation of any rule, regulation, pronouncement or opinion by the Financial Accounting Standards Board of the American Institute of Certified Public Accountants (or successor thereto or any agency with similar functions).

 

Administration Fee ” has the meaning specified in Section 2.05(c) .

 

Administrative Agent ” has the meaning specified in the first paragraph of this Agreement and shall include any successor administrative agent appointed in accordance with Section 9.09 .

 

1


 

Administrative Agent’s Office ” means, the Administrative Agent’s address and, as appropriate, account as set forth on Schedule 10.02 , or such other address or account as the Administrative Agent may from time to time notify the Borrower and the Lenders.

 

Administrative Questionnaire ” means an Administrative Questionnaire substantially in the form of Exhibit G .

 

Affiliate ” means, in respect of any Person:

 

(a)                                  any Person which, directly or indirectly, controls, is controlled by or is under common control with such Person; and for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlled by” or “under common control with”) means the power to direct or cause the direction of the management and policies of any Person, whether through the ownership of voting Equity Interests or by contract or otherwise;

 

(b)                                  any Person who beneficially owns or holds 10% or more of any class of shares (or, in the case of a Person that is not a corporation, 10% or more of the partnership or other Equity Interests) of such Person; or

 

(c)                                   any Person, 10% or more of any class of shares (or in the case of a Person that is not a corporation, 10% or more of the partnership or other Equity Interests) of which is beneficially owned or held by such Person or a Subsidiary of such Person.

 

Agent Parties ” has the meaning specified in Section 10.02(f) .

 

Agent-Related Persons ” means the Administrative Agent, together with its Affiliates, and the officers, directors, employees, agents and attorneys-in-fact of such Persons and Affiliates.

 

Aggregate Commitments ” means the Commitments of all the Lenders.  As of the Closing Date, the amount of the Aggregate Commitments is $50,000,000.

 

Agreement ” has the meaning specified in the introductory paragraph hereto.

 

Anti-Corruption Laws ” has the meaning specified in Section 5.15(f) .

 

Anti-Terrorism Law ” means any Requirement of Law related to money laundering or financing terrorism, including the PATRIOT Act, and its implementing regulations, The Currency and Foreign Transactions Reporting Act (also known as the Bank Secrecy Act, 31 U.S.C. §§ 5311-5330 and 12 U.S.C. §§ 1818(s), 1820(b) and 1951-1959), the Trading With the Enemy Act (50 U.S.C. § 1 et seq., as amended), Executive Order 13224 (effective September 24, 2001) and the Money Laundering Control Act of 1986 (18 U.S.C. §§ 1956 and 1957).

 

Applicable Lending Office ” means for any Lender, such Lender’s office, branch or affiliate designated for the Loans, as notified to the Administrative Agent and the Borrower or as otherwise specified in the Assignment and Assumption pursuant to which such Lender

 

2


 

became a party hereto, any of which offices may, subject to the applicable provisions of Article III , be changed by such Lender upon 10 days’ prior written notice to the Administrative Agent and the Borrower; provided that for the purposes of the definition of “Excluded Taxes” and Section 3.01 , any such change shall be deemed an assignment made pursuant to an Assignment and Assumption.

 

Applicable Rate ” means a percentage per annum equal to (x) with respect to Roll Up Loans, 2.0% and (y) with respect to New Money Loans, 11.0%.

 

Approved Fund ” means any Fund that is administered, advised or managed by (a) a Lender, (b) an Affiliate of a Lender, or (c) an entity or Affiliate of an entity that administers, advises or manages a Lender.

 

Assignment and Assumption ” means an Assignment and Assumption substantially in the form of Exhibit D .

 

Attorney Costs ” means and includes all reasonable and documented fees, out-of-pocket expenses and actual disbursements of any law firm or other external legal counsel.

 

Attributable Indebtedness ” means, at any date, (a) in respect of any Capital Lease Obligation (other than a lease resulting from a Sale Leaseback) of any Person, the capitalized amount thereof that would appear on a balance sheet of such Person prepared as of such date in accordance with GAAP, and (b) in respect of any Sale Leaseback, the lesser of (i) the present value, discounted in accordance with GAAP at the interest rate implicit in the related lease, of the obligations of the lessee for net rental payments over the remaining term of such lease (including any period for which such lease has been extended or may, at the option of the lessor be extended) and (ii) the fair market value of the assets subject to such transaction.

 

Bail-In Action ” means the exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of an EEA Financial Institution.

 

Bail-In Legislation ” means, with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule.

 

Bankruptcy Code ” means Title 11 of the United States Code entitled “Bankruptcy,” as now or hereafter in effect, or any successor thereto.

 

Borrower ” has the meaning specified in the introductory paragraph hereto.

 

Budget ” means the Initial Budget and as the same shall be supplemented pursuant to Section 6.01(e) with the consent of the Required Lenders not to be unreasonably withheld.

 

Business Day ” means any day other than a Saturday, Sunday or other day on which commercial banks are authorized or required to close under the Laws of, or are in fact

 

3


 

closed in, the State of New York .

 

Capital Lease ” means, with respect to any Person, any leasing or similar arrangement conveying the right to use any property, whether real or personal property, or a combination thereof, by that Person as lessee that, in conformity with GAAP, is required to be accounted for as a capital lease on the balance sheet of such Person.

 

Capital Lease Obligation ” means, with respect to any Person, all monetary or financial obligations of such Person and its Subsidiaries under any Capital Leases, and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP and the stated maturity thereof shall be the date of the last payment of rent or any other amount due under such lease prior to the first date on which such lease may be terminated by the lessee without payment of a penalty; provided that any obligations that were not required to be included on the balance sheet of such Person as capital lease obligations when incurred but are subsequently re-characterized as capital lease obligations due to a change in accounting rules after the Closing Date shall for all purposes hereunder not be treated as a Capital Lease Obligation.

 

Cash Equivalents ” means any of the following:  (a) readily marketable direct obligations of the Government of the United States or any agency or instrumentality thereof or obligations unconditionally guaranteed by the full faith and credit of the Government of the United States, (b) insured certificates of deposit of or time deposits with any commercial bank that is a Lender or any other domestic commercial bank having capital and surplus in excess of $500,000,000 maturing not more than one year after the date of issuance, (c) repurchase obligations of any Lender or of any commercial bank satisfying the requirements of clause (b) of this definition, having a term of not more than 30 days, with respect to securities issued or fully guaranteed or insured by the Government of the United States, (d) securities with maturities of 365 days or less from the date of acquisition that are issued or fully guaranteed by any state, district or territory of the United States, by any political subdivision or taxing authority of any such state, district or territory or by any foreign government, the securities of which state, district or territory, taxing authority or foreign government (as the case may be) are rated at least A by S&P or A by Moody’s, (e) commercial paper maturing not more than two hundred and seventy (270) days from the date of issue and issued by a corporation (other than an Affiliate of any Loan Party) organized under the laws of any state of the United States of America or of the District of Columbia and, at the time of acquisition thereof, rated A 2 or higher by S&P, P 2 or higher by Moody’s or F2 or higher by Fitch, (f) money market mutual or similar funds that invest substantially all of their assets in one or more type of securities satisfying the requirements of clauses (a) through (e) of this definition, (g) Investments, classified in accordance with GAAP as current assets of the Borrower or any of its Subsidiaries, in money market investment programs registered under the Investment Company Act of 1940, as amended, which are administered by financial institutions having capital of at least $500,000,000, and the portfolios of which are limited solely to Investments of the character, quality and maturity described in clauses (a) and (b) of this definition, (h) agencies (LSE’s), State (municipal bonds), or corporate bonds having a long term rating of at least A- or A3 from S&P, Moody’s or Fitch, having maturities of not more than fifteen (15) months from the date of acquisition and (i) money market funds having a rating of AAAm/Aaa or better from S&P, Moody’s or Fitch.

 

4


 

Casualty Event ” means any casualty, loss, damage, destruction or other similar loss with respect to real or personal property or improvements.

 

CERCLA ” means the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended from time to time.

 

CERCLIS ” means the Comprehensive Environmental Response, Compensation and Liability Information System maintained by the U.S. Environmental Protection Agency.

 

Certain Proceeds Reinvestment Budget ”  means a budget approved by the Required Lenders detailing the use of up to $12,000,000 of retained sale proceeds with respect to the Disposition under Section 7.05(i).

 

Change in Law ” means (a) the adoption of any law, treaty, order, policy, rule or regulation after the date of this Agreement, (b) any change in any law, treaty, order, policy, rule or regulation or in the interpretation or application thereof by any Governmental Authority after the date of this Agreement or (c) the making or issuance of any guideline, request or directive issued or made after the date hereof by any central bank or other Governmental Authority (whether or not having the force of law); provided that notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines, requirements or directives thereunder or issued in connection therewith or in implementation thereof and (y) all requests, rules, guidelines, requirements or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law”, regardless of the date enacted, adopted, issued or implemented; provided that increased costs as a result of a Change in Law pursuant to clauses (x) and (y) above shall only be reimbursable by the Borrower to a Lender to the extent such Lender is requiring reimbursement therefor generally from similarly situated borrowers under comparable credit facilities.

 

Change of Control ” means the occurrence of any of the following events:

 

(a)                                  any direct or indirect Subsidiary of Novelion on the Closing Date shall cease to be a Wholly-owned direct or indirect Subsidiary of Novelion;

 

(b)                                  the Borrower shall cease to be a Wholly-owned indirect Subsidiary of Novelion;

 

(c)                                   any Person or “group” (within the meaning of Rules 13d-3 and 13d-5 under the Exchange Act) shall have (x) acquired beneficial ownership or control of 25% or more on a fully diluted basis of the voting and/or economic interest in the Equity Interests of Novelion; or (y) obtained the power (whether or not exercised) to elect a majority of the members of the board of directors (or similar governing body) of Novelion; or

 

(d)                                  those individuals who are members of the board of directors (or similar governing body) of Novelion or the Borrower on the Closing Date (together with any new or replacement directors whose initial nomination for election was approved by a

 

5


 

majority of the directors who were either directors on the Closing Date or previously so approved) shall fail to constitute a majority of the board of directors (or similar governing body of Novelion or the Borrower, as applicable.

 

Closing Date ” means the date on which all the conditions precedent in Section 4.01 are satisfied or waived in accordance with Section 10.01 and the Loans are made.

 

Code ” means the U.S.  Internal Revenue Code of 1986, as amended from time to time.

 

Collateral ” means a collective reference to all real and personal property required to be pledged to the Administrative Agent, for the benefit of the Secured Parties, to secure all or part of the Obligations pursuant to the Collateral Documents.

 

Collateral Documents ” means, collectively, the Guarantee and Collateral Agreement, and, to the extent required hereunder or reasonably requested by the Administrative Agent and the Lenders, any Guarantee and Collateral Agreement Supplement, any mortgages, any collateral assignments, any security agreements, pledge agreements or other similar agreements, or any supplements to any of the foregoing, in each case delivered to the Administrative Agent and the Lenders in connection with this Agreement or any other Loan Document or any transaction contemplated hereby or thereby to secure or guarantee the payment of any part of the Obligations or the performance of any Loan Party’s other duties and obligations under the Loan Documents.

 

Commitment ” means, as to each Lender, its obligations to make New Money Loans pursuant to Section 2.01(a)  in an aggregate principal amount not to exceed the amount set forth opposite such Lender’s name on Schedule 2.01 hereto under the caption “Commitment”.  Commitments will terminate once advanced.

 

Commitment Fee ” has the meaning provided in Section 2.05(a) .

 

Committed Loan Notice ” means a notice of borrowing substantially in the form of Exhibit A-1 .

 

Communications ” has the meaning specified in Section 10.02(e) .

 

Compliance Certificate ” means a certificate substantially in the form of Exhibit C .

 

Contractual Obligation ” means, as to any Person, any provision of any security issued by such Person or of any agreement, instrument or other undertaking to which such Person is a party or by which it or any of its property is bound.

 

Convertible Notes ” means Indebtedness evidenced by the 2.00% convertible senior notes due 2019 issued under that certain Indenture dated as of August 15, 2014 between the Borrower and The Bank of New York Mellon Trust Company, N.A., as trustee thereunder.

 

6


 

Debtor Relief Laws ” means the Bankruptcy Code, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, fraudulent transfer, reorganization, or similar debtor relief Laws of the United States or any similar foreign, federal or state law for the relief of debtors from time to time in effect and affecting the rights of creditors generally.

 

Default ” means any event or condition that constitutes an Event of Default or that, with the giving of any notice, the passage of time, or both, would be an Event of Default.

 

Default Rate ” means an interest rate equal to the Applicable Rate plus 2.0% per annum.

 

Disposition ” or “ Dispose ” means the sale, transfer, license, lease or other disposition of any asset or property by a Loan Party or any of its Subsidiaries (including any Sale Leaseback and any sale of Equity Interests, but excluding any issuance by a Loan Party of its own Equity Interests); provided that none of the foregoing shall be considered a “Disposition” for purpose of Section 7.05 if and only if the aggregate value of the assets or property that are the subject of such transaction is less than $100,000 in the aggregate during the term of this Agreement.

 

Disqualified Equity Interests ” means, with respect to any Person, any Equity Interest of such Person which, by its terms, or by the terms of any security or other Equity Interests into which it is convertible or for which it is exchangeable, or upon the happening of any event or condition, (a) matures or is mandatorily redeemable (other than solely for Qualified Equity Interests), pursuant to a sinking fund obligation or otherwise (except as a result of a change of control or asset sale so long as any rights of the holders thereof upon the occurrence of a change of control or asset sale event shall be subject to the prior repayment in full of the Loans and all other Obligations that are accrued and payable and the termination of the Commitments), (b) is redeemable at the option of the holder thereof (other than solely for Qualified Equity Interests), in whole or in part, (c) provides for the scheduled payments of dividends in cash, or (d) is or becomes convertible into or exchangeable for Indebtedness or any other Equity Interests that would constitute Disqualified Equity Interests, in each case, prior to the date that is ninety one (91) days after June 30, 2019; provided that, if such Equity Interests are issued pursuant to a plan for the benefit of employees of the Borrower or any of its Subsidiaries or by any such plan to such employees, such Equity Interests shall not constitute Disqualified Equity Interests solely because they may be required to be repurchased by the Borrower or any of its Subsidiaries in order to satisfy applicable statutory or regulatory obligations.

 

Disqualified Person ” means any holder of any Indebtedness under the Convertible Notes or any direct competitor of Novelion or its Subsidiaries to the extent that all such Disqualified Persons have been listed on a schedule provided to the Lenders and the Administrative Agent prior to the Closing Date.

 

Dollars ” means lawful money of the United States.

 

EEA Financial Institution ” means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA

 

7


 

Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a)  of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a)  or (b)  of this definition and is subject to consolidated supervision with its parent.

 

EEA Member Country ” means any of the member states of the European Union, Iceland, Liechtenstein, and Norway.

 

EEA Resolution Authority ” means any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.

 

Eligible Assignee ” means any Person that meets the requirements to be an assignee under Section 10.07(b)(iii) , (v)  and (vi)  (subject to such consents, if any, as may be required under Section 10.07(b)(iii)) .

 

Environmental Action ” means any action, suit, demand, demand letter, claim, notice of non-compliance or violation, notice of liability or potential liability, investigation, proceeding, consent order or consent agreement relating to any Environmental Law, any Environmental Permit or Hazardous Material or arising from alleged injury or threat to health and safety as it relates to any Hazardous Material or the environment, including, without limitation, (a) by any Governmental Authority for enforcement, cleanup, removal, response, remedial or other actions or damages relating to Releases of Hazardous Materials or actual or alleged violations of Environmental Laws and (b) by any Governmental Authority or third party for damages, contribution, indemnification, cost recovery, compensation or injunctive relief.

 

Environmental Laws ” means any and all federal, provincial, local and foreign statutes, laws, regulations, ordinances, rules, decrees or other governmental restrictions of legal effect relating to the environment, to the release of any Hazardous Materials into the environment or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials but only to the extent such Environmental Laws are legally applicable to any Loan Party pursuant to any Environmental Law.

 

Environmental Liability ” in respect of any Person, any and all legal obligations and liabilities under Environmental Laws for any Release caused by such Person or which is discovered or uncovered during the ownership or control of any real property by such Person and which adversely impacts any Person, property or the environment whether or not caused by a breach of applicable laws (including Environmental Laws).

 

Environmental Permit ” means any permit, approval, hazardous waste identification number, license or other authorization issued by or submitted to a Governmental Authority required under any Environmental Law.

 

Equity Interests ” means, with respect to any Person, all of the shares of capital stock of (or other ownership or profit interests in) such Person, all of the warrants, options or other rights for the purchase or acquisition from such Person of shares of capital stock of (or other ownership or profit interests in) such Person, all of the securities convertible into or exchangeable for shares of capital stock of (or other ownership or profit interests in) such Person

 

8


 

or warrants, rights or options for the purchase or acquisition from such Person of such shares (or such other interests), and all of the other ownership or profit interests in such Person (including partnership, member or trust interests therein), whether voting or nonvoting.

 

ERISA ” means the Employee Retirement Income Security Act of 1974, as amended from time to time and Treasury regulations promulgated and rulings issued thereunder.

 

ERISA Affiliate ” means any trade or business (whether or not incorporated) that is under common control with any Loan Party and is treated as a single employer within the meaning of Section 414 of the Code or Section 4001 of ERISA.

 

ERISA Event ” means (a) a Reportable Event with respect to a Pension Plan; (b) a withdrawal by any Loan Party or any ERISA Affiliate from a Pension Plan subject to Section 4063 of ERISA during a plan year in which it was a substantial employer (as defined in Section 4001(a)(2) of ERISA) or a cessation of operations at any facility of any Loan Party or ERISA Affiliate as described in Section 4062(e) of ERISA; (c) a complete or partial withdrawal by any Loan Party or any ERISA Affiliate from a Multiemployer Plan, notification of any Loan Party or ERISA Affiliate concerning the imposition of withdrawal liability or notification that a Multiemployer Plan is insolvent or is in reorganization within the meaning of Title IV of ERISA (or that is in endangered or critical status, within the meaning of Section 305 of ERISA); (d) the filing of a notice of intent to terminate, the treatment of a Pension Plan amendment as a termination under Sections 4041 or 4041A of ERISA, or the commencement of proceedings by the PBGC to terminate a Pension Plan or Multiemployer Plan; (e) an event or condition which constitutes grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Pension Plan or Multiemployer Plan; (f) the imposition of any liability under Title IV of ERISA, other than for PBGC premiums due but not delinquent under Section 4007 of ERISA, upon any Loan Party or any ERISA Affiliate; (g) a determination that any Pension Plan is, or is expected to be, in “at-risk” status (within the meaning of Section 303(i)(4) of ERISA or Section 430(i)(4) of the Code); or (h) the conditions for imposition of a lien under Section 303(k) of ERISA shall have been met with respect to any Pension Plan.

 

EU Bail-In Legislation Schedule ” means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.

 

Event of Default ” has the meaning specified in Section 8.01 .

 

Exchange Act ” means the Securities Exchange Act of 1934, as amended from time to time.

 

Excluded Taxes ” means any of the following Taxes imposed on or with respect to a Recipient or required to be withheld or deducted from a payment to a Recipient, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i) imposed as a result of such Recipient being organized under the laws of, or having its principal office or, in the case of any Lender, its Applicable Lending Office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are

 

9


 

Other Connection Taxes, (b) in the case of a Lender, U.S. federal withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan or Commitment pursuant to a law in effect on the date on which (i) such Lender acquires such interest in the Loan or Commitment (other than pursuant to an assignment request by the Borrower under Section 3.04(b)  or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to Section 3.01 , amounts with respect to such Taxes were payable either to such Lender’s assignor immediately before such Lender became a party hereto or to such Lender immediately before it changed its lending office, (c) Taxes attributable to such Recipient’s failure to comply with Section 3.01(g)  and (d) any U.S. federal withholding Taxes imposed under FATCA.

 

Exit Fee ” has the meaning specified in Section 2.05(b) .

 

FATCA ” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not more onerous to comply with), any regulations or official interpretations thereof and any agreement entered into pursuant to Section 1471(b)(1) of the Code.

 

Federal Funds Rate ” means, for any day, the rate per annum equal to the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers on such day, as published by the Federal Reserve Bank on the Business Day next succeeding such day; provided that (a) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding Business Day as so published on the next succeeding Business Day and (b) if no such rate is so published on such next succeeding Business Day, the Federal Funds Rate for such day shall be the average rate of the quotations for such day on such transactions received by the Administrative Agent from three Federal funds brokers of recognized standing selected by it.

 

Financial Advisor ” means Ducera Partners LLC, in its capacity as financial advisor to the Lenders and their counsel solely with respect to the Loan Documents.

 

Fiscal Year ” means the fiscal year of the Borrower and its Subsidiaries, ending on December 31 of each calendar year.

 

Fitch ” means Fitch Ratings, Inc. and its successors.

 

Foreign Lender ” means (a) if the borrower is a U.S. Person, a Lender that is not a U.S. Person, and (b) if the Borrower is not a U.S. Person, a Lender that is a resident or organized under the laws of a jurisdiction other than that in which the Borrower is a resident for tax purposes.

 

“Foreign Subsidiary ” means any direct or indirect Subsidiary of the Borrower organized outside the United States.

 

FRB ” means the Board of Governors of the Federal Reserve System of the United States.

 

10


 

Fund ” means any Person (other than an individual) that is or will be engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course.

 

GAAP ” means generally accepted accounting principles in the United States, as in effect from time to time.

 

Governmental Authority ” means any nation or government, any provincial, state, local, municipal or other political subdivision thereof, and any entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government.

 

Governmental Authorization ” means any authorization, approval, consent, franchise, license, covenant, order, ruling, permit, certification, exemption, notice, declaration or similar right, undertaking or other action of, to or by, or any filing, qualification or registration with, any Governmental Authority.

 

Granting Lender ” has the meaning specified in Section 10.07(f) .

 

Guarantee and Collateral Agreement ” means, collectively, (a) the Guarantee and Collateral Agreement executed by the Loan Parties and the Administrative Agent substantially in the form of Exhibit E and (b) each Guarantee and Collateral Agreement Supplement executed and delivered pursuant to the provisions of Section 6.11 .

 

Guarantee and Collateral Agreement Supplement ” means a supplement to the Guarantee and Collateral Agreement, in form reasonably satisfactory to the Required Lenders, executed and delivered to the Administrative Agent pursuant to the provisions of Section 6.11 .

 

Guarantee Obligations ” means, with respect to any Person, any obligation or arrangement of such Person to guarantee or intended to guarantee any Indebtedness or other payment obligations (“ primary obligations ”) of any other Person (the “ primary obligor ”) in any manner, whether directly or indirectly, including, without limitation, (a) the direct or indirect guarantee, endorsement (other than for collection or deposit in the ordinary course of business), co-making, discounting with recourse or sale with recourse by such Person of the Obligation of a primary obligor, (b) the obligation to make take-or-pay or similar payments, if required, regardless of non-performance by any other party or parties to an agreement or (c) any obligation of such Person, whether or not contingent, (i) to purchase any such primary obligation or any property constituting direct or indirect security therefor, (ii) to advance or supply funds (A) for the purchase or payment of any such primary obligation or (B) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (iii) to purchase property, assets, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation or (iv) otherwise to assure or hold harmless the holder of such primary obligation against loss in respect thereof.  The amount of any Guarantee Obligation shall be deemed to be an amount equal to the stated or determinable amount of the primary obligation in respect of which such Guarantee Obligation is made (or, if less, the maximum amount of such primary obligation for which such Person may be liable pursuant to

 

11


 

the terms of the instrument evidencing such Guarantee Obligation) or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof (assuming such Person is required to perform thereunder), as determined by such Person in good faith.

 

Guarantors ” means the Subsidiary Guarantors.

 

Hazardous Materials ” means any material, substance or waste that is regulated, classified, or otherwise characterized under or pursuant to any Environmental Law as “hazardous”, “toxic”, a “pollutant”, a “contaminant”, a “deleterious substance”, “dangerous goods”, “radioactive” or words of similar meaning or effect, including petroleum and its by-products, asbestos, polychlorinated biphenyls, radon, greenhouse gases, mold, urea formaldehyde insulation, chlorofluorocarbons and all other ozone-depleting substances.

 

Indebtedness ” of any Person means, without duplication, (a) all obligations of such Person for borrowed money, (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person under conditional sale or other title retention agreements relating to property acquired by such Person, (d) all obligations of such Person in respect of the deferred purchase price of property or services (excluding (i) accounts payable and other accrued liabilities incurred in the ordinary course of business not past due for more than 120 days after its stated due date (except for accounts payable contested in good faith), (ii) any earn-out obligation until such obligation is both required to be reflected as a liability on the balance sheet of such Person in accordance with GAAP and not paid after becoming due and payable and (iii) deferred or equity compensation arrangements entered into in the ordinary course of business and payable to directors, officers or employees), (e) all Indebtedness (excluding prepaid interest thereon) of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed but, in the case of Indebtedness which is not assumed by such Person, limited to the lesser of (x) the amount of such Indebtedness and (y) the fair market value of such property, (f) all guarantees by such Person of Indebtedness of others, (g) all Attributable Indebtedness of such Person, (h) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty (excluding the portion thereof that has been fully cash collateralized in a manner permitted by this Agreement), (i) all obligations, contingent or otherwise, of such Person in respect of bankers’ acceptances, surety bonds and performance bonds, whether or not matured and (j) all obligations of such Person in respect of Disqualified Equity Interests.  The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is directly liable therefor as a result of such Person’s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor.  Anything herein to the contrary notwithstanding, obligations in respect of any Indebtedness that has been irrevocably defeased (either covenant or legal) or satisfied and discharged pursuant to the terms of the instrument creating or governing such Indebtedness shall not constitute Indebtedness.

 

Indemnified Liabilities ” has the meaning specified in Section 10.05(a) .

 

12


 

Indemnified Taxes ” means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of any Loan Party under any Loan Document and (b) to the extent not otherwise described in (a), Other Taxes.

 

Indemnitees ” has the meaning specified in Section 10.05(a) .

 

Information ” has the meaning specified in Section 10.08 .

 

Initial Budget ” means the initial 13 week cash flow forecast for the period commencing on the Closing Date that has been acknowledged and approved by the Financial Advisor as the Initial Budget under this Agreement in a written notice from the Financial Advisor to the Borrower on or prior to the Closing Date.

 

Initial Maturity Date ” means February 15, 2019.

 

Intellectual Property ” has the meaning specified in Section 5.17 .

 

Interest Payment Date ” means March 31, June 30, September 30 and December 31 of each year and the Maturity Date.

 

Investment ” in any Person, means any loan or advance to such Person, any purchase or other acquisition of any voting Equity Interests or other Equity Interests or Indebtedness or the assets comprising a division or business unit or a substantial part or all of the business of such Person, any capital contribution to such Person or any other direct or indirect investment in such Person.

 

Laws ” means, collectively, all international, foreign, federal, state, provincial and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority.

 

Lender ” means any Lender that may be a party to this Agreement from time to time, including its successors and assigns as permitted hereunder (each of which is referred to herein as a “Lender”).

 

Lien ” means any assignment, mortgage, charge, pledge, lien, encumbrance, title retention agreement (including Capital Leases but excluding operating leases) or any other security interest whatsoever, howsoever created or arising, whether fixed or floating, legal or equitable, perfected or not, but specifically excludes any legal, contractual or equitable right of set-off.

 

Loan ” means each New Money Loan and each Roll Up Loan.

 

Loan Documents ” means, collectively, (i) this Agreement, (ii) the Notes, (iii) the Collateral Documents, (iv) any agency fee letter entered into between the Borrower and the Administrative Agent in connection with this Agreement and the other Loan Documents, (v) the

 

13


 

Novelion Subordination Agreement and (vi) all other instruments and documents delivered from time to time by or on behalf of the Borrower or any of its Subsidiaries in connection herewith or therewith.

 

Loan Parties ” or “ Loan Party ” means, collectively or individually as the context may require, the Borrower and each Guarantor.

 

Material Adverse Effect ” means (a) a material adverse change in, or a material adverse effect upon, the operations, business, properties, assets, liabilities (actual or contingent), financial condition of the Borrower and its Subsidiaries, taken as a whole; (b) a material impairment of the ability of the Borrower to perform its material obligations under any Loan Document to which it is a party; (c) a material adverse effect upon the legality, validity, binding effect or enforceability against any Loan Party of any Loan Document to which it is a party; or (d) a material impairment of the Administrative Agent’s or the Lenders’ ability to enforce the Obligations or realize upon the Collateral.

 

Material Contracts ” means any Contractual Obligation of any Loan Party the failure to comply with which, or the termination (without contemporaneous replacement) of which, could reasonably be expected to have a Material Adverse Effect or otherwise result in liabilities in excess of $500,000.

 

Maturity Date ” means, the earliest to occur of (i) the date on which the Restructuring is consummated, (ii) the Initial Maturity Date, unless such date has been extended pursuant to Section 2.10 , in which case, June 30, 2019, and (iii) the date on which the Loans and other Obligations hereunder are accelerated and become due and payable following the occurrence of an Event of Default, in each case, pursuant to Section 8.02 .

 

Moody’s ” means Moody’s Investors Service, Inc. and its successors.

 

Mortgage ” means collectively, the deeds of trust, trust deeds, deeds to secure debt and mortgages creating and evidencing a Lien on real property granted by the Loan Parties in favor or for the benefit of the Administrative Agent, on behalf of the Secured Parties, in form and substance reasonably satisfactory to the Required Lenders and their counsel to account for local law matters) and otherwise in form and substance reasonably satisfactory to the Required Lenders, executed and delivered pursuant to the terms of this Agreement.

 

Multiemployer Plan” means a multiemployer plan, as defined in Section 4001(a)(3)  of ERISA, to which any Loan Party or any ERISA Affiliate is making or accruing an obligation to make contributions, or has within any of the preceding five plan years made or accrued an obligation to make contributions.

 

Net Cash Proceeds ” means:

 

(a)                                  with respect to the Disposition of any asset by any Loan Party or any Casualty Event the excess, if any, of (i) the sum of cash and Cash Equivalents received in connection with such Disposition or Casualty Event (including any cash or Cash Equivalents received by way of deferred payment pursuant to, or by monetization of, a note receivable or otherwise, but only as and when so received and, with respect to any

 

14


 

Casualty Event, any insurance proceeds or condemnation awards in respect of such Casualty Event actually received by or paid to or for the account of the Borrower or any of its Subsidiaries) over (ii) the sum of (A) the principal amount of any Indebtedness permitted by this Agreement that is secured by a lien (other than a Lien on the Collateral that is subordinated or junior to the Liens securing the Obligations) by the asset subject to such Disposition or Casualty Event and that is repaid (and is timely repaid) in connection therewith (other than Indebtedness under the Loan Documents), (B) the reasonable out-of-pocket expenses actually incurred and paid by the Borrower or any of its Subsidiaries in connection with such Disposition or Casualty Event (including, reasonable attorney’s, accountant’s and other similar professional advisor’s fees, investment banking fees, survey costs, title insurance premiums, and related search and recording charges, transfer taxes, deed or mortgage recording taxes, other customary expenses and brokerage, consultant, and other customary fees) to third parties (other than the Loan Parties or any of their Affiliates), (C) taxes paid or reasonably estimated to be actually payable or that are actually accrued in connection therewith with respect to the current tax year as a result of any gain recognized in connection therewith by such Person or any of the direct or indirect stockholders thereof and attributable to such Disposition or Casualty Event; provided that, if the amount of any estimated taxes pursuant to this subclause (C)  exceeds the amount of taxes actually required to be paid in cash, the aggregate amount of such excess shall constitute Net Cash Proceeds and (D) any reasonable reserve actually maintained in respect of (x) the sale price of such asset or assets established in accordance with GAAP, and (y) any liabilities associated with such asset or assets and retained by the Borrower or any of its Subsidiaries after such sale or other Disposition thereof, including pension and other post-employment benefit liabilities and liabilities related against any indemnification obligations associated with such transaction and it being understood that “Net Cash Proceeds” shall include any cash or Cash Equivalents (1) received upon the Disposition of any non-cash consideration received by such Person in any such Disposition, and (2) received upon the reversal (without the satisfaction of any applicable liabilities in cash in a corresponding amount) of any reserve described in subclause (D)  above or, if such liabilities have not been satisfied in cash and such reserve not reversed within two years after such Disposition or Casualty Event, the amount of such reserve; and

 

(b)                                  with respect to the incurrence or issuance of any Indebtedness by the Borrower or any of its Subsidiaries not permitted under Section 7.03 , the excess, if any, of (i) the sum of the cash received in connection with such incurrence or issuance over (ii) the investment banking fees, underwriting discounts, commissions, costs and other out-of-pocket expenses and other customary expenses (including reasonable attorney’s, accountant’s and other similar professional advisor’s fees), incurred by such Loan Party in connection with such incurrence or issuance to third parties (other than the Loan Parties or any of their Affiliates).

 

New Money Loans ” shall mean the Loans made pursuant to Section 2.01(a)  and, for the avoidance of doubt, shall exclude the Roll Up Loans.

 

Non-Consenting Lender ” has the meaning specified in Section 3.04(c) .

 

15


 

Note ” means a promissory note of the Borrower payable to a Lender or its assigns, substantially in the form of Exhibit B hereto, evidencing the aggregate Indebtedness of the Borrower owing to such Lender resulting from the Loans made by such Lender.

 

Novelion ” means Novelion Therapeutics Inc., a corporation organized under the laws of British Columbia.

 

Novelion Intercompany Loan Agreement ” means the Amended and Restated Loan and Security Agreement, dated as of March 15, 2018, between Novelion and the Borrower, as amended by the Amendment No. 1 to and Consent Under the Amended and Restated Loan and Security Agreement, dated as of the date hereof between Novelion and the Borrower.

 

Novelion Intercompany Loans ” means the intercompany loans advanced by Novelion to the Borrower pursuant to the Novelion Intercompany Loan Agreement, in an outstanding aggregate principal amount of $40,146,570 as of the Closing Date (prior to giving effect to any prepayment as described in Permitted Uses).

 

Novelion Shareholder Loans ” means the loans advanced to the Borrower by certain shareholders of Novelion in an outstanding aggregate principal amount of $21,215,757 as of the Closing Date pursuant to that certain Loan and Security Agreement dated as of March 15, 2018 between such shareholders, Wilmington Savings Fund Society, FSB, as administrative and collateral agent for such shareholders, and the Borrower.

 

Novelion Subordination Agreement ” means the Subordination Agreement dated as of the date hereof by and among the Administrative Agent, Novelion, Wilmington Savings Fund Society, FSB, the Borrower and the other parties named therein.

 

NPL ” means the National Priorities List under CERCLA.

 

Obligations ” means all advances to, and debts, liabilities, obligations, covenants and duties of, any Loan Party arising under any Loan Document or otherwise with respect to any Loan, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising.  Without limiting the generality of the foregoing, the Obligations of the Loan Parties under the Loan Documents include the obligation (including Guarantee Obligations) to pay principal, interest, reimbursement obligations, charges, expenses, fees, Attorney Costs, indemnities and other amounts payable by any Loan Party under any Loan Document.

 

Organization Documents ” means (a) with respect to any corporation, the certificate or articles of incorporation and the bylaws; (b) with respect to any limited liability company, the certificate or articles of formation or organization and operating agreement; and (c) with respect to any partnership, joint venture, trust or other form of business entity, the partnership, joint venture or other applicable agreement of formation or organization and any agreement, declaration, instrument, filing or notice with respect thereto filed in connection with its formation or organization with the applicable Governmental Authority in the jurisdiction of its formation or organization and, if applicable, any certificate or articles of formation or organization of such entity.

 

16


 

Other Connection Taxes ” means, with respect to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the jurisdiction imposing such Tax (other than connections arising from such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).

 

Other Taxes ” means all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment.

 

Participant ” has the meaning specified in Section 10.07(d) .

 

Participant Register ” has the meaning specified in Section 10.07(d) .

 

PBGC ” means the Pension Benefit Guaranty Corporation (or any successor thereof).

 

Pension Plan ” means any “employee pension benefit plan” (as such term is defined in Section 3(2)  of ERISA) other than a Multiemployer Plan, that is subject to Title IV of ERISA and is sponsored or maintained by any Loan Party or any ERISA Affiliate or to which any Loan Party or any ERISA Affiliate contributes or has an obligation to contribute, or in the case of a multiple employer or other plan described in Section 4064(a) of ERISA, has made contributions at any time since January 1, 2003.

 

Permitted Affiliate Services Payments ”  means payments by the Borrower to Novelion consisting of reimbursements for shared services and other expenses to the extent set forth as a separate line item in the Budget approved by Required Lenders (not to be unreasonably withheld).

 

Permitted Licensing Transaction ” has the meaning specified on Schedule 1.01 .

 

Permitted Liens ” has the meaning specified in Section 7.01 .

 

Permitted Uses ” means collectively: (i) general working capital and corporate purposes (including for costs and expenses incurred in connection with the Restructuring); (ii) on the Closing Date, funding of an aggregate amount not to exceed $24,715,757 to be simultaneously applied to the repayment of principal obligations of the Borrower owing in respect of (a) the Novelion Shareholder Loans in the full amount thereof equal to $21,215,757 and (b) the $15,000,000 portion of the Novelion Intercompany Loans that the Lenders agree not to challenge pursuant to the Novelion Subordination Agreement in an aggregate amount not to exceed $3,500,000 and (iii) payment of (a) all reasonable and documented pre- and post-petition professional fees and expenses incurred by the Administrative Agent and the Lenders, including, without limitation, those incurred in connection with the preparation, negotiation, documentation, administration and court approval of the documentation and transactions contemplated by this Agreement and the Loan Documents, (b) reasonable and documented fees

 

17


 

and expenses incurred by Novelion in connection with the documentation and transactions contemplated by this Agreement and the Loan Documents and (c) other fees and expenses scheduled and provided to the Lenders prior to the Closing Date subject to consent of the Lenders in all respects.

 

Person ” means any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.

 

Plan ” means any “employee benefit plan” (as such term is defined in Section 3(3) of ERISA) established by any Loan Party or, with respect to any such plan that is subject to Section 412 of the Code or Title IV of ERISA, any ERISA Affiliate.

 

Platform ” has the meaning specified in Section 10.02(e) .

 

Prepayment Notice ” means a notice of prepayment in respect of any voluntary or mandatory prepayment in substantially the form of Exhibit A-2 .

 

Pro Rata Share ” means, with respect to each Lender at any time a fraction (expressed as a percentage, carried out to the ninth decimal place), the numerator of which is the amount of the Commitment of such Lender at such time and the denominator of which is the amount of the Aggregate Commitments at such time; provided that if the Aggregate Commitments have been terminated, then the Pro Rata Share of each Lender shall be determined based on the outstanding principal amount of the Loans held by such Lender divided by the aggregate principal amount of all outstanding Loans held by all Lenders.

 

Proceeding ” has the meaning specified in Section 10.05(a) .

 

Public Lender ” has the meaning specified in Section 10.02(h) .

 

Qualified Equity Interests ” means any Equity Interests that are not Disqualified Equity Interests.

 

Recipient ” means the Administrative Agent or any Lender, as applicable.

 

Refinancing Indebtedness ” means refinancings, renewals, or extensions of Indebtedness, so long as:

 

(a)                                  such refinancings, renewals, or extensions do not result in an increase in the principal amount of the Indebtedness as of the time it is so refinanced, renewed, or extended (other than by the amount of the fees and expenses incurred in connection therewith);

 

(b)                                  such refinancings, renewals, or extensions do not result in a shortening of the average weighted maturity (measured as of the refinancing, renewal, or extension) of the Indebtedness so refinanced, renewed, or extended;

 

18


 

(c)                                   if the Indebtedness that is refinanced, renewed, or extended was subordinated in right of payment to the Obligations, then the terms and conditions of the refinancing, renewal, or extension must include subordination terms and conditions that are at least as favorable to the Lenders as those that were applicable to the refinanced, renewed, or extended Indebtedness; and

 

(d)                                  the Indebtedness that is refinanced, renewed, or extended is not recourse to any Person that is liable on account of the Obligations other than those Persons which were obligated with respect to the Indebtedness that was refinanced, renewed, or extended.

 

Register ” has the meaning specified in Section 10.07(c) .

 

Registered ” means, with respect to Intellectual Property, issued by, registered with, renewed by or the subject of a pending application before any Governmental Authority or Internet domain name registrar.

 

Related Parties ” means, with respect to any Person, such Person’s Affiliates and the partners, directors, officers, employees, agents, trustees, administrators, managers, advisors and representatives of such Person and of such Person’s Affiliates.

 

Release ” means any release, spill, emission, leaking, pumping, pouring, injection, escaping, deposit, disposal, discharge, leeching or migration of any Hazardous Material in or into the environment (including the abandonment or disposal of any barrels, tanks, containers or receptacles containing any Hazardous Material), or out of any vessel or facility, including the movement of any Hazardous Material through the air, soil, subsoil, surface, water, ground water, rock formation or otherwise.

 

Reportable Event ” means with respect to any Plan any of the events set forth in Section 4043(c)  of ERISA or the regulations issued thereunder, other than events for which the thirty (30) day notice period has been waived.

 

Required Lenders ” means, as of any date of determination, Lenders holding more than 50% of the aggregate principal amount of all outstanding Loans at such time; provided that if there are two (2) or more Lenders that are not Affiliates, then Required Lenders shall require at least two (2) Lenders that are not Affiliates holding more than 50% of the aggregate principal amount of all outstanding Loans at such time.

 

Requirement of Law ” means, as to any Person, any law (including common law), statute, ordinance, treaty, rule, regulation, order, decree, judgment, writ, injunction or settlement agreement, requirement or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.

 

Responsible Officer ” means the chief executive officer, president, chief financial officer, treasurer or, except for purposes of Sections 6.02 or 6.03 , any other similar officer or a Person performing similar functions of a Loan Party (and, as to any document delivered on the Closing Date, to the extent permitted or required by the terms of this Agreement, any secretary or assistant secretary of a Loan Party).  Any document delivered hereunder that is signed by a

 

19


 

Responsible Officer of a Loan Party shall be conclusively presumed to have been authorized by all necessary corporate, partnership and/or other action on the part of such Loan Party and such Responsible Officer shall be conclusively presumed to have acted on behalf of such Loan Party.

 

Restricted Payment ” means any:

 

(a)                                  dividend or other distribution (whether in cash, securities or other property) or any payment (whether in cash, securities or other property), in each case, with respect to any capital stock or other Equity Interest of any Person or any of its Subsidiaries, including any sinking fund or similar deposit, on account of the purchase, retraction, redemption, retirement, defeasance, acquisition, cancellation or termination of any such capital stock or other Equity Interest, or on account of any return of capital to any Person’s stockholders, partners or members (or the equivalent of any thereof and including any thereof acquired through the exercise of warrants or rights of conversion, exchange or purchase); and

 

(b)                                  payment of any management or similar type fees by a Loan Party to any Affiliate thereof.

 

Restricting Information ” has the meaning assigned to such term in Section 10.02(i) .

 

Restructuring ” means a restructuring of the Borrower pursuant to the terms and conditions of a restructuring support agreement or similar agreement among the Borrower, the Required Lenders and the requisite majority of the Borrower’s other debt holders, in form and substance satisfactory to the Required Lenders which, to the extent the terms and conditions of the Restructuring are satisfactory to the Required Lenders, shall treat the Roll Up Loans pari passu with the obligations of the Borrower under the Convertible Notes.

 

Roll Up Loans ” has the meaning assigned to such term in Section 2.01(b).

 

S&P ” means Standard & Poor’s Ratings Services LLC, a Standard & Poor’s Financial Services LLC business, and its successors.

 

Sale Leaseback ” means any transaction or series of related transactions pursuant to which the Borrower or any of its Subsidiaries (a) sells, transfers or otherwise disposes of any property, real or personal, whether now owned or hereafter acquired, and (b) as part of such transaction, thereafter rents or leases such property or other property that it intends to use for substantially the same purpose or purposes as the property being sold, transferred or disposed.

 

Sanctions ” means economic or financial sanctions or trade embargos imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by OFAC or the U.S. Department of State, or (b) the United Nations Security Council, the European Union, Canada, any European Union member state or Her Majesty’s Treasury of the United Kingdom.

 

20


 

Sanctioned Country ” means, at any time, a country or territory which is itself the subject or target of any Sanctions (at the time of this Agreement, Cuba, Iran, North Korea, Syria, and the Crimea region of Ukraine).

 

Sanctioned Person ” means any individual or entity, at any time, that is the subject or target or Sanctions, including (a) any individual or entity listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, the United Nations Security Council, the European Union, Canada, any Member State of the European Union, or the United Kingdom, (b) any individual or entity operating, organized or resident in a Sanctioned Country or (c) any entity that is, in the aggregate, 50 percent or greater owned, directly or indirectly or otherwise, or where relevant under Sanctions, controlled by any such person or entity described in clause (a).

 

SEC ” means the Securities and Exchange Commission, or any Governmental Authority succeeding to any of its principal functions.

 

Secured Parties ” means, collectively, the Administrative Agent, the Lenders and each Supplemental Administrative Agent.

 

SPC ” has the meaning specified in Section 10.07(f) .

 

Subsidiary ” is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person.  Unless the context otherwise requires, each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower.

 

Unless otherwise specified, all references herein to a “Subsidiary” or to “Subsidiaries” shall refer to a Subsidiary or Subsidiaries of the Borrower.

 

Subsidiary Guarantor ” means (a) each domestic Subsidiary of the Borrower other than Aegerion Securities Corporation, a Massachusetts corporation, including each Subsidiary listed under the heading “Subsidiary Guarantors” on Schedule 2 , and (b) each other Subsidiary that becomes a Guarantor pursuant to a Guarantee and Collateral Agreement Supplement or other documentation in form and substance reasonably satisfactory to the Required Lenders.

 

Supplemental Administrative Agent ” has the meaning specified in Section 9.13(a)  and “Supplemental Administrative Agents” shall have the corresponding meaning.

 

Tax Distributions ” means, distributions from the Borrower to Novelion Services USA, Inc. (“ US Parent ”) in the aggregate amount necessary to permit US Parent to pay all or a portion of the U.S. federal, state and local income tax liabilities which are then due and payable

 

21


 

and directly attributable to the income of the Borrower; provided that such amounts are used by such Person for such purpose and the amount of such distributions in any taxable period shall not exceed with respect to any taxable period in which the Borrower files a consolidated, combined, unitary or similar type income tax return with US Parent or any direct or indirect parent of US Parent as the common parent of such group, the amount of U.S. federal, state and local income tax the Borrower and its Subsidiaries would be required to pay with respect to such taxable period if they filed as a separate consolidated, combined, unitary or other similar group for income tax purposes with the Borrower as the common parent of such group.

 

Taxes ” means any and all present or future taxes, duties, levies, imposts, deductions, assessments, fees, stamp taxes, withholdings or other charges imposed by any Governmental Authority (including additions to tax, penalties and interest with respect thereto).

 

Termination Date ” has the meaning specified in Section 9.11(a)(i) .

 

Threshold Amount ” means $3 00,000.

 

Trade Date ” has the meaning specified in Section 10.07(h) .

 

Uniform Commercial Code ” means the Uniform Commercial Code as the same may from time to time be in effect in the State of New York or the Uniform Commercial Code (or similar code or statute) of another jurisdiction, to the extent it may be required to apply to any security interest in any item or items of Collateral.

 

United States ” and “ U.S. ” mean the United States of America.

 

U.S. Person ” means any Person that is a “United States Person” as defined in Section 7701(a)(30) of the Code.

 

U.S. Tax Compliance Certificate ” has the meaning specified in Section 3.01(g)(ii)(B)(3) .

 

USA PATRIOT Act ” means the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), as the same may be amended, supplemented, modified, replaced or otherwise in effect from time to time.

 

Wholly-owned ” means, with respect to a Subsidiary of a Person, a Subsidiary of such Person all of the outstanding Equity Interests of which (other than (x) director’s qualifying shares and (y) shares issued to foreign nationals to the extent required by applicable Law) are owned by such Person and/or by one or more wholly-owned Subsidiaries of such Person.

 

Withdrawal Liability ” means the liability of a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.

 

Withholding Agent ” means any Loan Party and the Administrative Agent.

 

22


 

Write-Down and Conversion Powers ” means, with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule.

 

Section 1.02                              Other Interpretive Provisions .  With reference to this Agreement and each other Loan Document, unless otherwise specified herein or in such other Loan Document:

 

(a)                                  The meanings of defined terms are equally applicable to the singular and plural forms of the defined terms.

 

(b)                                  The words “herein”, “hereto”, “hereof” and “hereunder” and words of similar import when used in any Loan Document shall refer to such Loan Document as a whole and not to any particular provision thereof.

 

(c)                                   Article, Section, paragraph, clause, subclause, Exhibit and Schedule references are to the Loan Document in which such reference appears.

 

(d)                                  The term “including” is by way of example and not limitation.

 

(e)                                   The term “documents” includes any and all instruments, documents, agreements, certificates, notices, reports, financial statements and other writings, however evidenced, whether in physical or electronic form.

 

(f)                                    In the computation of periods of time from a specified date to a later specified date, the word “from” means “from and including”; the words “to” and “until” each mean “to but excluding”; and the word “through” means “to and including”.

 

(g)                                   Section headings herein and in the other Loan Documents are included for convenience of reference only and shall not affect the interpretation of this Agreement or any other Loan Document.

 

(h)                                  Whenever the context may require, any pronoun shall include the corresponding masculine, feminine or neuter forms.

 

Section 1.03                              Accounting Terms .  (a) All accounting terms not specifically or completely defined herein shall be construed in conformity with, and all financial data (including financial ratios and other financial calculations) required to be submitted pursuant to this Agreement shall be prepared in conformity with, GAAP consistently applied, except as otherwise specifically prescribed herein; provided , however , that if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any Accounting Change occurring after the Closing Date or in the application thereof on the operation of such provision, regardless of whether any such notice is given before or after such Accounting Change or in the application thereof, then the Lenders and the Borrower agree that they will negotiate in good faith amendments to the provisions of this Agreement that are directly affected by such Accounting Change with the intent of having the respective positions of the Lenders and the Borrower after such Accounting Change conform as

 

23


 

nearly as possible to their respective positions as of the date of this Agreement and, until any such amendments have been agreed upon, (i) the provisions in this Agreement shall be calculated as if no such Accounting Change had occurred and (ii) the Borrower shall provide to the Administrative Agent and the Lenders a written reconciliation in form and substance reasonably satisfactory to the Required Lenders, between calculations of any baskets and other requirements hereunder before and after giving effect to such Accounting Change.

 

(b)                                  Where reference is made to a Person “and its Subsidiaries on a consolidated basis” or similar language, such consolidation shall not include any subsidiaries other than Subsidiaries.

 

Section 1.04                              References to Agreements, Laws, Etc.   Unless otherwise expressly provided herein, (a) references to documents, agreements (including the Loan Documents) and other contractual instruments shall be deemed to include all subsequent amendments, restatements, amendments and restatements, extensions, supplements and other modifications thereto, but only to the extent that such amendments, restatements, amendments and restatements, extensions, supplements and other modifications are not prohibited by any Loan Document; and (b) references to any Law shall include all statutory and regulatory provisions consolidating, amending, replacing, supplementing or interpreting such Law.

 

Section 1.05                              Times of Day .  Unless otherwise specified, all references herein to times of day shall be references to Eastern time (daylight or standard, as applicable).

 

Section 1.06                              Timing of Payment or Performance .  When the payment of any obligation or the performance of any covenant, duty or obligation is stated to be due or performance required on a day which is not a Business Day, the date of such payment or performance shall extend to the immediately succeeding Business Day.

 

ARTICLE II

 

THE COMMITMENTS AND THE LOANS

 

Section 2.01                              The Commitments and the Loans .

 

(a)                                  Subject to the terms and conditions set forth herein, each Lender severally agrees to make (or cause its Applicable Lending Office to make), to the Borrower, subject to the terms and conditions hereof, on the Closing Date, term loans in one drawing in an aggregate principal amount not to exceed such Lender’s Commitment; provided that the loans made by all Lenders under this Section 2.01(a) shall not exceed in the aggregate $50,000,000.  Amounts paid or prepaid in respect of New Money Loans may not be reborrowed.

 

(b)                                  On the Closing Date, $22,500,000 in principal amount of additional loans (in addition to those advanced under 2.01(a) above) shall be deemed to have been advanced by Lenders to Borrower under this Agreement in the amounts set forth for each Lender on Schedule 2.01 under the caption “Roll Up Loans” opposite such Lender’s name (such loans, the “ Roll Up Loans ”), the proceeds of which shall be deemed to have been disbursed, on behalf of the Borrower and at the Borrower’s direction, to each Lender in the same amount as set forth on such Schedule 2.01 in payment for the repurchase of Convertible Notes held by each such

 

24


 

Lender in the same principal amount as reflected on such Schedule and the Borrower shall be deemed to have repurchased such Convertible Notes in such amounts.  On the Closing Date, (x) Convertible Notes in the amount of $22,500,000 shall be cancelled in accordance with the terms of the Convertible Notes and related instructions delivered to the trustee for the Convertible Notes by the Borrower on the Closing Date and such cancellation shall be deemed to be simultaneous with the foregoing and (y) the Roll Up Loans shall be deemed to be Loans outstanding for all purposes under this Agreement owed by the Borrower to such Lenders in the aggregate principal amount of $22,500,000.  Amounts paid or prepaid in respect of Roll Up Loans may not be reborrowed.

 

Section 2.02                              Prepayments .  (a)  Optional Prepayments .  The Borrower may, upon delivery of a Prepayment Notice to the Administrative Agent, at any time or from time to time voluntarily prepay Loans, in whole or in part subject to payment of the Exit Fee at the time of such prepayment; provided that (1) such notice must be received by the Administrative Agent not later than 12:00 noon (New York, New York time) two (2) Business Days prior to any date of prepayment of Loans; and (2) any prepayment of Loans shall be in a principal amount of $5,000,000 or a whole multiple of $1,000,000 in excess thereof or, in each case, if less, the entire principal amount thereof then outstanding, in each case, with accrued and unpaid interest on the Loans to be repaid.  Each such notice shall specify the date and amount of such prepayment and whether the Loans to be prepaid are New Money Loans and/or Roll Up Loans.  The Administrative Agent will promptly notify each Lender of its receipt of each such notice, and of the amount of such Lender’s Pro Rata Share of such prepayment.  If such notice is given by the Borrower, the Borrower shall make such prepayment and the payment amount specified in such notice shall be due and payable on the date specified therein.  Each prepayment of Loans pursuant to this Section 2.02(a)  shall be paid to the Lenders in accordance with their respective Pro Rata Shares; provided that no prepayment shall be made with respect to Roll Up Loans unless and until all New Money Loans are paid in full and such prepayment of the Roll Up Loans is otherwise permitted by the Novelion Subordination Agreement, as certified by a Responsible Officer of the Borrower in the applicable Prepayment Notice.   For the avoidance of doubt, (x) the outstanding Loan amount shall include the Commitment Fee (added to the balance of the New Money Loans), accrued interest and capitalized interest already added to the Loan balance, and any prepayment of New Money Loans shall require payment of the Exit Fee and (y) any prepayment shall be applied in accordance with Section 8.03 if then applicable.

 

(b)                                  Mandatory Prepayments .  (i) If the Borrower or any of its Subsidiaries receives any Net Cash Proceeds from any Disposition (other than any Disposition permitted under Sections 7.05(b) , 7.05(c) , 7.05(e) , 7.05(f),  7.05(h)  or 7.05(i)   (which proceeds in the case of Section 7.05(i) shall be applied in accordance with Section 7.05(i)), the Borrower shall, subject to Section 2.02(c), cause to be prepaid an aggregate principal amount of the Loans equal to 100% of all Net Cash Proceeds received therefrom as promptly as reasonably practicable, but in any event prior to the date which is three (3) Business Days after the receipt of such Net Cash Proceeds.

 

(ii)                                   If the Borrower or any of its Subsidiaries receives any Net Cash Proceeds from any Casualty Event, the Borrower shall, subject to Section 2.02(c), cause to be prepaid an aggregate principal amount of the Loans equal to 100% of all Net Cash Proceeds received

 

25


 

therefrom as promptly as reasonably practicable, but in any event prior to the date which is three (3) Business Days after the receipt of such Net Cash Proceeds.

 

(iii)                                If the Borrower or any of its Subsidiaries incurs or issues any Indebtedness not expressly permitted to be incurred or issued pursuant to Section 7.03 , the Borrower shall cause to be prepaid an aggregate principal amount of the Loans equal to 100% of all Net Cash Proceeds received therefrom as promptly as reasonably practicable, but in any event, prior to the date which is one (1) Business Day after the receipt of such Net Cash Proceeds.

 

(iv)                               If the Borrower or any of its Subsidiaries receives any Net Cash Proceeds from any issuance of Equity Interests (including capital contributions), the Borrower shall cause to be prepaid an aggregate principal amount of the Loans equal to 100% of all Net Cash Proceeds received therefrom as promptly as reasonably practicable, but in any event, prior to the date which is three (3) Business Days after the receipt of such Net Cash Proceeds.

 

(v)                                  The Borrower shall notify the Administrative Agent in writing of any mandatory prepayment of Loans required to be made pursuant to clauses (i)  through ( iv ) of this Section 2.02(b)  at least two (2) Business Days prior to the date of such prepayment pursuant to a Prepayment Notice.  Each such notice shall specify the date of such prepayment and provide a reasonably detailed calculation of the amount of such prepayment.  The Administrative Agent will promptly notify each Lender of the contents of the Borrower’s Prepayment Notice and of such Lender’s Pro Rata Share of the prepayment, in each case, with accrued and unpaid interest on the Loans to be repaid and the Exit Fee with respect to such Loans.  Notwithstanding anything to the contrary herein, each such prepayment shall be applied first to prepay the New Money Loans, and thereafter, subject to the Novelion Subordination Agreement (as certified by a Responsible Officer of the Borrower in the applicable Prepayment Notice), to prepay the Roll Up Loans.  For the avoidance of doubt, (x) the outstanding Loan amount shall include the Commitment Fee (added to the balance of the New Money Loans), accrued interest and capitalized interest already added to the Loan balance, and any prepayment of New Money Loans shall require payment of the Exit Fee and (y) any prepayment shall be applied in accordance with Section 8.03 if then applicable.

 

(c)                                   Restrictions.                               Notwithstanding the foregoing, to the extent any or all of the Net Cash Proceeds of any Disposition by, or Casualty Event of, a Foreign Subsidiary otherwise giving rise to a prepayment pursuant to Section 2.02(b) is prohibited or delayed by any applicable local Requirements of Law from being repatriated to the Borrower including through the repayment of intercompany Indebtedness (each, a “ Repatriatio n”; with “ Repatriated ” having a correlative meaning) (Borrower hereby agreeing to use reasonable efforts to cause the applicable Foreign Subsidiary to take promptly all actions reasonably required by such Requirements of Law to permit such Repatriation), or if the Borrower has determined in good faith that Repatriation of any such amount would reasonably be expected to have material adverse tax consequences with respect to its Subsidiaries, after taking into account any foreign tax credit or benefit actually received in connection with such Repatriation, the portion of such Net Cash Proceeds so affected (such amount, the “ Excluded Prepayment Amount ”) will not be required to be applied to prepay Loans at the times provided in this Section 2.02; provided, that if and to the extent any such Repatriation ceases to be prohibited or delayed by applicable local Requirements of Law at any time immediately following the date on which the applicable

 

26


 

mandatory prepayment pursuant to this Section 2.02(b) was required to be made, the Borrower shall reasonably promptly Repatriate, or cause to be Repatriated, an amount equal to such portion of the Excluded Prepayment Amount, and the Borrower shall reasonably promptly pay such portion of the Excluded Prepayment Amount to the Lenders, which payment shall be applied in accordance with this Section 2.02.  For the avoidance of doubt, the non-application of any Excluded Prepayment Amount pursuant to this Section 2.02 shall not constitute a Default or an Event of Default.   For the avoidance of doubt, this Section 2.02(c) shall not apply to any Disposition consisting of a Permitted Licensing Transaction.

 

Section 2.03                              Repayment of Loans .  The Borrower shall repay on the Maturity Date to the Administrative Agent (for the ratable account of the Lenders) the aggregate principal amount of all Loans, together with all accrued and capitalized interest (including interest paid in kind) and fees thereon (including the Exit Fee and all other outstanding Obligations), outstanding on such date.

 

Section 2.04                              Interest .  (a) Subject to the provisions of Section 2.06(b) , each Loan shall bear interest on the outstanding principal amount thereof at a rate per annum equal to the Applicable Rate; provided that the accrued interest shall be paid in kind and added quarterly on each Interest Payment Date to the outstanding principal amount of the applicable Loan.

 

(b)                                  Commencing (x) upon the occurrence and during the continuance of any Event of Default at the request of the Administrative Agent (upon the instruction of the Required Lenders) the Borrower shall pay interest on (i) the principal amount of the Loans and (ii) to the extent then due and payable all other outstanding Obligations hereunder, in each case under clauses (i) and (ii), at an interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by applicable Laws.  Accrued and unpaid interest on past due amounts (including interest on past due interest to the fullest extent permitted by applicable Laws) shall be due and payable upon demand in cash.

 

(c)                                   Interest on each Loan shall be due and payable in arrears on each Interest Payment Date applicable thereto in accordance with Section 2.04(a) and at such other times as may be specified herein.  Interest hereunder shall be due and payable in accordance with the terms hereof before and after any judgment.

 

Section 2.05                              Fees .

 

(a)                                  Commitment Fee .  The Borrower shall pay to each Lender, a commitment fee (the “ Commitment Fee ”) equal to 2.00% of the Commitments with respect to New Money Loans provided by such Lender on the Closing Date. The Commitment Fee of each Lender shall be paid in kind by adding it to the outstanding principal amount of the New Money Loans of such Lender and shall be fully earned on the Closing Date and once paid shall not be refundable for any reason.

 

(b)                                  Exit Fee .  The Borrower shall pay to each Lender, on the earlier of (i) the date of repayment of all or a portion of any New Money Loans and (ii) the Maturity Date, for the account of each Lender, an exit fee (the “ Exit Fee ”) equal to 3.00% of the Commitments with respect to New Money Loans provided by such Lender on the Closing Date (whether or not such

 

27


 

Lender is a Lender as of the date of the payment of the Exit Fee), subject to proration in the case of any partial repayment of the New Money Loans in accordance with this Agreement.  The Exit Fee shall be fully earned on the Closing Date and once paid shall not be refundable for any reason.  For the avoidance of doubt, the Exit Fee payable with respect to the Roll Up Loans shall be 0.00%.

 

(c)                                   Administration Fee .  The Borrower shall pay to the Lenders or their respective designees on the Closing Date, for the account of each Lender, an administration fee (the “ Administration Fee ”) in the aggregate amount for all such Lenders equal to $35,000, paid ratably to the Lenders based on their Pro Rata Share of the Commitments.  The Administration Fee shall be fully earned on the Closing Date and once paid shall not be refundable for any reason.

 

(d)                                  Agent Fees .  The Borrower shall pay to the Administrative Agent, for its own account, the fees set forth in the separate fee letter as between the Borrower and the Administrative Agent.

 

Section 2.06                              Computation of Interest and Fees .  All computations of fees and interest shall be made on the basis of a three hundred and sixty (360) day year and actual days elapsed.  Interest shall accrue on each Loan for the day on which such Loan is made, and shall not accrue on such Loan, or any portion thereof, for the day on which such Loan or such portion is paid; provided that any such Loan that is repaid on the same day on which it is made shall, subject to Section 2.08(a) , bear interest for one (1) day.  Each determination by the Administrative Agent of an interest rate or fee hereunder shall be conclusive and binding for all purposes, absent manifest error.

 

Section 2.07                              Evidence of Indebtedness .  (a) The Loans made by each Lender shall be evidenced by one or more accounts or records maintained by such Lender and evidenced by one or more entries in the Register maintained by the Administrative Agent, as agent for the Borrower, in each case in the ordinary course of business.  The accounts or records maintained by the Administrative Agent and each Lender shall be prima facie evidence absent manifest error of the amount of the Loans made by the Lenders to the Borrower and the interest and payments thereon.  Any failure to so record or any error in doing so shall not, however, limit or otherwise affect the obligation of the Borrower hereunder to pay any amount owing with respect to the Obligations.  In the event of any conflict between the accounts and records maintained by any Lender and the accounts and records of the Administrative Agent in respect of such matters, the accounts and records of the Administrative Agent shall control in the absence of manifest error.  Upon the request of any Lender, the Borrower shall execute and deliver to such Lender a Note payable to such Lender, which shall evidence such Lender’s Loans in addition to such accounts or records.  Each Lender may attach schedules to its Note and endorse thereon the date, amount and maturity of its Loans and payments with respect thereto.

 

(b)                                  In addition to the accounts and records referred to in Section 2.07(c) , each Lender and the Administrative Agent shall maintain in accordance with its usual practice accounts or records.  In the event of any conflict between the accounts and records maintained by the Administrative Agent and the accounts and records of any Lender in respect of such matters,

 

28


 

the accounts and records of the Administrative Agent shall control in the absence of manifest error.

 

(c)                                   Entries made in good faith by the Administrative Agent in the Register pursuant to Section 2.07(a) , and by each Lender in its account or accounts pursuant to Section 2.07(a) , shall be prima facie evidence of the amount of principal and interest due and payable or to become due and payable from the Borrower to, in the case of the Register, each Lender and, in the case of such account or accounts, such Lender, under this Agreement and the other Loan Documents, absent manifest error; provided that the failure of the Administrative Agent or such Lender to make an entry, or any finding that an entry is incorrect, in the Register or such account or accounts shall not limit or otherwise affect the obligations of the Borrower under this Agreement and the other Loan Documents.

 

Section 2.08                              Payments Generally .  (a) All payments to be made by the Borrower shall be made without condition or deduction for any counterclaim, defense, recoupment or setoff.  Except as otherwise expressly provided herein, all payments by the Borrower hereunder shall be made to the Administrative Agent, for the account of the respective Lenders to which such payment is owed, at the applicable Administrative Agent’s Office and in immediately available funds not later than 2:00 p.m. (New York, New York time) on the date specified herein.  The Administrative Agent will promptly distribute to each Lender its Pro Rata Share (or other applicable share as provided herein) of such payment in like funds as received by wire transfer to such Lender’s Applicable Lending Office.  All payments received by the Administrative Agent after 2:00 p.m. (New York, New York time) shall be deemed received on the next succeeding Business Day and any applicable interest or fee shall continue to accrue.

 

(b)                                  If any payment to be made by the Borrower shall come due on a day other than a Business Day, payment shall be made on the next following Business Day, and such extension of time shall be reflected in computing interest or fees, as the case may be.

 

(c)                                   If any Lender makes available to the Administrative Agent funds for any Loan to be made by such Lender as provided in the foregoing provisions of this Article II , and such funds are not made available to the Borrower by the Administrative Agent because the conditions (if any) to the Loan set forth in Article IV are not satisfied or waived in accordance with the terms hereof, the Administrative Agent shall return such funds (in like funds as received from such Lender) to such Lender, without interest.

 

(d)                                  The obligations of the Lenders hereunder to make Loans are several and not joint.  The failure of any Lender to make any Loan on any date required hereunder shall not relieve any other Lender of its corresponding obligation to do so on such date, and neither the Administrative Agent nor any Lender shall be responsible for the failure of any other Lender to make its Loan.

 

(e)                                   Nothing herein shall be deemed to obligate any Lender to obtain the funds for any Loan in any particular place or manner or to constitute a representation by any Lender that it has obtained or will obtain the funds for any Loan in any particular place or manner.

 

29


 

(f)                                    Whenever any payment received by the Administrative Agent under this Agreement or any of the other Loan Documents is insufficient to pay in full all amounts due and payable to the Administrative Agent and the Lenders under or in respect of this Agreement and the other Loan Documents on any date, such payment shall be distributed by the Administrative Agent and applied by the Administrative Agent and the Lenders in the order of priority set forth in Section 8.03 .  If the Administrative Agent receives funds for application to the Obligations of the Loan Parties under or in respect of the Loan Documents under circumstances for which the Loan Documents do not specify the manner in which such funds are to be applied, the Administrative Agent may, but shall not be obligated to, elect to distribute such funds to each of the Lenders in accordance with such Lender’s Pro Rata Share of the aggregate principal amount of all Loans outstanding at such time.

 

Section 2.09                              Sharing of Payments .  If, other than as expressly provided elsewhere herein (including, without limitation, in Section 10.07 ), any Lender shall obtain on account of the Loans made by it in excess of its ratable share (or other share contemplated hereunder subject to the priorities set forth herein) thereof, such Lender shall immediately (a) notify the Administrative Agent of such fact and (b) purchase from the other Lenders such participations in the Loans made by them as shall be necessary to cause such purchasing Lender to share the excess payment in respect of such Loans pro rata with each of them; provided that if all or any portion of such excess payment is thereafter recovered from the purchasing Lender under any of the circumstances described in Section 10.06 (including pursuant to any settlement entered into by the purchasing Lender in its discretion), such purchase shall to that extent be rescinded and each other Lender shall repay to the purchasing Lender the purchase price paid therefor, together with an amount equal to such paying Lender’s ratable share (according to the proportion of (i) the amount of such paying Lender’s required repayment to (ii) the total amount so recovered from the purchasing Lender) of any interest or other amount paid or payable by the purchasing Lender in respect of the total amount so recovered, without further interest thereon.  The Borrower agrees that any Lender so purchasing a participation from another Lender may, to the fullest extent permitted by applicable Law, exercise all its rights of payment (including the right of setoff, but subject to Section 10.09 ) with respect to such participation as fully as if such Lender were the direct creditor of the Borrower in the amount of such participation.  The Administrative Agent will keep records (which shall be conclusive and binding in the absence of manifest error) of participations purchased under this Section 2.09 and will in each case notify the Lenders following any such purchases or repayments.  Each Lender that purchases a participation pursuant to this Section 2.09 shall from and after such purchase have the right to give all notices, requests, demands, directions and other communications under this Agreement with respect to the portion of the Obligations purchased to the same extent as though the purchasing Lender were the original owner of the Obligations purchased.

 

Section 2.10                              Extension Option .  The Borrower shall have one (1) option to extend the Initial Maturity Date to June 30, 2019, if each and all of the following conditions precedent shall have been fulfilled or complied with (unless waived by the Required Lenders):

 

(a)                                  The Borrower shall request the extension by written notice to the Administrative Agent by no later than February 1, 2019;

 

30


 

(b)                                  On or before the Initial Maturity Date, the Borrower shall have paid to each Lender an extension fee in cash equal to 3.00% of the amount of such Lender’s New Money Loans then outstanding on the Initial Maturity Date (such fee shall be fully earned upon the exercise by the Borrower of the extension option under this Section 2.10 and once paid shall not be refundable for any reason whatsoever);

 

(c)                                   The Borrower shall have provided to the Lenders or their counsel a term sheet setting forth the material terms of a sale (which may include a sale or merger of Novelion and one or more of its Subsidiaries (but including the Borrower), or any other transaction having a similar effect or result) of the Borrower or its assets that, in the reasonable opinion of the Borrower, may be acceptable to the Borrower and its board of directors; and

 

(d)                                  Since the Closing Date there shall not have been any event or circumstance, either individually or in the aggregate, that has had or would reasonably be expected to have a Material Adverse Effect except for (i) matters set forth in any public filings of Novelion prior to the Closing Date, (ii) any matters disclosed on the disclosure schedules to the Loan Documents as of the Closing Date, (iii) such events disclosed in writing to the Lenders or its Financial Advisor prior to the Closing Date and (iv) transactions expressly permitted by the Loan Documents.

 

(e)                                   At the time of the effectiveness of the extension, the representations and warranties of the Borrower and each other Loan Party contained in Article V (other than Section 5.05) or any other Loan Document shall be true and correct in all material respects on and as of such date (before and after giving effect to such extension); provided that to the extent that such representations and warranties specifically refer to an earlier date, they shall be true and correct in all material respects as of such earlier date; provided further that any representation and warranty that is qualified as to “materiality”, “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such respective dates.

 

ARTICLE III

 

TAXES, INCREASED COSTS PROTECTION AND ILLEGALITY

 

Section 3.01                              Taxes .

 

(a)                                  Defined Terms .  For purposes of this Section 3.01 , the term “applicable law” includes FATCA.

 

(b)                                  Payments Free of Taxes .  Any and all payments by or on account of any obligation of any Loan Party under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by applicable law.  If any applicable law (as determined in the good faith discretion of an applicable Withholding Agent) requires the deduction or withholding of any Tax from any such payment by a Withholding Agent, then the applicable Withholding Agent shall be entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in

 

31


 

accordance with applicable law and, if such Tax is an Indemnified Tax, then the sum payable by the applicable Loan Party shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section) the applicable Recipient receives an amount equal to the sum it would have received had no such deduction or withholding been made.

 

(c)                                   Payment of Other Taxes by the Loan Parties .  The Loan Parties shall timely pay to the relevant Governmental Authority in accordance with applicable law, or at the option of the Administrative Agent timely reimburse it for the payment of, any Other Taxes.

 

(d)                                  Indemnification by the Loan Parties .  The Loan Parties shall jointly and severally indemnify each Recipient, within 10 days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section) payable or paid by such Recipient or required to be withheld or deducted from a payment to such Recipient and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority.  A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf, shall be conclusive absent manifest error.

 

(e)                                   Indemnification by the Lenders .  Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that any Loan Party has not already indemnified the Administrative Agent for such Indemnified Taxes and without limiting the obligation of the Loan Parties to do so), (ii) any Taxes attributable to such Lender’s failure to comply with the provisions of Section 10.07(c)  relating to the maintenance of a Participant Register and (iii) any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority.  A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error.  Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this paragraph (e).

 

(f)                                    Evidence of Payments .  As soon as practicable after any payment of Taxes by any Loan Party to a Governmental Authority pursuant to this Section 3.01 , such Loan Party shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.

 

(g)                                   Status of Lenders .  (i) Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Loan Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed

 

32


 

documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding.  In addition, any Lender, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements.  Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in Section 3.01(g)(ii)(A) , (ii)(B)  and (ii)(D)  below) shall not be required if in the Lender’s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.

 

(ii)                                   Without limiting the generality of the foregoing, in the event that the Borrower is a U.S. Borrower,

 

(A)                                any Lender that is a U.S. Person shall deliver to the Borrower and the Administrative Agent on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed copies of IRS Form W-9 certifying that such Lender is exempt from U.S. federal backup withholding tax;

 

(B)                                any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), whichever of the following is applicable:

 

(1)                                  in the case of a Foreign Lender claiming the benefits of an income tax treaty to which the United States is a party (x) with respect to payments of interest under any Loan Document, executed copies of IRS Form W-8BEN (or W-8BEN-E, as applicable) establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “interest” article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, IRS Form W-8BEN (or W-8BEN-E, as applicable) establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “business profits” or “other income” article of such tax treaty;

 

(2)                                  executed copies of IRS Form W-8ECI;

 

(3)                                  in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Code, (x) a certificate substantially in the form provided by Administrative Agent and the other Lenders to the effect that such Foreign Lender is not a “bank”

 

33


 

within the meaning of Section 881(c)(3)(A) of the Code, a “10 percent shareholder” of the Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a “controlled foreign corporation” described in Section 881(c)(3)(C) of the Code (a “ U.S. Tax Compliance Certificate ”) and (y) executed copies of IRS Form W-8BEN (or W-8BEN-E, as applicable); or

 

(4)                                  to the extent a Foreign Lender is not the beneficial owner, executed copies of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN (or W-8BEN-E, as applicable), a U.S. Tax Compliance Certificate substantially in the form provided by Administrative Agent and the other Lenders, IRS Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided that if the Foreign Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate substantially in the form provided by Administrative Agent and the other Lenders on behalf of each such direct and indirect partner;

 

(C)                                any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed copies of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made; and

 

(D)                                if a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment.  Solely for purposes of this clause (D), “FATCA” shall include any amendments made to FATCA after the date of this Agreement.

 

34


 

Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so.

 

(h)                                  Treatment of Certain Refunds .  If any party determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this Section 3.01 (including by the payment of additional amounts pursuant to this Section 3.01 ), it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this Section with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund).  Such indemnifying party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this paragraph (h) (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental Authority.  Notwithstanding anything to the contrary in this paragraph (h), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this paragraph (h) the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid.  This paragraph shall not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the indemnifying party or any other Person.

 

(i)                                      Survival .  Each party’s obligations under this Section 3.01 shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under any Loan Document.

 

Section 3.02                              Increased Cost and Reduced Return; Capital and Liquidity Requirements.

 

(a)                                  Increased Costs Generally .  If any Change in Law shall:

 

(i)                                      impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender;

 

(ii)                                   subject any Recipient to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes and (C) Connection Income Taxes) on its loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto; or

 

35


 

(iii)                                impose on any Lender any other condition, cost or expense (other than Taxes) affecting this Agreement or Loans made by such Lender;

 

and the result of any of the foregoing shall be to increase the cost to such Lender or such other Recipient of making, converting to, continuing or maintaining any Loan or of maintaining its obligation to make any such Loan, or to reduce the amount of any sum received or receivable by such Lender or other Recipient hereunder (whether of principal, interest or any other amount) then, upon request of such Lender or other Recipient, the Borrower will pay to such Lender or other Recipient, as the case may be, such additional amount or amounts as will compensate such Lender or other Recipient, as the case may be, for such additional costs incurred or reduction suffered.

 

(b)                                  Capital Requirements .  If any Lender reasonably determines that any Change in Law affecting such Lender or any lending office of such Lender or such Lender’s holding company, if any, regarding capital or liquidity requirements, has or would have the effect of reducing the rate of return on such Lender’s capital or on the capital of such Lender’s holding company, if any, as a consequence of this Agreement, the Commitments of such Lender or the Loans made by such Lender to a level below that which such Lender or such Lender’s holding company could have achieved but for such Change in Law (taking into consideration such Lender’s policies and the policies of such Lender’s holding company with respect to capital adequacy), then from time to time the Borrower will pay to such Lender such additional amount or amounts as will compensate such Lender or such Lender’s holding company for any such reduction suffered.

 

(c)                                   Certificates for Reimbursement .  A certificate of a Lender setting forth the amount or amounts necessary to compensate such Lender or its holding company, as the case may be, as specified in paragraph (a) or (b) of this Section and delivered to the Borrower, shall be conclusive absent manifest error.  The Borrower shall pay such Lender the amount shown as due on any such certificate within 10 days after receipt thereof.

 

(d)                                  Delay in Requests .  Failure or delay on the part of any Lender to demand compensation pursuant to this Section 3.02 shall not constitute a waiver of such Lender’s right to demand such compensation; provided that the Borrower shall not be required to compensate a Lender pursuant to this Section for any increased costs incurred or reductions suffered more than nine months prior to the date that such Lender notifies the Borrower of the Change in Law giving rise to such increased costs or reductions, and of such Lender’s intention to claim compensation therefor (except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine-month period referred to above shall be extended to include the period of retroactive effect thereof).

 

Section 3.03                              Matters Applicable to All Requests for Compensation . The Administrative Agent or any Lender claiming compensation under this Article III shall deliver a certificate to the Borrower setting forth the additional amount or amounts to be paid to it hereunder, which shall be conclusive absent manifest error.  In determining such amount, the Administrative Agent or such Lender may use any reasonable averaging and attribution methods.

 

36


 

Section 3.04                              Mitigation Obligations; Replacement of Lenders under Certain Circumstances .

 

(a)                                  Designation of a Different Lending Office .  If any Lender requests compensation under Section 3.02 , or requires the Borrower to pay any Indemnified Taxes or additional amounts to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 3.01 , then such Lender shall (at the request of the Borrower) use reasonable efforts to designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the judgment of such Lender, such designation or assignment (i) would eliminate or reduce amounts payable pursuant to Section 3.02 or Section 3.01 , as the case may be, in the future, and (ii) would not subject such Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender.  The Borrower hereby agrees to pay all reasonable and documented costs and expenses incurred by any Lender in connection with any such designation or assignment.

 

(b)                                  Replacement of Lenders .  If any Lender requests compensation under Section 3.02 , or if the Borrower is required to pay any Indemnified Taxes or additional amounts to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 3.01 and, in each case, such Lender has declined or is unable to designate a different lending office in accordance with Section 3.04(a) , or if any Lender is a Non-Consenting Lender, then the Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in, and consents required by, Section 10.07(b) ), all of its interests, rights (other than its existing rights to payments pursuant to Section 3.02 or Section 3.01 ) and obligations under this Agreement and the related Loan Documents to an Eligible Assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment); provided that:

 

(i)                                      the Borrower shall have paid to the Administrative Agent the assignment fee (if any) specified in Section 10.07(b) ;

 

(ii)                                   such Lender shall have received payment of an amount equal to the outstanding principal of its Loans, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Loan Documents from the assignee (to the extent of such outstanding principal and accrued interest and fees) or the Borrower (in the case of all other amounts);

 

(iii)                                in the case of any such assignment resulting from a claim for compensation under Section 3.02 or payments required to be made pursuant to Section 3.01 , such assignment will result in a reduction in such compensation or payments thereafter;

 

(iv)                               such assignment does not conflict with applicable law; and

 

37


 

(v)                                  in the case of any assignment resulting from a Lender becoming a Non-Consenting Lender, the applicable assignee shall have consented to the applicable amendment, waiver or consent.

 

A Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply.

 

(c)                                   In the event that (i) the Borrower or the Administrative Agent has requested that the Lenders consent to a departure or waiver of any provisions of the Loan Documents or agree to any amendment thereto, (ii) the consent, waiver or amendment in question requires the agreement of all affected Lenders in accordance with the terms of Section 10.01 or all the Lenders and (iii) the Required Lenders have agreed to such consent, waiver or amendment, then any Lender who does not agree to such consent, waiver or amendment shall be deemed a “ Non-Consenting Lender ”.

 

Section 3.05                              Survival .  All of the Borrower’s obligations under this Article III shall survive termination of the Aggregate Commitments and repayment of all other Obligations hereunder.

 

ARTICLE IV

 

CONDITIONS PRECEDENT TO LOANS

 

Section 4.01                              Conditions to Loans .  The obligation of each Lender to make its Loans hereunder is subject to satisfaction of the following conditions precedent, except as otherwise agreed between the Borrower, the Administrative Agent and the Required Lenders:

 

(a)                                  The Administrative Agent’s or the Lenders’ (as applicable) receipt of the following, each properly executed by a Responsible Officer of the signing Loan Party, and each in form and substance reasonably satisfactory to the Required Lenders:

 

(i)                                      executed counterparts of this Agreement, the Guarantee and Collateral Agreement, the Novelion Subordination Agreement and each other Loan Document by each party thereto;

 

(ii)                                   an original Note executed by the Borrower in favor of each Lender that has requested a Note;

 

(iii)                                a Committed Loan Notice relating to the Loans; and

 

(iv)                               the certificates, documents, instruments, agreements, legal opinions and deliverables set forth on the Closing Checklist attached hereto as Schedule 1 .

 

(b)                                  The Administrative Agent and each Lender shall have received the Initial Budget.

 

38


 

(c)                                   The Borrower shall have paid all accrued and unpaid costs, fees and expenses (including applicable Attorney Costs (solely with respect to Latham & Watkins LLP, the amount of its invoice presented for closing on account of work undertaken in connection with this Agreement, the other Loan Documents and the transactions contemplated hereby; provided that, for the avoidance of doubt, such limitation shall not apply to amounts owing on account of work undertaken by Latham & Watkins LLP in connection with prior negotiations among the parties hereto in respect of a restructuring and financing not contemplated hereby) and the reasonable and documented out-of-pocket fees and expenses of the Financial Advisor not to exceed the cap separately agreed in the fee letter between the Financial Advisor and the Borrower dated as of the Closing Date, the reasonable and documented fees and expenses of Shipman & Goodwin LLP not to exceed $20,000 and any other advisors to the Administrative Agent and the Lenders) and any other compensation required to be paid to the Administrative Agent and the Lenders on or prior to the Closing Date shall have been received.

 

(d)                                  The Lenders shall have received on or prior to the Closing Date all documentation and other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including without limitation the USA PATRIOT Act, in order to allow the Lenders to comply therewith, in each case, to the extent requested at least five (5) Business Days prior to the Closing Date.

 

(e)                                   The Administrative Agent shall have received a certificate signed by a Responsible Officer of the Borrower in substantially the form of Exhibit F certifying that (i) the representations and warranties of the Borrower and each other Loan Party contained in Article V or any other Loan Document shall be true and correct in all material respects on and as of the Closing Date (before and after giving effect to the incurrence of the Loans); provided that to the extent that such representations and warranties specifically refer to an earlier date, they shall be true and correct in all material respects as of such earlier date; provided further that any representation and warranty that is qualified as to “materiality”, “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such respective dates and (ii) after giving effect to the amendments or consents relating to the Novelion Intercompany Loans and the Novelion Shareholder Loans as of the Closing Date, no Default or Event of Default shall exist, or would result from the incurrence of the Loans or from the application of the proceeds therefrom.

 

(f)                                    Since December 31, 2017, there has been no event or circumstance, either individually or in the aggregate, that has had or would reasonably be expected to have a Material Adverse Effect, except for (i) such events set forth in any public filings of Novelion prior to the Closing Date, (ii) any matters disclosed on the disclosure schedules to the Loan Documents as of the Closing Date and (iii) any other matters disclosed in writing to the Lenders or its Financial Advisor prior to the Closing Date.

 

(g)                                   The Lenders shall have received a customary payoff letter and lien termination statements with respect to the Novelion Shareholder Loans and upon funding of the New Money Loans on the Closing Date, the Novelion Shareholder Loans (and all obligations thereunder) shall have been paid in full and all liens securing such debt shall have been terminated.

 

39


 

Without limiting the generality of the provisions of Section 9.03 , for purposes of determining compliance with the conditions specified in this Section 4.01 , each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the Closing Date specifying its objection thereto.

 

ARTICLE V

 

REPRESENTATIONS AND WARRANTIES

 

The Borrower represents and warrants to the Administrative Agent and the Lenders that:

 

Section 5.01                              Existence, Qualification and Power; Compliance with Laws .  Except as set forth on Schedule 5.01 or, in the case of clause (d), Schedule 5.06, each Loan Party and each of its Subsidiaries (a) is duly incorporated, organized or formed, and validly existing and in good standing under the Laws of the jurisdiction of its incorporation or organization (to the extent such concept exists in such jurisdiction), (b) has all requisite power and authority to (i) own or lease its assets and carry on its business and (ii) execute, deliver and perform its obligations under the Loan Documents to which it is a party, (c) is duly qualified and in good standing (to the extent such concept exists) under the Laws of each jurisdiction where its ownership, lease or operation of properties or the conduct of its business requires such qualification, (d) is in compliance with all Laws (including, without limitation, Regulation X of the Board of Governors of the Federal Reserve System), orders, writs, injunctions and orders and (e) has all requisite governmental licenses, authorizations, consents and approvals to operate its business as currently conducted, except, with respect to the foregoing clauses (c), (d) and (e), as would not, individually or in the aggregate, be reasonably likely to have a Material Adverse Effect.

 

Section 5.02                              Authorization; No Contravention .  The execution, delivery and performance by each Loan Party of each Loan Document to which such Person is a party, and the consummation of the Transaction, (a) are within such Loan Party’s corporate or other powers, (b) have been duly authorized by all necessary corporate or other organizational action, and (c) do not and will not (i) contravene the terms of any of such Person’s Organization Documents, (ii) except as set forth on Schedule 5.02 , conflict with or result in any breach or contravention of, or the creation of any Lien under (other than as permitted by Section 7.01 ), or require any payment to be made under (x) any Material Contracts to which such Person is a party or affecting such Person or the properties of such Person or any of its Subsidiaries or (y) any material order, injunction, writ or decree of any Governmental Authority or any arbitral award to which such Person or its property is subject, or (iii) violate any material applicable Law.

 

Section 5.03                              Governmental Authorization; Other Consents .  No approval, consent, exemption, authorization, or other action by, or notice to, or filing with, any Governmental Authority or any other Person is necessary or required in connection with (a) the execution, delivery or performance by, or enforcement against, any Loan Party of this Agreement or any other Loan Document, (b) the grant by any Loan Party of the Liens granted by

 

40


 

it pursuant to the Collateral Documents, (c) the perfection or maintenance of the Liens created under the Collateral Documents (including the priority thereof) or (d) the exercise by the Administrative Agent or any Lender of its rights under the Loan Documents or the remedies in respect of the Collateral pursuant to the Collateral Documents, in each case, other than (a) those that have been duly obtained or made and which are in full force and effect, (b) the filing of UCC financing statements and (c) the filings or other actions necessary to perfect Liens under the Loan Documents.

 

Section 5.04                              Binding Effect .  This Agreement and each other Loan Document has been duly executed and delivered by each Loan Party that is party thereto.  This Agreement and each other Loan Document constitutes a legal, valid and binding obligation of such Loan Party, enforceable against each Loan Party that is party thereto in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization and other similar laws relating to or affecting creditors’ rights generally.

 

Section 5.05                              No Material Adverse Effect .  Since December 31, 2017, there has been no event or circumstance, either individually or in the aggregate, that has had or would reasonably be expected to have a Material Adverse Effect except for (i) such events set forth in any public filings of Novelion prior to the Closing Date, (ii) any matters disclosed on the disclosure schedules to the Loan Documents as of the Closing Date and (iii) any other matters disclosed in writing to the Lenders or its Financial Advisor prior to the Closing Date.

 

Section 5.06                              Litigation .  Except for claims, actions, suits, investigations, litigation or proceeding and set forth on Schedule 5.06 , there is no action, suit, investigation, litigation or proceeding affecting any Loan Party or its Subsidiaries, including any Environmental Action, pending or, to the knowledge of any Loan Party, threatened in writing before any Governmental Authority or arbitrator that (i) would be reasonably likely to result in liabilities in excess of the Threshold Amount or (ii) purports to affect the legality, validity or enforceability of any Loan Document.

 

Section 5.07                              Ownership of Property; Liens .  (a) Each Loan Party and its Subsidiaries is the legal and beneficial owner of the Collateral pledged by it free and clear of any Lien, except for Permitted Liens.

 

(b)                                  Each Loan Party and each of its Subsidiaries has good and marketable title in fee simple to, or valid leasehold interests in, or easements or other limited property interests in, all real property used in the ordinary conduct of its business, free and clear of all Liens except for defects in title that do not materially interfere with its ability to conduct its business or to utilize such assets for their intended purposes and Liens permitted by Section 7.01 and except where the failure to have such title or other interest would not reasonably be expected to have a Material Adverse Effect.  Set forth as Schedule 5.07(b)  hereto is a complete and accurate list of all real property owned by any Loan Party or any of its Subsidiaries, showing, as of the date hereof, the street address, state and any other relevant jurisdiction, record owner and fair market value.  Set forth on Schedule 5.07(b)  hereto is a complete and accurate list of all leases of real property under which any Loan Party or any Subsidiary is the tenant, showing as of the date hereof the street address, state and any other relevant jurisdiction, parties thereto, sublessee (if any), expiration date and annual base rental cost thereof.

 

41


 

Section 5.08                              Enforceable Obligations .  The provisions of the Collateral Documents are effective to create in favor of the Administrative Agent for the benefit of the Secured Parties, a legal, valid and enforceable first priority Lien or security interest in all right, title and interest of the Loan Parties in the Collateral and all proceeds thereof.

 

Section 5.09                              Environmental Compliance .  Except as set forth on Schedule 5.09 or as would not individually be reasonably expected to result in a liability in excess of $300,000 to the Loan Parties and their Subsidiaries (provided that the aggregate of all such events, circumstances, developments and liabilities could not reasonably be expected to result in a Material Adverse Effect):

 

(a)                                  The operations and properties of each Loan Party and each of its Subsidiaries comply in all material respects with all applicable Environmental Laws and Environmental Permits, all past non-compliance with such Environmental Laws and Environmental Permits has been resolved without ongoing obligations or costs, and no circumstances exist that would be reasonably likely to (A) to the knowledge of the Loan Parties, form the basis of an Environmental Action against any Loan Party or any Subsidiary or any of their properties or (B) cause any such property to be subject to any restrictions on ownership, occupancy, use or transferability under any Environmental Law.

 

(b)                                  None of the properties currently or, to the knowledge of the Loan Parties, formerly, owned or operated by any Loan Party or any of its Subsidiaries is listed or, to such Loan Party’s or each of its Subsidiaries’ knowledge, proposed for listing on the NPL or on the CERCLIS or any analogous foreign, state or local list or is adjacent to any such property; there are no, and, to the knowledge of the Loan Parties, never have been, any underground or aboveground storage tanks other than in compliance with applicable Environmental Laws or any surface impoundments, septic tanks, pits, sumps or lagoons in which Hazardous Materials are being or have been treated, stored or disposed on any property currently owned or operated by any Loan Party or any of its Subsidiaries or, to the best of its knowledge, on any property formerly owned or operated by any Loan Party or any of its Subsidiaries other than in compliance with applicable Environmental Laws; and other than in compliance with applicable Environmental Laws, there is no asbestos or asbestos-containing material on any property currently owned or operated by any Loan Party or any of its Subsidiaries; and Hazardous Materials have not been released, discharged or disposed of by any Loan Party or any of its Subsidiaries on any property currently or formerly owned or operated by any Loan Party or any of its Subsidiaries other than in material compliance with applicable Environmental Laws.

 

(c)                                   Neither any Loan Party nor any of its Subsidiaries is undertaking, and has not completed, either individually or together with other potentially responsible parties, any investigation or assessment or remedial or response action relating to any actual or threatened release, discharge or disposal of Hazardous Materials at any site, location or operation, either voluntarily or pursuant to the order of any governmental or regulatory authority or the requirements of any Environmental Law; and all Hazardous Materials generated, used, treated, handled or stored at, or transported by or on behalf of any Loan Party or any of its Subsidiaries to or from, any property currently or formerly owned or

 

42


 

operated by any Loan Party or any of its Subsidiaries have, to the knowledge of the Loan Parties, been disposed of in a manner not reasonably expected to result in material liability to any Loan Party or any of its Subsidiaries.

 

(d)                                  The Borrower and each of its Subsidiaries has obtained all material Environmental Permits required for ownership and operation of its property and business as presently conducted.  Neither the Borrower nor any of its Subsidiaries has received any written notification pursuant to any applicable Environmental Law or otherwise has knowledge that (A) any work, repairs, construction or capital expenditures are required to be made in order to be in or continue to be in compliance with any applicable Environmental Laws or any material Environmental Permit or (B) any Environmental Permit is about to be reviewed, made subject to new limitations or conditions, revoked, withdrawn or terminated.

 

(e)                                   Except as would not reasonably be expected to result in a material liability, no Loan Party nor any of its Subsidiaries has contractually assumed any liability or obligation under or relating to any applicable Environmental Law.

 

(f)                                    Nothing contained in this Section 5.09 is intended to apply to any action, suit, investigation, litigation or proceeding (including any Environmental Action) relating to exposure to asbestos, in any form, or any asbestos containing materials.

 

Section 5.10                              Taxes .  (a) Each of the Loan Parties and each of their respective Subsidiaries has timely filed all income and all other material tax returns and reports required to be filed, and have timely paid all Taxes (whether or not shown on such tax returns or reports) and all other amounts of federal, provincial, state, municipal, foreign and other taxes, assessments, fees and, except as prohibited by the Bankruptcy Code, other governmental charges levied or imposed upon them or their properties, income or assets otherwise due and payable, except those which are set forth on Schedule 5.10(a)  or are being contested in good faith by appropriate proceedings and for which adequate reserves have been provided in accordance with GAAP.

 

(b)                                  Except as set forth on Schedule 5.10(b)  or as would not, individually or in the aggregate, be reasonably likely to result in any material liability, (i) there are no claims being asserted in writing with respect to any amounts of taxes, (ii) there are no presently effective waivers or extensions of statutes in writing with respect to any amounts of taxes, and (iii) no tax returns are being examined by, and no written notification of intention to examine has been received from, the Internal Revenue Service or any other taxing authority, in each case, with respect to the Loan Parties or any of their respective Subsidiaries.

 

(c)                                   Neither the Borrower nor any of its Subsidiaries is party to any tax sharing agreement other than with an affiliate included in a consolidated or combined tax return.

 

Section 5.11                              Compliance with ERISA .  (a) Each Plan is in compliance with the applicable provisions of ERISA, the Code and other federal or state Laws, except as is not, either individually or in the aggregate, reasonably likely to have a Material Adverse Effect.

 

43


 

(b)                                  (i) No ERISA Event has occurred or is reasonably expected to occur; (ii) none of the Loan Parties or any of their Subsidiaries has incurred, or reasonably expects to incur, any liability (and no event has occurred which, with the giving of notice under Section 4219 of ERISA, would result in such liability) under Section 4201 et seq. or 4243 of ERISA with respect to a Multiemployer Plan; and (iii) none of the Loan Parties or any of their Subsidiaries or any ERISA Affiliate has engaged in a transaction that would be subject to Section 4069 or 4212(c) of ERISA.

 

Section 5.12                              Labor Matters .  There are no strikes pending or, to the knowledge of any Loan Party, threatened in writing against the Borrower or any of its Subsidiaries that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.  The (i) hours worked and payments made to employees of the Borrower or any of its Subsidiaries have not been in violation in any material respect of the Fair Labor Standards Act or any other applicable law dealing with such matters and (ii) all material payments due from the Borrower or any of its Subsidiaries or for which any claim may be made against the Borrower or any of its Subsidiaries, on account of wages and employee health and welfare insurance and other benefits have been paid or accrued as a liability on the books of the Borrower or such Subsidiary to the extent required by GAAP.

 

Section 5.13                              Insurance .  The properties of the Loan Parties and their Subsidiaries are insured in the manner contemplated by Section 6.07 .

 

Section 5.14                              Subsidiaries; Equity Interests .  As of the date hereof, Novelion and the Loan Parties do not have any Subsidiaries other than those specifically disclosed in Schedule 5.14 , and all of the outstanding Equity Interests in each such Person and each such Subsidiary have been validly issued, are fully paid and non-assessable.  As of the date hereof, Schedule 5.14 (a) sets forth the name and ownership interest of each Person that owns any Equity Interests in the direct and indirect Subsidiaries of Novelion, (b) sets forth the name and jurisdiction of organization of Novelion and each direct and indirect Subsidiary of Novelion and (c) sets forth the ownership interest of each direct and indirect Subsidiary of Novelion, including the percentage of such ownership.

 

Section 5.15                              Margin Regulations; Investment Company Act; Anti-Terrorism Laws; Sanctions and Other Regulations .  (a) None of the Loan Parties or any of their Subsidiaries is engaged nor will engage, principally or as one of its important activities, in the business of purchasing or carrying margin stock (within the meaning of Regulation U issued by the FRB), or extending credit for the purpose of purchasing or carrying margin stock, and no proceeds of any Loans will be used for any purpose that violates Regulation U issued by the FRB.

 

(b)                                  None of the Loan Parties or any of their Subsidiaries is required to be registered as an “investment company” under the Investment Company Act of 1940, as amended.

 

(c)                                   No Loan Party nor any of its Subsidiaries or to its knowledge any of the respective officers, directors, brokers or agents of such Loan Party or Subsidiary has violated any applicable Anti-Terrorism Law in any material respect.

 

44


 

(d)                                  No Loan Party, nor any of its Subsidiaries, any of their respective directors, officers or employees, or to the knowledge of the Loan Party, any agent of the Loan Party or any Subsidiary that act in any capacity in connection with the Loans, is (i) a Sanctioned Person, (ii) organized, resident or located in a Sanctioned Country, (iii) in violation of Sanctions, or (iv) engaged in any transactions or dealings with a Sanctioned Person or in a Sanctioned Country; and each Loan Party has instituted and maintains policies and procedures designed to ensure continued compliance by each Loan Party, its Subsidiaries, and their respective directors, officers, employees and agents with Sanctions.

 

(e)                                   No Loan Party or any of its Subsidiaries or to its knowledge any of the respective officers, directors, brokers or agents of such Loan Party or Subsidiary acting or benefiting in any capacity in connection with the Loans (i) deals in, or otherwise engages in any transaction related to, any property or interests in property blocked pursuant to any Anti-Terrorism Law or (ii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law.

 

(f)                                    No Loan Party nor any of its Subsidiaries or any of the respective officers, directors, brokers or agents of such Loan Party or Subsidiary will directly or indirectly use the proceeds of the Loans or otherwise make available such proceeds to any individual or entity (i) for the purpose of funding, financing, or facilitating any activities, business or transaction of or with a Sanctioned Person, or in any Sanctioned Country, or (ii) in any manner that would result in a violation of Sanctions by any party to this agreement.

 

(g)                                   None of the Loan Parties or any of its Subsidiaries nor, to the knowledge of the Borrower, any director, officer, agent, employee or other person acting on behalf of the Borrower or any of its Subsidiaries has taken any action, directly or indirectly, that would result in a material violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder or any other applicable anti-corruption law (collectively, “ Anti-Corruption Laws ”); and the Loan Parties have instituted and maintain policies and procedures designed to ensure continued compliance therewith in all material respects.

 

(h)                                  None of the Loan Parties or any of its Subsidiaries is a “holding company” or an “affiliate” of a “holding company” or a “subsidiary company” of a “holding company” as each term is defined and used in the Public Utility Holding Company Act of 2005.

 

Section 5.16                              Disclosure .  No report, financial statement, certificate or other written information furnished by or on behalf of the Borrower or any of its Subsidiaries to the Administrative Agent or any Lender in connection with the transactions contemplated hereby and the negotiation of this Agreement or delivered hereunder or any other Loan Document (as modified or supplemented by other information so furnished) when taken as a whole contains when furnished any material misstatement of fact or omits to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not materially misleading; provided to the extent any information is included in the Initial Budget or constitutes projections or other forward-looking information, the Borrower represents only that such information was prepared in good faith based upon assumptions believed to be reasonable

 

45


 

at the time of preparation; it being understood that such projections may vary from actual results and that such variances may be material.

 

Section 5.17                              Intellectual Property .  As of the date hereof, set forth on Schedule 5.17 and the schedules to the Collateral Documents is a complete and accurate list of all Registered patents, trademarks, service marks, domain names and copyrights, owned by the Borrower or any of its Subsidiaries and all IP Agreements (as defined in the Collateral Documents) as of such date, showing as of such date the jurisdiction in which each such item of Registered Intellectual Property is registered or in which an application is pending and the registration or application number.  The Borrower and each Subsidiary owns or has the right to use, all of the trademarks, service marks, trade names, domain names, copyrights, patents, know-how, technology and other intellectual property recognized under applicable Law (collectively, “ Intellectual Property ”) that are material to the operation of their respective businesses as currently conducted and, to the knowledge of the Loan Parties, except as set forth in the “Disputes or Litigation” section of Schedule 5.17, the use of such Intellectual Property by such Person or the operation of their respective businesses is not infringing upon any Intellectual Property rights held by any other Person and there are no other disputes or litigation proceedings involving such Intellectual Property.

 

Section 5.18                              Initial Budget (b)        .  The Initial Budget was prepared in good faith by the management of the Loan Parties, based on assumptions believed by the management of the Loan Parties to be reasonable at the time made and upon information believed by the management of the Loan Parties to have been accurate based upon the information available to the management of the Loan Parties at the time such Initial Budget was furnished (it being understood and agreed that financial projections are not a guarantee of financial performance, actual results may differ from financial projections and such differences may be material and financial projections are subject to significant uncertainties and contingencies, many of which are beyond the control of the Loan Parties).

 

Section 5.19                              EEA Financial Institution .  Neither the Borrower nor any other Loan Party is an EEA Financial Institution.

 

Section 5.20                              Contractual Obligations .  Set forth on Schedule 5.20 hereto are all Material Contracts to which the Loan Parties and their Subsidiaries are party as of the Closing Date.  As of the Closing Date, none of the Loan Parties or their Subsidiaries have knowledge of any events of default under any such Material Contracts.

 

ARTICLE VI

 

AFFIRMATIVE COVENANTS

 

So long as any Lender shall have any Commitment outstanding hereunder or any Loan or other Obligation hereunder which is accrued and payable shall remain unpaid or unsatisfied, the Borrower shall, and shall (except in the case of the covenants set forth in Section 6.01 , Section 6.02 and Section 6.03 ) cause each Subsidiary to:

 

46


 

Section 6.01                              Financial Statements .  Deliver to the Administrative Agent and to each Lender:

 

(a)                                  Quarterly and Annual Financial Statements .  (i) As soon as available, but in any event, within fifty-five (55) days after the end of each of the first three (3) fiscal quarters of each Fiscal Year of the Borrower (commencing with the first full fiscal quarter ended after the Closing Date), unaudited internally prepared balance sheet of the Borrower and its Subsidiaries as at the end of such fiscal quarter, and the related unaudited internally prepared consolidated statements of income or operations and cash flows for such fiscal quarter, certified by a Responsible Officer of the Borrower as fairly presenting in all material respects the financial condition, results of operations and cash flows of the Borrower and its Subsidiaries in accordance with GAAP, subject to year-end adjustments, and (ii) as soon as available, but no later than one hundred twenty (120) days after the last day of Borrower’s fiscal year, internally prepared consolidated financial statements of the Borrower for the fiscal year then ended (to be comprised of a consolidated balance sheet and income statement and cash flows covering the Borrower’s and its Subsidiaries’ operations for such fiscal year), prepared in a manner consistent with GAAP and with prior practices, and complete and correct in all material respects, subject to normal year-end adjustments that, in the aggregate, are not material to the Borrower’s business operations, certified by a Responsible Officer.

 

(b)                                  Management Discussion and Analysis Reports .  Simultaneously with the delivery of each set of consolidated financial statements referred to in Section 6.01(a) , a report setting forth management’s analysis and discussion of the condition (financial and otherwise) and operations, in respect of the business of Novelion and its Subsidiaries.

 

(c)                                   Budget .  By no later than 11:59 p.m. (New York, New York time) by the third Business Day of each calendar week, and commencing for the first full week following the Closing Date, the Borrower shall deliver to the Administrative Agent and the Lenders variance reports (in substantially the same format as the Budget) showing actual cash receipts and disbursements for the immediately preceding week, noting therein all variances, on a line-item basis, from values set forth for such period(s) in the Initial Budget or Budget, as applicable.  For the avoidance of doubt, such weekly variance reports shall include actual cash flows to Foreign Subsidiaries by geography broken down by use of funds.

 

(d)                                  Monthly Financial Statements .  At the request of the Required Lenders, the Borrower shall provide to the Lenders a consolidated balance sheet of the Borrower and its Subsidiaries as of the end of last fiscal month, and the related consolidated statements of income or operations for such fiscal month.

 

(e)                                   Budget Updates .  Borrower shall at the end of every 4 week period commencing from the Closing Date propose an update to the then-existing Initial Budget or Budget, as the case may be, adding thereto the forecast of cash receipts and cash disbursements for the 13 week period commencing on the date of such proposed update.  Each such update and the line items reflecting Permitted Affiliate Services Payments shall be subject to the consent of the Required Lenders (not to be unreasonably

 

47


 

withheld), and to the extent such consent is provided, the Budget shall be amended, and if no consent is provided, the prior Budget shall remain in effect; provided , that the Lenders agree that the line items in any proposed update reflecting any of the following shall not be subject to such consent requirement: (1) professional fees - restructuring in any nine week period to be increased by up to 15% from the amount set forth for such line item in the corresponding nine week period in the most recently approved Budget and (2) payroll and benefits in any nine week period to be increased by up to 15% from the amount set forth for each such line item in the corresponding nine week period in the most recently approved Budget ( provided that any increase in payroll or benefits for those employees listed on Schedule 6.01(e) shall not count against such 15% cap but, for the avoidance of doubt, each budget update for such increase shall be subject to the aforementioned consent right of the Required Lenders), so long as the cumulative percentage increases during the term of this Agreement for the items in clauses (1) and (2) do not exceed 50 percentage points beginning with the first revised Budget proposed after the Closing Date.  The Initial Budget and each proposed update shall include a memo item reflecting cumulative transfers that may be required to Foreign Subsidiaries irrespective of expense categories.  Each proposed update to the Initial Budget and any subsequent Budget shall include: (i) a consolidating cash flow schedule illustrating budgeted cash flows for the Foreign Subsidiaries aggregated by geography and broken down by use of funds; and (ii) a schedule of the updated proposed Budget variances segregating changes for payroll for those employees listed on Schedule 6.01 (e) from any other changes for payroll and benefits.

 

(f)                                    Other Statements .  Contemporaneous with the delivery to the lenders under the Novelion Intercompany Loan Agreement (and in any case no later than one (1) calendar day following such delivery), copies of all statements, reports, notices made available to Borrower’s security holders generally, to such lenders or to any other holders of Indebtedness for borrowed money, including, without limitation, (i) notice of the occurrence of any default, which notice shall specify the nature thereof, the period of existence thereof and what action the Borrower proposes to take with respect thereto and (ii) notice of the occurrence of any matter that has resulted or could reasonably be expected to result in a Material Adverse Effect.

 

(g)                                   Notices to Novelion Lenders .  Copies of all notices to or from, and agreements and documents (including any amendments or modifications thereto) entered into in connection with the Novelion Intercompany Loan Agreement or the holders of the Convertible Notes (or the trustee thereof), in each case, within one (1) Business Day of delivery, receipt or execution as the case may be.

 

Section 6.02                              Certificates; Reports; Other Information .  Promptly deliver to the Administrative Agent and to each Lender:

 

(a)                                  upon delivery of the financial statements referred to in Section 6.01(a)  a duly completed Compliance Certificate signed by a Responsible Officer of the Borrower;

 

(b)                                  promptly after the same are publicly available, copies of all annual, regular, periodic and special reports and registration statements which the Borrower files with

 

48


 

the SEC or with any successor Governmental Authority (other than amendments to any registration statement (to the extent such registration statement, in the form it became effective, is delivered), exhibits to any registration statement and, if applicable, any registration statement on Form S-8) and in any case not otherwise required to be delivered to the Administrative Agent pursuant hereto; and

 

(c)                                   promptly upon receipt thereof, notice that any third party has expressed an interest in writing (either formally or informally) in acquiring all or substantially all of the Loan Parties’ business.

 

Delivery of any reports, information and documents under Section 6.01 and Section 6.02 as well as any such reports, information and documents pursuant to this Agreement, to the Administrative Agent and the Lenders is for informational purposes only and the Administrative Agent’s and Lenders’ receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Borrower’s compliance with any of its covenants hereunder (as to which the Administrative Agent and the Lenders are entitled to rely exclusively on the Compliance Certificates).  The Administrative Agent and the Lenders shall have no responsibility or liability for the filing, timeliness or content of any report required under Section 6.01 or Section 6.02 or any other reports, information and documents required under this Agreement (aside from any report that is expressly the responsibility of the Lenders subject to the terms hereof).

 

Section 6.03                              Notice Requirements; Other Information .  Promptly after a Responsible Officer obtains knowledge thereof, notify the Administrative Agent and each Lender of each of the following events or circumstances and provide to the Administrative Agent and each Lender the following information and documents:

 

(a)                                  the occurrence of any Default, which notice shall specify the nature thereof, the period of existence thereof and what action the Borrower proposes to take with respect thereto;

 

(b)                                  the occurrence of any matter that has resulted or could reasonably be expected to result in a Material Adverse Effect;

 

(c)                                   the commencement of, or any material development in, any litigation or governmental proceeding (including without limitation pursuant to any applicable Environmental Laws) pending against the Borrower or any of the Subsidiaries that could reasonably be expected to be determined adversely and, if so determined, to result in a Material Adverse Effect;

 

(d)                                  the occurrence of any ERISA Event above the Threshold Amount or the breach of any representation in Section 5.12 ;

 

(e)                                   any information with respect to environmental matters as required by Section 6.04(b) ;

 

(f)                                    copies of all notices, requests and other documents received by any Loan Party or any of its Subsidiaries under or pursuant to any instrument, indenture, loan or

 

49


 

credit or similar agreement relating to Indebtedness in excess of the Threshold Amount regarding or related to any breach or default by any party thereto or any other event that could materially impair the value of the interests or the rights of any Loan Party or otherwise have a Material Adverse Effect and copies of any amendment, modification or waiver of any provision of any such instrument, indenture, loan or credit or similar agreement relating to Indebtedness in excess of the Threshold Amount and, from time to time upon request by the Administrative Agent (at the direction of the Required Lenders), such information and reports regarding such instruments, indentures and loan and credit and similar agreements relating to Indebtedness in excess of the Threshold Amount as the Administrative Agent may reasonably request (at the direction of the Required Lenders);

 

(g)                                   a tax event or liability not previously disclosed in writing by the Borrower to the Administrative Agent which would reasonably be expected to result in a material liability, together with any other information as may be reasonably requested by the Required Lenders to enable the Required Lenders to evaluate such matters;

 

(h)                                  any occurrence of a Change of Control; and

 

(i)                                      any change (i) in any Loan Party’s corporate name, (ii) any Loan Party’s identity and corporate structure, (iii) any Loan Party’s taxpayer identification number or (iv) any Loan Party’s jurisdiction of incorporation.

 

Section 6.04                              Environmental Matters .  (a) Comply and cause each of its Subsidiaries to comply, in all material respects, with all applicable Environmental Laws and Environmental Permits; obtain and renew, and cause each of its Subsidiaries to obtain and renew, all material Environmental Permits required under Environmental Laws for its operations and properties; and conduct, and cause each of its Subsidiaries to conduct, any investigation, study, sampling and testing, and undertake any cleanup, removal, remedial or other action required to remove and clean up all releases or threatened releases of Hazardous Materials from any of its properties, as required under, and in accordance with the requirements of all Environmental Laws; provided , however , that neither the Borrower nor any of its Subsidiaries shall be required to undertake any such cleanup, removal, remedial or other action to the extent that its obligation to do so is being contested in good faith and by proper proceedings and, to the extent required by GAAP, appropriate reserves are being maintained with respect to such circumstances.

 

(b)                                  Promptly, and in any event within ten (10) Business Days, after a Responsible Officer obtains knowledge thereof, notify the Administrative Agent of or, deliver to the Administrative Agent, for further distribution to each Lender, copies of any and all material, non-privileged written communications and material, non-privileged documents concerning:

 

(i)                                      any Environmental Action against or of any non-compliance by any Loan Party or any of its Subsidiaries with any Environmental Law or Environmental Permit that would (1) reasonably be expected to result in a liability to any Loan Party in excess of $300,000 or (2) cause any Mortgaged Properties to be subject to any restrictions on ownership, occupancy, use or transferability under any Environmental Law;

 

50


 

(ii)                                   to the extent any of the following is reasonably expected to result in a liability to any Loan Party in excess of $300,000: (1) any occurrence of any release or threatened release of Hazardous Materials required to be reported to any Governmental Authority under applicable Environmental Law, (2) any remedial actions taken by any Loan Party or its Subsidiaries in respect of any such release or threatened release that could reasonably be expected to result in an Environmental Action or (3) the Loan Parties’ discovery of any occurrence of or condition on any real property adjoining or in the vicinity of any site or facility that would be reasonably expected to cause such site or facility or any part thereof to be subject to any restrictions on the ownership, occupancy, transferability or use thereof under any Environmental Laws;

 

(iii)                                to the extent any of the following is reasonably expected to result in a liability to any Loan Party in excess of $300,000: (1) any Permitted Acquisition that could reasonably be expected to (A) expose the Borrower or any of its Subsidiaries to, or result in, Environmental Actions or (B) affect the ability of the Borrower and its Subsidiaries to maintain in full force and effect all Governmental Authorizations and Environmental Permits required for the continued operations of their respective businesses existing prior to such Permitted Acquisition and (2) any action proposed to be taken by the Borrower or any of its Subsidiaries to modify current operations in a manner that would reasonably be expected to subject the Borrower and its Subsidiaries to any material additional obligations or requirements under Environmental Laws;

 

(iv)                               copies of all material environmental reports or audits (whether produced by the Borrower or its Subsidiaries or any third party or Governmental Authority) and any Phase I or Phase II reports in respect of any sites or real property owned, leased or operated by the Borrower and its Subsidiaries that are in possession or control of any Loan Party or any of its Subsidiaries;

 

(v)                                  to the extent any of the following is reasonably expected to result in a liability to any Loan Party in excess of $300,000: copies of any and all material, non-privileged written communications with respect to (A) any Environmental Action, (B) any release or threatened release or non-compliance with any Environmental Law required to be reported to any Governmental Authority and (C) any request for information from a Governmental Authority that suggests such Governmental Authority is investigating the potential responsibility of the Borrower or any of its Subsidiaries as a potentially responsible party;

 

(vi)                               the good faith belief that a release of Hazardous Materials, or a violation of Environmental Law reasonably likely to result in a fine or penalty in excess of $300,000, has occurred on or after the Closing Date, and within 60 days after such request and at the expense of the Borrower, any additional environmental site assessment reports for any of its or its Subsidiaries’ properties described in such request prepared by an environmental consulting firm acceptable to the Required Lenders, indicating the presence or absence of such Hazardous Materials and the estimated cost of any compliance, removal or remedial action in connection with any such Hazardous Materials on such properties; without limiting the generality of the foregoing, if the Required Lenders reasonably determine at any time that a material risk exists that any such report

 

51


 

will not be provided within the time referred to above, the Administrative Agent may retain an environmental consulting firm to prepare such report at the expense of the Borrower, and the Borrower hereby grants and agrees to cause any Subsidiary that owns any property described in such request to grant at the time of such request to the Administrative Agent, the Lenders, such firm and any agents or representatives thereof, the right, subject to the rights of tenants, to enter onto their respective properties to undertake such an assessment; and

 

(vii)                            any such other documents and information as the Administrative Agent (at the direction of the Required Lenders) may reasonably request from time to time.

 

Section 6.05                              Maintenance of Existence .  (a) Preserve, renew and maintain in full force and effect its legal existence, structure and name under the Laws of the jurisdiction of its organization and (b) take all commercially reasonable action to maintain all rights, privileges (including its good standing), permits, licenses and franchises necessary or desirable in the normal conduct of its business, except (i) other than with respect to any Loan Party, to the extent the Borrower’s board of directors (or in the case of clause (b), a Responsible Officer) shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Borrower and its Subsidiaries and to the extent that the loss thereof shall not be disadvantageous to Borrower, its Subsidiaries or the Lenders in any material respect, (ii) pursuant to a transaction permitted by Section 7.04 or Section 7.05 or (iii) in the case of clause (b), failure to do so could not reasonably be expected to have a Material Adverse Effect.

 

Section 6.06                              Maintenance of Properties .  (a) Maintain, preserve and protect all of its material properties and equipment that are used or useful in the operation of its business in good working order, repair and condition, ordinary wear and tear excepted and casualty or condemnation excepted, and make all commercially reasonable and appropriate repairs, renewals, replacements, modifications, improvements, upgrades, extensions and additions thereof except where failure to do so would not reasonably be expected to materially adversely affect the use of the related property.

 

Section 6.07                              Maintenance of Insurance .  Maintain with financially sound and reputable insurance companies (in the good faith judgment of management of the Borrower), insurance with respect to its properties and business against loss or damage of the kinds customarily insured against by Persons engaged in the same or similar business, of such types and in such amounts (after giving effect to any self-insurance reasonable and customary for similarly situated Persons engaged in the same or similar businesses as the Borrower and its Subsidiaries) as are customarily carried by Person engaged in similar businesses and owning or leasing similar properties in the same general areas in which the Borrower or such Subsidiary operates. Borrower shall cause all property policies to have a lender’s loss payable endorsement showing Administrative Agent as lender loss payee and use commercially reasonable efforts to cause such endorsement to provide that the insurer must give Administrative Agent at least twenty (20) days’ notice before canceling, amending, or declining to renew its policy.  All liability policies shall show, or have endorsements showing, Administrative Agent as an additional insured, and all such policies (or the loss payable and additional insured endorsements) shall provide that the insurer shall give Administrative Agent at least twenty (20)

 

52


 

days’ notice before canceling, amending, or declining to renew its policy.  At any Lender’s request, each Loan Party shall deliver certified copies of policies and evidence of all premium payments.  Proceeds payable under any casualty policy in connection with a Casualty Event shall be subject to Section 2.02(b)(ii).

 

Section 6.08                              Compliance with Laws .  Comply in all material respects with the requirements of all Laws and all orders, writs, injunctions, decrees and judgments applicable to it or to its business or property, except where such non-compliance is not, either individually or in the aggregate, reasonably likely to have a Material Adverse Effect.

 

Section 6.09                              Books and Records .  Maintain proper books of record and account, in which entries that are full, true and correct in all material respects and as are sufficient to permit the preparation of financial statements in conformity with GAAP consistently applied, shall be made of all material financial transactions and matters involving the assets and business of any of the Loan Parties.

 

Section 6.10                              Inspection Rights; Lender Calls .  (a) Permit representatives and independent contractors of the Administrative Agent and each Lender (including, without limitation, financial advisors retained by or for the benefit of the Administrative Agent or the Lenders or their counsel, including the Financial Advisor) to visit and inspect any properties and books and records of the Borrower and its Subsidiaries (subject, in the case of third party customer sites, to customary access agreements) and to discuss its affairs, finances and accounts with its directors, officers, advisors and independent public accountants, all at the reasonable expense of the Borrower and at such reasonable times during normal business hours and as often as may be reasonably desired, upon reasonable advance notice to the Borrower; provided , however , that such visits and inspections shall be coordinated through the Required Lenders and any review of books and records shall be done no more frequently than once per month absent the continuation of an Event of Default.  The Administrative Agent and the Lenders shall give the Borrower the opportunity to participate in any discussions with the Borrower’s independent public accountants to the extent reasonably feasible.  Neither the Borrower nor any Subsidiary shall be required to disclose to the Administrative Agent or any Lender any information that, in the opinion of counsel to the Borrower or such Subsidiary, is prohibited by Law to be disclosed, is subject to attorney client privilege or constitutes attorney work product or the disclosure of which would cause a material breach of a binding non-disclosure agreement with a third party to the extent such agreement is not made in contemplation of the avoidance of this Section 6.10 .

 

(b)                                  Up to one (1) time in every two-week period, upon the reasonable request of the Required Lenders, the Borrower’s chief financial officer, together with the Borrower’s financial advisor shall hold a conference call (at a mutually agreeable time, the cost of such call to be paid by the Borrower) with the Administrative Agent and the Lenders, on which conference calls shall be reviewed the Loan Parties’ financial performance, operations, current trends and variance reports.

 

Section 6.11                              Additional Guarantors .  To the extent any Person is required to become a Guarantor under the Loan Documents, (i) cause such Person to become a Guarantor by executing and delivering to the Administrative Agent a counterpart of the Guarantee and Collateral Agreement or a Guarantee and Collateral Agreement Supplement substantially in the

 

53


 

form attached to the Guarantee and Collateral Agreement, and (ii) deliver to the Administrative Agent any applicable documents of the types referred to in Section 4.01(a)  and, if reasonably requested by the Required Lenders, favorable opinions of counsel to such Person under New York Law, if applicable (which shall cover, among other things, the legality, validity, binding effect and enforceability of the Guarantee and Collateral Agreement), all in form, content and scope reasonably satisfactory to the Required Lenders.

 

Section 6.12                              Use of Proceeds .  Use the proceeds of any Loan, whether directly or indirectly, solely in a manner consistent with the Permitted Uses.  Notwithstanding the foregoing, no part of the proceeds of any Loan shall be used directly or indirectly to finance in any way payment of the fees and expenses of any Person incurred in connection with (i) the investigation (including discovery proceedings), initiation or prosecution of any claims, causes of action, adversary proceedings, suits, arbitrations, proceedings, applications, motions or other litigation of any type adverse to any of the Secured Parties or any of their respective Affiliates, agents or representatives, or their respective rights and remedies under or in respect of the Loans provided pursuant to this Agreement; (ii) challenging the amount, validity, perfection, priority or enforceability of, or asserting any defense, counterclaim or offset to, the obligations and liens and security interests granted under the Loan Documents, applicable non-bankruptcy law or otherwise; or (iii) attempting to prevent, hinder or otherwise delay any of the Lenders’ or the Administrative Agent’s assertion, enforcement or realization upon any of the Collateral.

 

Section 6.13                              Anti-Corruption and Sanctions Laws .  To the extent existing on the Closing Date, the Borrower will maintain in effect such policies and procedures designed to promote compliance in all material respects by the Borrower, its Subsidiaries, and their respective directors, officers, employees, and agents with the FCPA and any other applicable anti-corruption laws as well as Sanctions.

 

Section 6.14                              Taxes .  Pay and discharge, and will cause each of its Subsidiaries to pay and discharge, all Taxes, assessments and governmental charges or levies arising after the Closing Date imposed upon it or upon its income or profits, or upon any properties belonging to it, in each case on a timely basis, which, if unpaid when due and payable, may reasonably be expected to become a tax Lien upon any properties of the Borrower or any of its Subsidiaries thereof not otherwise permitted under this Agreement; provided that neither the Borrower nor any of its Subsidiaries shall be required to pay any such Tax, assessment, charge, levy or claim which is being contested in good faith and by proper proceedings if it has maintained adequate reserves with respect thereto in accordance with GAAP unless and until any tax Lien resulting therefrom attaches to its property and becomes enforceable against its other creditors.

 

Section 6.15                              End of Fiscal Years; Fiscal Quarters .  Cause (i) its fiscal year to end on or about December 31 of each calendar year and (ii) its fiscal quarters to end on or about March 31, June 30, September 30 and December 31 of each calendar year, in each case unless otherwise approved by the Required Lenders.

 

Section 6.16                              ERISA .  (a)  ERISA Events and ERISA Reports .  (i) Promptly and in any event within ten (10) days after any Loan Party, any Subsidiary or any ERISA Affiliate knows or has reason to know that any ERISA Event has occurred, a statement of a Responsible Officer of the Borrower describing such ERISA Event and the action, if any, that such Loan

 

54


 

Party, such Subsidiary or such ERISA Affiliate has taken and proposes to take with respect thereto and (ii) on the date any records, documents or other information must be furnished to the PBGC with respect to any Plan pursuant to Section 4010 of ERISA, a copy of such records, documents and information.

 

(b)                                  Plan Terminations .  Promptly and in any event within five (5) Business Days after receipt thereof by any Loan Party or any ERISA Affiliate, copies of each notice from the PBGC stating its intention to terminate any Plan or to have a trustee appointed to administer any Plan.

 

(c)                                   Plan Annual Reports .  Promptly and in any event within 30 days after the filing thereof with the Internal Revenue Service, copies of each Schedule B (Actuarial Information) to the annual report (Form 5500 Series) with respect to each Plan.

 

(d)                                  Multiemployer Plan Notices .  Promptly and in any event within five (5) Business Days after receipt thereof by any Loan Party, any Subsidiary or any ERISA Affiliate from the sponsor of a Multiemployer Plan, copies of each notice concerning (i) the imposition of Withdrawal Liability by any such Multiemployer Plan, (ii) the reorganization or termination, or a determination that such Multiemployer Plan is in endangered or critical status, within the meaning of Title IV of ERISA, of any such Multiemployer Plan or (iii) the amount of liability incurred, or that may be incurred, by such Loan Party, such Subsidiary or such ERISA Affiliate in connection with any event described in clause (i) or (ii).

 

Section 6.17                              Further Assurances .  Execute and deliver, or cause to be executed and delivered, to the Administrative Agent such reasonable documents and agreements, and shall take or cause to be taken such reasonable actions, as the Administrative Agent may, from time to time, reasonably request to carry out the terms and conditions of this Agreement and the other Loan Documents.

 

Section 6.18                              Business .  The Borrower will only, and will only permit the Subsidiaries to, engage directly or indirectly in the business engaged in by the Borrower and the Subsidiaries as of the Closing Date and reasonable extensions thereof and businesses ancillary, corollary, synergistic or complimentary thereto.

 

Section 6.19 Post-Closing Matters .   To the extent not prohibited by any Requirement of Law and not otherwise resulting in material adverse tax consequences to the Borrower and its Subsidiaries, at the request of the Required Lenders (or automatically to the extent requested under the Novelion Intercompany Loan Agreement), the Borrower shall cause its Foreign Subsidiaries designated by the Required Lenders to execute such guarantees, pledge agreements and security documents as shall be customary in such local jurisdictions to grant to Administrative Agent, for the benefit of the Secured Parties, a guaranty of the Obligations secured by the equity interests and substantially all assets of such Subsidiaries within 45 days of such request (or such longer period as the Required Lenders may agree in their sole discretion).   In addition, the Borrower shall deliver the following within 30 days of the Closing Date (or such longer period as the Required Lenders may agree in their sole discretion): (i) control agreements with respect to the Borrower’s deposit accounts listed on the schedules to the Collateral Documents (other than any Excluded Account (as defined in the Collateral Documents)) and (ii)

 

55


 

insurance endorsements in accordance with Section 6.07, in each case in form and substance reasonably acceptable to the Administrative Agent (subject to indemnity provisions in such control agreements being subject to the Administrative Agent’s approval in its sole discretion) and the Required Lenders.

 

ARTICLE VII

 

NEGATIVE COVENANTS

 

So long as any Lender shall have any Commitment outstanding hereunder or any Loan or other Obligation hereunder which is accrued and payable shall remain unpaid or unsatisfied, the Borrower shall not, and shall not permit any of its Subsidiaries to, directly or indirectly:

 

Section 7.01                              Liens .  Create, incur, assume or suffer to exist any Lien upon any of its property, assets or revenues (including accounts receivable), whether now owned or hereafter acquired, other than the following Liens (collectively, “ Permitted Liens ”):

 

(a)                                  Liens pursuant to any Loan Document;

 

(b)                                  Liens existing on the Closing Date and listed on Schedule 7.01(b) ;

 

(c)                                   Liens for taxes, assessments or governmental charges which are not overdue for a period of more than thirty (30) days or which are being contested in good faith and by appropriate proceedings, if adequate reserves with respect thereto are maintained on the books of the applicable Person to the extent required in accordance with GAAP;

 

(d)                                  statutory or common law Liens of landlords, carriers, warehousemen, mechanics, materialmen, repairmen, suppliers, construction contractors or other like Liens arising in the ordinary course of business which secure amounts not to exceed $50,000 and not overdue for a period of more than thirty (30) days or if more than thirty (30) days overdue, are unfiled (or if filed have been discharged or stayed) and no other action has been taken to enforce such Lien or which are being contested in good faith, if adequate reserves with respect thereto are maintained on the books of the applicable Person to the extent required in accordance with GAAP;

 

(e)                                   (i) pledges and deposits in the ordinary course of business securing liability for reimbursement or indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the benefit of) insurance carriers providing property, casualty or liability insurance to the Borrower or any Subsidiary and (ii) Liens securing the financing of insurance premiums (to the extent such Liens extend to the unearned premiums for such insurance) in the ordinary course of business;

 

(f)                                    Liens consisting of deposits made in connection with Indebtedness of the types permitted under Sections 7.03(e)  or 7.03(g)  (in each case, other than for borrowed money) entered into in the ordinary course of business or to secure the obligations otherwise permitted;

 

56


 

(g)                                   easements, rights-of-way, covenants, conditions, restrictions, encroachments, and other survey defects protrusions and other similar encumbrances and minor title defects affecting real property which were not incurred in connection with Indebtedness and do not in any case materially and adversely interfere with the use of the property encumbered thereby for its intended purposes;

 

(h)                                  Liens securing Indebtedness permitted under Section 7.03(c) ; provided that (i) such Liens attach concurrently with or within 120 days after the acquisition, or the completion of the construction, repair, replacement or improvement (as applicable) of the property subject to such Liens, (ii) such Liens do not at any time encumber any property other than the property financed by such Indebtedness, replacements thereof and additions and accessions to such property and the proceeds and the products thereof and customary security deposits, and (iii) with respect to Capital Leases, such Liens do not at any time extend to or cover any assets (except for additions and accessions to such assets, replacements and products thereof and customary security deposits) other than the assets subject to such Capital Leases;

 

(i)                                      Liens arising by virtue of any contractual, statutory or common law provision relating to banker’s Liens, rights of set-off or similar rights and remedies (i) relating to the establishment of depository relations with banks or other financial institutions not given in connection with the incurrence of Indebtedness, (ii) relating to pooled deposit or sweep accounts of the Borrower or any Subsidiary Guarantor (so long as such Subsidiary remains a Subsidiary Guarantor) to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business of the Borrower or such Subsidiary Guarantor or (iii) relating to purchase orders and other agreements entered into with customers of the Borrower or any of its Subsidiaries in the ordinary course of business;

 

(j)                                     Liens arising from precautionary Uniform Commercial Code financing statement filings regarding leases entered into by the Borrower and its Subsidiaries in the ordinary course of business;

 

(k)                                  any zoning, land-use or similar law or right reserved to or vested in any Governmental Authority to control or regulate the use of any real property;

 

(l)                                      the modification, replacement, renewal or extension of any Lien permitted by clause (b)  of this Section 7.01 ; provided that (i) the Lien does not extend to any additional property or additional Indebtedness (except with respect to paid-in-kind obligations pursuant to the terms of such Indebtedness as in effect on the Closing Date) other than (A) after-acquired property that is affixed or incorporated into the property covered by such Lien or financed by Indebtedness permitted under Section 7.03 , and (B) proceeds and products thereof; and (ii) the renewal, extension or refinancing of the obligations secured or benefited by such Liens is permitted by Section 7.03 ;

 

(m)                              nonconsensual statutory Liens arising after the Closing Date;

 

(n)                                  judgment Liens in existence for less than thirty (30) days after the entry

 

57


 

thereof, or with respect to which execution has been stayed or the payment of which is covered in full by insurance maintained with responsible insurance companies, or which judgment Liens do not otherwise result in an Event of Default under Section 8.01(h) ;

 

(o)                                  any interest or title of a lessor, licensor or sublessor under any lease, license or sublease entered into by the Borrower or any of its Subsidiaries in the ordinary course of its business and covering only the assets so leased, or subleased;

 

(p)                                  other Liens not on borrowed money with respect to which the aggregate amount of the obligations secured thereby does not exceed $100,000 at any time outstanding; provided , that no such Liens shall be on Equity Interests of the Borrower or any of its direct or indirect Subsidiaries;

 

(q)                                  to the extent constituting a Lien and permitted under Section 7.05, any non-exclusive licenses of Intellectual Property granted to third parties and set forth on Schedule 5.17 and other non-exclusive licenses after the Closing Date, in each case to the extent not resulting in a legal transfer of title of the licensed Intellectual Property and in the ordinary course of business, subject to exclusivity on territory aside from the United States or Europe;

 

(r)                                     to the extent constituting Liens and permitted under Section 7.05, any leases, subleases, licenses, or sublicenses (other than licenses of Intellectual Property) granted to third parties that do not materially interfere with the Loan Parties’ ordinary course of business;

 

(s)                                    Liens securing Indebtedness permitted under Section 7.03(j) to the extent in accordance with and subject to the Novelion Subordination Agreement; provided, that in no event shall the Liens securing such Indebtedness be more expansive than the Liens securing the Obligations; and

 

(t)                                     Liens consisting of cash deposits not to exceed $200,000 securing Indebtedness permitted under Section 7.03(i).

 

Section 7.02                              Investments .  Make any Investments, except:

 

(a)                                  Investments by the Borrower or its Subsidiaries in cash and Cash Equivalents;

 

(b)                                  loans and advances to officers, directors or employees in the ordinary course of the business of the Borrower and its Subsidiaries in an aggregate principal amount not to exceed $50,000 at any time outstanding;

 

(c)                                   Investments existing as of the Closing Date and disclosed on Schedule 7.02(c)  and Investments consisting of any modification, replacement, renewal, reinvestment or extension of any such Investment; provided that the amount of any Investment permitted pursuant to this Section 7.02(c)  is not increased from the amount of such Investment on the Closing Date;

 

58


 

(d)                                  so long as immediately before and after giving effect to any such Investment, no Default has occurred and is continuing, other Investments that do not exceed $250,000 in the aggregate (net of any return or distribution of capital or repayments of principal in respect thereof) to the extent expressly set forth in the Budget;

 

(e)                                   Investments received in connection with the bankruptcy or reorganization of, or settlement of delinquent accounts and disputes with, customers and suppliers, in each case in the ordinary course of business; and

 

(f)                                    other Investments made (i) by any Subsidiary that is not a Loan Party in any other Subsidiary that is not a Loan Party, (ii) by any Loan Party in any Foreign Subsidiary for operating expenses in Latin America, Europe, Middle East and Africa and operating expenses and manufacturing costs of inventory in the United Kingdom, in each case consistent with past practices and in the ordinary course of business and to the extent set forth in the Budget for such Investments in Foreign Subsidiaries in an aggregate amount and not to exceed $25,000,000 in the aggregate during the term of this Agreement and (iii) by any Subsidiary that is not a Loan Party in any Person to the extent not exceeding $100,000 outstanding at any one time.

 

Section 7.03                              Indebtedness .  Create, incur, assume or suffer to exist any Indebtedness, except the following, without duplication:

 

(a)                                  Indebtedness of the Borrower and other Loan Parties under the Loan Documents;

 

(b)                                  Indebtedness outstanding on the Closing Date and listed on Schedule 7.03(b) ;

 

(c)                                   additional Capital Leases incurred after the Closing Date and purchase money Indebtedness in an aggregate amount not to exceed $750,000 in the aggregate at any time outstanding, and any Refinancing Indebtedness in respect of such Indebtedness; provided that any such Indebtedness (x) in the case of additional Capital Leases or purchase money Indebtedness, shall be secured only by the asset subject to such additional Capital Leases or acquired asset in connection with the incurrence of such Indebtedness, as the case may be, and (ii) in the case of purchase money Indebtedness, shall constitute not less than 75% of the aggregate consideration paid with respect to such asset;

 

(d)                                  other unsecured Indebtedness in an aggregate principal amount not to exceed $250,000 at any time outstanding;

 

(e)                                   Indebtedness in respect of performance of bids, trade contracts, governmental contracts and leases (other than Indebtedness for borrowed money), statutory obligations, surety, stay, indemnity, customs and appeal bonds, performance bonds and other obligations of a like nature (including those to secure health, safety and environmental obligations), and, in each case, letters of credit in respect thereof, incurred in the ordinary course of business;

 

59


 

(f)                                    non-recourse Indebtedness incurred by the Borrower or any of its Subsidiaries to finance the payment of insurance premiums of such Person;

 

(g)                                   Indebtedness owed to any Person providing worker’s compensation, unemployment insurance and other social security legislation, health, disability or other employee benefits or property, casualty or liability insurance to the Borrower or any of its Subsidiaries incurred in connection with such Person providing such benefits or insurance pursuant to customary reimbursement or indemnification obligations to such Person;

 

(h)                                  to the extent constituting Indebtedness, each of the Investments permitted pursuant to Section 7.02 ;

 

(i)                                      reimbursement obligations owed to banks and financial institutions with respect to credit card services in an aggregate amount at any one time not exceeding $200,000;

 

(j)                                     Indebtedness of the Borrower and the Loan Parties under the Novelion Intercompany Loan Agreement in an aggregate principal amount of $36,829,803 (after giving effect to the Permitted Uses) plus any paid-in-kind interest in accordance with the terms thereof) and subject to the Novelion Subordination Agreement; provided ¸ that no Subsidiaries of the Borrower shall guaranty such Indebtedness unless such Subsidiaries also guaranty the Obligations; and

 

(k)                                  Indebtedness consisting of accounts payable incurred in the ordinary course of business past due for more than 120 days after its stated due date (except for accounts payable contested in good faith) which do not in the aggregate exceed $750,000.

 

Section 7.04                              Fundamental Changes .  Merge, dissolve, liquidate, consolidate with or into another Person, split or allow any change to the ownership of the Borrower or any of its Subsidiaries, or Dispose of (whether in one transaction or in a series of transactions) all or substantially all of its assets (whether now owned or hereafter acquired) to or in favor of any Person.

 

Section 7.05                              Dispositions .  Make any Disposition or enter into any agreement to make any Disposition, except:

 

(a)                                  Dispositions of obsolete, worn out or surplus property, whether now owned or hereafter acquired, in the ordinary course of business and Dispositions of property no longer used or useful in the conduct of the business of the Borrower and its Subsidiaries, in each case to the extent constituting immaterial property;

 

(b)                                  Dispositions in the ordinary course of business of Cash Equivalents;

 

(c)                                   sales of inventory in the ordinary course of business;

 

(d)                                  Dispositions (other than of material Intellectual Property or of assets relating to metreleptin) for fair market value; provided that (i) the aggregate amount of

 

60


 

Dispositions during any fiscal year does not exceed $250,000, (ii) immediately prior to and immediately after giving effect to such Disposition, no Default or Event of Default shall have occurred and be continuing or would result therefrom and (iii) no less than one hundred percent (100%) of the consideration received for any such Disposition is received in cash;

 

(e)                                   the leasing, as lessor, of real or personal property not presently used or useful in such Person’s business and is otherwise in the ordinary course of business;

 

(f)                                    Dispositions of equipment or other assets, to the extent that such equipment is exchanged for credit against the purchase price of similar replacement equipment or assets or the proceeds of such Dispositions are reasonably promptly applied to the purchase price of similar replacement equipment, all in the ordinary course of business;

 

(g)                                   Dispositions constituting an Intellectual Property that is not material to the conduct of the business of the Borrower and its Subsidiaries;

 

(h)                                  Dispositions otherwise permitted by Sections 7.01, 7.02 or 7.03 and Dispositions from any Subsidiary that is not a Loan Party to any other Subsidiary that is not a Loan Party; and

 

(i)                                      any Permitted Licensing Transaction; provided that (A) the aggregate Net Cash Proceeds received shall be no less than the amount specified in Schedule 1.01, of which the first $15,000,000 shall be retained by the Borrower of which up to $12,000,000 of such retained proceeds shall be used in accordance with the Certain Proceeds Reinvestment Budget and the balance of such $15,000,000 used in accordance with the Budget and the remaining Net Cash Proceeds applied in accordance with the application requirement specified on Schedule 1.01 ; provided , that in no event shall any of the proceeds retained by the Borrower be used to fund litigation, investigation or affirmative claims of any kind against the holders of the Convertible Notes or any Lender, including challenging the validity or enforceability of the Loans or the Liens Securing same or the Convertible Notes; provided , further , that if Novelion or any of its Subsidiaries (other than Borrower or any of its Subsidiaries) initiates litigation, investigations, proceedings or any other affirmative claims against, or threatens in writing to initiate litigation, investigations, proceedings or bring any affirmative claims against, any Lender in connection with this Agreement, any Loan Document or the Loans or the holders of the Convertible Notes in connection with the Convertible Notes, including, challenging the validity or enforceability of the Convertible Notes or the Loans or the Liens securing same, or otherwise breaches the terms of the Novelion Subordination Agreement, then all of such Net Cash Proceeds in excess of $15,000,000 shall be applied to the New Money Loans (it being understood and agreed that any action taken by Novelion in defense of any Subordinated Obligations (as defined in the Novelion Subordination Agreement) or otherwise in pursuit of its rights and claims in accordance with the Novelion Subordination Agreement, is excluded from the scope of this proviso clause).

 

61


 

provided that, in the case of Dispositions under Section 7.05(i), the Borrower shall provide prior written notice to the Lenders of any such Disposition, and provided further that the proceeds of any other Dispositions permitted hereunder shall be applied in accordance with the requirements of Section 2.02(b)(i)  to the extent required under such section.

 

Section 7.06                              Restricted Payments .  Declare or make, directly or indirectly, any Restricted Payment, except:

 

(a)                                  to the extent constituting a Restricted Payment, the payment of fees of non-insider directors to the extent expressly set forth in the Budget and the reimbursement of reasonable expenses;

 

(b)                                  the Subsidiaries of the Borrower may make direct or indirect Restricted Payments to the Borrower and other Subsidiaries of the Borrower that are Loan Parties;

 

(c)                                   so long as no Event of Default has occurred and is continuing, Restricted Payments to Novelion to be used for (i) customary director indemnification payments to Novelion’s director nominees serving on the board of directors of Borrower, and (ii) financial and other reporting and similar customary administrative costs and expenses attributable and fairly allocable to the Loan Parties (including audit and professional fees and other ordinary course operating and administrative expenses incurred by Novelion in its capacity as the ultimate holding company of the Borrower), in the case of this clause (ii) to the extent expressly set forth in the Budget;

 

(d)                                  the Borrower and each Subsidiary may declare and make dividend payments or other distributions payable solely in the common stock or other common Equity Interests of such Person (other than Disqualified Equity Interests);

 

(e)                                   Restricted Payments consisting of Tax Distributions to the extent set forth in the Budget;

 

(f)                                    Permitted Affiliate Services Payments to the extent constituting a Restricted Payment; and

 

(g)                                   To the extent constituting a Restricted Payment, any prepayment of the Novelion Intercompany Loans to the extent required by Section 7.05(i).

 

Section 7.07                              Change in Nature of Business .  Engage in any line of business other than those lines of business conducted by the Borrower and its Subsidiaries on the date hereof or any business reasonably related or ancillary thereto; provided , that Aegerion Securities Corporation shall not engage in any business activities,  maintain any assets or incur any Indebtedness, except it may maintain cash not to exceed $19,000,000 for the period commencing on December 15, 2018 and ending on January 4, 2019, after which period such cash shall be immediately returned to the Borrower.

 

Section 7.08                              Transactions with Affiliates .  Enter into any transaction of any kind with any Affiliate of the Borrower, whether or not in the ordinary course of business, other than:

 

62


 

(a)                                  transactions to the extent expressly set forth in the Budget including Permitted Affiliate Services Payments;

 

(b)                                  transactions contemplated by the Restructuring;

 

(c)                                   any transactions expressly permitted under Section 7.02, Section 7.04 and Section 7.06; provided that all parties to such transactions are Loan Parties or their Wholly-owned Subsidiaries;

 

(d)                                  so long as it has been approved by the Borrower’s or its applicable Subsidiary’s board of directors or other governing body to the extent required in accordance with applicable law, (i) customary indemnifications of non-officer directors of the Loan Parties and their respective Subsidiaries and (ii) the payment of reasonable and customary compensation and indemnification arrangements and benefit plans for officers and employees of the Loan Parties and their respective Subsidiaries in the ordinary course of business, in each case to the extent expressly set forth in the Budget and approved by all independent directors of the Borrower’s board of directors; provided , such indemnifications shall not be required to be set forth in the Budget;

 

(e)                                   transactions under the agreements existing on the Closing Date and listed on Schedule 7.08; provided , that any expenditures, monetary transfers or other use of cash or the proceeds of any Loans are set forth in the Budget; and

 

(f)                                    any payments under the Novelion Intercompany Loan Agreement to the extent required by Section 7.05(i).

 

Section 7.09                              Prepayments and Modifications of Certain Agreements .  (a) Amend or modify any of the terms of any Indebtedness in an outstanding amount exceeding the Threshold Amount of any of the Loan Parties or their Subsidiaries if such amendment or modification would add or change any terms in a manner adverse to the Loan Parties or the Lenders, or shorten the final maturity or average life to maturity of any such Indebtedness or require any payment to be made sooner than originally scheduled or increase the interest rate applicable thereto; provided that any amendments or modifications to any of the terms of the Novelion Intercompany Loans shall be governed by the Novelion Subordination Agreement.

 

(b)                                  Make or permit any distribution or payment (whether in cash or otherwise) of principal, interest or any other amounts on any Indebtedness, or seek or obtain approval by the Borrower’s board of directors to permit the foregoing other than with respect to the Obligations and Indebtedness under the Novelion Intercompany Loan Agreement solely to the extent any payments under the Novelion Intercompany Loan Agreement are permitted under the Novelion Subordination Agreement.

 

(c)                                   Amend or modify, or permit the amendment, modification or waiver of, any provision of any Material Contract to which any Loan Party or any Subsidiary thereof is a party or by which it or any of its property or assets is bound, in each case after the original execution and delivery thereof (or, if later, the date hereof) in any substantive manner that would be adverse to the Lenders’ interests hereunder, without the written consent of the Required Lenders; provided that any amendments, modifications or waivers of any provision of the

 

63


 

Novelion Intercompany Loan Agreement or any “Loan Document” referenced therein shall be governed by the Novelion Subordination Agreement.

 

Section 7.10                              Negative Pledge .  Enter into or suffer to exist, or permit any of its Subsidiaries to enter into or suffer to exist, (x) any agreement prohibiting or conditioning the creation or assumption of any Lien upon any of its property or assets except (a) agreements in favor of the Administrative Agent or (b) prohibitions or conditions under (i) any Capital Lease permitted by Section 7.03(c)  solely to the extent that such Capital Lease prohibits a Lien on the property subject thereto, or (ii) by reason of customary provisions restricting pledges, assignments, subletting or other transfers contained in leases, licenses and similar agreements entered into in the ordinary course of business ( provided that such restrictions are limited to the property or assets subject to such leases, licenses or similar agreements, as the case may be) or (iii) any Indebtedness outstanding on the Closing Date (including, for the avoidance of doubt, the Novelion Intercompany Loans and the Convertible Notes) or (y) any agreement or arrangement limiting the ability of any of its Subsidiaries to declare or pay dividends or other distributions in respect of its Equity Interests or repay or prepay any Indebtedness owed to, make loans or advances to, or otherwise transfer assets to or make Investments in, the Borrower or any of its Subsidiaries of the Borrower (whether through a covenant restricting dividends, loans, asset transfers or investments, a financial covenant or otherwise), except (a) the Loan Documents and (b) any Indebtedness outstanding on the Closing Date (including, for the avoidance of doubt, the Novelion Intercompany Loans and the Convertible Notes).

 

Section 7.11                              Amendments to Organization Documents .  Amend, or permit any of its Subsidiaries to amend, its certificate of incorporation or bylaws or other Organization Documents in a manner adverse to the interests of the Lenders hereunder, without the written consent of the Required Lenders.

 

Section 7.12                              Use of Proceeds .  (a)  Use, directly or indirectly, the proceeds of the Loans, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person, (x) to fund, finance, or facilitate any activities, business, or transaction of or with any Sanctioned Person, or in any Sanctioned Country, or (y) in any other manner that would result in a violation of Sanctions by any Person (including any Person participating in the Loans, whether as underwriter, advisor, investor, or otherwise).

 

(b)                                  Use any part of the proceeds of the Loans directly or indirectly, in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Law.

 

Section 7.13                              Accounting Changes .  Make any change in (a) accounting policies or reporting practices, except as required by GAAP or (b) Fiscal Year.

 

Section 7.14                              OFAC .  (a)   Become a Sanctioned Person, (b) become organized, resident or located in a Sanctioned Country, or (c) engage in any transactions or dealings with a Sanctioned Person or in a Sanctioned Country in violation of Sanctions.

 

Section 7.15                              Ownership of Subsidiaries .  Notwithstanding any other provisions of this Agreement to the contrary, organize, create, acquire or permit to exist after the Closing Date

 

64


 

any Subsidiaries of the Borrower other than those existing on the Closing Date and set forth on Schedule 5.14 .

 

Section 7.16                              Compliance with Budget .  Except as otherwise provided herein or approved by the Required Lenders, the Loan Parties shall not (a) use any cash or the proceeds of any Loans or Collateral or the proceeds thereof in a manner or for a purpose other than in accordance with this Agreement and the Budget, (b) permit operating disbursements (as defined in the Initial Budget) for the first week following the Closing Date, to be more than the corresponding amounts set forth in the Initial Budget for such period subject to a variance of not greater than 25%, (c) permit operating disbursements (as defined in the Initial Budget) for the two week period following the Closing Date, to be more than the corresponding amounts set forth in the Initial Budget for such period, subject to a variance of not greater than 25%, and (d) permit operating disbursements (as defined in the Initial Budget or Budget, as then applicable) for the third week and each week thereafter, to be tested after the fourth week after the Closing Date on a trailing four week basis, to be more than the corresponding amounts set forth in the Initial Budget or Budget, as then applicable, for such period, subject to a variance of not greater than 15% (the foregoing covenants (b), (c) and (d) to be tested every week, commencing with the first week following the Closing Date), (e) permit cumulative total cash receipts (as defined in the Initial Budget) for the first two full weeks after the Closing Date to be less than the corresponding amounts set forth in the Initial Budget for such period subject to a variance of not greater than 25%, (f) permit cumulative total cash receipts (as defined in the Initial Budget or Budget, as then applicable) for the fourth week after the Closing Date and every two weeks thereafter, to be no less than the corresponding amounts set forth in the Initial Budget or Budget, as then applicable, for such two week period, subject to a variance of not greater than 20% (the foregoing covenants (e) and (f) to be tested every second week, commencing with the second full week following the Closing Date); provided further for 7.16(e) and 7.16(f), if a cash receipt that was scheduled to be received in the Initial Budget or Budget, as then applicable, in the week this covenant is tested is received within three business days after the test week, this receipt shall be applied as if it was received during the test week. Notwithstanding anything in this Agreement or the other Loan Documents to the contrary, in no event shall the Loan Parties make any expenditures, payments, repayments or prepayments, dividends, distributions, reimbursements or similar transaction to Novelion or any Subsidiary thereof (excluding Borrower and any Subsidiary thereof) during the term of this Agreement unless expressly set forth in the line item of the Budget titled “Permitted Affiliate Services Payments” or expressly permitted by the Novelion Subordination Agreement.

 

Section 7.17                              Compliance With Certain Laws .

 

(a)                                  (i) Violate any Anti-Terrorism Laws, (ii) engage in any transaction, investment, undertaking or activity that conceals the identity, source or destination of the proceeds from any category of prohibited offenses designated by the Organization for Economic Co-operation and Development’s Financial Action Task Force on Money Laundering or (iii) permit any of their respective Affiliates to violate these laws or engage in these actions.

 

(b)                                  (i) Deal in, or otherwise engage in any transaction related to, any property or interests in property blocked pursuant to any Anti-Terrorism Law, (ii) engage in or conspire to

 

65


 

engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempt to violate, any of the prohibitions set forth in any Anti-Terrorism Law.

 

(c)                                   Become an “investment company” or a company controlled by an “investment company” under the Investment Company Act of 1940, as amended.

 

ARTICLE VIII

 

EVENTS OF DEFAULT AND REMEDIES

 

Section 8.01                              Events of Default .  Any of the following events referred to in this Section 8.01 shall constitute an “ Event of Default ”:

 

(a)                                  Non-Payment .  Any Loan Party fails to pay (i) when and as required to be paid herein, any amount of principal of any Loan or (ii) within three (3) Business Days after the same becomes due in cash, any interest on any Loan or any other amount payable hereunder or with respect to any other Loan Document; or

 

(b)                                  Specific Covenants .  The Borrower fails to perform or observe any term, covenant or agreement contained in any of Section 6.01(c) , Section 6.01(d ), Section 6.01(e), Section 6.01(f),  Section 6.03(a) , Section 6.05 , Section 6.07 , Section 6.10(b) , Section 6.12, Section 6.19 or Article VII ; or

 

(c)                                   Other Defaults .  Any Loan Party fails to perform or observe any other covenant or agreement (not specified in Section 8.01(a)  or (b)  above) contained in any Loan Document on its part to be performed or observed and such failure continues for fifteen (15) days after receipt by the Borrower of written notice thereof by the Administrative Agent or the Required Lenders; or

 

(d)                                  Representations and Warranties .  Any representation, warranty, certification or statement of fact made or deemed made by or on behalf of any Loan Party herein, in any other Loan Document, or in any document required to be delivered in connection herewith or therewith shall be incorrect or misleading in any material respect when made or deemed made; or

 

(e)                                   Cross-Default .  Any Loan Party or any Subsidiary (A) fails to make any payment beyond the applicable grace period with respect thereto, if any (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of any Indebtedness (other than Indebtedness hereunder) having an aggregate principal amount of not less than the Threshold Amount, or (B) fails to observe or perform any other agreement or condition relating to any such Indebtedness, or any other event occurs, the effect of which default or other event is to cause, or to permit the holder or holders of such Indebtedness (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, with the giving of notice if required, such Indebtedness to become due or to be repurchased, prepaid, defeased or redeemed (automatically or otherwise), or an offer to repurchase, prepay, defease or redeem such Indebtedness to be made, prior to its stated maturity; or

 

66


 

(f)                                    Insolvency Proceedings, Etc .  Any Loan Party or any Subsidiary institutes or consents to the institution of any proceeding under any Debtor Relief Law, or makes a general assignment for the benefit of creditors; or applies for or consents to the appointment of any receiver, interim receiver, receiver and manager, trustee, custodian, conservator, liquidator, rehabilitator, administrator, administrative receiver or similar officer for it or for all or any material part of its property; or any receiver, interim receiver, receiver and manager, trustee, custodian, conservator, liquidator, rehabilitator, administrator, administrative receiver or similar officer is appointed without the application or consent of such Person and the appointment continues undischarged or unstayed for sixty (60) calendar days; or any proceeding under any Debtor Relief Law relating to any such Person or to all or any material part of its property is instituted without the consent of such Person and continues undismissed or unstayed for sixty (60) calendar days; or an order for relief is entered in any such proceeding; or

 

(g)                                   Inability to Pay Debts; Attachment .  (i) Any Loan Party or any Subsidiary becomes unable or admits in writing its inability or fails generally to pay its debts as they become due, or (ii) any writ or warrant of attachment or execution or similar process in respect of a claim in excess of the Threshold Amount is issued or levied against all or any material part of the property of the Loan Parties and their Subsidiaries, taken as a whole, and is not released, vacated, stayed or fully bonded within sixty (60) days after its issue or levy; or

 

(h)                                  Judgments .  There is entered against any Loan Party or any Subsidiary a final judgment or order for the payment of money in an aggregate amount exceeding the Threshold Amount (to the extent not covered by independent third-party insurance as to which the insurer has been notified of such judgment or order and does not deny or fail to confirm coverage) and such judgment or order shall not have been satisfied, vacated, discharged or stayed or bonded pending an appeal for a period of sixty (60) consecutive days; or

 

(i)                                      ERISA .  (i) An ERISA Event occurs with respect to a Pension Plan or Multiemployer Plan which has resulted or would reasonably be expected to result in liability of any Loan Party under Title IV of ERISA in an aggregate amount which would reasonably be expected to exceed the Threshold Amount, (ii) any Loan Party, any Subsidiary or any ERISA Affiliate fails to pay when due, after the expiration of any applicable grace period, any installment payment with respect to its Withdrawal Liability under Section 4201 of ERISA under a Multiemployer Plan in an aggregate amount which would reasonably be expected to exceed the Threshold Amount, or (iii) any Loan Party, any Subsidiary or any ERISA Affiliate shall have been notified by the sponsor of a Multiemployer Plan that such Multiemployer Plan is in reorganization or is being terminated, within the meaning of Title IV of ERISA, and as a result of such reorganization or termination the aggregate annual contributions of the Loan Parties, the Subsidiaries and the ERISA Affiliates to all Multiemployer Plans that are then in reorganization or being terminated have been or will be increased over the amounts contributed to such Multiemployer Plans for the plan years of such Multiemployer Plans immediately preceding the plan year in which such reorganization or termination occurs

 

67


 

by an aggregate amount which would reasonably be expected to exceed the Threshold Amount; or

 

(j)                                     Invalidity of Loan Documents .  Any material provision of any Loan Document, at any time after its execution and delivery and for any reason other than as expressly permitted hereunder or thereunder or the satisfaction in full of all the Obligations, ceases to be in full force and effect; or any Loan Party contests in any manner the validity or enforceability of any provision of any Loan Document; or any Loan Party denies that it has any or further liability or obligation under any Loan Document (other than as a result of repayment in full of the Obligations and termination of the Aggregate Commitments), purports to revoke or rescind any Loan Document or asserts that any Collateral Document is invalid or unenforceable; or

 

(k)                                  Change of Control; Structure .  There occurs any (i) Change of Control or (ii) any change to the ownership of direct and indirect Subsidiaries of Novelion from the ownership structure set forth on Schedule 5.14 ; or

 

(l)                                      Liens .  Any Collateral Document shall for any reason cease to create a valid and perfected Lien (having the priorities specified therein and the Novelion Subordination Agreement) on and security interest in the Collateral; or

 

(m)                              Dissolution or Liquidation .  Any Loan Party voluntarily or involuntarily dissolves or is dissolved, liquidates or is liquidated or files a motion with a bankruptcy court seeking authorization to dissolve or liquidate; or

 

(n)                                  Failure to Conduct Business .  If any Loan Party is enjoined, restrained or in any way prevented by court order from continuing to conduct all or any material part of its business affairs or any Loan Party or any of their respective Subsidiaries’ cessation of all or any material part of its business operations (other than in connection with a sale of assets permitted by the Loan Documents or otherwise consented to by the Required Lenders); or

 

(o)                                  Novelion .  (i) Novelion or any of such Subsidiaries becomes the subject of any event described in Sections 8.01(f), or (ii) with respect to the board of directors of the Borrower, (A) any of the independent directors on such board resigns, is terminated or is otherwise removed (unless replaced with the prior consent of the Required Lenders, which consent not to be unreasonably withheld, conditioned or delayed, concurrently at the time of such termination or removal or within five Business Days, in the case of resignation), (B) the number of independent directors is reduced or (C) the independent directors no longer constitute 50% of such board of directors;

 

(p)                                  Financial Advisor .  The Borrower no longer retains Alix Partners as its financial advisor unless replaced with a financial advisor acceptable to the Required Lenders; or

 

(q)                                  Subordination .   The Novelion Subordination Agreement or any other subordination agreement shall for any reason be revoked or invalidated or otherwise cease to be in full force and effect, any Person shall be in breach thereof (including

 

68


 

receipt of any payment or other property in violation of the Novelion Subordination Agreement or any other subordination agreement) or contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder, or the Obligations shall for any reason be subordinated or shall not have the priority contemplated by this Agreement, in each case except as set forth in the Novelion Subordination Agreement.

 

Section 8.02                              Remedies Upon Event of Default .  (a) If any Event of Default occurs and is continuing, the Administrative Agent may take any or all of the following actions:

 

(i)                                      declare the commitment of each Lender to make Loans to be terminated, whereupon such commitments shall be terminated;

 

(ii)                                   declare the unpaid principal amount of all outstanding Loans, all interest accrued and unpaid thereon, and all other amounts owing or payable hereunder or under any other Loan Document to be immediately due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived by the Borrower;

 

(iii)                                set-off against any outstanding Obligations amounts held for the account of the Loan Parties as cash collateral or in the accounts of any Loan Party maintained by or with the Administrative Agent, any Lender or their respective Affiliates; and

 

(iv)                               take any action or exercise on behalf of itself and the Lenders all rights and remedies available to it and the Lenders under the Loan Documents or applicable Law.

 

(b)                                  If an Event of Default has occurred and is continuing:  (i) the Administrative Agent shall have for the benefit the Secured Parties, in addition to all other rights of the Administrative Agent and the Lenders, the rights and remedies of a secured party under the Uniform Commercial Code; (ii) the Administrative Agent may, at any time, take possession of the Collateral and keep it on any Loan Party’s premises, at no cost (including any charge pursuant to Section 506(c) of the Bankruptcy Code) to the Administrative Agent or any Lender, or remove any part of it to such other place or places as the Administrative Agent may desire, or the Borrower shall, upon the Administrative Agent’s demand, at the Borrower’s cost, assemble the Collateral and make it available to the Administrative Agent at a place or places reasonably convenient to the Administrative Agent; and (iii) the Administrative Agent may sell and deliver any Collateral at public or private sales, for cash, upon credit or otherwise, at such prices and upon such terms as the Administrative Agent deems advisable at the direction of the Required Lenders, and may, if the Administrative Agent at the direction of the Required Lenders deems it reasonable, postpone or adjourn any sale of the Collateral by an announcement at the time and place of sale or of such postponed or adjourned sale without giving a new notice of sale.  Without in any way requiring notice to be given in the following manner, the Loan Parties agree that any notice by the Administrative Agent of sale, disposition or other intended action hereunder or in connection herewith, whether required by the Uniform Commercial Code or otherwise, shall constitute reasonable notice to the Loan Parties if such notice is mailed by

 

69


 

registered or certified mail, return receipt requested, postage prepaid, or is delivered personally against receipt to the Borrower, at least ten (10) Business Days prior to such action to the Borrower’s address specified herein.  If any Collateral is sold on terms other than payment in full at the time of sale, no credit shall be given against the Obligations until the Administrative Agent or the Lenders receive payment, and if the buyer defaults in payment, the Administrative Agent may resell the Collateral without further notice to the Loan Parties.  In the event the Administrative Agent seeks to take possession of all or any portion of the Collateral by judicial process, the Loan Parties irrevocably waives:  (A) the posting of any bond, surety or security with respect thereto which might otherwise be required; (B) any demand for possession prior to the commencement of any suit or action to recover the Collateral; and (C) any requirement that the Administrative Agent retain possession and not dispose of any Collateral until after trial or final judgment.  The Loan Parties agree that the Administrative Agent has no obligation to preserve rights to the Collateral or marshal any Collateral for the benefit of any Person.  The Administrative Agent is hereby granted a license or other right to use, without charge, but subject to the terms of the of licenses to the Loan Parties with respect to Intellectual Property licensed to the Loan Parties, the Loan Parties’ Intellectual Property and advertising matter, or any similar property, in completing production of, advertising or selling any Collateral,  provided, that such licenses to be granted hereunder with respect to trademarks and service marks shall be subject to the maintenance of quality standards with respect to the goods and services on which such trademarks and service marks are used sufficient to preserve the validity and enforceability of such trademark and service marks and the applicable Loan Party’s rights under all licenses and all franchise agreements shall inure to the Administrative Agent’s benefit for such purpose.  The proceeds of sale shall be applied first to all expenses of sale, including attorneys’ fees, and then to the Obligations in accordance with Section 8.03.

 

Section 8.03                              Application of Funds .  If the circumstances described in Section 2.08(f)  have occurred, or after the exercise of remedies provided for in Section 8.02 any amounts received on account of the Obligations shall be applied by the Administrative Agent in the following order, subject to the terms and conditions of the Novelion Subordination Agreement:

 

First , to payment of that portion of the Obligations constituting fees, indemnities, expenses and other amounts (other than principal and interest, but including Attorney Costs payable under Section 10.04 and amounts payable under Article III ) payable to the Administrative Agent in its capacity as such;

 

Second , to payment of that portion of the Obligations constituting fees, indemnities and other amounts (other than principal and interest) payable to the Lenders (including Attorney Costs payable under Section 10.04 and amounts payable under Article III ), ratably among them in proportion to the amounts described in this clause Second payable to them;

 

Third , to payment of that portion of the Obligations constituting accrued and unpaid interest and fees in respect of the New Money Loans (including, but not limited to, post-petition interest), ratably among the Lenders in proportion to the respective amounts described in this clause Third payable to them;

 

70


 

Fourth , to payment of that portion of the Obligations constituting unpaid principal or face amounts of the New Money Loans, ratably among the Lenders in proportion to the respective amounts described in this clause Fourth held by them;

 

Fifth , to the payment of that portion of the Obligations constituting accrued and unpaid interest in respect of the Roll Up Loans, ratably among the Lenders in proportion to the respective amounts described in this clause Fifth payable to them;

 

Sixth , to the payment of that portion of the Obligations constituting unpaid principal or face amounts of the Roll Up Loans, ratably among the Lenders in proportion to the respective amounts described in this clause Sixth held by them;

 

Seventh , to the payment of all other Obligations of the Loan Parties that are due and payable to the Administrative Agent and the other Secured Parties on such date, ratably based upon the respective aggregate amounts of all such Obligations owing to the Administrative Agent and the other Secured Parties on such date; and

 

Last , the balance, if any, after all of the Obligations have been indefeasibly paid in full, for the account of and paid to the Loan Parties or whoever may be lawfully entitled thereto.

 

The Loan Parties shall remain liable for any deficiency.

 

ARTICLE IX

 

ADMINISTRATIVE AGENT AND OTHER AGENTS

 

Section 9.01                              Appointment and Authorization .  (a) Each Lender hereby irrevocably appoints, designates and authorizes the Administrative Agent to take such action on its behalf under the provisions of this Agreement and each other Loan Document and to exercise such powers and perform such duties as are expressly delegated to it by the terms of this Agreement or any other Loan Document, together with such powers as are reasonably incidental thereto.  Notwithstanding any provision to the contrary contained in this Agreement or in any other Loan Document, the Administrative Agent shall have no duties or responsibilities, except those expressly set forth herein, nor shall the Administrative Agent have or be deemed to have any fiduciary relationship with any Lender or Participant, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or any other Loan Document or otherwise exist against the Administrative Agent.  Without limiting the generality of the foregoing sentence, the use of the term “agent” herein and in the other Loan Documents with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable Law.  Instead, such term is used merely as a matter of market custom, and is intended to create or reflect only an administrative relationship between independent contracting parties.

 

Notwithstanding any provision contained in this Agreement providing for any action in the Administrative Agent’s reasonable discretion or approval of any action or matter in the Administrative Agent’s reasonable satisfaction, the Administrative Agent shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary

 

71


 

rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents) which may be delivered by electronic transmission (including e-mail by such Lenders or counsel to the Required Lenders (which on the date hereof is Latham & Watkins LLP); provided that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable Law and shall, in the Administrative Agent’s sole discretion, be accompanied by indemnity or security satisfactory to the Administrative Agent and subject to the indemnification set forth in Section 9.07.  The Administrative Agent shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to the Borrower, any other Loan Party or any of their respective Affiliates that is communicated to or obtained by the Person serving as the Administrative Agent or any other Agent-Related Person in any capacity.

 

The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document, or the creation, perfection or priority of any Lien purported to be created by the Collateral Documents, (v) the value or the sufficiency of any Collateral, or (vi) the satisfaction of any condition set forth in Article IV or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.

 

(b)                                  The Administrative Agent shall also act as the “collateral agent” under the Loan Documents, and each of the Lenders (in its capacity as a Lender) hereby irrevocably appoints and authorizes the Administrative Agent to act as the agent of (and to hold any security interest, charge or other Lien created by the Collateral Documents for and on behalf of or on trust for) such Lender for purposes of acquiring, holding and enforcing any and all Liens on Collateral granted by any of the Loan Parties to secure any of the Obligations, together with such powers and discretion as are reasonably incidental thereto.  In this connection, the Administrative Agent, as “collateral agent” (and any co-agents, sub-agents and attorneys-in-fact appointed by the Administrative Agent pursuant to Section 9.02 for purposes of holding or enforcing any Lien on the Collateral (or any portion thereof) granted under the Collateral Documents, or for exercising any rights and remedies thereunder at the direction of the Administrative Agent), shall be entitled to the benefits of all provisions of this Article IX (including Section 9.07 , as though such co-agents, sub-agents and attorneys-in-fact were the “collateral agent” under the Loan Documents) as if set forth in full herein with respect thereto.

 

Section 9.02                              Delegation of Duties .  The Administrative Agent may execute any of its duties under this Agreement or any other Loan Document (including for purposes of holding or enforcing any Lien on the Collateral (or any portion thereof) granted under the

 

72


 

Collateral Documents or of exercising any rights and remedies thereunder) by or through Affiliates, agents, employees or attorneys-in-fact, such sub-agents as shall be deemed necessary by the Administrative Agent, and shall be entitled to advice of counsel, both internal and external, and other consultants or experts concerning all matters pertaining to such duties.  The Administrative Agent shall not be responsible for the negligence or misconduct of any agent or sub-agent or attorney-in-fact that it selects in the absence of gross negligence or willful misconduct as determined by a final nonappealable judgment of a court of competent jurisdiction.

 

Section 9.03                              Liability of the Administrative Agent .  No Agent-Related Person shall (a) be liable to any Lender for any action taken or omitted to be taken by any of them under or in connection with this Agreement or any other Loan Document or the transactions contemplated hereby (except for its own gross negligence or willful misconduct, as determined by the final nonappealable judgment of a court of competent jurisdiction, in connection with its duties expressly set forth herein), or (b) be responsible in any manner to any Lender or Participant for any recital, statement, representation or warranty made by any Loan Party or any officer thereof, contained herein or in any other Loan Document, or in any certificate, report, statement or other document referred to or provided for in, or received by the Administrative Agent under or in connection with, this Agreement or any other Loan Document, or the validity, effectiveness, genuineness, enforceability or sufficiency of this Agreement or any other Loan Document, or the perfection or priority of any Lien or security interest created or purported to be created under the Collateral Documents, or for any failure of any Loan Party or any other party to any Loan Document to perform its obligations hereunder or thereunder. No Agent-Related Person shall be under any obligation to any Lender or Participant to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this Agreement or any other Loan Document, or to inspect the properties, books or records of any Loan Party or any Affiliate thereof. The Administrative Agent shall not be responsible or liable for special, indirect, punitive or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Administrative Agent has been advised of the likelihood of such loss or damage and regardless of the form of action.  In no event shall the Administrative Agent be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, future changes in applicable law or regulation, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Administrative Agent shall use reasonable efforts consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.

 

Section 9.04                              Reliance by the Administrative Agent .  (a) The Administrative Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing, communication, signature, resolution, representation, notice, consent, certificate, affidavit, letter, telegram, facsimile, telex or telephone message, electronic mail message, statement or other document or conversation believed by it in good faith to be genuine and correct and to have been signed, sent or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to any Loan Party), independent accountants and other experts selected by the Administrative Agent.  The Administrative Agent shall be fully justified in

 

73


 

failing or refusing to take any action under any Loan Document unless it shall first receive such advice or concurrence of the Required Lenders as it deems appropriate and, if it so requests, it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense which may be incurred by it by reason of taking or continuing to take any such action.  The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement or any other Loan Document in accordance with a request or consent of the Required Lenders (or such greater number of Lenders as may be expressly required hereby in any instance) and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders.

 

(b)                                  For purposes of determining compliance with the conditions specified in Section 4.01 , each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Closing Date specifying its objection thereto.

 

Section 9.05                              Notice of Default .  The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default, except with respect to defaults in the payment of principal, interest and fees required to be paid to the Administrative Agent for the account of the Lenders, unless the Administrative Agent shall have received written notice from a Lender or the Borrower referring to this Agreement, describing such Default and stating that such notice is a “notice of default”.  The Administrative Agent will promptly notify the Lenders of its receipt of any such notice.  The Administrative Agent shall take such action with respect to any Event of Default as may be directed by the Required Lenders in accordance with Article VIII ; provided that unless and until the Administrative Agent has received any such direction, the Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Event of Default as it shall deem advisable or in the best interest of the Lenders.

 

Section 9.06                              Credit Decision; Disclosure of Information by the Administrative Agent .  Each Lender acknowledges that no Agent-Related Person has made any representation or warranty to it, and that no act by the Administrative Agent hereafter taken, including any consent to and acceptance of any assignment or review of the affairs of any Loan Party or any Affiliate thereof, shall be deemed to constitute any representation or warranty by any Agent-Related Person to any Lender as to any matter, including whether Agent-Related Persons have disclosed material information in their possession.  Each Lender represents to the Administrative Agent that it has, independently and without reliance upon any Agent-Related Person and based on such documents and information as it has deemed appropriate, made its own appraisal of and investigation into the business, prospects, operations, property, financial and other condition and creditworthiness of the Loan Parties and their respective Subsidiaries, and all applicable bank or other regulatory Laws relating to the transactions contemplated hereby, and made its own decision to enter into this Agreement and to extend credit to the Borrower and the other Loan Parties hereunder. Each Lender also represents that it will, independently and without reliance upon any Agent-Related Person and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Loan Documents, and to make

 

74


 

such investigations as it deems necessary to inform itself as to the business, prospects, operations, property, financial and other condition and creditworthiness of the Borrower and the other Loan Parties. Except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative Agent herein, the Administrative Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the business, prospects, operations, property, financial and other condition or creditworthiness of any of the Loan Parties or any of their respective Affiliates which may come into the possession of any Agent-Related Person.

 

Section 9.07                              Indemnification of the Administrative Agent .  Whether or not the transactions contemplated hereby are consummated, the Lenders shall indemnify upon demand each Agent-Related Person (to the extent not reimbursed by or on behalf of any Loan Party and without limiting the obligation of any Loan Party to do so), pro rata, and hold harmless each Agent-Related Person from and against any and all Indemnified Liabilities to the extent incurred by it; provided that no Lender shall be liable for the payment to any Agent-Related Person of any portion of such Indemnified Liabilities to the extent resulting from such Agent-Related Person’s own gross negligence or willful misconduct, as determined by the final non-appealable judgment of a court of competent jurisdiction; provided that no action taken in accordance with the directions of the Required Lenders (or such other number or percentage of the Lenders as shall be required by the Loan Documents) shall be deemed to constitute gross negligence or willful misconduct for purposes of this Section 9.07 .  In the case of any investigation, litigation or proceeding giving rise to any Indemnified Liabilities, this Section 9.07 applies whether any such investigation, litigation or proceeding is brought by any Lender or any other Person.  Without limitation of the foregoing, each Lender shall reimburse the Administrative Agent upon demand for its ratable share of any costs or out-of-pocket expenses (including Attorney Costs) incurred by the Administrative Agent in connection with the preparation, execution, delivery, administration, modification, amendment or enforcement (whether through negotiations, legal proceedings or otherwise) of, or legal advice in respect of rights or responsibilities under, this Agreement, any other Loan Document, or any document contemplated by or referred to herein, to the extent that the Administrative Agent is not reimbursed for such expenses by or on behalf of the Borrower; provided that such reimbursement by the Lenders shall not affect the Borrower’s continuing reimbursement obligations with respect thereto, if any.  The undertaking in this Section 9.07 shall survive termination of the Aggregate Commitments, the payment of all other Obligations and the resignation or removal of the Administrative Agent.

 

Section 9.08                              The Administrative Agent in its Individual Capacity .  The Administrative Agent and its Affiliates may make loans to, issue letters of credit for the account of, accept deposits from, acquire Equity Interests in and generally engage in any kind of banking, trust, financial advisory, underwriting or other business with each of the Loan Parties and their respective Affiliates as though the Administrative Agent were not the Administrative Agent hereunder and without notice to or consent of the Lenders.  The Lenders acknowledge that, pursuant to such activities, the Administrative Agent or its Affiliates may receive information regarding any Loan Party or any Affiliate of a Loan Party (including information that may be subject to confidentiality obligations in favor of such Loan Party or such Affiliate) and acknowledge that the Administrative Agent shall not be under any obligation to provide such information to them.  With respect to its Loans, the Administrative Agent shall have the same rights and powers under this Agreement as any other Lender and may exercise such rights and

 

75


 

powers as though it were not the Administrative Agent, and the terms “Lender” and “Lenders” include Cantor Fitzgerald Securities in its individual capacity.

 

Section 9.09                              Successor Agents .  The Administrative Agent may resign as the Administrative Agent upon thirty (30) days’ notice to the Lenders and the Borrower.  If the Administrative Agent resigns under this Agreement, the Required Lenders shall appoint a successor agent for the Lenders.  If no successor agent is appointed prior to the effective date of the resignation of the Administrative Agent, the retiring Administrative Agent may appoint, after consulting with the Lenders, a successor agent from among the Lenders.  Upon the acceptance of its appointment as successor agent hereunder, the Person acting as such successor agent shall succeed to all the rights, powers and duties of the retiring Administrative Agent and the term “Administrative Agent”, shall mean such successor administrative agent and/or supplemental administrative agent, as the case may be, and the retiring Administrative Agent’s appointment, powers and duties as the Administrative Agent shall be terminated.  After the retiring Administrative Agent’s resignation hereunder as the Administrative Agent, the provisions of this Article IX and Section 10.04 and Section 10.05 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was the Administrative Agent under this Agreement.  If no successor agent has accepted appointment as the Administrative Agent by the date which is thirty (30) days following the retiring Administrative Agent’s notice of resignation, the retiring Administrative Agent’s resignation shall nevertheless thereupon become effective and the Lenders shall perform all of the duties of the Administrative Agent hereunder until such time, if any, as the Required Lenders appoint a successor agent as provided for above.  Lenders assuming the role of Administrative Agent as specified in the immediately preceding sentence shall assume the rights and obligations of the Administrative Agent (including the indemnification provisions set forth in Section 9.07 ) as if each such Lender were the Administrative Agent.  Upon the acceptance of any appointment as the Administrative Agent hereunder by a successor and upon the execution and filing or recording of such financing statements, or amendments thereto, and such amendments or supplements to the Mortgages, and such other instruments or notices, as may be necessary or desirable, or as the Required Lenders may reasonably request, in order to continue the perfection of the Liens granted or purported to be granted by the Collateral Documents, the successor Administrative Agent shall thereupon succeed to and become vested with all the rights, powers, discretion, privileges, and duties of the retiring Administrative Agent, and the retiring Administrative Agent shall be discharged from its duties and obligations under the Loan Documents.

 

Section 9.10                              Administrative Agent May File Proofs of Claim .  The Administrative Agent (irrespective of whether the principal of any Loan shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered, by intervention in such proceeding or otherwise:

 

(a)                                  to file and prove an administrative claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders and the Administrative Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Lenders and the Administrative Agent and their respective agents and

 

76


 

counsel and all other amounts due the Lenders and the Administrative Agent under Section 2.05 and Section 10.04 or otherwise hereunder) allowed in an applicable proceeding; and

 

(b)                                  to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same; and

 

(c)                                   any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due to the Administrative Agent under Section 2.05 and Section 10.04 or otherwise hereunder.

 

Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such proceeding.

 

Section 9.11                              Release of Collateral and Guarantee .  The Lenders irrevocably agree and authorize the Administrative Agent:

 

(a)                                  to release any Lien on any property granted to or held by the Administrative Agent under any Loan Document (i) upon termination of the Aggregate Commitments and payment in full in cash of all Obligations (other than (A) contingent indemnification obligations not yet accrued and payable and (B) any other obligation (including a guarantee) that is contingent in nature) (the date upon which the conditions in this Section 9.11(a)(i)  shall have been satisfied, the “ Termination Date ”), (ii) upon any permitted sale, lease, transfer or other disposition of any item of Collateral of any Loan Party (including, without limitation, as a result of the sale, in accordance with the terms of the Loan Documents, of the Loan Party that owns such Collateral) in accordance with the terms of the Loan Documents, (iii) subject to Section 10.01 , if the release of such Lien is approved, authorized or ratified in writing by the Required Lenders, or (iv) if the property subject to such Lien is owned by a Guarantor, upon release of such Guarantor from its obligations under the Guarantee and Collateral Agreement pursuant to clause (b)  below; and

 

(b)                                  in the case of any Subsidiary, such Person ceasing to be subject to Section 6.11 as a result of a transaction permitted hereunder (as certified by a Responsible Officer) and the Borrower notifying the Administrative Agent in writing that it wishes such Guarantor to be released from its obligations under the Guarantee and Collateral Agreement.

 

77


 

The Administrative Agent will, at the Borrower’s expense, execute and deliver to such Loan Party such documents as such Loan Party may reasonably request to evidence the release of Collateral pursuant to this Section 9.11 from the assignment and security interest granted under the Collateral Documents (or the release of the Guarantor from its Guarantee Obligations in respect of the Obligations) in accordance with the terms of the Loan Documents ( provided that the Borrower shall have delivered to the Administrative Agent a certificate of a Responsible Officer certifying that such transaction has been consummated in compliance with the Loan Documents and the execution and delivery of such documents are authorized and permitted under the Loan Documents, and the Administrative Agent may conclusively rely on such certification without further inquiry).  Upon request by the Administrative Agent at any time, the Required Lenders will confirm in writing the Administrative Agent’s authority to release its interest in particular types or items of property in accordance with this Section 9.11 .

 

Section 9.12                              Other Agents; Arrangers and Managers .  None of the Lenders shall have any right, power, obligation, liability, responsibility or duty under this Agreement other than those applicable to all Lenders as such.  Without limiting the foregoing, none of the Lenders shall have or be deemed to have any fiduciary relationship with any other Lender.  Each Lender acknowledges that it has not relied, and will not rely, on any of the other Lenders in deciding to enter into this Agreement or in taking or not taking action hereunder.

 

Section 9.13                              Appointment of Supplemental Administrative Agent .  (a) It is the purpose of this Agreement and the other Loan Documents that there shall be no violation of any Law of any jurisdiction denying or restricting the right of banking corporations or associations to transact business as agent or trustee in such jurisdiction.  It is recognized that in case of litigation under this Agreement or any of the other Loan Documents, and in particular in case of the enforcement of any of the Loan Documents, or in case the Administrative Agent deems in its reasonable discretion that by reason of any present or future Law of any jurisdiction it may not exercise any of the rights, powers or remedies granted herein or in any of the other Loan Documents or take any other action which may be desirable or necessary in connection therewith, the Administrative Agent is hereby authorized to appoint an additional individual or institution selected by the Administrative Agent in its sole discretion as a separate trustee, co-trustee, administrative agent, collateral agent, administrative sub-agent or administrative co-agent (any such additional individual or institution being referred to herein individually as a “ Supplemental Administrative Agent ” and collectively as “ Supplemental Administrative Agents ”).

 

(b)                                  In the event that the Administrative Agent appoints a Supplemental Administrative Agent with respect to any Collateral, (i) each and every right, power, privilege or duty expressed or intended by this Agreement or any of the other Loan Documents to be exercised by or vested in or conveyed to the Administrative Agent with respect to such Collateral shall be exercisable by and vest in such Supplemental Administrative Agent to the extent, and only to the extent, necessary to enable such Supplemental Administrative Agent to exercise such rights, powers and privileges with respect to such Collateral and to perform such duties with respect to such Collateral, and every covenant and obligation contained in the Loan Documents and necessary to the exercise or performance thereof by such Supplemental Administrative Agent shall run to and be enforceable by either the Administrative Agent or such Supplemental Administrative Agent, and (ii) the provisions of this Article IX and of Section 10.04 and

 

78


 

Section 10.05 that refer to the Administrative Agent shall inure to the benefit of such Supplemental Administrative Agent and all references therein to the Administrative Agent shall be deemed to be references to the Administrative Agent and/or such Supplemental Administrative Agent, as the context may require.

 

(c)                                   Should any instrument in writing from any Loan Party be required by any Supplemental Administrative Agent so appointed by the Administrative Agent for more fully and certainly vesting in and confirming to him or it such rights, powers, privileges and duties, the Borrower shall, or shall cause such Loan Party to, execute, acknowledge and deliver any and all such instruments promptly upon request by the Administrative Agent.  In case any Supplemental Administrative Agent, or a successor thereto, shall die, become incapable of acting, resign or be removed, all the rights, powers, privileges and duties of such Supplemental Administrative Agent, to the extent permitted by Law, shall vest in and be exercised by the Administrative Agent until the appointment of a new Supplemental Administrative Agent.

 

ARTICLE X

 

MISCELLANEOUS

 

Section 10.01                       Amendments, Etc.   No amendment or waiver of any provision of this Agreement, nor consent to any departure by any Loan Party therefrom, shall in any event be effective unless the same shall be in writing and signed by the Required Lenders and the Borrower, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given; provided , however , that:

 

(a)                                  no amendment, waiver or consent shall, unless in writing and signed by all of the Lenders, do any of the following at any time:

 

(i)                                      change the number of Lenders or the percentage of (x) the Commitments or (y) the aggregate unpaid principal amount of Loans that, in each case, shall be required for the Lenders or any of them to take any action hereunder (including pursuant to any change to the definition of “Required Lenders”),

 

(ii)                                   release one or more Guarantors (or otherwise limit such Guarantors’ liability with respect to the Obligations owing to the Administrative Agent and the Lenders under the Guarantee and Collateral Agreement), if such release or limitation is in respect of all or substantially all of the value represented by the Guarantee and Collateral Agreement to the Lenders,

 

(iii)                                release, or subordinate the Administrative Agent’s Liens in, all or substantially all of the Collateral in any transaction or series of related transactions (other than as expressly permitted herein),

 

(iv)                               amend any provision of Section 2.10 , or

 

(v)                                  amend any provision of this Section 10.01 ;

 

79


 

(b)                                  no amendment, waiver or consent shall, unless in writing and signed by each Lender specified below for such amendment, waiver or consent:

 

(i)                                      increase the Commitments of a Lender without the consent of such Lender;

 

(ii)                                   reduce the principal of, or stated rate of interest on, the Loans owed to a Lender or any fees or other amounts stated to be payable hereunder or under the other Loan Documents to such Lender without the consent of such Lender; provided if the Required Lenders agree to waive any Event of Default and such waiver is effective in accordance with this Section 10.01 or if the Required Lenders agree to change any financial definitions that would reduce the stated rate of interest or any fees or other non-principal amounts stated to be payable hereunder or under the other Loan Documents pursuant to any amendment, waiver or consent not being effected in order to reduce the stated rate of interest or such fees or other amounts, then only the consent of the Required Lenders shall be necessary to waive any obligation of the Borrower to pay interest at the Default Rate in connection with such waived Event of Default or reduce the stated rate of interest or such fees in connection with such amendment, waiver or consent described in this proviso to clause (b)(ii), as applicable; or

 

(iii)                                postpone any date scheduled for any payment of principal of, or interest on, the Loans pursuant to Section 2.03 or Section 2.04 , any date scheduled for payment or for any date fixed for any payment of fees hereunder in each case payable to a Lender without the consent of such Lender; or

 

(iv)                               modify Section 8.03 in any manner that adversely affects the Lenders without the consent of each Lender directly and adversely affected thereby; or

 

(v)                                  modify Section 2.09 without the consent of each Lender directly and adversely affected thereby;

 

provided further that no amendment, waiver or consent shall, unless in writing and signed by the Administrative Agent in addition to the Lenders required above to take such action, affect the rights or duties of the Administrative Agent under this Agreement or the other Loan Documents.

 

Section 10.02                       Notices and Other Communications; Facsimile and Electronic Copies .  (a)  General .  Unless otherwise expressly provided herein, all notices and other communications provided for hereunder or under any other Loan Document shall be in writing (including by facsimile transmission) (and, as to service of process, only in writing and in accordance with applicable law) and, to the extent set forth in Section 10.02(e) , in an electronic medium and delivered as set forth in Section 10.02(e) .  All such written notices shall be mailed, faxed or delivered to the applicable address, facsimile number or electronic mail address, and all notices and other communications expressly permitted hereunder to be given by telephone shall be made to the applicable telephone number, as follows:

 

(i)                                      if to any Loan Party:

 

80


 

Aegerion Pharmaceuticals, Inc.
One Main Street, Suite 800
Cambridge, MA 02142
Attention:  Barbara Chan

Facsimile No.: (617) 945-7968

Email: barbara.chan@aegerion.com

 

With a copy (which shall not constitute notice) to:

 

Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019

Attention: Leonard Klingbaum, Esq.

Facsimile No.: (212) 728-9290

Email: lklingbaum@willkie.com

 

(ii)                                   if to the Administrative Agent, to the address, facsimile number, electronic mail address or telephone number specified for such Person on Schedule 10.02 or to such other address, facsimile number, electronic mail address or telephone number as shall be designated by such party in a notice to the other parties from time to time; and

 

(iii)                                if to any other Lender, to the address, facsimile number or electronic mail address specified in its Administrative Questionnaire or to such other address, facsimile number, electronic mail address or telephone number as shall be designated by such party in a written notice to the Borrower and the Administrative Agent.

 

All such notices and other communications shall be deemed to be given or made upon the earlier to occur of (i) actual receipt by the relevant party hereto and (ii) (A) if delivered by hand or by courier, when signed for by or on behalf of the relevant party hereto; (B) if delivered by mail, four (4) Business Days after deposit in the mails, postage prepaid; (C) if delivered by facsimile, when sent and receipt has been confirmed by telephone; and (D) if delivered by electronic mail (which form of delivery is subject to the provisions of Section 10.02(b) ), when delivered; provided that notices and other communications to the Borrower and the Administrative Agent pursuant to Article II shall not be effective until actually received by such Person during the Person’s normal business hours.  In no event shall a voice mail message be effective as a notice, communication or confirmation hereunder.

 

(b)                                  Effectiveness of Facsimile Documents and Signatures .  Loan Documents may be transmitted and/or signed by facsimile or other electronic transmission (including a .pdf or .tif copy); provided that original copies are delivered promptly thereafter (it being understood that the failure to request or deliver the same shall not limit the effectiveness of any document or signature delivered by facsimile or electronic transmission).

 

(c)                                   Reliance by the Administrative Agent and Lenders .  The Administrative Agent and the Lenders shall be entitled to rely and act upon any notices (including telephonic

 

81


 

Committed Loan Notices) in good faith purportedly given by or on behalf of the Borrower even if (i) such notices were not made in a manner specified herein, were incomplete or were not preceded or followed by any other form of notice specified herein, or (ii) the terms thereof, as understood by the recipient, varied from any confirmation thereof.  The Borrower shall indemnify each Agent-Related Person and each Lender from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given by or on behalf of the Borrower in the absence of gross negligence or willful misconduct by such Agent-Related Person or such Lender as determined by a final non-appealable judgment.

 

(d)                                  Notice to other Loan Parties .  The Borrower agrees that notices to be given to any other Loan Party under this Agreement or any other Loan Document may be given to the Borrower in accordance with the provisions of this Section 10.02 with the same effect as if given to such other Loan Party in accordance with the terms hereunder or thereunder.

 

(e)                                   The Borrower hereby agrees that it will provide to the Administrative Agent all information, documents and other materials that it is obligated to furnish to the Administrative Agent pursuant to the Loan Documents, including, without limitation, all notices, requests, financial statements, financial and other reports, certificates and other information materials, but excluding any such communication that (i) relates to a request for a new Loan, (ii) relates to the payment of any principal or other amount due under this Agreement prior to the scheduled date therefor, (iii) provides notice of any Default or Event of Default under this Agreement or (iv) is required to be delivered to satisfy any condition precedent to the effectiveness of this Agreement and/or any Loan hereunder (all such non-excluded communications being referred to herein collectively as “ Communications ”), by transmitting the Communications in an electronic/soft medium in a format acceptable to the Administrative Agent to an electronic mail address specified by the Administrative Agent to the Borrower.  In addition, the Borrower agrees to continue to provide the Communications to the Administrative Agent in the manner specified in the Loan Documents but only to the extent requested by the Administrative Agent.  The Borrower further agrees that the Administrative Agent may make the Communications available to the Lenders by posting the Communications on IntraLinks or a substantially similar electronic transmission system (the “ Platform ”).

 

(f)                                    THE PLATFORM IS PROVIDED “AS IS” AND “AS AVAILABLE.”  THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE COMMUNICATIONS OR THE ADEQUACY OF THE PLATFORM AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS OR OMISSIONS IN THE COMMUNICATIONS.  NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY THE AGENT PARTIES IN CONNECTION WITH THE COMMUNICATIONS OR THE PLATFORM.  IN NO EVENT SHALL THE ADMINISTRATIVE AGENT OR ANY OF ITS AFFILIATES OR ANY OF THEIR RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, ADVISORS OR REPRESENTATIVES (COLLECTIVELY, “ AGENT PARTIES ”) HAVE ANY LIABILITY TO THE BORROWER, ANY LENDER OR ANY OTHER PERSON OR ENTITY FOR DAMAGES OF ANY KIND, INCLUDING, WITHOUT LIMITATION, DIRECT OR

 

82


 

INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES (WHETHER IN TORT, CONTRACT OR OTHERWISE) ARISING OUT OF THE BORROWER’S OR THE ADMINISTRATIVE AGENT’S TRANSMISSION OF COMMUNICATIONS THROUGH THE PLATFORM, EXCEPT TO THE EXTENT THE LIABILITY OF ANY AGENT PARTY IS FOUND IN A FINAL NON-APPEALABLE JUDGMENT BY A COURT OF COMPETENT JURISDICTION TO HAVE RESULTED PRIMARILY FROM SUCH AGENT PARTY’S GROSS NEGLIGENCE OR WILLFUL MISCONDUCT.

 

(g)                                   The Administrative Agent agrees that the receipt in accordance with Section 10.02 of the Communications by the Administrative Agent at its e-mail address set forth on Schedule 10.02 shall constitute effective delivery of the Communications to the Administrative Agent for purposes of the Loan Documents.  Each Lender agrees that notice to it (as provided in the next sentence) specifying that the Communications have been posted to the Platform shall constitute effective delivery of the Communications to such Lender for purposes of the Loan Documents.  Each Lender agrees (i) to notify the Administrative Agent in writing (including by electronic communication) from time to time of such Lender’s e-mail address to which the foregoing notice may be sent by electronic transmission and (ii) that the foregoing notice may be sent to such e-mail address.  Nothing herein shall prejudice the right of the Administrative Agent or any Lender to give any notice or other communication pursuant to any Loan Document in any other manner specified in such Loan Document.

 

(h)                                  Each Loan Party hereby acknowledges that certain of the Lenders may be “public-side” Lenders (i.e., Lenders that do not wish to receive material non-public information with respect to any Loan Party or its securities) (each, a “ Public Lender ”).  Each Loan Party hereby agrees that (i) Communications that are to be made available on the Platform to Public Lenders who notify the Borrower and the Administrative Agent of such Lender’s status as a Public Lender shall be clearly and conspicuously marked by such Loan Party as “PUBLIC,” which, at a minimum, shall mean that the word “PUBLIC” shall appear prominently on the first page thereof, (ii) by marking Communications “PUBLIC,” each Loan Party shall be deemed to have authorized the Administrative Agent and the Lenders to treat such Communications as either publicly available information or not material information (although it may contain sensitive business information and remains subject to the confidentiality undertakings of Section 10.08 ) with respect to such Loan Party or its securities for purposes of United States Federal and state securities laws, (iii) all Communications marked “PUBLIC” are permitted to be made available through a portion of the Platform designated “Public Side Information,” and (iv) the Administrative Agent shall be entitled to treat any Communications that are not marked “PUBLIC” as being suitable only for posting on a portion of the Platform not designated “Public Side Information.”

 

(i)                                      EACH LENDER ACKNOWLEDGES THAT UNITED STATES FEDERAL AND STATE SECURITIES LAWS PROHIBIT ANY PERSON WITH MATERIAL, NON-PUBLIC INFORMATION ABOUT AN ISSUER FROM PURCHASING OR SELLING SECURITIES OF SUCH ISSUER OR, SUBJECT TO CERTAIN LIMITED EXCEPTIONS, FROM COMMUNICATING SUCH INFORMATION TO ANY OTHER PERSON.  EACH LENDER AGREES TO COMPLY WITH APPLICABLE LAW AND ITS RESPECTIVE CONTRACTUAL OBLIGATIONS WITH RESPECT TO CONFIDENTIAL

 

83


 

AND MATERIAL NON-PUBLIC INFORMATION.  Each Lender that is not a Public Lender confirms to the Administrative Agent that such Lender has adopted and will maintain internal policies and procedures reasonably designed to permit such Lender to take delivery of Restricting Information (as defined below) and maintain its compliance with applicable law and its respective contractual obligations with respect to confidential and material non-public information.  A Public Lender may elect not to receive Communications and Information that contains material non-public information with respect to the Loan Parties or their securities (such Communications and Information, collectively, “ Restricting Information ”), in which case it will identify itself to the Administrative Agent as a Public Lender.  Such Public Lender shall not take delivery of Restricting Information and shall not participate in conversations or other interactions with the Agent Parties, any Lender or any Loan Party in which Restricting Information may be discussed.  No Agent Party, however, shall by making any Communications and Information (including Restricting Information) available to a Lender (including any Public Lender), by participating in any conversations or other interactions with a Lender (including any Public Lender) or otherwise, be responsible or liable in any way for any decision a Lender (including any Public Lender) may make to limit or to not limit its access to the Communications and Information.  In particular, no Agent Party shall have, and the Administrative Agent, on behalf of all Agent Parties, hereby disclaims, any duty to ascertain or inquire as to whether or not a Lender (including any Public Lender) has elected to receive Restricting Information, such Lender’s policies or procedures regarding the safeguarding of material nonpublic information or such Lender’s compliance with applicable laws related thereto.  Each Public Lender acknowledges that circumstances may arise that require it to refer to Communications and Information that might contain Restricting Information.  Accordingly, each Public Lender agrees that it will nominate at least one designee to receive Communications and Information (including Restricting Information) on its behalf and identify such designee (including such designee’s contact information) on such Public Lender’s Administrative Questionnaire.  Each Public Lender agrees to notify the Administrative Agent in writing from time to time of such Public Lender’s designee’s address to which notice of the availability of Restricting Information may be sent.  Each Public Lender confirms to the Administrative Agent and the Lenders that are not Public Lenders that such Public Lender understands and agrees that the Administrative Agent and such other Lenders may have access to Restricting Information that is not available to such Public Lender and that such Public Lender has elected to make its decision to enter into this Agreement and to take or not take action under or based upon this Agreement, any other Loan Document or related agreement knowing that, so long as such Person remains a Public Lender, it does not and will not be provided access to such Restricting Information.  Nothing in this Section 10.02(i)  shall modify or limit a Lender’s (including any Public Lender) obligations under Section 10.08 with regard to Communications and Information and the maintenance of the confidentiality of or other treatment of Communications or Information.

 

Section 10.03                       No Waiver; Cumulative Remedies .  No failure by any Lender or the Administrative Agent to exercise, and no delay by any such Person in exercising, any right, remedy, power or privilege hereunder or under any other Loan Document shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.  The rights, remedies, powers and privileges herein provided, and provided under each other Loan Document, are cumulative and not exclusive of any rights, remedies, powers and privileges provided by Law.

 

84


 

Section 10.04                       Costs and Expenses .  The Borrower agrees (a) to pay or reimburse the Administrative Agent and Lenders for all reasonable and documented out-of-pocket costs and expenses incurred before, on or after the Closing Date in connection with the preparation, execution, delivery and administration of this Agreement and the other Loan Documents, and any amendment, waiver, consent or other modification of the provisions hereof and thereof requested by the Borrower or negotiated in consultation with Borrower (in each case, whether or not the transactions contemplated thereby are consummated), including all Attorney Costs of Latham & Watkins LLP, as counsel to the Lenders, and Shipman & Goodwin LLP, as counsel to the Administrative Agent (and, in the event of any actual conflict of interest, additional counsel to the affected parties), (b) to pay or reimburse the Administrative Agent and each Lender for all reasonable and documented out-of-pocket costs and expenses incurred in connection with the enforcement of any rights or remedies under this Agreement or the other Loan Documents (including all costs and expenses incurred in connection with any workout or restructuring in respect of the Loans, all such costs and expenses incurred during any legal proceeding and including one counsel to the Administrative Agent and one counsel to the Lenders and, to the extent reasonably necessary, local counsel for each of the Administrative Agent and the Lenders in any relevant jurisdiction (and, in the event of any actual conflict of interest, additional counsel to the affected parties) and (c) without limiting the generality of the foregoing, to pay all reasonable and documented out-of-pocket fees and expenses of any financial advisory, appraisers or accounting firm retained by or for the benefit of the Administrative Agent or Lenders or by Latham & Watkins LLP, as counsel to the Lenders, including, without limitation, the fees and expenses of the Financial Advisor (subject to Section 4.01(c) with respect to fees and expenses through the Closing Date).  The foregoing costs and expenses shall include all reasonable search, filing, recording and title insurance charges and fees related thereto, and other reasonable and documented out-of-pocket expenses incurred by the Administrative Agent.  The agreements in this Section 10.04 shall survive the termination of the Aggregate Commitments and repayment of all other Obligations.  All amounts due under this Section 10.04 shall be paid within ten (10) Business Days of receipt by the Borrower of an invoice relating thereto setting forth such expenses in reasonable detail.  If any Loan Party fails to pay when due any costs, expenses or other amounts payable by it hereunder or under any Loan Document, such amount may be paid on behalf of such Loan Party by the Administrative Agent in its sole discretion.

 

Section 10.05                       Indemnification by the Borrower .  (a) Whether or not the transactions contemplated hereby are consummated, the Borrower shall indemnify and hold harmless the Administrative Agent, each Agent-Related Person (including without limitation, Shipman & Goodwin LLP), each Lender and their respective Affiliates, directors, officers, employees, counsel, agents, trustees, advisors and attorneys-in-fact (including without limitation, Latham & Watkins LLP and Ducera Partners LLC)  (collectively the “ Indemnitees ”) from and against any and all liabilities, obligations, losses, taxes, damages, penalties, claims, demands, actions, judgments, suits, costs, expenses and disbursements (including one counsel to the Administrative Agent and a separate counsel to the Lenders, taken as a whole) (and, in the event of any actual conflict of interest, additional counsel to the affected parties) of any kind or nature whatsoever which may at any time be imposed on, incurred by or asserted against any such Indemnitee in any way relating to or arising out of or in connection with (i) the execution, delivery, enforcement, performance or administration of any Loan Document or any other agreement, letter or instrument delivered in connection with the transactions contemplated thereby or the consummation of the transactions contemplated thereby, (ii) any Commitment or

 

85


 

Loan or the use or proposed use of the proceeds therefrom, (iii) any actual or alleged presence or release of Hazardous Materials on, at, under or from any property currently or formerly owned or operated by the Borrower, any Subsidiary or any other Loan Party, or any Environmental Liability related to the Borrower, any Subsidiary or any other Loan Party, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory (including any investigation of, preparation for, or defense of any pending or threatened claim, investigation, litigation or proceeding)  (any of the foregoing described in this clause (iv), a “ Proceeding ”) (all the foregoing described in clauses (i) to (iv), collectively, the “ Indemnified Liabilities ”), in all cases, whether or not caused by or arising, in whole or in part, out of the negligence of the Indemnitee and whether brought by an Indemnitee, a third party or by the Borrower or any other Loan Party or any of the Borrower’s or such Loan Party’s directors, shareholders or creditors, and regardless of whether any Indemnitee is a party thereto and whether or not any of the transactions contemplated hereby are consummated; provided that such indemnity shall not, as to any Indemnitees, be available to the extent that such liabilities, obligations, losses, damages, penalties, claims, demands, actions, judgments, suits, costs, expenses or disbursements resulted from the gross negligence or willful misconduct of such Indemnitee or of any affiliate, director, officer, employee, counsel, agent or attorney-in-fact of such Indemnitee as determined by a final non-appealable judgment of a court of competent jurisdiction.  No Indemnitee shall be liable for any damages arising from the use by others of any information or other materials obtained through the Platform, nor shall any Indemnitee or any Loan Party have any liability for any special, punitive, indirect or consequential damages relating to this Agreement or any other Loan Document.  All amounts due in respect of costs, expenses and disbursements under this Section 10.05 shall be paid within ten (10) Business Days after demand therefor; provided , that each Indemnitee receiving any such reimbursement shall repay such amounts to the relevant Loan Party in the event that such Indemnitee shall not be entitled thereto pursuant to the provisions hereof.  The agreements in this Section 10.05 shall survive the resignation or removal of the Administrative Agent, the replacement of any Lender, the termination of the Aggregate Commitments and the repayment, satisfaction or discharge of all the other Obligations.

 

(b)                                  The Borrower shall not be liable for any settlement of any Proceedings effected without its consent (which consent shall not be unreasonably withheld or delayed), but if settled with the Borrower’s consent or if there is a final judgment for the plaintiff in such Proceedings, the Borrower shall indemnify and hold harmless each Indemnitee from and against any Indemnified Liabilities in accordance with the foregoing clause (a).  The Borrower shall not, without the prior written consent of an Indemnitee (which consent shall not be unreasonably withheld or delayed), effect any settlement or consent to the entry of any judgment of any pending or threatened Proceedings in respect of which indemnity could have been sought hereunder by such Indemnitee unless (i) such settlement includes an unconditional release of such Indemnitee in form and substance satisfactory to such Indemnitee from all liability on claims that are the subject matter of such Proceedings, (ii) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnitee and (iii) contains customary confidentiality and non-disparagement provisions.

 

(c)                                   In the event that an Indemnitee is requested or required to appear as a witness in any action brought by or on behalf of or against the Borrower or any of its Subsidiaries or Affiliates in which such Indemnitee is not named as a defendant, the Borrower

 

86


 

shall reimburse such Indemnitee for all reasonable and documented expenses incurred by it in connection with such Indemnitee’s appearing and preparing to appear as such a witness, including without limitation, the reasonable and documented fees and expenses of its legal counsel.

 

Section 10.06                       Payments Set Aside .  To the extent that any payment by or on behalf of the Borrower is made to the Administrative Agent or any Lender, or the Administrative Agent or any Lender exercises its right of setoff, and such payment or the proceeds of such setoff or any part thereof is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by the Administrative Agent or such Lender in its discretion) to be repaid to a trustee, receiver or any other party, in connection with any proceeding, then (a) to the extent of such recovery, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such setoff had not occurred, and (b) each Lender severally agrees to pay to the Administrative Agent upon demand its applicable share of any amount so recovered from or repaid by the Administrative Agent, plus interest thereon from the date of such demand to the date such payment is made at a rate per annum equal to the Federal Funds Rate.

 

Section 10.07                       Successors and Assigns .

 

(a)                                  Successors and Assigns Generally .  The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby, except that neither the Borrower nor any other Loan Party may assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender, and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to an assignee in accordance with the provisions of Section 10.07(b) , (ii) by way of participation in accordance with the provisions of Section 10.07(d) , (iii) by way of pledge or assignment of a security interest subject to the restrictions of Section 10.07(e)  or (iv) to an SPC in accordance with the provisions of Section 10.07(f)  (and any other attempted assignment or transfer by any party hereto shall be null and void).  Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Participants to the extent provided in Section 10.07(d)  and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement.

 

(b)                                  Assignments by Lenders .  Any Lender may at any time assign to one or more assignees all or a portion of its Commitment and/or the Loans at the time owing to it (and its rights and obligations under this Agreement relating thereto); provided that any such assignment shall be subject to the following conditions:

 

(i)                                      Minimum Amounts .

 

(A)                                in the case of an assignment of the entire remaining amount of the assigning Lender’s Commitment and/or the Loans at the time owing to it or contemporaneous assignments to related Approved Funds (determined after giving effect to such assignments) that equal at least the amount specified in

 

87


 

paragraph (b)(i)(B)  of this Section in the aggregate or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned; and

 

(B)                                in any case not described in paragraph (b)(i)(A)  of this Section, the aggregate amount of the Commitment (which for this purpose includes Loans outstanding thereunder) or, if the applicable Commitment is not then in effect, the principal outstanding balance of the Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if “Trade Date” is specified in the Assignment and Assumption, as of the Trade Date) shall not be less than $1,000,000 unless the Borrower consents (such consent not to be unreasonably withheld or delayed and shall not be required if an Event of Default exists).

 

(ii)                                   Proportionate Amounts .  Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender’s rights and obligations under this Agreement with respect to the Loan or the Commitment assigned.

 

(iii)                                Required Consents .  Any such assignment shall require the prior written consent of the Borrower, which consent shall not be unreasonably withheld, conditioned, delayed or burdened ( provided , that it shall be deemed to be reasonable for the Borrower not to consent to any assignment to any Disqualified Person); provided , however , that (A) no consent of the Borrower shall be required for an assignment to a Lender, to an Affiliate of a Lender, to an Approved Fund or, if an Event of Default has occurred and is continuing, to any other assignee other than to any Disqualified Person, and (B) the Borrower shall be deemed to have consented to any such assignment unless it objects thereto by written notice delivered to the Administrative Agent within ten (10) Business Days after having received notice thereof; and

 

(iv)                               Assignment and Assumption .  The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $3,500; provided that the Administrative Agent may, in its sole discretion, elect to waive such processing and recordation fee in the case of any assignment.  The assignee, if it is not a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire and the tax documentation required pursuant to Section 3.01.

 

(v)                                  No Assignment to Certain Persons .  No such assignment shall be made to the Borrower or any of the Borrower’s Affiliates or Subsidiaries or any Disqualified Person.

 

(vi)                               No Assignment to Natural Persons .  No such assignment shall be made to a natural Person (or a holding company, investment vehicle or trust for, or owned and operated for the primary benefit of, a natural Person).

 

88


 

Subject to acceptance and recording thereof by the Administrative Agent pursuant to Section 10.07(c) , from and after the effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of Sections 3.01 , 3.02 , 10.04 and 10.05 with respect to facts and circumstances occurring prior to the effective date of such assignment.  Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this paragraph shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (d) of this Section.

 

(c)                                   Register .  The Administrative Agent, acting solely for this purpose as an agent of the Borrower, shall maintain at the Administrative Agent’s Office a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the “ Register ”).  The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement.  The Register shall be available for inspection by the Borrower and any Lender, at any reasonable time and from time to time upon reasonable prior notice.

 

(d)                                  Participations .  Any Lender may at any time, without the consent of, or notice to, the Borrower or the Administrative Agent, sell participations to any Person (other than a natural Person, or a holding company, investment vehicle or trust for, or owned and operated for the primary benefit of, a natural Person, or the Borrower or any of the Borrower’s Affiliates or Subsidiaries or any Disqualified Person) (each, a “ Participant ”) in all or a portion of its Commitment and/or the Loans at the time owing to it (and its rights and obligations under this Agreement relating thereto); provided that (i) such Lender’s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, and (iii) the Borrower, the Administrative Agent and Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement.  For the avoidance of doubt, each Lender shall be responsible for the indemnity under Section 9.07 with respect to any payments made by such Lender to its Participant(s).

 

Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and the other Loan Documents and to approve any amendment, modification or waiver of any provision of this Agreement or the other Loan Documents; provided that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, waiver or other modification described in Section 10.01(a)  or Section 10.01(b)  that directly and adversely affects such Participant.  The Borrower agrees that each Participant

 

89


 

shall be entitled to the benefits of Sections 3.01 and 3.02 (subject to the requirements and limitations therein, including the requirements under Section 3.01(g)  (it being understood that the documentation required under Section 3.01(g)  shall be delivered to the participating Lender)) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of this Section; provided that such Participant shall not be entitled to receive any greater payment under Sections 3.01 or 3.02 , with respect to any participation, than its participating Lender would have been entitled to receive, except to the extent such entitlement to receive a greater payment results from a Change in Law that occurs after the Participant acquired the applicable participation.  Each Lender that sells a participation agrees, at the Borrower’s request and expense, to use reasonable efforts to cooperate with the Borrower to effectuate the provisions of Section 3.04(b)  with respect to any Participant.  To the extent permitted by applicable Law, each Participant also shall be entitled to the benefits of Section 10.09 as though it were a Lender; provided that such Participant agrees to be subject to Section 2.09 as though it were a Lender.  Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or other obligations under the Loan Documents (the “ Participant Register ”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant’s interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations.  The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.  For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.

 

(e)                                   Certain Pledges .  Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement (including under its Note, if any) to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or central bank having jurisdiction over such Lender; provided that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.

 

(f)                                    SPCs .  Notwithstanding anything to the contrary contained herein, any Lender (a “ Granting Lender ”) may grant to a special purpose funding vehicle identified as such in writing from time to time by the Granting Lender to the Administrative Agent and the Borrower (an “ SPC ”) the option to provide all or any part of any Loan that such Granting Lender would otherwise be obligated to make pursuant to this Agreement; provided that (i) nothing herein shall constitute a commitment by any SPC to fund any Loan and (ii) if an SPC elects not to exercise such option or otherwise fails to make all or any part of such Loan, the Granting Lender shall be obligated to make such Loan pursuant to the terms hereof.  Each party hereto hereby agrees that (i) neither the grant to any SPC nor the exercise by any SPC of such option shall increase the costs or expenses or otherwise increase or change the obligations of the Borrower under this Agreement (including its obligations under Section 3.01 or 3.02 ), (ii) no

 

90


 

SPC shall be liable for any indemnity or similar payment obligation under this Agreement for which a Lender would be liable and such liability shall remain with the Granting Lender, and (iii) the Granting Lender shall for all purposes, including the approval of any amendment, waiver or other modification of any provision of any Loan Document, remain the lender of record hereunder.  The making of a Loan by an SPC hereunder shall utilize the Commitment of the Granting Lender to the same extent, and as if, such Loan were made by such Granting Lender.  Notwithstanding anything to the contrary contained herein, any SPC may (i) with notice to, but without prior consent of the Borrower and the Administrative Agent, assign all or any portion of its right to receive payment with respect to any Loan to the Granting Lender and (ii) disclose on a confidential basis any non-public information relating to its funding of Loans to any rating agency, commercial paper dealer or provider of any surety or Guarantee Obligation or credit or liquidity enhancement to such SPC.

 

(g)                                   Notwithstanding anything to the contrary contained herein, (1) any Lender may in accordance with applicable Law create a security interest in all or any portion of the Loans owing to it and the Note, if any, held by it and (2) any Lender that is a Fund may create a security interest in all or any portion of the Loans owing to it and the Note, if any, held by it to the trustee for holders of obligations owed, or securities issued, by such Fund as security for such obligations or securities; provided that unless and until such trustee actually becomes a Lender in compliance with the other provisions of this Section 10.07 , (i) no such pledge shall release the pledging Lender from any of its obligations under the Loan Documents and (ii) such trustee shall not be entitled to exercise any of the rights of a Lender under the Loan Documents even though such trustee may have acquired ownership rights with respect to the pledged interest through foreclosure or otherwise.

 

Section 10.08                       Confidentiality .  Each of the Administrative Agent and the Lenders agrees to maintain the confidentiality of the Information and to not use or disclose such information, except that Information may be disclosed (a) to its Affiliates and its and its Affiliates’ directors, officers, employees, trustees, investment advisors and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential); (b) to the extent requested by any Governmental Authority or examiner regulating any Lender or the Administrative Agent; (c) to the extent required by applicable Laws or regulations or by any subpoena or similar legal process; (d) to any other party to this Agreement; (e) to any pledgee referred to in Section 10.07(e)  or Section 10.07(g) , Eligible Assignee of or Participant in, or any prospective Eligible Assignee of or Participant in, any of its rights or obligations under this Agreement (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential); (f) with the written consent of the Borrower; (g) to the extent such Information becomes publicly available other than as a result of a breach of this Section 10.08 by the disclosing party; (h) to any rating agency when required by it (it being understood that, prior to any such disclosure, such rating agency shall undertake to preserve the confidentiality of any Information relating to the Loan Parties received by it from such Lender); (i) to the extent not known by it to consist of non-public information, (j) for purposes of establishing a “due diligence” defense or (k) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or

 

91


 

thereunder.  In addition, the Administrative Agent and the Lenders may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry, and service providers to the Administrative Agent and the Lenders in connection with the administration and management of this Agreement, the other Loan Documents, the Commitments and the Loans.  For the purposes of this Section 10.08 , “ Information ” means all information received from any Loan Party or its Affiliates or its Affiliates’ directors, officers, employees, trustees, investment advisors or agents, relating to the Borrower or any of their Subsidiaries or their business, other than any such information that is publicly available to the Administrative Agent or any Lender prior to disclosure by any Loan Party other than as a result of a breach of this Section 10.08 , including, without limitation, information delivered pursuant to Section 6.01 , 6.02 or 6.03 hereof.

 

Section 10.09                       Setoff .  In addition to any rights and remedies of the Administrative Agent and the Lenders provided by Law, upon the occurrence and during the continuance of any Event of Default, each Lender and its Affiliates and the Administrative Agent and its Affiliates is authorized at any time and from time to time, without prior notice to the Borrower or any other Loan Party, any such notice being waived by the Borrower (on its own behalf and on behalf of each Loan Party and its Subsidiaries) to the fullest extent permitted by applicable Law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held by, and other Indebtedness at any time owing by, such Lender and its Affiliates or the Administrative Agent and its Affiliates, as the case may be, to or for the credit or the account of the respective Loan Parties and their Subsidiaries against any and all Obligations owing to such Lender and its Affiliates or the Administrative Agent and its Affiliates hereunder or under any other Loan Document, now or hereafter existing, irrespective of whether or not the Administrative Agent or such Lender or Affiliate shall have made demand under this Agreement or any other Loan Document and although such Obligations may be contingent or unmatured or denominated in a currency different from that of the applicable deposit or Indebtedness.  Each Lender and the Administrative Agent agrees promptly to notify the Borrower and the Administrative Agent after any such set off and application made by such Lender or the Administrative Agent, as the case may be; provided that the failure to give such notice shall not affect the validity of such setoff and application.  The rights of the Administrative Agent and each Lender under this Section 10.09 are in addition to other rights and remedies (including other rights of setoff) that the Administrative Agent and such Lender may have.

 

Section 10.10                       Counterparts .  This Agreement and each other Loan Document may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  Delivery by facsimile transmission or other electronic transmission (including a .pdf or .tif copy) of an executed counterpart of a signature page to this Agreement and each other Loan Document shall be effective as delivery of an original executed counterpart of this Agreement and such other Loan Document; provided that original signatures shall be promptly delivered thereafter, it being understood that that the failure to request or deliver the same shall not limit the effectiveness of any document or signature delivered by facsimile or electronic transmission.

 

Section 10.11                       Integration .  This Agreement comprises the complete and integrated agreement of the parties on the subject matter hereof and thereof and supersedes all

 

92


 

prior agreements, written or oral, on such subject matter.  In the event of any conflict or inconsistency between the provisions of this Agreement and those of any other Loan Document, the provisions of this Agreement shall control; provided that the inclusion of supplemental rights or remedies in favor of the Administrative Agent or the Lenders in any other Loan Document shall not be deemed a conflict or inconsistency with this Agreement.  Each Loan Document was drafted with the joint participation of the respective parties thereto and shall be construed neither against nor in favor of any party, but rather in accordance with the fair meaning thereof.

 

Section 10.12                       Survival of Representations and Warranties .  All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof.  Such representations and warranties have been or will be relied upon by the Administrative Agent and each Lender, regardless of any investigation made by the Administrative Agent or any Lender or on their behalf and notwithstanding that the Administrative Agent or any Lender may have had notice or knowledge of any Default at the time of any Loan, and shall continue in full force and effect as long as any Loan or any other Obligation hereunder shall remain unpaid or unsatisfied.

 

Section 10.13                       Severability .  If any provision of this Agreement or the other Loan Documents is held to be illegal, invalid or unenforceable, the legality, validity and enforceability of the remaining provisions of this Agreement and the other Loan Documents shall not be affected or impaired thereby.  The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

Section 10.14                       GOVERNING LAW .  (a) THIS AGREEMENT AND EACH OTHER LOAN DOCUMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK (EXCEPT, WITH RESPECT TO ANY OTHER LOAN DOCUMENT, AS OTHERWISE EXPRESSLY PROVIDED THEREIN); PROVIDED THAT THE ADMINISTRATIVE AGENT AND THE LENDERS SHALL RETAIN ALL RIGHTS ARISING UNDER FEDERAL LAW.

 

(b)                                  ANY LEGAL ACTION OR PROCEEDING ARISING UNDER ANY LOAN DOCUMENT OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO ANY LOAN DOCUMENT, OR THE TRANSACTIONS RELATED HERETO OR THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, MAY BE BROUGHT IN THE COURTS OF THE STATE OF NEW YORK LOCATED IN NEW YORK COUNTY OR OF THE UNITED STATES FOR THE SOUTHERN DISTRICT OF SUCH STATE, AND BY EXECUTION AND DELIVERY OF THIS AGREEMENT, THE BORROWER, THE ADMINISTRATIVE AGENT AND EACH LENDER CONSENTS, FOR ITSELF AND IN RESPECT OF ITS PROPERTY, TO THE NON-EXCLUSIVE JURISDICTION OF THOSE COURTS.  THE BORROWER, THE ADMINISTRATIVE AGENT AND EACH LENDER IRREVOCABLY WAIVES ANY OBJECTION, INCLUDING ANY OBJECTION TO THE LAYING OF VENUE OR BASED ON THE GROUNDS OF FORUM NON CONVENIENS, WHICH IT MAY NOW OR HEREAFTER HAVE TO THE BRINGING OF ANY ACTION OR PROCEEDING IN SUCH JURISDICTION IN RESPECT OF ANY LOAN DOCUMENT OR OTHER DOCUMENT RELATED THERETO.

 

93


 

Section 10.15                       WAIVER OF RIGHT TO TRIAL BY JURY .  EACH PARTY TO THIS AGREEMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION ARISING UNDER ANY LOAN DOCUMENT OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO ANY LOAN DOCUMENT, OR THE TRANSACTIONS RELATED HERETO OR THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER FOUNDED IN CONTRACT OR TORT OR OTHERWISE; AND EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 10.15 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE SIGNATORIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

 

Section 10.16                       Binding Effect .  This Agreement shall become effective when it shall have been executed by the Borrower and the Administrative Agent, and the Administrative Agent shall have been notified by each Lender that each such Lender has executed it and thereafter shall be binding upon and inure to the benefit of the Borrower, the Administrative Agent and each Lender and their respective successors and assigns, except that the Borrower shall not have the right to assign its rights hereunder or any interest herein without the prior written consent of the Required Lenders.

 

Section 10.17                       Lender Action .  Each Lender agrees that it shall not take or institute any actions or proceedings, judicial or otherwise, for any right or remedy against any Loan Party or any other obligor under any of the Loan Documents (including the exercise of any right of setoff, rights on account of any banker’s lien or similar claim or other rights of self-help), or institute any actions or proceedings, or otherwise commence any remedial procedures, with respect to any Collateral or any other property of any such Loan Party, without the prior written consent of the Administrative Agent.  The provision of this Section 10.17 are for the sole benefit of the Lenders and shall not afford any right to, or constitute a defense available to, any Loan Party.

 

Section 10.18                       PATRIOT Act .  Each Lender hereby notifies the Borrower that pursuant to the requirements of the PATRIOT Act, it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender to identify the Borrower in accordance with the PATRIOT Act.  The Borrower agrees to provide, and to cause each other Loan Party to provide, such information promptly upon request.

 

Section 10.19                       No Advisory or Fiduciary Responsibility .  In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), the Borrower acknowledges and agrees, and acknowledges and agrees that it has informed its other Affiliates, that: (i) (A) no fiduciary, advisory or agency relationship between any of the Borrower and its Subsidiaries and the Administrative Agent or any Lender is intended to be or has been created in respect of any of the transactions contemplated hereby and by the other Loan Documents,

 

94


 

irrespective of whether the Administrative Agent or any Lender has advised or is advising any of the Borrower and its Subsidiaries on other matters, (B) the arranging and other services regarding this Agreement provided by the Administrative Agent and the Lenders are arm’s-length commercial transactions between the Loan Parties, on the one hand, and the Administrative Agent and the Lenders, on the other hand, (C) the Borrower has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (D) the Borrower is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents; (ii) (A) the Administrative Agent and the Lenders each is and has been acting solely as a principal and, except as may otherwise be expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for the Borrower or any of its Affiliates, or any other Person and (B) none of the Administrative Agent or any Lender has any obligation to the Borrower or any of its Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents; and (iii) the Administrative Agent and the Lenders and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower and its Affiliates, and none of the Administrative Agent or any Lender has any obligation to disclose any of such interests and transactions to the Borrower or any of its Affiliates.  To the fullest extent permitted by law, the Borrower hereby waives and releases any claims that it may have against the Administrative Agent and the Lenders with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby.

 

Section 10.20                       Acknowledgement and Consent to Bail-In of EEA Financial Institutions .  Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Lender that is an EEA Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of an EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by:

 

(a)                                  the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may be payable to it by any Lender that is an EEA Financial Institution; and

 

(b)                                  the effects of any Bail-In Action on any such liability, including, if applicable:

 

(i)                                      a reduction in full or in part or cancellation of any such liability;

 

(ii)                                   a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document; or

 

95


 

(iii)                                the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of any EEA Resolution Authority.

 

Section 10.21                       Novelion Subordination Agreement .  Each Lender hereby authorizes and directs the Administrative Agent to enter into the Novelion Subordination Agreement on behalf of such Lender and agrees that the Administrative Agent may take such actions on behalf of such Lender as are contemplated by the terms of the Novelion Subordination Agreement.  Any provision in the Novelion Subordination Agreement requiring the consent or approval of the Administrative Agent and/or the Senior Lenders (as defined in the Novelion Subordination Agreement) may be consented to or approved by the Administrative Agent at the direction of the Required Lenders or all Lenders as the case may be (which consent or approval shall be binding on all Lenders). Notwithstanding anything herein to the contrary, the Lien and security interest granted to the Administrative Agent pursuant to this Agreement or any other Loan Document and the exercise of any right or remedy by the Administrative Agent hereunder or under any other Loan Document are subject to the provisions of the Novelion Subordination Agreement. In the event of any conflict between the terms of the Novelion Subordination Agreement, this Agreement and any other Loan Document, the terms of the Novelion Subordination Agreement shall govern and control.

 

[Remainder of Page Intentionally Blank]

 

96


 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

 

 

AEGERION PHARMACEUTICALS, INC.,

 

as Borrower

 

 

 

By:

/s/ Barbara Chan

 

Name: Barbara Chan

 

Title: President

 

[Signature Page to Bridge Credit Agreement]

 


 

 

CANTOR FITZGERALD SECURITIES,

 

as Administrative Agent

 

 

 

By:

/s/ James Buccola

 

Name: James Buccola

 

Title: Head of Fixed Income

 

[Signature Page to Bridge Credit Agreement]

 


 

 

ATHYRIUM OPPORTUNITIES II ACQUISITION, LP,

 

as a Lender

 

 

 

By: Athyrium Opportunities Associates II LP, its general partner

 

 

 

By: Athyrium GP Holdings LLC, its general partner

 

 

 

By:

/s/ Andrew C. Hyman

 

Name: Andrew C. Hyman

 

Title: Authorized Signatory

 

 

 

ATHYRIUM OPPORTUNITIES III ACQUISITION, LP,

 

as a Lender

 

 

 

By: Athyrium Opportunities Associates III LP, its general partner

 

 

 

By: Athyrium Opportunities Associates III GP LLC, its general partner

 

 

 

By:

/s/ Andrew C. Hyman

 

Name: Andrew C. Hyman

 

Title: Authorized Signatory

 

[Signature Page to Bridge Credit Agreement]

 


 

 

1992 MSF INTERNATIONAL, LTD.,

 

as a Lender

 

 

 

 

By:

/s/ Jonathan Segal

 

Name: Jonathan Segal

 

Title: Managing Director

 

 

 

1992 TACTICAL CREDIT MASTER FUND, L.P.,

 

as a Lender

 

 

 

 

By:

/s/ Jonathan Segal

 

Name: Jonathan Segal

 

Title: Managing Director

 

[Signature Page to Bridge Credit Agreement]

 


Exhibit 10.2

 

Execution Version

 

AMENDMENT NO. 1 TO AND CONSENT UNDER THE

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT

 

This Amendment No. 1 to and Consent Under the Amended and Restated Loan and Security Agreement (this “ Amendment ”), dated as of November 8, 2018, is entered into by and among Aegerion Pharmaceuticals, Inc., a Delaware corporation (“ Borrower ”), Aegerion Pharmaceuticals Holdings, Inc., a Delaware corporation (“ New Guarantor ”) and Novelion Therapeutics Inc. (“ Novelion ”), a British Columbia corporation, as lender (in such capacity, “ Lender ”).

 

BACKGROUND

 

WHEREAS, Borrower and Lender are party to that certain Amended and Restated Loan and Security Agreement, dated as of March 15, 2018 (as amended, restated or otherwise modified from time to time, including, for the avoidance of doubt, as amended by this Amendment, the “ Intercompany Loan Agreement ”);

 

WHEREAS, Borrower, Sarissa Capital Offshore Master Fund LP (“ Sarissa Master Fund ”), Sarissa Capital Catapult Fund LLC (“ Sarissa Catapult Fund ”), Broadfin Healthcare Master Fund Ltd. (“ Broadfin Master Fund, ” together with Sarissa Master Fund and Sarissa Catapult Fund, the “ Shareholder Lenders ”), and Wilmington Savings Fund Society, FSB, as agent (the “ Shareholder Agent ”), are party to that certain Loan and Security Agreement, dated as of March 15, 2018 (as amended, restated or otherwise modified from time to time, the “ Shareholder Loan Agreement ” and, together with the Intercompany Loan Agreement, the “ Existing Loan Agreements ”);

 

WHEREAS, Lender and the Shareholder Lenders are party to that certain Subordination Agreement, dated as of March 15, 2018 (the “ Shareholder Subordination Agreement ”), which governs the relative priority of Borrower’s indebtedness under the Intercompany Loan Agreement and the Shareholder Loan Agreement;

 

WHEREAS, as of the date hereof (before giving effect to the transactions contemplated herein) the aggregate outstanding amount of (i) the Obligations with respect to the Term Loans (including, for the avoidance of doubt, outstanding principal and accrued and unpaid interest) under the Intercompany Loan Agreement is $40,146,570, and (ii) the “Obligations” (as defined in the Shareholder Loan Agreement) with respect to the “Term Loans” (including, for the avoidance of doubt, outstanding principal and accrued and unpaid interest) under the Shareholder Loan Agreement is $21,215,757 (“ Outstanding Shareholder Loans ”).

 

WHEREAS, in connection with the extension to Borrower of a new secured term loan facility in an aggregate original principal amount not to exceed $50,000,000 and of a roll up of certain existing Convertible Notes held by the Bridge Lenders in an amount not to exceed $22,500,000 pursuant to that certain Bridge Credit Agreement, dated as of November 8, 2018 (the “ Bridge Credit Agreement ”) attached hereto at Annex B , among Borrower, each lender party thereto (the “ Bridge Lenders ”) and Cantor Fitzgerald Securities, as agent to the Bridge Lenders, Borrower has requested that Lender (i) consent to Borrower (A) entering into the Bridge Credit Agreement and the other “Loan Documents” (as defined in the Bridge Credit Agreement (the “ Bridge Loan Documents ”)), (B) incurring additional Indebtedness in the form the “New Money Loans” (as defined in the Bridge Credit Agreement) (the “ New Money Bridge Loans ”) in an aggregate original principal amount not to exceed $50,000,000, (C) incurring additional Subordinated Debt in the form of the “Roll Up Loans” (as defined in the Bridge Credit Agreement) (the “ Junior Roll Up Loans ”, together with the New Money Bridge Loans, the “ Bridge Loans ”) in an aggregate principal amount not to exceed $22,500,000, provided that the Junior Roll Up Loans shall be subordinated and junior in right of payment to the Intercompany Loans on the terms and conditions set forth in the Subordination Agreement, dated as of November 8, 2018 (the “ Bridge

 


 

Subordination Agreement ”) among the lenders making the New Money Bridge Loans (in such capacity, the “ Senior Bridge Lenders ”), the lenders making the Junior Roll Up Loans (in such capacity, the “ Junior Bridge Lenders ”) and Lender and one hundred percent (100%) of the proceeds of the Junior Roll Up Loans will be applied to purchase Convertible Notes, which will be surrendered to the Trustee for cancellation and cancelled, (D) granting Liens and security interests in the Collateral in favor of the Bridge Lenders; provided that the Liens and security interests securing the Roll Up Loans shall be subordinated and junior to the Liens securing the Obligations under the Intercompany Loan Agreement on the terms and conditions set forth in the Bridge Subordination Agreement, (E) paying the reasonable and documented out-of-pocket costs and expenses of the Bridge Lenders in accordance with Section 10.04 of the Bridge Credit Agreement, and (F) repaying in full the Outstanding Shareholder Loans from the proceeds of the New Money Bridge Loans, subject to the contemporaneous termination of any commitments under the Shareholder Loan Agreement and the Shareholder Loan Agreement and all “Loan Documents” as defined therein and the release of all Liens securing Borrower’s obligations in respect of the foregoing on the terms and conditions set forth herein and in the Bridge Credit Agreement (the foregoing clauses (A)-(F), collectively, the “ Bridge Transactions ”), and (ii) agree to amend the Intercompany Loan Agreement as set forth herein;

 

WHEREAS, in consideration of Lender’s willingness to provide such consent and to amend the Intercompany Loan Agreement, in each case, as set forth herein and pursuant to the terms and conditions set forth herein, the parties hereto have agreed to join the New Guarantor as a Guarantor to the Intercompany Loan Agreement and the other Loan Documents, including the grant of a perfected security interest in and Lien on substantially all of its assets, which Lien and security interest shall be junior only to the “New Senior Debt,” as defined in, and as the term is set forth in, the Bridge Subordination Agreement, to secure the payment and performance in full of all of the Obligations under the Intercompany Loan Agreement and the other Loan Documents; and

 

WHEREAS, Lender is willing, subject and pursuant to the terms and conditions set forth herein and in the Intercompany Loan Agreement (as amended) to (i) consent to the Bridge Transactions and (ii) enter into this Amendment.

 

NOW, THEREFORE, in consideration of the matters set forth in the background above and the covenants and provisions herein set forth, and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

AGREEMENT

 

Section 1                                               Definitions .  Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Intercompany Loan Agreement (as amended by this Amendment); provided that each of “Certain Proceeds Reinvestment Budget,” “Permitted Designated Licensing Transaction” and “Permitted Designated Licensing Transaction Amount” has the meaning set forth on Annex D hereto and “Compliance Certificate” means the form set forth on Annex E hereto

 

Section 2                                               Conditions Precedent . The effectiveness of this Amendment is subject to the satisfaction or waiver of the following conditions precedent:

 

(a)                                  Lender shall have received, in form and substance satisfactory to Lender:

 

i.       counterparts of this Amendment executed by the Loan Parties;

 

ii.      the Guaranty, duly executed and delivered by New Guarantor, which Guaranty shall be substantially in the form attached hereto at Annex C;

 

2


 

iii.     a certificate of the Secretary or Assistant Secretary (or other equivalent officer or manager) of each Loan Party, dated as of the date hereof, which shall certify (A) copies of resolutions of the board of directors of such Loan Party authorizing (x) the execution, delivery and performance of this Amendment and the other Loan Documents to which such Loan Party is a party and (y) the granting by each Loan Party of the Liens upon the Collateral to secure the Obligations, (B) the incumbency and signature of the officers of each Loan Party authorized to execute this Amendment and the other Loan Documents and (C) copies of the Organizational Documents of each Loan Party as in effect on such date, complete with all amendments thereto;

 

iv.     good standing certificates of each Loan Party certified by the Secretary of State of the State of Delaware as of a date no earlier than thirty (30) days prior to the date hereof;

 

v.      a certificate of the appropriate official(s) of each jurisdiction of foreign qualification of each Loan Party, except for such jurisdictions where the failure to be so qualified would not reasonably be expected to have a Material Adverse Change, individually or in the aggregate, certifying as of a recent date not more than thirty (30) days prior to the date hereof, as to the subsistence in good standing of such Loan Party;

 

vi.     the Perfection Certificate of each Loan Party in form and substance satisfactory to Lender, dated as of the date hereof;

 

vii.    a certificate of a Responsible Officer of the Borrower certifying that (A) after giving effect to this Amendment, each of the representations and warranties of the Loan Parties set forth in the Intercompany Loan Agreement and each other Loan Document to which such Loan Party is true and correct in all material respects with the same effect as though made on and as of the date hereof (except, in each case, to the extent stated to relate to an earlier date, in which case such representation or warranty shall have been true and correct in all material respects on and as of such earlier date), provided that any representation and warranty that is qualified as to “materiality”, “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such respective dates; (B) before and after giving effect to this Amendment and the Bridge Transactions no Default or Event of Default exists; (C) each of the each of the representations and warranties of the Loan Parties set forth in Section 6 below is true and correct; and (D) attached thereto is a true, correct and complete copy of the Initial Budget; and

 

viii.   a legal opinion of counsel to the Loan Parties, dated as of the effective date hereof, in form and substance satisfactory to Lender.

 

(b)                                  Lender shall have received the results of recent lien searches in the jurisdiction or organization of each Loan Party and each jurisdiction where assets of the Loan Parties are located or such other jurisdictions as required by Lender, and such search results shall reveal no Liens on any of the assets of the Loan Parties except for Permitted Liens or Liens which shall be discharged on or prior to the date hereof pursuant to a payoff letter or other similar documentation satisfactory to Lender;

 

3


 

(c)                                   Lender shall have received evidence, satisfactory to Lender, that Borrower has paid, or caused to be paid, in-kind (being added to the principal amount of the Term Loans) on the date of the closing of the Bridge Transactions, to Lender, solely in its capacity as Lender under the Intercompany Loan Agreement, a fee equal to 0.50% of the aggregate outstanding principal the Term Loans after giving effect to the repayment of the Term Loans contemplated under Section 2(e)  below, which fee is equal to $183,233;

 

(d)                                  Lender shall have received evidence, satisfactory to Lender, that Borrower has paid, or caused to be paid, the reasonable and invoiced fees, costs and expenses of Goodwin Procter LLP and Evercore Group L.L.C., which Lender incurred in connection with the negotiation of this Amendment, the Bridge Subordination Agreement, the Guaranty and the other documents, agreements and transactions contemplated hereby and thereby, which amount shall not be in excess of $500,000;

 

(e)                                   Lender shall have received a payment of $3,500,000 from the proceeds of the “New Money Loans” (as defined in the Bridge Credit Agreement) in satisfaction of a portion of the outstanding Term Loans, which payment shall be made in accordance with Section 2.4 of the Intercompany Loan Agreement;

 

(f)                                    Lender shall have received, in each case in form and substance satisfactory to Lender, (i) a payoff letter or other evidence that (A) all “Obligations” (as defined in the Shareholder Loan Agreement) (other than inchoate indemnity obligations) have been satisfied in full and each Shareholder Lender is under no further obligations thereunder, (B) all commitments of the Shareholder Lenders under the Shareholder Loan Agreement have been terminated and (C) that all Liens granted under the Shareholder Loan Agreement are terminated and released, (ii) evidence that all Liens and security interests granted under the Shareholder Loan Agreement and the other “Loan Documents” (as defined in the Shareholder Loan Agreement) have been released and terminated and are no longer in force and effect, including, but not limited to, UCC-3 termination statements and releases with respect to filings at the United States Patent and Trademark Office and/or United States Copyright Office, as applicable, and (iii) evidence that the Convertible Notes purchased with the proceeds of the Junior Roll Up Loans have been surrendered to the Trustee for cancellation, and so cancelled, are no longer outstanding;

 

(g)                                   Lender shall have received executed counterparts to the Bridge Subordination Agreement, in form and substance satisfactory to Lender, duly executed and delivered by each of the Bridge Lenders;

 

(h)                                  Lender shall have received evidence that all of the conditions to funding the “New Money Loans” (as defined in the Bridge Credit Agreement) and the “Roll Up Loans” (as defined in the Bridge Credit Agreement) under the Bridge Credit Agreement (other than the consent contemplated under Section 8 hereof) shall have been satisfied or waived; and

 

(i)                                      Since December 31, 2017, there has been no event or circumstance, either individually or in the aggregate, that has had or would reasonably be expected to have a Material Adverse Change, except for (i) any matters set forth in any public filings of Novelion prior to the First Amendment Effective Date, (ii) any matters disclosed on the disclosure schedules to the “Loan Documents” (as defined in the Bridge Credit Agreement) as of the First Amendment Effective Date, and (iii) such events disclosed in writing to Lender or its Professionals prior to the First Amendment Effective Date.

 

Section 3                                               Amendment to the Intercompany Loan Agreement . The Intercompany Loan Agreement is hereby amended to delete the bold, stricken text (indicated textually in the same manner as the following example:  stricken text ) and to add the bold, double-underlined text (indicated textually in the same manner as the following example:  double underlined text ) as set forth in the pages of the

 

4


 

Intercompany Loan Agreement attached hereto as Annex A .

 

Section 4                                               Joinder to Loan Documents . By execution of this Amendment, the New Guarantor hereby joins as, assumes the duties, obligations, indebtedness, liabilities, covenants and undertakings of, adopts the obligations, liabilities and role of and becomes a Guarantor under the Intercompany Loan Agreement and the other Loan Documents.  All references to “Guarantor” or “Guarantors” and to “Loan Party” or “Loan Parties” contained in the Intercompany Loan Agreement and the other Loan Documents are hereby deemed for all purposes to also refer to and include the New Guarantor as a Guarantor or a Loan Party, as the case may be, and the New Guarantor hereby agrees to be bound by and comply with all terms and conditions of the Intercompany Loan Agreement and the other Loan Documents as if it were an original signatory to the Intercompany Loan Agreement and the other Loan Documents in such capacities, and the Intercompany Loan Agreement and the other Loan Documents are hereby deemed amended, as appropriate, to so provide.  Without limiting the generality of the provisions of this Section 4 , the New Guarantor agrees that it is, and will be, jointly and severally liable as a Guarantor for all Guarantee Obligations incurred prior to the date hereof by the existing Loan Parties under the Intercompany Loan Agreement and the other Loan Documents.

 

Section 5                                               Creation of Security Interest; Reaffirmation of Obligations .

 

(a)                                  Grant of Security Interest . Without limiting the generality of Section 4 or Sections 5(b)  and 5(d)  hereof, each Loan Party hereby grants to the Lender, to secure the payment and performance in full of all of the Obligations, a continuing security interest in, and pledges to Lender, the Collateral, wherever located, whether now owned or hereafter acquired or arising, and all proceeds and products thereof.  The grant of a security interest in the foregoing sentence is in addition to, and in furtherance of, Borrower’s grant of a security interest under the Intercompany Loan Agreement and, all security interests in and the pledges of the Collateral granted under the Intercompany Loan Agreement (the “ Existing Liens ”) are hereby ratified, confirmed, renewed, extended and carried forward by the Loan Parties as security for the Obligations.  The security interests in and pledges of the Collateral granted by the Intercompany Loan Agreement are in addition to and not a novation of the Existing Liens.  If the Intercompany Loan Agreement is terminated, the Lien granted thereafter in the Collateral shall continue until the Obligations (other than inchoate indemnity obligations) are satisfied in full, and at such time, Lender shall, at the Loan Parties’ sole cost and expense, terminate the security interests granted hereunder in the Collateral and all rights therein shall revert to the Loan Parties.

 

(b)                                  Priority of Security Interest .  The Loan Parties represent, warrant and covenant that (i) the security interest granted herein, under the Original Loan Agreement and under the Intercompany Loan Agreement, in each case, is and shall at all times continue to be a legal and valid perfected security interest in all Collateral, subordinated and junior only to (A) the Permitted Liens having priority by operation of applicable law, (B) the Permitted Liens which are permitted to have priority pursuant to the terms of the Intercompany Loan Agreement and (C) the New Money Bridge Loans and only to the extent of the terms set forth in the Bridge Subordination Agreement and (ii) the Obligations are not subject to offset, deduction, defense or claim against Lender.

 

(c)                                   Authorization to File Financing Statements and Other Perfection Documents .  Each Loan Party hereby authorizes Lender to file financing statements, without notice to such Loan Party, with all appropriate jurisdictions to perfect or protect Lender’s interests or rights hereunder. Each Loan Party hereby further authorizes Lender to file or record with the United States Patent and Trademark Office (and any successor office) such documents as may be necessary or advisable to perfect or protect Lender’s interest or rights hereunder. Notwithstanding the foregoing authorizations, each Loan Party agrees to file and deliver to Lender upon recording such financing statements as are or may be necessary to establish and maintain a valid, enforceable, perfected security interest in the Collateral as provided

 

5


 

herein and the other rights and security contemplated hereby or as Lender may from time to time reasonably request, and authorization to Lender hereunder shall not relieve the Loan Parties of its obligation to make such filings.

 

(d)                                  Reaffirmation of Obligations .  Each Loan Party hereby (i) acknowledges, affirms and reaffirms its obligations as set forth in the Intercompany Loan Agreement and the other Loan Documents, (ii) acknowledges, confirms and agrees that as of the date hereof, after giving effect to the payments contemplated to be made on the date hereof under Sections 2(c)  and 2(e) , the aggregate outstanding amount of Obligations with respect to the Term Loans under the Intercompany Loan Agreement is $36,829,803, (iii) agrees to continue to comply with, and be subject to, all of the terms, provisions, conditions, covenants, agreements and obligations applicable to it set forth in the Intercompany Loan Agreement and the other Loan Documents and (iv) acknowledges, confirms and agrees that the Intercompany Loan Agreement and each other Loan Documents is, and shall continue to be, in full force and effect, and is, and shall continue to be, the valid and binding obligation of such Loan Party, both before and after giving effect to this Amendment, and the consummation of the transactions contemplated hereby.

 

Section 6                                               Representations and Warranties . To induce the Lender to execute this Amendment, the Loan Parties hereby represents and warrants to Lender as follows:

 

(a)                                  the execution, delivery and performance of this Amendment has been duly authorized by all requisite action of each Loan Party, and this Amendment constitutes the legal, valid and binding obligation of each Loan Party, enforceable against such Loan Party in accordance with its terms, subject to bankruptcy, insolvency and similar laws affecting the enforceability of creditors’ rights generally and to general principles of equity;

 

(b)                                  after giving effect to this Amendment, each of the representations and warranties of the Loan Parties set forth in the Intercompany Loan Agreement and each other Loan Document to which such Loan Party is a party is true and correct in all material respects with the same effect as though made on and as of the date hereof (except, in each case, to the extent stated to relate to an earlier date, in which case such representation or warranty shall have been true and correct in all material respects on and as of such earlier date); provided that any representation or warranty that is qualified as to “materiality”, “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such respective dates;

 

(c)                                   all of the conditions to initial funding of the Bridge Loans and to the effectiveness of the consent pursuant to Section 8 below and the amendment of the Intercompany Loan Agreement pursuant to Section 3 above, have been satisfied or will be satisfied simultaneously with effectiveness of the consent pursuant to Section 8 below and the amendment of the Intercompany Loan agreement pursuant to Section 3 above; and

 

(d)                                  the Convertible Notes purchased with the proceeds of the Junior Roll Up Loans shall have been, or on the date of funding of the Bridge Loans shall be, (i) repurchased in the open market, by tender offer or exchange offer, by private agreement through counterparties or as otherwise permitted by applicable law and Section 2.11 of the Indenture and, in any case, in accordance with applicable law and (ii) surrendered to the Trustee for cancellation, and so cancelled, and no longer outstanding;

 

(e)                                   both before and after giving effect to this Amendment, no Default or Event of Default exists; and

 

6


 

(f)                                    a true, correct and complete copy of the Bridge Credit Agreement is attached hereto as Annex B and a true, correct and complete copy of the Initial Budget has been provided to Lender on the First Amendment Effective Date.

 

Section 7                                               Release .  Effective as of the date hereof, each of the Borrower and the Guarantor, on behalf of itself and its Subsidiaries, successors, assigns, administrators and legal representatives (each, a “ Company Releasor ”) hereby irrevocably releases and forever discharges Lender and each of its Subsidiaries (other than the Borrower and its Subsidiaries), successors and assigns, and each of its and their respective current, former or future equity holders (other than the Shareholder Lenders), directors, officers, employees, agents, or other representatives of any of them (collectively, “ Company Releasees ”), from all actions, causes of action, suits, claims and demands whatsoever, in law or in equity (collectively “ Claims ”), which any Company Releasor ever had, now has, or hereafter shall or may have, against any or all of the Company Releasees, whether known or unknown, contingent or accrued, liquidated or unliquidated, relating in any way to the Borrower, the Guarantor or their Subsidiaries, including, any Claims relating to the Original Loan Agreement, the Intercompany Loan Agreement, the other Loan Documents, or any Company Releasee’s direct or indirect ownership of any interest or investment in the Borrower, the Loan Parties or any of their Subsidiaries or any of their respective businesses, properties, assets or Contracts.  Notwithstanding the foregoing, this release shall not affect any of the liabilities or obligations of each Company Releasees (i) under this Amendment or the Intercompany Loan Agreement, or (ii) which arise out of fraud on the part of such Company Releasee. Each Company Releasor acknowledges that it may hereafter discover facts in addition to or different from those that it now knows or believes to be true with respect to the subject matter of this release and that the releases contained herein shall be and remain in effect as full and complete general releases, subject to the terms hereof notwithstanding the discovery or existence of any such additional or different facts.  Each Company Releasor (i) represents, warrants and acknowledges that it is familiar with the contents of Section 1542 of the Civil Code of the State of California (“ Section 1542 ”) and (ii) expressly waives and relinquishes any rights or benefits under Section 1542 or any similar statute or common law principle of any jurisdiction.  Section 1542 states: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.”

 

Section 8                                               Consent . Subject to the satisfaction of the conditions set forth in Section 2 hereof, on the terms and conditions set forth herein, Lender hereby consents to the Bridge Transactions; provided that no proceeds of the Bridge Loans shall be used to pay or reimburse any Person for the costs, fees and expenses incurred in connection with (including any investigation of or preparation therefor and whether or not the subject of any action or proceeding) any contest, challenge or dispute of the validity, attachment, perfection, priority (or lack of priority, with respect to the Liens securing) of the Term Loans and other Obligations or the Liens securing the Term Loans and other Obligations.

 

Section 9                                               Miscellaneous .

 

(a)                                  Effect of this Amendment . The parties hereto agree and acknowledge that nothing contained in this Amendment in any manner or respect limits or terminates any of the provisions of the Intercompany Loan Agreement or any of the other Loan Documents other than as expressly set forth herein and further agree and acknowledge that the Intercompany Loan Agreement and each of the other Loan Documents remain and continue in full force and effect and are hereby ratified and confirmed, in each case, as amended and supplemented hereby.  Except to the extent expressly set forth herein, the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any rights, power or remedy of Lender under the Intercompany Loan Agreement or any other Loan Document, nor constitute a waiver of any provision of the Intercompany Loan Agreement or any other Loan Document.  No delay on the part of Lender in exercising any of its respective rights, remedies, powers and privileges

 

7


 

under the Intercompany Loan Agreement or any of the Loan Documents or partial or single exercise thereof, shall constitute a waiver thereof.  None of the terms and conditions of this Amendment may be changed, waived, modified or varied in any manner, whatsoever, except in accordance with Section 12.6 of the Intercompany Loan Agreement.

 

(b)                                  Loan Document . For the avoidance of doubt, this Amendment shall be deemed a Loan Document as defined under the Intercompany Loan Agreement.   Any breach of any provision of this Agreement shall be an Event of Default under Section 8 of the Intercompany Loan Agreement.

 

(c)                                   Counterparts .  This Amendment may be executed in any number of counterparts and by the different parties on separate counterparts, and each such counterpart shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument.  Delivery of the executed counterpart of this Amendment by telecopy or electronic mail shall constitute effective delivery of such signature page.

 

(d)                                  Severability .  The illegality or unenforceability of any provision of this Amendment or any instrument or agreement required hereunder shall not in any way affect or impair the legality or enforceability of the remaining provisions of this Amendment or any instrument or agreement required hereunder.

 

(e)                                   Captions .  Section captions used in this Amendment are for convenience only, and shall not affect the construction of this Amendment.

 

(f)                                    Entire Agreement .  This Amendment, together with the Intercompany Loan Agreement and the other Loan Documents, embodies the entire agreement and understanding among the parties hereto and supersedes all prior or contemporaneous agreements and understandings of such Persons, verbal or written, relating to the subject matter hereof.

 

(g)                                   References .  Any reference to the Intercompany Loan Agreement contained in any notice, request, certificate, or other document executed concurrently with or after the execution and delivery of this Amendment shall be deemed to include this Amendment unless the context shall otherwise require.  Reference in any of this Amendment, the Intercompany Loan Agreement or any other Loan Document to the Intercompany Loan Agreement shall be a reference to the Intercompany Loan Agreement as amended hereby and as further amended, modified, restated, supplemented or extended from time to time.

 

(h)                                  Governing Law .  THIS AMENDMENT SHALL BE A CONTRACT MADE UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE. WITHOUT LIMITING THE FOREGOING, THIS AMENDMENT IS SUBJECT TO SECTION 11 OF THE INTERCOMPANY LOAN AGREEMENT.

 

(i)                                      Waiver of Jury Trial . TO THE FULLEST EXTENT PERMITTED BY LAW, BORROWER, GUARANTOR AND LENDER EACH WAIVES THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AMENDMENT, THE INTERCOMPANY LOAN AGREEMENT, THE OTHER LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR EACH PARTY TO ENTER INTO THIS AMENDMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.

 

8


 

[signature pages follow]

 

9


 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officers as of the day and year first above written.

 

 

AEGERION PHARMACEUTICALS, INC., as Borrower

 

 

 

 

By:

/s/ Barbara Chan

 

Name:

Barbara Chan

 

Title:

President

 

[Signature Page to Amendment]

 


 

 

AEGERION PHARMACEUTICALS HOLDINGS, INC., as New Guarantor

 

 

 

 

By:

/s/ Benjamin Harshbarger

 

Name:

Benjamin Harshbarger

 

Title:

President and Secretary

 

[Signature Page to Amendment]

 


 

 

NOVELION THERAPEUTICS INC., as Lender

 

 

 

 

By:

/s/ Benjamin S. Harshbarger

 

Name:

Benjamin S. Harshbarger

 

Title:

General Counsel and Secretary

 

[Signature Page to Amendment]

 


 

ANNEX A

 

Amendments to the Intercompany Loan Agreement

 


 

Execution Version

 

THE INDEBTEDNESS AND OTHER OBLIGATIONS OF AEGERION PHARMACEUTICALS, INC. (“BORROWER”) UNDER OR EVIDENCED HEREBY AND THE LIENS AND SECURITY INTERESTS SECURING THE SAME ARE SUBORDINATED AND SUBJECT TO THE TERMS AND CONDITIONS OF THE SUBORDINATION AGREEMENT, DATED AS OF 7, 2018, AMONG BORROWER, NOVELION THERAPEUTICS INC., AND THE LENDERS PARTY THERETO AS “NEW LENDERS”.

 

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT

 

THIS AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “ Agreement ”) dated as of March 15, 2018, between NOVELION THERAPEUTICS INC., a corporation incorporated under the laws of British Columbia (“ Lender ”), and AEGERION PHARMACEUTICALS, INC. , a Delaware corporation (“ Borrower ”) , AEGERION PHARMACEUTICALS HOLDINGS, INC., as a Guarantor, and the other Guarantors from time to time party hereto , provides for the amendment and restatement of the Original Loan Agreement (as defined below) and the terms on which, from and after the Restatement Effective Date (as defined below), Lender shall lend to Borrower and Borrower shall repay Lender.

 

The parties agree as follows:

 

1A .                              WAIVER.  Any default or event of default existing under the Original Loan Agreement as of the Restatement Effective Date, including without limitation any violation of any financial covenant is hereby irrevocably waived.  Without limiting the foregoing, Lender waives any right to require Borrower to pay default interest under the Original Loan Agreement with respect to any such defaults or events of default.

 

1                                          ACCOUNTING AND OTHER TERMS

 

Accounting terms not defined in this Agreement shall be construed following GAAP.  Calculations and determinations must be made following GAAP.  Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in Section 13.  All other terms contained in this Agreement, unless otherwise indicated, shall have the meaning provided by the Code to the extent such terms are defined therein.

 

2                                          LOAN AND TERMS OF PAYMENT

 

2.1                                Promise to Pay .  Borrower and Lender have entered into the Loan and Security Agreement, dated as of June 14, 2016, as amended by Amendment No. 1 to Loan and Security Agreement, dated as of October 20, 2017, between Borrower and Lender (as so amended and as otherwise modified prior to the Restatement Effective Date, the “ Original Loan Agreement ”).  As of the date hereof Restatement Effective Date, the outstanding principal balance of the Term Loans (as defined in the Original Loan Agreement), including PIK Interest (as defined in the Original Loan Agreement ) , is was $38,084,861 ( , and, as of the First Amendment Effective Date the outstanding principal balance of the Term Loans is $36,829,803 (inclusive of all PIK Interest through and including the First Amendment Effective Date, the “ Term Loans ”).  Borrower hereby unconditionally promises to pay Lender the outstanding principal amount of all Term Loans and accrued and unpaid interest thereon as and when due in accordance with this Agreement.

 

2.1.1                      Term Loans.

 

(a)  [Reserved.]

 


 

(a)                                  (b)  Interest Period .  Commencing on the Payment Date falling in the first quarter following the month in which the Effective Date occurs, and continuing on each Payment Date thereafter, Borrower shall make quarterly payments of interest, in arrears, on the outstanding principal amount of the Term Loans, at the rate set forth in Section 2.2(a).

 

(b)                                  (c)  Repayment .  All outstanding principal and accrued and unpaid interest under the Term Loans, and all other outstanding Obligations with respect to the Term Loans, are due and payable in full in cash on the Term Loan Maturity Date.  Once repaid, the Term Loans may not be reborrowed.

 

(c)                                   (d)  Permitted Prepayment .  Borrower shall have the option to prepay all or a portion of the Term Loans made by Lender under this Agreement, without premium or penalty, provided Borrower (i) provides written notice (which may be delivered by electronic mail) to Lender of (x) its election to prepay Term Loans at least one (1) Business Day prior to such prepayment and (y) the amount of such prepayment, and (ii) pays, on the date of such prepayment (A) the principal amount of such prepayment, (B) accrued and unpaid interest on such Term Loans so prepaid, and (C) all other sums, if any, that shall have become due and payable hereunder, including interest at the Default Rate with respect to any past due amounts.

 

(d)                                  (e)  Mandatory Prepayment Upon Acceleration .  If the Term Loans are accelerated by Lender pursuant to Section 9.1(a) following the occurrence of an Event of Default, Borrower shall immediately pay to Lender an amount in cash equal to the sum of: (i) all outstanding principal plus accrued interest under the Term Loans, (ii) accrued and unpaid interest on the Term Loans, and (iii) all other sums, if any, that shall have become due and payable hereunder, including interest at the Default Rate with respect to any past due amounts.

 

(e)                                   Mandatory Prepayment Upon Execution of the First Amendment. Upon the execution of, and as a condition to the effectiveness of, the First Amendment and Lender’s consent to the Bridge Transactions, Borrower shall immediately pay to Lender $3,500,000 from the proceeds of the “New Money Loans” (as defined in the New Bridge Credit Agreement), which payment shall be made on or before the First Amendment Effective Date in accordance with Section 2.4 hereof.

 

(f)                                    Mandatory Prepayment Upon a Permitted Designated Licensing Transaction. Upon the consummation of a Permitted Designated Licensing Transaction, as promptly as reasonably practicable, but in any event on the earlier to occur of (i) the date on which prepayment is made to the New Bridge Lenders pursuant to Section 2.02(b) of the New Bridge Credit Agreement (as in effect on the First Amendment Effective Date) with respect to Section 7.05(i) of the New Bridge Credit Agreement (as in effect on the First Amendment Effective Date), and (ii) three (3) Business Days after the receipt of the net proceeds thereof , Borrower shall pay to Lender the Permitted Designated Licensing Transaction Amount in accordance with Section 2.4 hereof and Annex D to the First Amendment.

 

2.2                                Payment of Interest on the Term Loans.

 

(a)                                  Interest Rate .  Subject to Section 2.2(b) , the principal amount outstanding under the Term Loans (including any PIK Interest that has been previously capitalized) shall accrue interest at a fixed per annum rate equal to (i)  eight percent (8.00%) through and including December 31, 2018 and (ii) eight and one-half percent (8.50%) from January 1, 2019 until the Term Loans are paid in full and shall be payable quarterly in accordance with Sections 2.2(d) and (e) below.

 

2


 

(b)                                  Default Rate .  Immediately upon the occurrence and during the continuance of an Event of Default Obligations shall bear interest at a rate per annum which is three percentage points (3.00%) above the rate that is otherwise applicable thereto (the “ Default Rate ”) unless Lender otherwise elects from time to time in its sole discretion to impose a smaller increase .  Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents (including, without limitation, Lender Expenses) but are not paid when due shall bear interest until paid at a rate equal to the highest rate applicable to the Obligations.  Payment or acceptance of the increased interest rate provided in this Section 2.2(b) is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of Lender.

 

(c)                                   Computation: 360-Day Year .  In computing interest, the date of the making of any Term Loans shall be included and the date of payment shall be excluded; provided, however, that if any Term Loans are repaid on the same day on which it is made, such day shall be included in computing interest on such Term Loans.  Interest shall be computed on the basis of a 360-day year for the actual number of days elapsed.

 

(d)                                  PIK Interest .  At Borrower’s option, Borrower shall have the right to elect that interest payable hereunder shall be paid in kind and shall be capitalized and added to the outstanding principal amount of the Term Loans (“ PIK Interest ”) on each Payment Date. As of the Restatement Effective Date, Borrower has made such election and interest payable hereunder shall be paid as PIK Interest, be compounded and be, and be deemed to be, part of the outstanding principal of the Term Loans.  Such election shall continue until such time as Borrower provides written notice that it will make payments of interest payable hereunder in cash or Borrower pays accrued and unpaid interest as of an Interest Payment Date in cash in accordance with Section 2.4.

 

(e)                                   Interest Payment Date .  Unless otherwise provided, interest is payable quarterly on each Payment Date, and, for the avoidance of doubt, interest payable hereunder and paid as PIK Interest shall be compounded quarterly.  Interest hereunder shall be due and payable in accordance with the terms hereof before and after any judgment.

 

2.3                                Fees; Lender Expenses .

 

(a)                                  Borrower shall pay to Lender on request (accompanied by invoice) all Lender Expenses (including invoiced attorneys’ fees and expenses) when due, subject to Section 2.3(b) below.  Borrower acknowledges that whether or not Lender refrains from time to time from invoicing Borrower for Lender Expenses does not release or otherwise affect Borrower’s obligation to pay Lender Expenses upon Lender’s invoice therefor.

 

(b)                                  Borrower will provide Lender written notice upon (and in any event within one (1) Business Day of) agreeing to pay (or to reimburse) any fees, costs and expenses of any counsel, financial advisor, consultant or other professional (collectively “Professionals”) of any lender or other creditor of Borrower or any of its subsidiaries.  Borrower will not agree with any Person to not pay or reimburse (or agree to withhold or refrain from paying or reimbursing) any Lender Expenses, except to the extent set forth in the New Bridge Intercreditor Agreement.

 

(a)  [Reserved.]

 

(b)  Upon written request therefor from Lender , Borrower shall pay to Lender all Lender Expenses (including reasonable documented attorneys’ fees and expenses) when due.

 

3


 

2.4                                Payments .

 

(a)                                  All cash payments (including prepayments) to be made by Borrower under any Loan Document shall be made in immediately available funds in U.S. Dollars, without setoff or counterclaim, before 1:00 p.m. Eastern time on the date when due.  Payments of principal and/or interest received after 1:00 p.m. Eastern time are considered received at the opening of business on the next Business Day.  When a payment is due on a day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall continue to accrue until paid.

 

2.5                                Taxes.

 

2.5.1                      Defined Terms .  For purposes of this Section 2.5, the term “applicable law” includes FATCA.

 

2.5.2                      Status of Lender .

 

(a)                                  To the extent it is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Loan Document, Lender shall deliver to Borrower, at the time or times reasonably requested by Borrower, such properly completed and executed documentation reasonably requested by Borrower as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, Lender, if reasonably requested by Borrower, shall deliver such other documentation prescribed by applicable law or reasonably requested by Borrower as will enable Borrower to determine whether or not such Lender is subject to backup withholding or information reporting requirements.

 

(b)                                  Without limiting the generality of Section 2.5.2(a), Lender shall, to the extent it is legally entitled to do so, deliver to Borrower (in such number of copies as shall be requested by Borrower) on or prior to the date on which Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of Borrower), whichever of the following is applicable:

 

i.                                           If Lender is claiming the benefits of an income tax treaty to which the United States is a party (x) with respect to payments of interest under any Loan Document, executed copies of IRS Form W-8BEN or W-8BEN-E establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “interest” article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, IRS Form W-8BEN or W-8BEN-E establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “business profits” or “other income” article of such tax treaty, or

 

ii.                                        Executed copies of IRS Form W-8ECI.

 

(c)                                   Without limiting the generality of Section 2.5.2(a), Lender shall, to the extent it is legally entitled to do so, deliver to Borrower (in such number of copies as shall be requested by Borrower) on or prior to the date on which Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of Borrower), executed copies of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to permit Borrower to determine the withholding or deduction required to be made.

 

(d)                                  Without limiting the generality of Section 2.5.2(a), if a payment made to Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), Lender shall deliver to Borrower at

 

4


 

the time or times prescribed by law and at such time or times reasonably requested by Borrower such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by Borrower as may be necessary for Borrower to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment.  Solely for purposes of this clause (d), “FATCA” shall include any amendments made to FATCA after the date of this Agreement .

 

(e)                                   Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification, provide such successor form, or promptly notify Borrower in writing of its legal inability to do so.

 

(f)                                    Provided that Lender has complied with the relevant provisions above in this Section 2.5.2, or has provided the documentation described above on or prior to the relevant interest payment date, Borrower shall make all payments hereunder free and clear of any Indemnified Tax, and shall hold Lender harmless against any United States withholding Tax that may be asserted by reason of a change in applicable law; provided that no Lender shall be entitled to receive any greater payment under this Section 2.5.2(f) than Lender as of the date of this Agreement would have been entitled to receive, taking into account any change in applicable law that would have been applicable to such Lender.

 

3                                          CONDITIONS OF LOANS

 

3.1                                Conditions Precedent to the Restatement Effective Date .  The effectiveness of this Agreement is subject to the following conditions precedent:

 

(a)                                  Lender shall have received, in form and substance satisfactory to Lender:

 

i.                                           Borrower’s duly executed signatures to the Loan Documents;

 

ii.                                        a certificate of the Secretary or Assistant Secretary (or other equivalent officer or manager) of Borrower dated as of the Effective Date which shall certify (i) copies of resolutions of the board of directors of Borrower authorizing (x) the execution, delivery and performance of this Agreement and the other Loan Documents to which Borrower is a party, and (y) the granting by Borrower of the Liens upon the Collateral to secure the Obligations, (ii) the incumbency and signature of the officers of Borrower authorized to execute this Agreement and the other Loan Documents, and (iii) copies of the Organizational Documents of Borrower as in effect on such date, complete with all amendments thereto;

 

iii.                                     good standing certificate of Borrower certified by the Secretary of State of the State of Delaware as of a date no earlier than thirty (30) days prior to the Effective Date;

 

iv.                                    a certificate of the appropriate official(s) of each jurisdiction of foreign qualification of Borrower, certifying as of a recent date not more than thirty (30) days prior to the Effective Date, as to the subsistence in good standing of Borrower in such jurisdictions, except to the extent such failure to be so qualified would not reasonably be expected to have a material adverse effect on Borrower’s and its Subsidiaries’ businesses taken as a whole;

 

v.                                       copies, dated as of a recent date, of financing statement searches, as Lender shall reasonably request, accompanied by written evidence (including any UCC termination statements) that the Liens indicated in any such financing statements either constitute Permitted Liens or have been or will be terminated or released;

 

5


 

vi.                                    the Perfection Certificate of Borrower; and

 

vii.                                 a legal opinion of Borrower’s counsel dated as of the Restatement Effective Date substantially in the form of Exhibit C attached hereto ; .

 

(b)                                  Borrower and Lenders under the Subordinated Loan Agreement (the “Subordinated Lenders”) shall have entered into the Subordinated Loan Agreement, which, together with the warrants issues in connection therewith, shall be in form and substance reasonably acceptable to Lender; and

 

(c)                                   all of the conditions to funding the loans under the Subordinated Loan Agreement shall have been satisfied or waived (other than the effectiveness of this Agreement). .

 

3.2                                Additional Conditions Precedent to the Restatement Effective Date .  The effectiveness of this Agreement is further subject to the following conditions precedent:

 

(a)  [Reserved];

 

(a)                                  (b)  the representations and warranties in this Agreement shall be true and correct in all material respects on the Restatement Effective Date; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date, and no Event of Default shall have occurred and be continuing or result from the making of the applicable Term Loans.  Borrower’s acceptance of each Term Loan is Borrower’s representation and warranty on such date that the representations and warranties in this Agreement are true, accurate, and complete in all material respects as of such date; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date; and

 

(b)                                  (c)  there shall exist no Default or Event of Default.

 

4                                          CREATION OF SECURITY INTEREST

 

4.1                                Grant of Security Interest Borrower Each of the Loan Parties hereby grants to the Lender, to secure the payment and performance in full of all of the Obligations, a continuing security interest in, and pledges to Lender, the Collateral, wherever located, whether now owned or hereafter acquired or arising, and all proceeds and products thereof.  The grant of a security interest in the foregoing sentence is in addition to, and in furtherance of, Borrower’s grant of a security interest under the Original Loan Agreement.

 

If this Agreement is terminated, the Lien granted hereunder in the Collateral shall continue until the Obligations (other than inchoate indemnity obligations) are satisfied in full, and at such time, Lender shall, at Borrower’s sole cost and expense, terminate the security interests granted hereunder in the Collateral and all rights therein shall revert to Borrower the Loan Parties .

 

4.2                                Priority of Security Interest Borrower Each Loan Party represents, warrants, and covenants that the security interest granted herein (i) is and shall at all times continue to be a legal and valid security interest, and (ii) subject to the filings described in Section 4.3(a), a first priority perfected security interest in all Collateral in which a security interest may be perfected by filing, recording or

 

6


 

registering a financing statement or analogous document in the United States (or any political subdivision thereof) and its territories and possessions pursuant to the Code (subject only to (x) Permitted Liens that expressly have superior priority to the Lien granted under this Agreement , and (y) in the case of Permitted Liens in favor of the Subordinated New Bridge Lenders, the Subordination New Bridge Intercreditor Agreement).  If Borrower a Loan Party shall acquire a commercial tort claim, Borrower such Loan Party shall promptly notify Lender in a writing signed by Borrower such Loan Party of the general details thereof and grant to Lender in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to Lender.

 

4.3                                Authorization to File Financing Statements and Other Perfection Documents .  (a)  Borrower Each Loan Party hereby authorizes Lender to file financing statements, without notice to Borrower such Loan Party , with all appropriate jurisdictions to perfect or protect Lender’s interests or rights hereunder, including a notice that any disposition of the Collateral, by Borrower such Loan Party or any other Person, shall be deemed to violate the rights of Lender under the Code.  (b)  Borrower Each Loan Party hereby further authorizes the Lender to file or record with the United States Patent and Trademark Office (and any successor office) such documents as may be necessary or advisable to perfect or protect Lender’s interest or rights hereunder.

 

5                                          REPRESENTATIONS AND WARRANTIES

 

Borrower represents and warrants as follows , as of the First Amendment Effective Date :

 

5.1                                Due Organization, Authorization; Power and Authority Borrower The Loan Parties and each of its Subsidiaries are duly existing and in good standing as Registered Organizations in their respective jurisdictions and are qualified and licensed to do business and are in good standing in any other jurisdiction in which the conduct of their business or ownership of property requires that they be qualified except where the failure to do so would not reasonably be expected to have a material adverse effect on Borrower’s and its Subsidiaries’ business taken as a whole result in a Material Adverse Change .  In connection with this Agreement, Borrower each Loan Party has delivered to Lender a completed certificate signed by Borrower such Loan Party , entitled “Perfection Certificate”.  Borrower Each Loan Party represents and warrants to Lender that (a)  Borrower’s such Loan Party’s exact legal name is that indicated on the Perfection Certificate and on the signature page hereof; (b)  Borrower such Loan Party is an organization of the type and is organized in the jurisdiction set forth in the Perfection Certificate; (c) the Perfection Certificate accurately sets forth Borrower’s such Loan Party’s organizational identification number or accurately states that Borrower such Loan Party has none; (d) the Perfection Certificate accurately sets forth Borrower’s such Loan Party’s place of business, or, if more than one, its chief executive office as well as Borrower’s such Loan Party’s mailing address (if different than its chief executive office); (e)  Borrower except as set forth in Section 1(g) of the Perfection Certificate, such Loan Party (and each of its predecessors) has not, in the past five (5) years, changed its jurisdiction of formation, organizational structure or type, or any organizational number assigned by its jurisdiction; and (f) all other information set forth on the Perfection Certificate pertaining to Borrower each Loan Party is accurate and complete (it being understood and agreed that Borrower such Loan Party may from time to time update certain information in the Perfection Certificate after the Effective Date to the extent permitted by one or more specific provisions in this Agreement).  Any new information in any revised perfection certificate shall not be deemed to be included in the Perfection Certificate unless consented to by Lender in writing pursuant to the terms and conditions hereunder.

 

The execution, delivery and performance by Borrower each Loan Party of the Loan Documents to which it is a party have been duly authorized, and do not (i) conflict with any of Borrower’s such

 

7


 

Loan Party’s Organizational Documents, (ii) contravene, conflict with, constitute a default under or violate any material applicable law, (iii) contravene, conflict or violate any material applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower such Loan Party or any of its property or assets may be bound or affected, (iv) require any action by, filing, registration, or qualification with, or Governmental Approval from, any Governmental Authority (except such Governmental Approvals which have already been obtained and are in full force and effect and filings necessary to perfect the Liens granted hereunder) or (v) result in a default by the Borrower such Loan Party under any agreement to which it is a party or by which it is bound except where such default would not reasonably be expected to have a material adverse effect on Borrower’s and its Subsidiaries’ business taken as a whole result in a Material Adverse Change .

 

5.2                                Collateral Borrower Each Loan Party has good title to, has rights in, and the power to transfer each item of the Collateral upon which it purports to grant a Lien hereunder, except where the failure to have such title or other interest would not reasonably be expected to result in, individually or in the aggregate, a Material Adverse Change, free and clear of any and all Liens except Permitted Liens.  Borrower Each Loan Party has no deposit accounts other than the deposit accounts, if any, described in the Perfection Certificate delivered to Lender in connection herewith, or of which Borrower such Loan Party has subsequently given the Lender notice.

 

The Collateral is not in the possession of any third party bailee (such as a warehouse) except as otherwise provided in the Perfection Certificate (as it may be updated from time to time pursuant to the provisions of Section 5.1).   None of the components of the Collateral (other than equipment with an aggregate value not exceeding One Hundred and Fifty Thousand Dollars ($150,000) in the aggregate in the possession of Borrower’s employees or agents) shall be maintained at locations other than as provided in the Perfection Certificate or as permitted pursuant to Section 7.2.

 

All Inventory is in all material respects of good quality, free from material defects.  Lender hereby acknowledges that the Inventory includes pharmaceutical products not yet approved for commercial sale.

 

Borrower Each Loan Party is the sole owner of the Intellectual Property which it owns or purports to own except for (a) licenses (which may be exclusive as to specified fields of use, geographic areas and/or time periods) granted to its licensees in the ordinary course of business, (b) over-the-counter software that is commercially available to the public, and (c) Intellectual Property licensed to Borrower such Loan Party in the ordinary course of business, to the extent material to the conduct of Borrower’s business.  Each Patent which it owns or purports to own and which is material to Borrower’s such Loan Party’s business is valid and enforceable, and no part of the Intellectual Property which Borrower such Loan Party owns or purports to own and which is material to Borrower’s such Loan Party’s business has been judged invalid or unenforceable, in whole or in part.  To Borrower’s Loan Party’s knowledge, no claim has been made that any part of the Intellectual Property violates the rights of any third party except to the extent such claim would not reasonably be expected to have a material adverse effect on Borrower’s business result in a Material Adverse Change .

 

Except as noted on the Perfection Certificate,  Borrower neither Loan Party is not a party to, nor is it bound by, any Restricted License.

 

5.3                                Litigation .  Except as has been disclosed in the Perfection Certificate, there are no actions or proceedings pending or, to the knowledge of the Responsible Officers, threatened in writing by or against Borrower , Guarantor or any of its either of their Subsidiaries involving before any Governmental Authority or arbitrator that (i) would be reasonably likely to result in liabilities of

 

8


 

more than, individually or in the aggregate, Three Hundred Thousand Dollars ($300,000) , or (ii) purport to affect the legality, validity or enforceability of any Loan Document .

 

5.4                                Insurance. The properties of the Loan Parties and any of either of their Subsidiaries are insured in a manner contemplated by Section 6.5.

 

5.5                                Subsidiaries; Equity Interests. As of the First Amendment Effective Date, the Loan Parties do not have any Subsidiaries other than those specifically disclosed in the Perfection Certificate, and all of the outstanding Equity Interests in each such Person and each such Subsidiary have been validly issued, are fully paid and non-assessable.  As of the First Amendment Effective Date, the Perfection Certificate (a) sets forth the name and ownership interest of each person that owns any Equity Interests in the direct and indirect subsidiaries of each of Borrower and Guarantor, and (b) sets forth the name and jurisdiction of organization of Borrower, Guarantor and each direct and indirect Subsidiary of each of Borrower and Guarantor, including the percentage ownership.

 

5.4 [Reserved].

 

5.5 [Reserved].

 

5.6                                Regulatory Compliance Borrower No Loan Party is not an “investment company” or a company “controlled” by an “investment company” under the Investment Company Act of 1940, as amended.  Borrower is not No Loan Party is engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors).  Borrower Each Loan Party has complied in all material respects with the Federal Fair Labor Standards Act.  Neither Borrower , Guarantor nor any of its their Subsidiaries is a “holding company” or an “affiliate” of a “holding company” or a “subsidiary company” of a “holding company” as each term is defined and used in the Public Utility Holding Company Act of 2005.  Except as has been disclosed in writing to Lender prior to the First Amendment Effective Date, Borrower no Loan Party has not violated any laws, ordinances or rules, the violation of which would reasonably be expected to have a material adverse effect on its business.  None result in a Material Adverse Change.  Except as would not individually be reasonably expected to result in a liability in excess of $300,000 to the Loan Parties and their Subsidiaries (provided that the aggregate of all such liabilities could not reasonably be expected to result in a Material Adverse Change), none of Borrower’s , Guarantor’s or any of its their Subsidiaries’ properties or assets has been used by Borrower , Guarantor or any Subsidiary or, to Borrower’s each Loan Party’s knowledge, by previous Persons, in disposing, producing, storing, treating, or transporting any hazardous substance other than legally in compliance with applicable environmental laws .  Borrower , Guarantor and each of its their Subsidiaries have obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all Government Authorities that are necessary to continue their respective businesses as currently conducted.   Lender acknowledges that Borrower’s pharmaceutical products have not yet been approved for commercial sale.

 

5.7                                Subsidiaries; Investments Borrower does not own No Loan Party owns any stock, partnership interest or other equity securities except for Permitted Investments.

 

5.8                                Tax Returns and Payments; Pension Contributions Borrower Except as disclosed in the Perfection Certificate, each Loan Party has timely filed all required income and all other material tax returns and reports, and Borrower each Loan Party has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower such Loan Party , subject to the following sentence.  Borrower Each Loan Party may defer payment of any contested

 

9


 

taxes, provided that Borrower such Loan Party (a) in good faith contests its obligation to pay the taxes by appropriate proceedings promptly and diligently instituted and conducted, and (b)  notifies Lender in writing of the commencement of, and any material development in, the proceedings, and (c) posts bonds or takes any other steps required to prevent the governmental authority levying such contested taxes from obtaining a Lien upon any of the Collateral that is other than a “Permitted Lien”.  Borrower is unaware has provided adequate reserves therefor in accordance with GAAP.  No Loan Party is aware of any claims or adjustments proposed for any of Borrower’s such Loan Party’s prior tax years which would result in additional taxes becoming due and payable by Borrower.  Borrower such Loan Party’s.  Each Loan Party has paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms, and Borrower has not no Loan Party has withdrawn from participation in, and has not permitted partial or complete termination of, or permitted the occurrence of any other event with respect to, any such plan which would reasonably be expected to result in any material liability of Borrower such Loan Party , including any material liability to the Pension Benefit Guaranty Corporation or its successors or any other governmental agency.

 

5.9                                Use of Proceeds .  The proceeds of the Term Loans shall be used solely for working capital and general corporate purposes.

 

5.10                         Full Disclosure .  No written representation, warranty or other statement of Borrower in any certificate or written statement given furnished by or on behalf of any Loan Party or any of  their Subsidiaries to Lender in connection with the Loan Documents of or the transactions contemplated thereby, as of the date such representation, warranty, or other statement was made, taken together with all such written certificates and written statements given to Lender, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the certificates such information or statements, in light of the circumstances in which they were made, not misleading (it being recognized by Lender that the projections and forecasts provided by Borrower ; provided that to the extent any information is included in the Initial Budget or constitutes projections or other forward-looking information, Borrower represents only that such information was prepared in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results). believed to be reasonable at the time of preparation; it being understood that such projections may vary from actual results and that such variances may be material.

 

5.11                         Definition of “Knowledge.”   For purposes of the Loan Documents, whenever a representation or warranty is made to Borrower’s either Loan Party’s knowledge or awareness, to the “best of” Borrower’s Loan Party’s knowledge, or with a similar qualification, knowledge or awareness means the actual knowledge of the Responsible Officers after due inquiry.

 

5.12 Intellectual Property.  Borrower shall not transfer (except as permitted pursuant to Section 7.1 hereof) and shall be the sole owner of any and all items of intellectual property (as defined in (a)- (f) of the definition of Intellectual Property herein) developed or acquired by Borrower until this Agreement is terminated and all Obligations are satisfied in full.

 

5.12                         Intellectual Property.  As of the date hereof, set forth in the Perfection Certificate is a complete and accurate list of all Intellectual Property, owned by the Borrower or any of its Subsidiaries as of such date, showing as of such date the jurisdiction in which each such item of Intellectual Property is registered or in which an application is pending and the registration or application number.  The Borrower and each Subsidiary owns or has the right to use, all of the Intellectual Property that is material to the operation of their respective businesses as currently

 

10


 

conducted and, to the knowledge of the Loan Parties, except as set forth in Section 9 of the Perfection Certificate, the use of such Intellectual Property by such Person or the operation of their respective businesses is not infringing upon any Intellectual Property rights held by any other Person and there are no other disputes or litigation proceedings involving such Intellectual Property.

 

5.13                         No Material Adverse Change.  Since December 31, 2017, there has been no event or circumstance, either individually or in the aggregate, that has had or would reasonably be expected to have a Material Adverse Change, except for (i) any matters set forth in any public filings of Novelion prior to the First Amendment Effective Date, (ii) any matters disclosed on the disclosure schedules to the Perfection Certificate or other Loan Documents as of the First Amendment Effective Date, and (iii) any other matters disclosed in writing (identifying this Section 5.13) to the Lender or its Professionals prior to the First Amendment Effective Date.

 

6                                          AFFIRMATIVE COVENANTS

 

Borrower Each Loan Party shall do all of the following:

 

6.1                                Government Compliance.

 

(a)                                  Maintain its and (except as permitted by Section 7.3) all its Subsidiaries’ legal existence and good standing in their respective jurisdictions of formation and maintain qualification in each jurisdiction except where the failure to do so would not reasonably be expected to have a material adverse effect on Borrower’s and its Subsidiaries’ business or operations taken as a whole.  Borrower Material Adverse Change.  Each Loan Party shall comply, and have each Subsidiary comply, in each case in all material respects, with all laws, ordinances and regulations to which it is subject, except to the extent such noncompliance would not reasonably be expected to have a material adverse effect on Borrower’s and its Subsidiaries’ business taken as a whole result in a Material Adverse Change ; and

 

(b)                                  Obtain all of the Governmental Approvals necessary for the performance by Borrower each Loan Party of its obligations under the Loan Documents and the grant of a security interest to Lender in all of the Collateral.  Borrower Each Loan Party shall promptly provide copies of any such obtained Governmental Approvals to Lender.

 

6.2                                Financial Statements, Reports, Certificates .  Deliver to Lender:

 

(a)                                  Quarterly and Annual Financial Statements (i)  As soon as available, but no later than sixty in any event, within fifty-five ( 60 55 ) days after the last day end of each quarter (other than the last quarter of the fiscal year), a company prepared consolidated balance sheet and income statement of covering, on a consolidated basis, Borrower’s of the first three (3) fiscal quarters of each fiscal year of Borrower (commencing with the first full fiscal quarter ended after the First Amendment Effective Date), unaudited internally prepared balance sheet of Borrower and its Subsidiaries as at the end of such fiscal quarter, and the related unaudited internally prepared consolidated statements of income or operations and cash flows for such fiscal quarter, certified by a Responsible Officer and in a form reasonably agreed between Borrower and Lender of Borrower as fairly presenting in all material respects the financial condition, results of operations and cash flows of Borrower and its subsidiaries in accordance with GAAP, subject to year-end adjustments (the “ Quarterly Financial Statements ”);

 

(b) and (ii) as [Reserved] ;

 

11


 

(c)  Monthly Cash Reports .  As soon as available, but no later than thirty (30) days after the last day of each month, a certification by a Responsible Officer setting forth the aggregate amount of unrestricted cash, Cash Equivalents, short-term investments and long-term investments maintained in Borrower’s name, together with copies of all month-end account statements for each deposit account or investment/securities accounts maintained by Borrower;

 

(d)  Annual Financial Statements .  As soon as available, but no later than one hundred twenty (120) days after the last day of Borrower’s fiscal year, internally prepared consolidated financial statements of Borrower for the fiscal year then ended (to be comprised of a consolidated balance sheet and income statement and cash flows covering , on a consolidated basis, Borrowers’ and its Subsidiaries’ operations for such fiscal year), prepared in a manner consistent with GAAP and with prior practices, and complete and correct in all material respects, subject to normal year-end adjustments that, in the aggregate, are not material to Borrower’s business operations, certified by a Responsible Officer;

 

(e)  Other Statements .  Within fifteen (15) days of delivery, copies of all statements, reports and notices made available to Borrower’s security holders generally or to any holders of Subordinated Debt;

 

(f)  [Reserved] ;

 

(b)                                  Management Discussion and Analysis Reports.  Contemporaneous with the delivery of each set of consolidated financial statements referred to in Section 6.2(a), a report setting forth management’s analysis and discussion of the condition (financial and otherwise) and operations in respect of the business of the Borrower and its Subsidiaries;

 

(c)                                   Monthly Financial Statements.  On the date provided to the New Bridge Lenders (or if the New Money Debt has been repaid in full in accordance with the terms of the New Bridge Intercreditor Agreement, at the request of Lender), the Borrower shall provide to the Lender a consolidated balance sheet of the Borrower and its Subsidiaries as of the end of last fiscal month, and the related consolidated statements of income or operations for such fiscal month;

 

(d)                                  Other Statements; Compliance Certificate.  (i) Contemporaneous with the delivery to the New Bridge Lenders (and in any case no later than one (1) calendar day following such delivery), copies of all statements, reports, notices made available to Borrower’s security holders generally, to the New Bridge Lenders or to any other holders of Subordinated Debt, including, without limitation, (A) notice of the occurrence of any default, which notice shall specify the nature thereof, the period of existence thereof and what action the Borrower proposes to take with respect thereto and (B) notice of the occurrence of any matter that has resulted or could reasonably be expected to result in a Material Adverse Change; and (ii) upon delivery of the financial statements referred to in Section 6.2(a) a duly completed Compliance Certificate signed by a Responsible Officer of the Borrower;

 

(e)                                   Budget.  By no later than 11:59 p.m. (New York, New York time) by the third Business Day of each calendar week, and commencing for the first full week following the First Amendment Effective Date, the Borrower shall deliver to the Lender variance reports (in substantially the same format as the Budget) showing actual cash receipts and disbursements for the immediately preceding week, noting therein all variances, on a line-item basis, from values set forth for such period(s) in the Initial Budget or Budget, as applicable.  For the avoidance of doubt, such weekly variance reports shall include actual cash flows to Foreign Subsidiaries by geography broken down by use of funds;

 

12


 

(f)                                    Budget Updates. Borrower shall at the end of every 4 week period commencing from the First Amendment Effective Date propose an update to the then-existing Initial Budget or Budget, as the case may be, adding thereto the forecast of cash receipts and cash disbursements for the 13 week period commencing on the date of such proposed update.  Each such update and the line items reflecting Permitted Affiliate Services Payments shall be subject to the consent of the New Bridge Lenders (and, if the New Money Debt is repaid in full in accordance with the New Bridge Credit Agreement, the Lender, such consent not to be unreasonably withheld), and to the extent such consent is provided, the Budget shall be amended, and if no consent is provided, the prior Budget shall remain in effect; provided, that the Lender agrees that the line items in any proposed update reflecting any of the following shall not be subject to such consent requirement: (1) professional fees — restructuring in any nine week period to be increased by up to 15% from the amount set forth for such line item in the corresponding nine week period in the most recently approved Budget and (2) payroll and benefits in any nine week period to be increased by up to 15% from the amount set forth for each such line item in the corresponding nine week period in the most recently approved Budget (provided that any increase in payroll or benefits for those employees listed on Schedule 6.01(e) of the New Bridge Credit Agreement shall not count against such 15% cap but, for the avoidance of doubt, each budget update for such increase shall be subject to the aforementioned consent right of the New Bridge Lenders (and, if the New Money Debt is repaid in full in accordance with the New Bridge Credit Agreement, the Lender) so long as the cumulative percentage increases during the term of this Agreement for the items in clauses (1) and (2) do not exceed 50 percentage points beginning with the first revised Budget proposed after the First Amendment Effective Date.  The Initial Budget and each proposed update shall include a memo item reflecting cumulative transfers that may be required to Foreign Subsidiaries irrespective of expense categories.  Each proposed update to the Initial Budget and any subsequent Budget shall include: (i) a consolidating cash flow schedule illustrating budgeted cash flows for the Foreign Subsidiaries aggregated by geography and broken down by use of funds; and (ii) a schedule of the updated proposed Budget variances segregating changes for payroll for those employees listed on Schedule 6.01(e) of the New Bridge Credit Agreement from any other changes for payroll and benefits;

 

(g)                                  Legal Action Notice A prompt report of any legal actions pending or threatened in writing against Promptly after a Responsible Officer obtains knowledge thereof, the commencement of, or any material development in, any litigation or governmental proceeding (including without limitation pursuant to any applicable environmental laws) pending against the Borrower or any of its the Subsidiaries that would result in damages or costs to Borrower or any of its Subsidiaries of, individually or in the aggregate, Three Hundred Thousand Dollars ($300,000) or more; could reasonably be expected to be determined adversely and, if so determined, to result in a Material Adverse Change;

 

(h)  [Reserved];

 

(h)                                  Other Financial Information.  Other financial information reasonably requested by Lender , including, without limitation, copies of all notices, requests and other documents received by any Loan Party or any of its Subsidiaries under or pursuant to any instrument, indenture, loan or credit or similar agreement relating to Indebtedness in excess of three hundred thousand Dollars ($300,000) regarding or related to any breach or default by any party thereto or any other event that could materially impair the value of the interests or the rights of any Loan Party or otherwise result in a Material Adverse Change and copies of any amendment, modification or waiver of any provision of any such instrument, indenture, loan or credit or similar agreement relating to Indebtedness in excess of the three hundred thousand Dollars ($300,000) and, from time to time upon request by Lender, such information and reports regarding such instruments,

 

13


 

indentures and loan and credit and similar agreements relating to Indebtedness in excess of three hundred thousand Dollars ($300,000) as Lender may reasonably request ; and

 

(i)                                      Subordinated Lender Notices to New Bridge Lenders .  Copies of all notices to or from, and agreements and documents (including any amendments or modifications thereto) entered into with , the Subordinated New Bridge Lenders (or the Subordinated Loan Agent New Bridge Agent) (including, without limitation, any notices delivered pursuant to Section 6.02 of the New Bridge Credit Agreement ) or the holders of the Convertible Notes (or the trustee thereof), in each case, within five one (1)  Business Days Day of delivery, receipt or execution , ( as the case may be ; and ).  For the avoidance of doubt, all such notices, agreements and documents shall be delivered to Lender in the same form received or delivered to Borrower.

 

6.3                                Maintenance of Properties.  Maintain, preserve and protect all of its material properties and equipment that are used or useful in the operation of its business in good working order, repair and condition, ordinary wear and tear excepted and casualty or condemnation excepted, and make all commercially reasonable and appropriate repairs, renewals, replacements, modifications, improvements, upgrades, extensions and additions thereof except where failure to do so would not reasonably be expected to materially adversely affect the use of the related property.

 

(j)  Other Financial Information .  Other financial information reasonably requested by Lender .

 

6.3 Inventory; Returns.  Keep all Inventory in good condition, free from material defects.  Returns and allowances between Borrower and its account debtors shall follow Borrower’s customary practices as they exist at the Effective Date.  Borrower must promptly notify Lender of all returns, recoveries, disputes and claims that involve more than Three Hundred Thousand Dollars ($300,000) .

 

6.4                                Taxes; Pensions .  Timely file, and require each of its Subsidiaries to timely file, all required tax returns and reports and timely pay, and require each of its Subsidiaries to timely pay, all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower and each of its Domestic Subsidiaries, except for deferred payment of any taxes contested pursuant to the terms of Section  5.7 hereof, and shall deliver to Lender, promptly following demand, appropriate certificates attesting to such payments 5.8 hereof , and pay all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms.

 

6.5                                Insurance .  Keep its business and the Collateral insured for risks and in amounts standard for companies in Borrower’s or Guarantor’s industry and location and as Lender may reasonably request.  Insurance policies shall be in a form, with companies, and in amounts that are reasonably satisfactory to Lender.  Within The Borrower shall, within a reasonable period of time, upon Lender’s written request, (a)  cause all property policies to have a lender’s loss payable endorsement showing Lender as lender loss payee and use commercially reasonable efforts to cause such endorsement to provide that the insurer must give Lender at least twenty (20) days’ notice before canceling, amending, or declining to renew its policy .  upon Lender’s written request , and (b) cause all liability policies shall to show, or have endorsements showing, Lender as an additional insured, and use commercially reasonable efforts to cause all such policies (or the loss payable and additional insured endorsements) shall to provide that the insurer shall give Lender at least twenty (20) days’ notice before canceling, amending, or declining to renew its policy.  At Lender’s request, Borrower each Loan Party shall deliver certified copies of insurance policies and evidence of all premium payments.  Proceeds payable under any casualty policy shall, at Lender’s option, be payable to Lender on account of the Obligations.  Notwithstanding the foregoing, (a) so long as no Event of Default has occurred and is continuing,

 

14


 

Borrower each Loan Party shall have the option of applying the proceeds of any casualty policy up to Two Hundred Fifty Thousand Dollars ($250,000) with respect to any loss, but not exceeding Five Hundred Thousand Dollars ($500,000) in the aggregate for all losses under all casualty policies in any one year, toward the replacement or repair of destroyed or damaged property; provided that any such replaced or repaired property (i) shall be of equal or like value as the replaced or repaired Collateral and (ii) shall be deemed Collateral in which Lender has been granted a first priority (subject to (i) Permitted Liens that expressly have superior priority to Lender’s Lien under this Agreement, and (ii) in the case of Permitted Liens in favor of the Subordinated Lenders, the New Bridge Intercreditor Agreement) security interest, and (b) after the occurrence and during the continuance of an Event of Default, all proceeds payable under such casualty policy shall, at the option of Lender, be payable to Lender on account of the Obligations subject to the New Bridge Intercreditor Agreement .

 

6.6                                Operating Accounts.

 

(a)                                  Maintain  Borrower’s each Loan Party’s operating, depository, securities accounts and other Collateral Accounts, with the banks and other depository institutions identified on the Perfection Certificate or such other banks and other depository institutions as selected by Borrower such Loan Party and upon reasonable prior written notice to Lender.

 

(b)                                  For each Collateral Account that Borrower a Loan Party at any time maintains and in which there is on deposit for more than three consecutive Business Days a balance of more than Fifty Thousand Dollars ($50,000) for any individual Collateral Account or Three Hundred Thousand Dollars ($300,000) in the aggregate for all Collateral Accounts (except for such amounts on deposit but subject to an uncleared check or in-process wire, ACH or similar transfers), Borrower (other than any Excluded Account), each Loan Party shall use its reasonable best efforts promptly to cause the applicable bank or financial institution (excluding the Offshore Accounts) at or with which any Collateral Account is maintained to execute and deliver a Control Agreement or other appropriate instrument with respect to such Collateral Account to perfect the Lien granted hereunder in such Collateral Account in accordance with the terms hereunder which Control Agreement may not be terminated without the prior written consent of Lender .  The provisions of the previous sentence shall not apply to deposit accounts exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of Borrower’s employees and identified to Lender by Borrower as such. , other than pursuant to the terms of the New Bridge Intercreditor Agreement.

 

6.7                                Protection of Intellectual Property Rights. Except as expressly permitted by this Agreement:

 

(a)  (i) Protect, defend and maintain the validity and enforceability of Intellectual Property material to Borrower’s business; (ii) promptly advise Lender in writing of material infringements of Intellectual Property material to Borrower’s business; and (iii) not allow any Intellectual Property material to Borrower’s business to be abandoned, forfeited or dedicated to the public without Lender’s written consent.

 

(b)  Provide written notice to Lender within fifteen (15) days of entering or becoming bound by any Restricted License (other than over-the-counter software that is commercially available to the public).  Borrower shall take such steps as Lender reasonably requests to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (i) any Restricted License to be deemed “Collateral” and for Lender to have a security interest in it that might otherwise be restricted or prohibited by law or by the terms of any such Restricted License, whether now existing or entered into in the future, and (ii) Lender to have the ability in the event of

 

15


 

a liquidation of any Collateral to dispose of such Collateral in accordance with Lender’s rights and remedies under this Agreement and the other Loan Documents.

 

(a)                                  Each Loan Party agrees that it will not knowingly do any act or omit to do any act whereby any material Patent that is necessary to the normal conduct of such Loan Party’s business may become prematurely invalidated, abandoned, lapsed or dedicated to the public, and agrees that it shall take commercially reasonable steps with respect to any material products covered by any such Patent as necessary to establish and preserve its rights under applicable patent laws.

 

(b)                                  Each Loan Party will, for each material Trademark necessary to the normal conduct of such Loan Party’s business, (i) maintain such Trademark in full force free from any adjudication of abandonment or invalidity for non-use, (ii) maintain the quality of products and services offered under such Trademark, (iii) display such Trademark with notice of federal or foreign registration or claim of trademark or service mark as required under applicable law and (iv) not knowingly use or knowingly permit its licensees’ use of such Trademark in violation of any third-party rights.

 

(c)                                   Each Loan Party will, for each work covered by a material Copyright necessary to the normal conduct of such Loan Party’s business that it publishes, displays and distributes, use a copyright notice as necessary and sufficient to establish and preserve its rights under applicable copyright laws.

 

(d)                                  Each Loan Party will not do any act or omit to do any act to cause such Loan Party’s Trade Secrets to lose its Trade Secret status.

 

(e)                                   Each Loan Party shall notify the Lender promptly if it knows that any material Patent, Trademark or Copyright necessary to the normal conduct of such Loan Party’s business may imminently become abandoned, lapsed or dedicated to the public, or of any materially adverse determination or development, excluding office actions and similar determinations or developments in the United States Patent and Trademark Office, United States Copyright Office, any court or any similar office of any country, regarding such Loan Party’s ownership of any such material Patent, Trademark or Copyright or its right to register or to maintain the same.

 

(f)                                    Each Loan Party, either itself or through any agent, employee, licensee or designee, shall (i) inform the Lender on a quarterly basis of each application by itself, or through any agent, employee, licensee or designee, for any Patent with the United States Patent and Trademark Office and each registration of any Trademark or Copyright with the United States Patent and Trademark Office, the United States Copyright Office or any comparable office or agency in any other country filed during the preceding twelve month period, and (ii) upon the reasonable request of the Lender, promptly execute and deliver any and all agreements, instruments, documents and papers as the Lender may reasonably request to evidence the Lender’s security interest in such Patent, Trademark, or Copyright, including Intellectual Property security documentation with respect to Intellectual Property acquired or developed after the date hereof consisting of issued United States Patents and applications therefor, registered United States Trademarks and applications therefor, registered United States Copyrights and applications therefor, exclusive Copyright Licenses in respect of registered United States Copyrights for which such Loan Party is the licensee; provided that the provisions hereof shall automatically apply to any such Intellectual Property and any such Intellectual Property shall automatically constitute Collateral as if such would have constituted Collateral at the time of execution hereof and be

 

16


 

subject to the Lien and security interest created by this Agreement without further action by any party.

 

(g)                                  Each Loan Party shall exercise its reasonable business judgment consistent with the practice in any proceeding before the United States Patent and Trademark Office, the United States Copyright Office or any comparable office or agency in any other country with respect to maintaining and pursuing each application relating to any Patent, Trademark and/or Copyright (and obtaining the relevant grant or registration) material to the normal conduct of such Loan Party’s business and to maintain (i) each issued Patent and (ii) the registrations of each Trademark and each Copyright that is material to the normal conduct of such Loan Party’s business, including, when applicable and necessary in such Loan Party’s reasonable business judgment, timely filings of applications for renewal, affidavits of use, affidavits of incontestability and payment of maintenance fees, and, if any Loan Party believes necessary in its reasonable business judgment, to initiate opposition, interference and cancellation proceedings against third parties.

 

(h)                                  In the event that any Loan Party knows or has reason to know that any Collateral consisting of a Patent, Trademark or Copyright necessary to the normal conduct of its business has been materially infringed, misappropriated or diluted by a third party, such Loan Party shall, if such Loan Party deems it necessary in its reasonable business judgment, promptly take actions as are reasonably appropriate under the circumstances.

 

6.8                                Litigation Cooperation .  From the date hereof and continuing through the termination of this Agreement, make available to Lender, without expense to Lender, Borrower each Loan Party and its officers, employees and agents and Borrower’s each Loan Party’s books and records, to the extent that Lender may deem them reasonably necessary to prosecute or defend any third-party suit or proceeding instituted by or against Lender with respect to any Collateral or relating to Borrower .

 

6.9 Access to Collateral; Books and Records.  Allow Lender, or its agents, at reasonable times, on five (5) Business Days’ notice (provided no notice is required if an Event of Default has occurred and is continuing ), to inspect the Collateral and audit and copy Borrower’s Books.  Such inspections or audits shall be conducted no more often than once every twelve (12) months unless an Event of Default has occurred and is continuing.  The foregoing inspections and audits shall be at Borrower’s expense.

 

6.9                                Access to Collateral; Inspection Rights.

 

(a)                                  After the occurrence of an Event of Default and during the continuance thereof, the Lender shall have the right to verify under reasonable procedures the validity, amount, quality, quantity, value, condition and status of, or any other matter relating to, the Collateral, including, in the case of Accounts or Collateral in the possession of any third person, by contacting Account Debtors or the third person possessing such Collateral for the purpose of making such a verification.

 

(b)                                  Permit representatives and independent contractors of the Lender (including, without limitation, financial advisors retained by or for the benefit of the Lender or their counsel) to visit and inspect any properties and books and records of the Borrower and its Subsidiaries (subject, in the case of third party customer sites, to customary access agreements) and to discuss its affairs, finances and accounts with its directors, officers, advisors and independent public accountants, all at the reasonable expense of the Borrower and at such reasonable times during normal business hours and as often as may be reasonably desired, upon reasonable advance

 

17


 

notice to the Borrower; provided, however, that such visits and inspections shall be coordinated through the Lender and any review of books and records shall be done no more frequently than once per month absent the continuation of an Event of Default.  The Lender shall give the Borrower the opportunity to participate in any discussions with the Borrower’s independent public accountants to the extent reasonably feasible.  Neither the Borrower nor any Subsidiary shall be required to disclose to the Lender any information that, in the opinion of counsel to the Borrower or such Subsidiary, is prohibited by law to be disclosed, is subject to attorney client privilege or constitutes attorney work product or the disclosure of which would cause a material breach of a binding non-disclosure agreement with a third party to the extent such agreement is not made in contemplation of the avoidance of this Section 6.9.

 

6.10                         Formation or Acquisition of Subsidiaries .  At the time that Borrower each Loan Party forms any direct or indirect Domestic Subsidiary or acquires any direct or indirect Domestic Subsidiary after the First Amendment Effective Date, Borrower each Loan Party shall (a) cause such new Domestic Subsidiary to become a co-borrower Guarantor hereunder, together with such appropriate financing statements, all in form and substance reasonably satisfactory to Lender (including being sufficient to grant Lender a first priority Lien (subject to (i) Permitted Liens that expressly have superior priority to Lender’s Lien under this Agreement, and (ii) in the case of Permitted Liens in favor of the Subordinated Lenders, the Subordination New Bridge Intercreditor Agreement) in and to the assets of such newly formed or acquired Domestic Subsidiary (substantially as described on Exhibit A hereto)), (b) provide to Lender appropriate certificates and powers and financing statements, pledging all of the direct or beneficial ownership interest in such new Domestic Subsidiary, in form and substance reasonably satisfactory to Lender, and (c) provide to Lender all other documentation in form and substance reasonably satisfactory to Lender, including one or more opinions of counsel satisfactory to Lender, which in its opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above.  Any document, agreement, or instrument executed or issued pursuant to this Section 6.10 shall be a Loan Document.

 

6.11                         Further Assurances .

 

(a)                                  Execute any further instruments and take further action as Lender reasonably requests to perfect or continue its Liens in the Collateral or to effect the purposes of this Agreement; provided, however, that the foregoing shall not require the creation or perfection of pledges of or security interests in, or the obtaining of title insurance, legal opinions or other deliverables with respect to, particular assets of the Borrower Loan Parties ,  (i) if Lender and Borrower such Loan Party reasonably agree that the cost, burden, difficulty or consequence of creating or perfecting such pledges or security interests in such assets, or obtaining such title insurance, legal opinions or other deliverables in respect of such assets, outweighs the benefits to be obtained by the Lenders therefrom, and (ii) to the extent such actions would be taken under the law of a jurisdiction other than an jurisdiction within the United States with respect to any of Borrower’s such Loan Party’s assets outside of the United States.  Without limiting the foregoing, (i) Borrower shall deliver to Lender intellectual property security agreements in the form(s) requested by Lender, duly executed, within ten (10) Business Days of the Restatement Effective Date (or if such forms are later received from Lender, ten (10) Business Days after receipt thereof), (ii) Borrower shall deliver to Lender supplements to the Perfection Certificate in form and substance reasonably satisfactory to Lender within ten (10) Business Days of the Restatement Effective Date and and (iii) Borrower shall use commercially reasonable efforts to deliver to Lender Control Agreement(s) with respect to each Collateral Account required hereunder to be subject to such a control agreement within forty-five (45) days of the Restatement Effective Date.

 

18


 

(b)                                  Without limiting the foregoing, subject to the New Bridge Intercreditor Agreement, to the extent not prohibited by any Requirement of Law and not otherwise resulting in material adverse tax consequences to the Borrower and its Subsidiaries, at the request of the Lender (or automatically to the extent requested under the New Bridge Credit Agreement), the Borrower shall cause its Foreign Subsidiaries designated by the Lender to execute such guarantees, pledge agreements and security documents as shall be customary in such local jurisdictions to grant to Lender, a guaranty of the Obligations secured by the equity interests and substantially all assets of such Subsidiaries within 45 days of such request (or such longer period as the “Required Lenders” (as defined in the New Bridge Credit Agreement) may agree in their sole discretion).

 

(c)                                   In addition, the Borrower shall deliver the following within 30 days of the First Amendment Effective Date (or such longer period as the New Bridge Lenders may agree): (i) Control Agreements with respect to the Borrower’s deposit accounts listed in Section 5(b) of the Perfection Certificate (other than Excluded Accounts), and (ii) insurance endorsements in accordance with Section 6.5, in each case in form and substance reasonably acceptable to the Lender (subject to indemnity provisions in such Control Agreements being subject to the Lender’s approval in its sole discretion).

 

6.12                         Lender Calls. Up to one (1) time in every two-week period, upon the reasonable request of the Lender, the Borrower’s chief financial officer, together with the Borrower’s financial advisor shall hold a conference call (at a mutually agreeable time, the cost of such call to be paid by the Borrower) with the Lender, on which conference calls shall be reviewed the Loan Parties’ financial performance, operations, current trends and variance reports.

 

7                                          NEGATIVE COVENANTS

 

Borrower The Loan Parties shall not do, and shall not permit any of its their respective Subsidiaries to do , any of the following without Lender’s prior written consent (or as otherwise provided herein):

 

7.1                                Dispositions .  Except with respect to a Permitted Myalept Spin-Out Designated Licensing Transaction, convey, sell, lease, transfer, assign, or otherwise dispose of (collectively, “ Transfer ”), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, except for Transfers (a)  Transfers of Inventory in the ordinary course of business; (b)  of worn-out, Transfers of obsolete , worn out or surplus Equipment or unmerchantable Inventory property, whether now owned or hereafter acquired, in the ordinary course of business and Transfers of property no longer used or useful in the conduct of the business of the Borrower and its Subsidiaries, in each case to the extent constituting immaterial property ; (c)  Transfers in connection with Permitted Liens and Permitted Investments; (d)  Transfers of non-exclusive licenses for the use of the property of Borrower or its , Guarantor or their Subsidiaries in the ordinary course of business and licenses that would not result in a legal transfer of title of the licensed property but that may be exclusive in respects other than territory and that may be exclusive as to territory only as to discreet geographical areas outside of the United States; and (e)  Transfers of Intellectual Property owned by a Subsidiary of Borrower to any other Subsidiary of Borrower in the ordinary course of business . ; (f) Transfers (other than of material Intellectual Property or of assets relating to metreleptin) for fair market value; provided that (i) the aggregate amount of Transfers during any fiscal year does not exceed $250,000, (ii) immediately prior to and immediately after giving effect to such Transfer, no Default or Event of Default shall have occurred and be continuing or would result therefrom and (iii) no less than one hundred percent (100%) of the consideration received for any such Transfer is received in cash; (g) Transfers of equipment or other assets, to the extent that such equipment is exchanged for credit against the purchase price of similar replacement equipment or assets or the

 

19


 

proceeds of such Transfers are reasonably promptly applied to the purchase price of similar replacement equipment, all in the ordinary course of business; (h) Transfers constituting an Intellectual Property that is not material to the conduct of the business of the Borrower and its Subsidiaries; (i) Transfers otherwise permitted by Sections 7.4, 7.5 or 7.7 (and Transfers from any Subsidiary that is not a Loan Party to any other Subsidiary that is not a Loan Party); (j) Transfers in the ordinary course of business of Cash Equivalents; and (k) Transfers where the aggregate value of the assets or property that are subject to such Transfer is less than $100,000 in the aggregate during the term of this Agreement.

 

7.2                                Changes in Business, Management, Ownership, or Business Locations .  (a) Engage in or permit any of its Subsidiaries to engage in any business other than the businesses currently engaged in by Borrower , Guarantor and such Subsidiary, as applicable, or reasonably related, or complementary,  thereto; provided , that Aegerion Securities Corporation shall not engage in any business activities,  maintain any assets or incur any Indebtedness, except it may maintain cash not to exceed $19,000,000 for the period commencing on December 15, 2018 and ending on January 4, 2019, after which period such cash shall be immediately returned to the Borrower; (b) liquidate or dissolve; or (c) permit a Change of Control ; provided that the Myalept Spin-Out Transaction shall be permitted if the Successor Company acknowledges that the Liens granted hereunder (and , for the avoidance of doubt, under the Original Loan Agreement) with respect to any assets subject to the Myalept Spin-Out Transaction continue to secure the Obligations and delivers a duly executed joinder to this Agreement as a co-borrower or otherwise as a joint and several obligor of the Obligations to the extent of such Collateral  and such other related documentation as Lender may reasonably request , all such documentation to be in form and substance reasonably satisfactory to Lender (the “Permitted Myalept Spin-Out Transaction”). .

 

Borrower The Loan Parties shall not, and shall not permit any of its their respective Subsidiaries to, without at least notice to Lender within fifteen (15) days prior written notice to Lender of such change : (1) add any new offices or business locations, including warehouses (unless each such new office or business location contains less than Five Hundred Thousand Dollars ($500,000) in Borrower’s or Guarantor’s assets or property ) or deliver any portion of the Collateral valued , individually or in the aggregate, in excess of Five Hundred Thousand Dollars ($500,000) to a bailee at a location other than to a bailee and at a location already disclosed in the Perfection Certificate (as it may be updated from time to time pursuant to the provisions of Section 5.1 ), (2) change its jurisdiction of organization, (3) change its organizational structure or type, (4) change its legal name, or (5) change any organizational number (if any) assigned by its jurisdiction of organization.   If Borrower intends to deliver any portion of the Collateral valued, individually or in the aggregate, in excess of Five Hundred Thousand Dollars ($500,000) to a bailee, and Lender and such bailee are not already parties to a bailee agreement governing both the Collateral and the location to which Borrower intends to deliver the Collateral, then Borrower shall use reasonable efforts to deliver a bailee agreement in form and substance satisfactory to Lender in its reasonable discretion prior thereto.

 

7.3                                Mergers or Acquisitions Other than a Permitted Myalept Spin-Out Transaction, merge Merge or consolidate, or permit any of its Subsidiaries to merge or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the capital stock or property of another Person.   A Subsidiary may merge or consolidate into another Subsidiary or into Borrower.

 

7.4                                Indebtedness .  Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than Permitted Indebtedness.

 

20


 

7.5                                Encumbrance .  Create, incur, allow, or suffer any Lien on any of its property, or assign or convey any right to receive income, including the sale of any Accounts, or permit any of its Subsidiaries to do so, except for Permitted Liens, permit any Collateral not to be subject to the security interest granted herein, or enter into any agreement, document, instrument or other arrangement (except with or in favor of Lender) with any Person which directly or indirectly prohibits or has the effect of prohibiting Borrower or any Subsidiary from assigning, mortgaging, pledging, granting a security interest in or upon, or encumbering any of Borrower’s or any Subsidiary’s Intellectual Property, except as is otherwise permitted in Section 7.1 hereof and the definition of “Permitted Liens” herein.

 

7.6                                Maintenance of Collateral Accounts .  Maintain any Collateral Account except pursuant to the terms of Section 6.6(b) hereof.

 

7.7                                Distributions; Investments .  Except with respect to Permitted Affiliate Services Payments, Tax Distribution (to the extent set forth in the Budget) or a Permitted Myalept Spin-Out Designated Licensing Transaction (including, for the avoidance of doubt, payment of the Permitted Designated Licensing Transaction Amount) , (a) pay any dividends or make any distribution or payment on the account of its capital stock or redeem, retire or purchase any of its capital stock, provided that (i) Borrower may convert any of its convertible securities into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof, (ii)  the Borrower and each Subsidiary may pay dividends solely in common stock and or other Equity Interests of such Person, (iii) any Subsidiary of Borrower may make dividends or distributions to Borrower , Guarantor or to any of its their Subsidiaries in the ordinary course of business , (iv) to the extent Borrower would otherwise be prohibited by this Section 7.7, Borrower may pay the fees of non-insider directors to the extent expressly set forth in the Budget and reimburse reasonable expense, and (v) so long as no Event of Default has occurred and is continuing , Borrower may make payments to Novelion to be used for (x) customary director indemnification payments to Novelion’s director nominees serving on the board of directors of Borrower , and (y) financial and other reporting and similar customary administrative costs and expenses attributable and fairly allocable to the Loan Parties (including audit and professional fees and other ordinary course operating and administrative expenses incurred by Novelion in its capacity as the ultimate holding company of the Borrower), in the case of this clause (y) to the extent expressly set forth in the Budget ; or (b) directly or indirectly make any Investment other than Permitted Investments, or permit any of its Subsidiaries to do so.

 

7.8                                Transactions with Affiliates .  Except with respect to a Permitted Myalept Spin-Out Affiliate Services Payment, a Permitted Designated Licensing Transaction , directly or indirectly or as set forth in the Perfection Certificate, enter into or permit to exist any material transaction of any kind with any Affiliate of the Borrower, except for transactions that are whether or not in the ordinary course of Borrower’s business, upon fair and reasonable terms that are no less favorable to Borrower than would be obtained in an arm’s length transaction with a non-affiliated Person. business, other than:

 

(a)                                  transactions to the extent expressly set forth in the Budget including Permitted Affiliate Services Payments;

 

(b)                                  any transactions expressly permitted under Section 7.3 and Section 7.7; provided that all parties to such transactions are Loan Parties or their wholly-owned Subsidiaries;

 

(c)                                   so long as it has been approved by the Borrower’s or its applicable Subsidiary’s board of directors or other governing body to the extent required in accordance with applicable law, (i) customary indemnifications of non-officer directors of the Loan Parties and their respective Subsidiaries and (ii) the payment of reasonable and customary

 

21


 

compensation and indemnification arrangements and benefit plans for officers and employees of the Loan Parties and their respective Subsidiaries in the ordinary course of business, in each case to the extent expressly set forth in the Budget and approved by all independent directors of the Borrower’s board of directors; provided , such indemnifications shall not be required to be set forth in the Budget; and

 

(d)                                  transactions under the agreements existing on the First Amendment Effective Date and listed on Schedule IX of the Perfection Certificate; provided, that any expenditures, monetary transfers or other use of cash or the proceeds of any Term Loans are set forth in the Budget.

 

7.9                                Subordinated Other Debt .  (a) Make or permit any payment on any Subordinated New Bridge Debt, except under the terms of the subordination, intercreditor, or other similar agreement to which such Subordinated Debt is subject, (b) amend any provision in any document relating to the Subordinated Debt, except under New Bridge Credit Agreement (unless such payment is expressly prohibited by the terms of the Subordination New Bridge Intercreditor Agreement or other subordination agreement, if any, to which such New Bridge Debt is subject), or ( c b ) make or permit any distribution or payment (whether in cash or otherwise) of principal or interest on any Indebtedness, or seek or obtain approval by the Board to permit the foregoing, other than on (i) the Indebtedness of the Borrower owing to the Lender pursuant to this Agreement, or (ii) on any Subordinated New Bridge Debt, as permitted pursuant to the preceding clause (a) . ; provided , that, notwithstanding anything herein to the contrary, subject to Section 6.2(i), the Loan Parties shall not be prohibited from amending or modifying any provision in any document relating to the New Bridge Debt unless such amendment or modification is prohibited under the terms of the New Bridge Intercreditor Agreement.

 

7.10                         OFAC. (a) Become a person whose property or interest in property is blocked or subject to blocking pursuant to Section 1 of Executive Order 13224 of September 23, 2001 Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit or Support Terrorism (66 Fed. Reg. 49079 (2000)), (b) engage in any dealings or transactions prohibited by Section 2 of such executive order, or is otherwise associated with any such person in any manner that violates Section 2 of such executive order or (c) become a person on the list of “Specially Designated Nationals and Blocked Persons” or subject to the limitations or prohibitions under any other U.S. Department of Treasury’s Office of Foreign Assets Control regulation or executive order.

 

7.11                         7.10 Compliance .  Become with Laws. (a) (i) Violate any Anti-Terrorism Laws, (ii) engage in any transaction, investment, undertaking or activity that conceals the identity, source or destination of the proceeds from any category of prohibited offenses designated by the Organization for Economic Co-operation and Development’s Financial Action Task Force on Money Laundering or (iii) permit any of their respective Affiliates to violate these laws or engage in these actions; (b) deal in, or otherwise engage in any transaction related to, any property or interests in property blocked pursuant to Anti-Terrorism Law, (ii) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempt to violate, any of the prohibitions set forth in any Anti-Terrorism Law or (iii) permit any of their respective Affiliates to do any of the foregoing; or (c)  become an “investment company” or a company controlled by an “investment company” , under the Investment Company Act of 1940, as amended, as amended, or undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Term Loans for that purpose ; fail to meet the minimum funding requirements of ERISA, permit a Reportable Event or Prohibited Transaction, as defined in ERISA, to occur; fail

 

22


 

to (a) comply with the Federal Fair Labor Standards Act or (b) violate any other law or regulation, if the violation would reasonably be expected to have a material adverse effect on Borrower’s business, or permit any of its Subsidiaries to do so; withdraw or permit any Subsidiary to withdraw from participation in, permit partial or complete termination of, or permit the occurrence of any other event with respect to, any present pension, profit sharing and deferred compensation plan which would reasonably be expected to result in any liability of Borrower, including any liability to the Pension Benefit Guaranty Corporation or its successors or any other governmental agency. .

 

7.12                         Compliance with Budget.  Except as otherwise provided herein or approved by the “Required Lenders” (as defined in the New Bridge Credit Agreement) (or if the New Senior Debt (as defined in the New Bridge Credit Agreement) is repaid in full in accordance with the New Bridge Credit Agreement, the Lender), the Loan Parties shall not (a) use any cash or the proceeds of any Term Loans or Collateral or the proceeds thereof in a manner or for a purpose other than in accordance with this Agreement and the Budget, (b) permit operating disbursements (as defined in the Initial Budget) for the first week following the First Amendment Effective Date, to be more than the corresponding amounts set forth in the Initial Budget for such period subject to a variance of not greater than 25%, (c) permit operating disbursements (as defined in the Initial Budget) for the two week period following the First Amendment Effective Date, to be more than the corresponding amounts set forth in the Initial Budget for such period, subject to a variance of not greater than 25%, and (d) permit operating disbursements (as defined in the Initial Budget or Budget, as then applicable) for the third week and each week thereafter, to be tested after the fourth week after the First Amendment Effective Date on a trailing four week basis, to be more than the corresponding amounts set forth in the Initial Budget or Budget, as then applicable, for such period, subject to a variance of not greater than 15% (the foregoing covenants (b), (c) and (d) to be tested every week, commencing with the first week following the First Amendment Effective Date), (e) permit cumulative total cash receipts (as defined in the Initial Budget) for the first two full weeks after the First Amendment Effective Date to be less than the corresponding amounts set forth in the Initial Budget for such period subject to a variance of not greater than 25%, (f) permit cumulative total cash receipts (as defined in the Initial Budget or Budget, as then applicable) for the fourth week after the First Amendment Effective Date and every two weeks thereafter, to be no less than the corresponding amounts set forth in the Initial Budget or Budget, as then applicable, for such two week period, subject to a variance of not greater than 20% (the foregoing covenants (e) and (f) to be tested every second week, commencing with the second full week following the First Amendment Effective Date); provided further for 7.12(e) and 7.12(f), if a cash receipt that was scheduled to be received in the Initial Budget or Budget, as then applicable, in the week this covenant is tested is received within three business days after the test week, this receipt shall be applied as if it was received during the test week.  Notwithstanding anything in this Agreement or the other Loan Documents to the contrary, in no event shall the Loan Parties make any expenditures, payments, repayments or prepayments, dividends, distributions, reimbursements or similar transaction to Novelion or any Subsidiary thereof (excluding Borrower and any Subsidiary thereof) during the term of this Agreement unless expressly set forth in the line item of the Budget titled “Permitted Affiliate Services Payments” or expressly permitted by the New Bridge Intercreditor Agreement.

 

8                                          EVENTS OF DEFAULT

 

The delivery by Lender of a notice (a “Default Notice”) that one of the following shall have occurred shall constitute an event of default (an “Event of Default”) under this Agreement, provided that the mere occurrence of any event or condition set forth in Section 8.5 and 8.6 shall be an Event of Default upon its occurrence or existence, as the case may be:

 

23


 

The occurrence of any one of the following shall constitute an event of default (an “Event of Default”) under this Agreement:

 

8.1                                Payment Default Borrower Any Loan Party fails to pay ( a i make any payment when and as required to be paid herein, any amount of principal of the any Term Loan when due or or (ii) within three (3) Business Days after the same becomes due in cash, any interest on any Term Loans within three Business Days after its due date, or (b) pay any other Obligations within ten (10) Business Days after such Obligations are due and payable (it being understood that no such cure period shall apply to payments due on the Term Loan Maturity Date)..  During the cure period, the failure to make or pay any payment specified under clause (a) or (b) hereunder is not an Event of Default; Loan or any other amount payable hereunder or with respect to any other Loan Document;

 

8.2                                Covenant Default.

 

(a)                                  Borrower Any Loan Party fails or neglects to perform any obligation in Sections 6.2(c), 6.2(d), 6.2(e), 6.2(f), 6.5, 6.6, 6.7 6.11 (b) , or 6.10 6.12 or violates any covenant in Section 7; or

 

(b)                                  Borrower Any Loan Party fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement contained in this Agreement or any Loan Documents, and as to any default (other than those specified in this Section 8) under such other term, provision, condition, covenant or agreement that can be cured, has failed to cure the default within ten fifteen ( 10 15 ) days after the occurrence thereof; provided, however, that if the default cannot by its nature be cured within the ten (10) day period or cannot after diligent attempts by Borrower be cured within such ten (10) day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30) days) to attempt to cure such default, and within such reasonable time period the failure to cure the default shall not be deemed an Event of Default.  Cure periods provided under this section shall not apply, among other things, to financial covenants or any other covenants set forth in clause (a) above; receipt by the Borrower of written notice thereof by the Lender;

 

8.3                                [Reserved].

 

8.4                                Restraint on Business.  Any Loan Party is enjoined, restrained or in any way prevented by court order from continuing to conduct all or any material part of its business affairs or any Loan Party or any of their respective Subsidiaries’ cessation of all or any material part of its business operations (other than in connection with a sale of assets permitted by the Loan Documents or otherwise consented to by the Lender);

 

8.5                                Insolvency; Attachment; Levy.  (a) Any Loan Party or any Subsidiary institutes or consents to the institution of any Insolvency Proceeding, or makes a general assignment for the benefit of creditors; or applies for or consents to the appointment of any receiver, interim receiver, receiver and manager, trustee, custodian, conservator, liquidator, rehabilitator, administrator, administrative receiver or similar officer for it or for all or any material part of its property; or any receiver, interim receiver, receiver and manager, trustee, custodian, conservator, liquidator, rehabilitator, administrator, administrative receiver or similar officer is appointed without the application or consent of such Person and the appointment continues undischarged or unstayed for sixty (60) calendar days; or any Insolvency Proceeding relating to any such Person or to all or any material part of its property is instituted without the consent of such Person and continues undismissed or unstayed for sixty (60) calendar days; or an order for relief is entered in any such

 

24


 

Insolvency Proceeding; (b) any Loan Party or any Subsidiary becomes unable or admits in writing its inability or fails generally to pay its debts as they become due; or (c) any writ or warrant of attachment or execution or similar process in respect of a claim in excess of Three Hundred Thousand Dollars ($300,000)is issued or levied against all or any material part of the property of the Loan Parties and their Subsidiaries, taken as a whole, and is not released, vacated, stayed or fully bonded within sixty (60) days after its issue or levy;

 

8.6                                Other Agreements.  Any Loan Party or any Subsidiary (A) fails to make any payment beyond the applicable grace period with respect thereto, if any (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of any Indebtedness (other than Indebtedness hereunder) having an aggregate principal amount of not less than Three Hundred Thousand Dollars ($300,000) , or (B) fails to observe or perform any other agreement or condition relating to any such Indebtedness, or any other event occurs, the effect of which default or other event is to cause, or to permit the holder or holders of such Indebtedness (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, with the giving of notice if required, such Indebtedness to become due or to be repurchased, prepaid, defeased or redeemed (automatically or otherwise), or an offer to repurchase, prepay, defease or redeem such Indebtedness to be made, prior to its stated maturity; (it being acknowledge and agreed that any “Event of Default” under Article VIII of the New Bridge Credit Agreement (or any successor provision) shall be an Event of Default under this Section 8.6);

 

8.3 Material Adverse Change.  A Material Adverse Change occurs and continues for more than ten (10) Business Days;

 

8.4 Attachment; Levy; Restraint on Business.

 

(a)  (i) a notice of lien or levy is filed against any of Borrower’s assets by any government agency, and the same is not, within ten (10) days after the occurrence thereof, discharged or stayed (whether through the posting of a bond or otherwise); or

 

(b)  (i) any material portion of Borrower’s assets is attached, seized, levied on, or comes into possession of a trustee or receiver, or (ii) any court order enjoins, restrains, or prevents Borrower from conducting any material part of its business;

 

8.5 Insolvency.  (a) Borrower or any Responsible Officer makes a public statement or provides a written notice to any Person to the effect that Borrower is unable to pay its debts (including trade debts) as they become due; (b) Borrower begins an Insolvency Proceeding; or (c) an Insolvency Proceeding is begun against Borrower and not dismissed or stayed within forty-five (45) days;

 

8.6 Other Agreements.  There is, under any agreement to which Borrower is a party with a third party or parties (including, for the avoidance of doubt, the Subordinated Loan Agreement or the Indenture), (a) any default resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of Three Hundred Thousand Dollars ($300,000); or (b) any default by Borrower, the result of which would have a material adverse effect on Borrower’s and its Subsidiaries’ business, taken as a whole;

 

8.7                                Judgments Other than any Disclosed Settlement, one or more final judgments, orders, or decrees There is entered against any Loan Party or any Subsidiary a final judgment or order for the payment of money in an amount, individually or in the aggregate, of at least aggregate

 

25


 

amount exceeding Three Hundred Thousand Dollars ($300,000) ( to the extent not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower and the same are not, within ten (10) days after the entry thereof the insurer has been notified of such judgment or order and does not deny or fail to confirm coverage) and such judgment or order shall not have been satisfied, vacated , discharged or execution thereof stayed or bonded pending an appeal , or such judgments are not discharged prior to the expiration of any such stay for a period of sixty (60) consecutive days ;

 

8.8                                Misrepresentations Borrower Any Loan Party makes any representation, warranty, or other statement now or later in this Agreement or any Loan Document, and such representation, warranty, or other statement is incorrect in any material respect when made;

 

8.9                                Subordination Agreement Agreements ; Subordinated Debt .  Any document, instrument, or agreement evidencing any Roll Up Loans or Subordinated Debt or the Subordination (including the New Bridge Intercreditor Agreement or any other subordination agreement) shall for any reason be revoked or invalidated or otherwise cease to be in full force and effect, any Person New Lender (as defined in the New Bridge Intercreditor Agreement) shall be in breach thereof (including receipt of any payment or other property in violation of the Subordination New Bridge Intercreditor Agreement or any other subordination agreement ) or contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder, or the Obligations shall for any reason be subordinated or shall not have the priority contemplated by this Agreement ; or , except as set forth in the New Bridge Intercreditor Agreement;

 

8.10 Governmental Approvals.  Any Governmental Approval shall have been (a) revoked, rescinded, suspended, modified in an adverse manner or not renewed in the ordinary course for a full term or (b) subject to any decision by a Governmental Authority that designates a hearing with respect to any applications for renewal of any of such Governmental Approval or that would result in the Governmental Authority taking any of the actions described in clause (a) above, and such decision or such revocation, rescission, suspension, modification or non-renewal has, or would reasonably be expected to have, a Material Adverse Change.

 

8.10                         Change of Control; Structure.  There occurs any (i) Change of Control or (ii) any change to the ownership of direct and indirect Subsidiaries of Novelion from the ownership structure set forth on Schedule I to the Perfection Certificate;

 

8.11                         Liens.  Any Loan Document shall for any reason cease to create a valid and perfected Lien (having the priorities specified therein and the New Bridge Intercreditor Agreement) on and security interest in the Collateral;

 

8.12                         Dissolution or Liquidation.  Any Loan Party voluntarily or involuntarily dissolves or is dissolved, liquidates or is liquidated or files a motion with a bankruptcy court seeking authorization to dissolve or liquidate; or

 

8.13                         Invalidity of Loan Documents.  Any material provision of any Loan Document, at any time after its execution and delivery and for any reason other than as expressly permitted hereunder or thereunder or the satisfaction in full of all the Obligations, ceases to be in full force and effect; or any Loan Party contests in any manner the validity or enforceability of any provision of any Loan Document; or any Loan Party denies that it has any or further liability or obligation under any Loan Document (other than as a result of repayment in full of the Obligations), purports to revoke or rescind any Loan Document or asserts that any Loan Document is invalid or unenforceable.

 

26


 

9                                          LENDER’S RIGHTS AND REMEDIES .

 

9.1                                Rights and Remedies .  While an Event of Default occurs and continues Lender may, without notice or demand, do any or all of the following, to the extent not prohibited by applicable law;

 

(a)                                  declare all Obligations immediately due and payable (but if an Event of Default described in Section 8.5 occurs all Obligations are immediately due and payable without any action by Lender);

 

(b)                                  stop advancing money or extending credit for Borrower’s benefit under this Agreement or under any other agreement between Borrower and Lender;

 

(c)  [Reserved];

 

(d)  [Reserved];

 

(c)                                   (e)  settle or adjust disputes and claims directly with account debtors for amounts on terms and in any order that Lender considers advisable, notify any Person owing Borrower a Loan Party money of Lender’s security interest in such funds, and verify the amount of such account;

 

(d)                                  (f)  make any payments and do any acts it considers necessary or reasonable to protect the Collateral and/or its security interest in the Collateral.  Borrower Each Loan Party shall assemble the Collateral if Lender requests and make it available as Lender designates at any location that is reasonably convenient to Lender and Borrower such Loan Party .  Lender may peaceably enter premises where the Collateral is located, take and maintain possession of any part of the Collateral, and pay, purchase, contest, or compromise any Lien which appears to be prior or superior to its security interest and pay all expenses incurred.  Borrower Each Loan Party grants Lender a license to enter and occupy any of its premises, without charge, by Borrower such Loan Party , to exercise any of Lender’s rights or remedies;

 

(g)  [Reserved];

 

(e)                                   (h)  ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell the Collateral.  Lender is hereby granted a non-exclusive, royalty-free license or other right to use, without charge, Borrower’s each Loan Party’s labels, Patents, Copyrights, mask works, rights of use of any name, trade secrets, trade names, Trademarks, and advertising matter, or any similar property as it pertains to the Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Lender’s exercise of its rights under this Section, Borrower’s each Loan Party’s rights under all licenses and all franchise agreements inure to Lender’s benefit;

 

(i)  [Reserved];

 

(f)                                    (j)  demand and receive possession of Borrower’s each Loan Party’s Books; and

 

(g)                                  (k)  exercise all rights and remedies available to Lender under the Loan Documents or at law or equity, including all remedies provided under the Code (including disposal of the Collateral pursuant to the terms thereof).

 

9.2                                Power of Attorney Borrower Each Loan Party hereby irrevocably appoints Lender as its lawful attorney-in-fact, exercisable upon the occurrence and during the continuance of an Event of

 

27


 

Default, to: (a) endorse Borrower’s such Loan Party’s name on any checks or other forms of payment or security; (b) sign Borrower’s such Loan Party’s name on any invoice or bill of lading for any Account or drafts against account debtors; (c) settle and adjust disputes and claims about the Accounts directly with account debtors, for amounts and on terms Lender determines reasonable; (d) make, settle, and adjust all claims under Borrower’s such Loan Party’s insurance policies; (e) pay, contest or settle any Lien, charge, encumbrance, security interest, and adverse claim in or to the Collateral, or any judgment based thereon, or otherwise take any action to terminate or discharge the same; and (f) transfer the Collateral into the name of Lender or a third party as the Code permits.  Borrower Each Loan Party hereby appoints Lender as its lawful attorney-in-fact to sign Borrower’s such Loan Party’s name on any documents necessary to perfect or continue the perfection of Lender’s security interest in the Collateral regardless of whether an Event of Default has occurred until all Obligations (other than inchoate indemnity obligations) have been satisfied in full and Lender is under no further obligation to make Term Loans hereunder.  Lender’s foregoing appointment as Borrower’s such Loan Party’s attorney in fact, and all of Lender’s rights and powers, coupled with an interest, are irrevocable until all Obligations (other than inchoate indemnity obligations) have been fully repaid and performed.

 

9.3                                Protective Payments .  If Borrower a Loan Party fails to obtain the insurance called for by Section 6.5 or fails to pay any premium thereon or fails to pay any other amount which Borrower such Loan Party is obligated to pay under this Agreement or any other Loan Document, Lender may obtain such insurance or make such payment, and all amounts so paid by Lender are Lender Expenses and immediately due and payable, bearing interest at the then highest rate applicable to the Obligations, and secured by the Collateral.  Lender will make reasonable efforts to provide Borrower such Loan Party with notice of Lender obtaining such insurance at the time it is obtained or within a reasonable time thereafter.  No payments by Lender are deemed an agreement to make similar payments in the future or Lender’s waiver of any Event of Default.

 

9.4                                Application of Payments and Proceeds Upon Default .  If an Event of Default has occurred and is continuing, Lender may apply any funds in its possession, whether from payments, proceeds realized as the result of any collection of Accounts or other disposition of the Collateral, or otherwise, to the Obligations in such order as Lender shall determine in its sole discretion.  Any surplus shall be paid to Borrower or other Persons legally entitled thereto; Borrower shall remain liable to Lender for any deficiency.  If Lender, in its good faith business judgment, directly or indirectly enters into a deferred payment or other credit transaction with any purchaser at any sale of Collateral, Lender shall have the option, exercisable at any time, of either reducing the Obligations by the principal amount of the purchase price or deferring the reduction of the Obligations until the actual receipt by Lender of cash therefor.

 

9.5                                Lender’s Liability for Collateral .  So long as Lender complies with applicable law and reasonable banking practices regarding the safekeeping of the Collateral in the possession or under the control of Lender, Lender shall not be liable or responsible for: (a) the safekeeping of the Collateral; (b) any loss or damage to the Collateral; (c) any diminution in the value of the Collateral; or (d) any act or default of any carrier, warehouseman, bailee, or other Person.  Borrower Each Loan Party bears all risk of loss, damage or destruction of the Collateral.

 

9.6                                No Waiver; Remedies Cumulative .  Lender’s failure, at any time or times, to require strict performance by Borrower any Loan Party of any provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Lender thereafter to demand strict performance and compliance herewith or therewith.  No waiver hereunder shall be effective unless signed by the party granting the waiver and then is only effective for the specific instance and purpose for which it is given.  Lender’s rights and remedies under this Agreement and the other Loan Documents are cumulative.  Lender has all rights and remedies provided under the Code, by law, or in equity.  Lender’s exercise of

 

28


 

one right or remedy is not an election and shall not preclude Lender from exercising any other remedy under this Agreement or other remedy available at law or in equity, and Lender’s waiver of any Event of Default is not a continuing waiver.  Lender’s delay in exercising any remedy is not a waiver, election, or acquiescence.

 

9.7                                Demand Waiver Borrower Each Loan Party waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees held by Lender on which Borrower such Loan Party is liable.

 

10                                   NOTICES

 

All notices, consents, requests, approvals, demands, or other communication by any party to this Agreement or any other Loan Document must be in writing and shall be deemed to have been validly served, given, or delivered: (a) upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid; (b) upon transmission, when sent by electronic mail; (c) one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address, facsimile number, or email address indicated below.  Lender or , Borrower or Guarantor may change its mailing or electronic mail address or facsimile number by giving the other party written notice thereof in accordance with the terms of this Section 10.

 

If to Borrower any Loan Party :                   Aegerion Pharmaceuticals, Inc.
One Main Street, Suite 800
Cambridge, MA 02142
Attn: Barbara Chan, President                            
Fax:  617-945-7968

Email:  barbara.chan@aegerion.com

 

With a copy (which shall not constitute notice) to:

 

Willkie Farr & Gallagher LLP

787 Seventh Avenue

New York, NY 10019

Attn: Leonard Klingbaum                                             
Fax:  212-728-9290

Email:  lklingbaum@willkie.com

 

If to Lender:                                                                                                                            Novelion Therapeutics Inc.
c/o Norton Rose Fulbright
1800 - 510 West Georgia Street, Vancouver, BC V6B 0M3 Canada

Attn: Michael Price, Chief Financial Officer Ben Harshbarger, General Counsel
Email: michael.price@novelion.com ben.harshbarger@novelion.com

 

With a copy (which shall not constitute notice) to:

 

29


 

Goodwin Procter LLP

100 Northern Avenue

Boston, MA 02210

Attn: Anna Dodson

Fax: 617-977-9451

Email: adodson@goodwinlaw.com

 

11                                   CHOICE OF LAW, VENUE, AND JURY TRIAL WAIVER

 

New York law governs the Loan Documents.  Borrower Each Loan Party and Lender each submit to the exclusive jurisdiction of the State and Federal courts in New York, New York; provided, however, that nothing in this Agreement shall be deemed to operate to preclude Lender from bringing suit or taking other legal action in any other jurisdiction to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other court order in favor of Lender.  Borrower Each Loan Party expressly submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower each Loan Party hereby waives any objection that it may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such legal or equitable, relief as is deemed appropriate by such court.  Borrower Each Loan Party hereby waives personal service of the summons, complaints, and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower such Loan Party at the address set forth in Section 10 of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower’s such Loan Party’s actual receipt thereof or three (3) days after deposit in the U.S. mails, proper postage prepaid.

 

TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER , GUARANTOR AND LENDER EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS.  THIS WAIVER IS A MATERIAL INDUCEMENT FOR BOTH ALL PARTIES TO ENTER INTO THIS AGREEMENT.  EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.

 

12                                   GENERAL PROVISIONS

 

12.1                         Successors and Assigns .  This Agreement binds and is for the benefit of the successors and permitted assigns of each party.  Borrower Neither Loan Party may not assign this Agreement or any rights or obligations under it without Lender’s prior written consent (which may be granted or withheld in Lender’s discretion).  Lender has the right (with the consent of Borrower (not to be unreasonably withheld, delayed or conditioned), unless an Event of Default has occurred and is continuing or the Term Loan Maturity Date has occurred in either such case no such consent shall be required), to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, Lender’s obligations, rights, and benefits under this Agreement and the other Loan Documents, subject to Sections 12.2.1 and 12.2.2.

 

12.2                         Register and Participants .

 

12.2.1               Register .  Each Lender shall provide, and Borrower shall maintain at its offices, a copy of each agreement pursuant to which any Lender purports to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, such Lender’s obligations, rights, and benefits under this Agreement and the other Loan Documents.   Borrower shall maintain at its offices a register for the

 

30


 

recordation of the names and addresses of Lenders, and the commitments of, and principal amounts (and stated interest) owing to, each Lender pursuant to the terms hereof from time to time (the “ Register ”).  The entries in the Register shall be conclusive absent manifest error, and Borrower and Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender and the owner of the amounts owing to it under the Loan Documents as reflected in the Register for all purposes of the Loan Documents.  The Register shall be available for inspection by any Lender, at any reasonable time and from time to time upon reasonable prior notice.  No sale, transfer, assignment or negotiation of all or any part of, or any interest in, such a Lender’s obligations, rights, and benefits under this Agreement and the other Loan Documents shall be permitted or effective unless it is recorded on the Register.

 

12.2.2               Participations .  Any Lender may at any time grant participations to any Person (other than a natural Person, or a holding company, investment vehicle or trust for, or owned and operated for the primary benefit of, a natural Person, or Borrower or any of Borrower’s Affiliates or Subsidiaries a Loan Party or any of Affiliate or Subsidiary of any Loan Party ) (each, a “ Participant ”) in all or a portion of such Lender’s rights and/or obligations under this Agreement and other Loan Documents; provided that (i) such Lender’s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, and (iii)  Borrower the Loan Parties and Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement.  Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement. Borrower Each Loan Party agrees that each Participant shall be entitled to the benefits of Section 2.5 ( Taxes ) (subject to the requirements and limitations therein, including the requirements under Section 2.5.2( Taxes — Status of Lenders ) (it being understood that the documentation required under Section 2.5.2 ( Taxes — Status of Lenders ) shall be delivered to the participating Lender)) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of this Section; provided that such Participant shall not be entitled to receive any greater payment under Section 2.5.2(f) ( Taxes — Status of Lenders ) with respect to any participation, than its participating Lender would have been entitled to receive.  Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or other obligations under the Loan Documents (the “ Participant Register ”); provided, further, that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant’s interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations, or is otherwise required thereunder. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.  No grant of a participation to any Person shall be permitted or effective unless it is recorded on the Participant Register.

 

12.3                         Indemnification Borrower Each Loan Party agrees to indemnify, defend and hold Lender and its directors, officers, employees, agents, attorneys, or any other Person affiliated with (other than any other Loan Party or any Subsidiary of a Loan Party) or representing Lender ( including without limitation, Goodwin Procter LLP and any Professionals) ( each, an “ Indemnified Person ”) harmless against: (a) (i)  all obligations, demands, claims, and liabilities (collectively, “ Claims ”) claimed or asserted by any other party Person in connection with the transactions contemplated by the Loan Documents; and ( b ii ) all losses or expenses (including Lender Expenses but subject to the limitation thereon as set forth in the definition of such term) in any way suffered, incurred, or paid by such

 

31


 

Indemnified Person as a result of, following from, consequential to, or arising from transactions between Lender and Borrower any Loan Party contemplated by the Loan Documents (including reasonable and documented attorneys’ fees and expenses), except with respect to any Indemnified Person for Claims and/or losses directly caused by any such Indemnified Person’s gross negligence or willful misconduct; and (b)(i) all Claims claimed or asserted by any Person in connection with (A) the First Amendment, including the consent provided under Section 8 thereof, and (B) the use of the proceeds of the New Bridge Debt on the First Amendment Effective Date, and (ii) all losses or expenses (including Lender Expenses but subject to the limitations thereon as set forth in the definition of such term) in any way suffered, incurred, or paid by such Indemnified Person as a result of, following from, consequential to, or arising from transactions between Lender and any Loan Party contemplated by the foregoing clauses (b)(i)(A) and (b)(i)(B) (including reasonable and documented attorneys’ fees and expenses) , except with respect to any Indemnified Person for Claims and/or losses directly caused by such Indemnified Person’s gross negligence or willful misconduct.

 

12.4                         Time of Essence .  Time is of the essence for the performance of all Obligations in this Agreement.

 

12.5                         Severability of Provisions .  Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision.

 

12.6 [Reserved.] .

 

12.6                         12.7 Amendments in Writing; Waiver; Integration .  No purported amendment or modification of any Loan Document, or waiver, discharge or termination of any obligation under any Loan Document, shall be enforceable or admissible unless, and only to the extent, expressly set forth in a writing signed by Borrower each Loan Party and Lender.  Without limiting the generality of the foregoing, no oral promise or statement, nor any action, inaction, delay, failure to require performance or course of conduct shall operate as, or evidence, an amendment, supplement or waiver or have any other effect on any Loan Document.  Any waiver granted shall be limited to the specific circumstance expressly described in it, and shall not apply to any subsequent or other circumstance, whether similar or dissimilar, or give rise to, or evidence, any obligation or commitment to grant any further waiver.  The Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements.  All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of the Loan Documents merge into the Loan Documents.

 

12.7                         12.8 Counterparts .  This Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement.

 

12.8                         12.9 Survival .  All covenants, representations and warranties made in this Agreement continue in full force until this Agreement has terminated pursuant to its terms and all Obligations (other than inchoate indemnity obligations and any other obligations which, by their terms, are to survive the termination of this Agreement) have been paid in full and satisfied.  The obligation of Borrower each Loan Party under Section 12.3 to indemnify Lender shall survive until the statute of limitations with respect to such claim or cause of action shall have run.

 

12.9                         12.10 Confidentiality .  In handling any confidential information, Lender shall exercise the same degree of care that it exercises for its own proprietary information, but disclosure of information may be made: (a) to Lender’s Subsidiaries, Affiliates or any senior executive officers, directors, partners, managers or members (as applicable) of such Affiliates (such Subsidiaries and Affiliates, together with Lender, collectively, “ Lender Entities ”); (b) as required by law, regulation, subpoena, or other order; and

 

32


 

(c) as Lender considers appropriate in exercising remedies under the Loan Documents.  Confidential information does not include information that is either: (i) in the public domain or in Lender’s possession when disclosed to Lender, or becomes part of the public domain after disclosure to Lender; or (ii) disclosed to Lender by a third party if Lender does not know that the third party is prohibited from disclosing the information.

 

12.10                  12.11 Right of Set Off Borrower Each Loan Party hereby grants to Lender, a lien, security interest and right of set off as security for all Obligations to Lender, whether now existing or hereafter arising upon and against all deposits, credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of Lender or any entity under the control of Lender (including a subsidiary or Lender) or in transit to any of them.  At any time after the occurrence and during the continuance of an Event of Default, without demand or notice, Lender may set off the same or any part thereof and apply the same to any Obligations of Borrower any Loan Party then due, regardless of the adequacy of any other collateral securing the Obligations.  ANY AND ALL RIGHTS TO REQUIRE LENDER TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED.

 

12.11                  12.12 Electronic Execution of Documents .  The words “ execution, ” “ signed, ” “ signature ” and words of like import in any Loan Document shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act.

 

12.12                  12.13 Captions .  The headings used in this Agreement are for convenience only and shall not affect the interpretation of this Agreement.

 

12.13                  12.14 Construction of Agreement .  The parties mutually acknowledge that they and their attorneys have participated in the preparation and negotiation of this Agreement.  In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused the uncertainty to exist.

 

12.14                  12.15 Relationship .  The relationship of the parties to this Agreement is determined solely by the provisions of this Agreement.  The parties do not intend to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different from those of parties to an arm’s-length contract.

 

12.15                  12.16 Third Parties .  Nothing in this Agreement, whether express or implied, is intended to: (a) confer any benefits, rights or remedies under or by reason of this Agreement on any persons other than the express parties to it and their respective permitted successors and assigns; (b) relieve or discharge the obligation or liability of any person not an express party to this Agreement; or (c) give any person not an express party to this Agreement any right of subrogation or action against any party to this Agreement.

 

12.17 [Reserved].

 

12.16                  12.18 Disclosure Requirements .  Any requirement of Borrower any Loan Party to disclose or make available to Lender any information that is publicly available shall be deemed to be satisfied if such information is filed with the appropriate Governmental Authority on or prior to the date such information is required to be disclosed or made available hereunder.

 

33


 

12.19 Convertible Note Restructuring; Myalept Spin-Out Transaction.

 

(a)  [Reserved]

 

(b)  Borrower shall timely provide Lender with all material transaction documents with respect to the Convertible Note Restructuring.  Borrower shall deliver notice to Lender of each Subordinated Lender that has elected, promptly following any such elections, to (x) declare all Obligations to such Lender immediately due and payable in cash on the Convertible Note Restructuring Date or (y) convert all Obligations to such Lender then due and owing on a dollar-for-dollar basis into (i) any security or loans being issued by Novelion or any of its Subsidiaries (including Borrower) in exchange for cash consideration to be provided in connection with any Convertible Note Restructuring or (ii) any security into which the Convertible Notes are converted or exchanged in connection with such Convertible Note Restructuring.  In the event of a material change in the Convertible Note Restructuring, Borrower shall update Lender on the changed terms of the Convertible Note Restructuring.

 

(c)  The Borrower shall timely provide Lender with all material transaction documents with respect to any Myalept Spin-Out Transaction.  Borrower shall deliver notice to Lender of each Subordinated Lender that has elected, promptly following any such election, to (x) maintain its loan with Borrower (in which case the terms of this Agreement will remain in effect with respect to such Lender)  or (y) cause Borrower to cause the Successor Company to assume in whole, and not in part, the loan to such Lender on terms and conditions consistent with the Subordinated Loan Agreement (including the grant of a lien on substantially all of the available assets the Successor Company).  In the event of such a material change to the terms of the Myalept Spin-Out Transaction, the Borrower shall promptly update Lender on the changed terms of the Myalept Spin-Out Transaction.

 

13                                   DEFINITIONS

 

13.1                         Definitions .  As used in the Loan Documents, the word “ shall ” is mandatory, the word “ may ” is permissive, the word “ or ” is not exclusive, the words “ includes ” and “ including ” are not limiting, the singular includes the plural, and numbers denoting amounts that are set off in brackets are negative. As used in this Agreement, the following capitalized terms have the following meanings:

 

Account ” is any “ account ” as defined in the Code with such additions to such term as may hereafter be made, and includes, without limitation, all accounts receivable and other sums owing to Borrower.

 

Affiliate ” is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any Person that controls or is controlled by or is under common control with the Person .

 

Agreement ” is defined in the preamble hereof.

 

“Anti-Terrorism Law” means any Requirement of Law related to money laundering or financing terrorism, including the PATRIOT Act, and its implementing regulations, The Currency and Foreign Transactions Reporting Act (also known as the Bank Secrecy Act, 31 U.S.C. sections 5311-5330 and 12 U.S.C. sections 1818(s), 1820(b) and 1951-1959), the Trading with the Enemy Act (50 U.S.C. section 1 et seq., as amended), Executive Order 13224 (effective September 24, 2001) and the Money Laundering Control Act of 1986 (18 U.S.C. sections 1956 and 1957).

 

34


 

Board ” means Borrower’s board of directors.

 

Borrower ” is defined in the preamble hereof.

 

Borrower’s Books ” are all Borrower’s or Guarantor’s, as applicable, books and records including ledgers, federal and state tax returns, records regarding Borrower’s or Guarantor’s, as applicable, assets or liabilities, the Collateral, business operations or financial condition, and all computer programs or storage or any equipment containing such information.

 

Borrower ” is defined in the preamble hereof.

 

“Bridge Transactions ” has the meaning set forth in the First Amendment.

 

“Budget” means the Initial Budget and as the same shall be supplemented pursuant to Section 6.2(f) with the consent of the New Bridge Lenders under the New Bridge Credit Agreement.

 

Business Day ” is any day that is not a Saturday, Sunday or a legal holiday on which commercial banks are authorized or required by law to be closed for business in New York, New York.

 

Cash Equivalents ” means (a) marketable direct obligations issued and unconditionally guaranteed by the United States Government; (b) agencies (LSE’s), State (municipal bonds), or Corporate Bonds having a long term rating of at least A- or A3 from Standard & Poor’s Ratings Group, Fitch Ratings Inc. or Moody’s Investor Services, Inc. thereof having maturities of not more than fifteen months from the date of acquisition; (c) commercial paper maturing no more than 270 days from date of acquisition and having a rating of A2/P2/F2 or better from Standard & Poor’s Ratings Group, Fitch Ratings Inc. or Moody’s Investors Services, Inc.; and (d) money market funds having a rating of AAAm/Aaa or better from Standard & Poor’s Ratings Group, Fitch Ratings Inc. or Moody’s Investors Services, Inc.

 

Change of Control ” means any person or group of persons (within the meaning of Section 13(d) or 14(a) of the Exchange Act) shall have acquired (a) beneficial ownership (within the meaning of Rule 13d-3 promulgated by the SEC under the Exchange Act) of fifty percent (50%) or more of the voting equity interests of Borrower, or (b) all or substantially all of the assets of Borrower.

 

Code ” is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of New York; provided, that, to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern; provided further, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, or priority of, or remedies with respect to, the Liens on any Collateral granted hereunder is governed by the Uniform Commercial Code in effect in a jurisdiction other than the State of New York, the term “ Code ” shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority, or remedies and for purposes of definitions relating to such provisions.

 

Collateral ” is any and all properties, rights and assets of Borrower and Guarantor described on Exhibit A .

 

Collateral Account ” is any Deposit Account, Securities Account, or Commodity Account.

 

35


 

Commodity Account ” is any “commodity account” as defined in the Code with such additions to such term as may hereafter be made.

 

“Compliance Certificate” means a certificate substantially in the form of Annex E to the First Amendment.

 

Contingent Obligation ” is, for any Person, any direct or indirect liability, contingent or not, of that Person for (a) any indebtedness, lease, dividend, letter of credit or other obligation of another such as an obligation, in each case, directly or indirectly guaranteed, endorsed, co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable; (b) any obligations for undrawn letters of credit for the account of that Person; and (c) all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices; but “Contingent Obligation” does not include endorsements in the ordinary course of business.  The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement.

 

Control Agreement ” is any control agreement entered into among the depository institution at which Borrower or Guarantor maintains a Deposit Account or the securities intermediary or commodity intermediary at which Borrower or Guarantor maintains a Securities Account or a Commodity Account, Borrower, Guarantor and Lender and the Subordinated Loan Agent pursuant to which Lender and Subordinated Loan Agent each obtains control (within the meaning of the Code) over such Deposit Account, Securities Account, or Commodity Account.

 

Convertible Notes ” means Borrower’s 2.00% Convertible Senior Notes due 2019 issued under the Indenture.

 

“Convertible Note Restructuring” means any restructuring or recapitalization of all or substantially all of the Convertible Notes, including any exchange offer or similar transaction; provided that such transaction has been approved by Borrower’s board of directors.

 

Copyrights ” are any and all copyright rights, copyright applications, copyright registrations and like protections in each work or authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret.

 

Default ” shall mean an event, circumstance or condition which, with the giving of notice or passage of time or both, would constitute an Event of Default.

 

Default Notice ” is defined in Section 8.

 

Default Rate ” is defined in Section 2.2(b).

 

Deposit Account ” is any “deposit account” as defined in the Code with such additions to such term as may hereafter be made.

 

Disclosed Settlements ” means the settlements or proposed settlements disclosed on the Perfection Certificate on the First Amendment Effective Date.

 

36


 

Dollars, ” “ dollars ” or use of the sign “ S ” means only lawful money of the United States and not any other currency, regardless of whether that currency uses the “ $ ” sign to denote its currency or may be readily converted into lawful money of the United States.

 

Domestic Subsidiary ” means a Subsidiary organized under the laws of the United States or any state or territory thereof or the District of Columbia.

 

Equipment ” is all “equipment” as defined in the Code with such additions to such term as may hereafter be made, and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), leasehold improvements, software and any interest in any of the foregoing.

 

“Equity Interests” means, with respect to any Person, all of the shares of capital stock of (or other ownership or profit interests in) such Person, all of the warrants, options or other rights for the purchase or acquisition from such Person of shares of capital stock of (or other ownership or profit interests in) such Person, all of the securities convertible into or exchangeable for shares of capital stock of (or other ownership or profit interests in) such Person or warrants, rights or options for the purchase or acquisition from such Person of such shares (or such other interests), and all of the other ownership or profit interests in such Person (including partnership, member or trust interests therein), whether voting or nonvoting.

 

ERISA ” is the Employee Retirement Income Security Act of 1974, as amended, and its regulations.

 

Event of Default ” is defined in Section 8.

 

Exchange Act ” is the Securities Exchange Act of 1934, as amended.

 

“Excluded Account” shall mean any Deposit Account or Securities Account that (a) is solely used for the purpose of (x) making payroll and withholding tax payments related thereto and other employee wage and benefits payments and accrued and unpaid employee compensation payments (including salaries, wages, benefits, and expense reimbursements, 401(k) and other retirement plans and employee benefits, including rabbi trusts for deferred compensation and health care benefits) or (y) paying taxes, including sales taxes, (b) is an escrow, defeasance or redemption account, (c) is a fiduciary or trust account or otherwise held exclusively for the benefit of an unaffiliated third party, or (d) has an average daily balance of less than $50,000 individually, provided, that the average daily balance of all such accounts under this clause (d) shall not exceed $300,000 in the aggregate at any time.

 

“Excluded Collateral” has the meaning set forth on Exhibit A.

 

Excluded Taxes ” means any of the following Taxes imposed on or with respect to Lender or required to be withheld or deducted from a payment to Lender, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i) imposed as a result of Lender being organized under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) U.S. federal withholding Taxes that are (or would be) required to be withheld pursuant to a law in effect on the date Lender becomes a Lender under this Agreement, (c) Taxes attributable to Lender’s failure to comply with Section 2.5.2, (d) any U.S. federal withholding Taxes imposed under FATCA, (e) U.S. backup withholding Taxes, (f) Taxes resulting from the gross negligence or willful misconduct of Lender, (g) penalties, interest and additions to Tax relating to any of the foregoing; and (h) Taxes excluded from the definition of Other Taxes.

 

37


 

FATCA ” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof and any agreement entered into pursuant thereto, including any intergovernmental agreements and any rules or guidance implementing such intergovernmental agreements.

 

“Financial Advisor” means Evercore Group, L.L.C., in its capacity as financial advisor to the Lender and its counsel solely with respect to the Loan Documents.

 

“First Amendment” means that certain Amendment No. 1 and Consent under the Amended and Restated Loan and Security Agreement, dated November 8, 2018, among Borrower, Guarantor and Lender.

 

“First Amendment Effective Date” means November 8, 2018.

 

“Fiscal Year” means the fiscal year of Borrower and its subsidiaries, ending on December 31 of each calendar year.

 

“Foreign Subsidiary” means any direct or indirect Subsidiary of the Borrower organized outside the United States.

 

GAAP ” means generally accepted accounting principles in the United States of America in effect from time to time.

 

Governmental Approval ” is any consent, authorization, approval, order, license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority.

 

Governmental Authority ” is any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, including any multinational authority, any securities exchange and any self-regulatory organization.

 

“Guarantee Obligations” means, with respect to any Person, any obligation or arrangement of such Person to guarantee or intended to guarantee any Indebtedness or other payment obligations (“primary obligations”) of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, including, without limitation, (a) the direct or indirect guarantee, endorsement (other than for collection or deposit in the ordinary course of business), co-making, discounting with recourse or sale with recourse by such Person of the Obligation of a primary obligor, (b) the obligation to make take-or-pay or similar payments, if required, regardless of non-performance by any other party or parties to an agreement or (c) any obligation of such Person, whether or not contingent, (i) to purchase any such primary obligation or any property constituting direct or indirect security therefor, (ii) to advance or supply funds (A) for the purchase or payment of any such primary obligation or (B) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (iii) to purchase property, assets, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation or (iv) otherwise to assure or hold harmless the holder of such primary obligation against loss in respect thereof.  The amount of any Guarantee Obligation shall be deemed to be an amount equal to the stated or determinable amount of the primary obligation in respect of which such

 

38


 

Guarantee Obligation is made (or, if less, the maximum amount of such primary obligation for which such Person may be liable pursuant to the terms of the instrument evidencing such Guarantee Obligation) or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof (assuming such Person is required to perform thereunder), as determined by such Person in good faith.

 

“Guarantor” means (a) each domestic Subsidiary of the Borrower other than Aegerion Securities Corporation, a Massachusetts corporation, including each Subsidiary listed under the heading “Guarantors” on Schedule 1, and (b) each other Subsidiary that becomes a Guarantor pursuant to the terms hereof

 

Indebtedness ” is (a) indebtedness for borrowed money or the deferred purchase price of property or services (other than accounts payable to the trade creditors in the ordinary course of business), such as reimbursement and other obligations for surety bonds and letters of credit, (b) obligations evidenced by notes, bonds, debentures or similar instruments, (c) capital lease obligations, and (d) Contingent Obligations.

 

Indemnified Person ” is defined in Section 12.3.

 

“Indemnified Taxes” means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of Borrower under any Loan Document and (b) to the extent not otherwise described in (a), Other Taxes.

 

Indenture ” means the indenture dated as of August 15, 2014 (as amended, modified, supplemented, renewed, restated or replaced from time to time and in effect on or prior to the First Amendment Effective Date), pursuant to which the Convertible Notes have been issued.

 

“Initial Budget” means the initial thirteen (13) week cash flow forecast for the period commencing on the First Amendment Effective Date substantially in the form delivered to the Lender on the First Amendment Effective Date, that has been acknowledged and approved by the “Financial Advisor” (as defined in the New Bridge Credit Agreement) as the Initial Budget under the New Bridge Credit Agreement and this Agreement in a written notice from the “Financial Advisor” (as defined under the New Bridge Credit Agreement) to the Borrower on or prior to the First Amendment Effective Date.

 

Insolvency Proceeding ” is any proceeding by or against any Person under the United States Bankruptcy Code, or any other bankruptcy or insolvency law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement, or other relief.

 

Intellectual Property ” means all of Borrower’s or Guarantor’s right, title, and interest in and to the following:

 

(a)                                  its Copyrights, Trademarks and Patents;

 

(b)                                  any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how, operating manuals;

 

(c)                                   any and all source code;

 

39


 

(d)                                  any and all design rights which may be available to Borrower or Guarantor, as applicable ;

 

(e)                                   any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above;

 

(f)                                    all amendments, renewals and extensions of any of the Copyrights, Trademarks or Patents; and

 

(g)                                   license or other rights to any third party rights of the same nature as those described in (a) through (f), above.

 

Inventory ” is all “inventory” as defined in the Code in effect on the date hereof with such additions to such term as may hereafter be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory as is temporarily out of Borrower’s or Guarantor’s, as applicable, custody or possession or in transit and including any returned goods and any documents of title representing any of the above.

 

Investment ” is any beneficial ownership interest in any Person (including stock, partnership interest or other securities), and any loan, advance or capital contribution to any Person.

 

Lender ” is defined in the preamble hereof; provided, that any reference to Lender in this Agreement or any of the other Loan Documents shall be deemed to include Lender’s successors and permitted assigns.

 

Lender Expenses ” are all  audit reasonable fees and expenses , costs, and expenses (including reasonable and documented attorneys’ fees and expenses ) for and all fees and expenses of Lender’s financial advisors or any other Professionals) for or in connection with preparing, executing, delivering, amending , modifying , negotiating, administering, defending and enforcing the Loan Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings ) or otherwise incurred with respect to Borrower. or any workout or restructuring or audit or inspection fees, costs and expenses), whether incurred before, on or after the First Amendment Effective Date, incurred by or on behalf of Lender (in such capacity).

 

Lien ” is a claim, mortgage, deed of trust, levy, charge, pledge, security interest or other encumbrance of any kind, whether voluntarily incurred or arising by operation of law or otherwise against any property.

 

Loan Documents ” are, collectively, this Agreement, the  Subordination New Bridge Intercreditor Agreement, the Perfection Certificate , the First Amendment , any intellectual property security agreement, any subordination agreement, any note, or notes or guaranties executed by Borrower or Guarantor , and any other present or future agreement between Borrower , Guarantor and/or for the benefit of Lender in connection with any of the foregoing, all as amended, restated, supplemented, renewed, restated or replaced from time to time.

 

“Loan Parties” or “Loan Party” means, collectively or individually as the context may require, the Borrower and each Guarantor.

 

40


 

Material Adverse Change ” means (a) a material impairment in the perfection or priority of Lender’s Lien in all or a material portion of the Collateral or in the value of all or a material portion of the Collateral; (b) a material, adverse change in the business, , or a material adverse effect upon, the operations, or condition ( business, properties, assets, liabilities (actual or contingent), financial or otherwise) of condition of the Borrower and its Subsidiaries , taken as a whole; or ( c b ) a material impairment of the prospect of repayment of any portion of ability of the Borrower to perform its material obligations under any Loan Document to which it is a party; (c) a material adverse effect upon the legality, validity, binding effect or enforceability against any Loan Party of any Loan Document to which it is a party; or (d) a material impairment of the Lender’s ability to enforce the Obligations when due or realize upon the Collateral .

 

“Myalept Spin-Out Transaction” means a dividend, distribution, conveyance or other transfer by the Borrower to another Person (a “Successor Company”) of all or substantially all of Borrower’s assets constituting the Myalept Intellectual Property and the products and indications therefor, whether made in one transaction or a series of related transactions, which transaction or transactions have been approved by the board of directors of Borrower .

 

“New Bridge Agent” means Cantor Fitzgerald Securities , in its capacity as agent under the New Bridge Credit Agreement and related loan documents, together with its successors and assigns in such capacity.

 

“New Bridge Credit Agreement” means that certain Bridge Credit Agreement, dated November 8, 2018, among Borrower, the lenders party thereto and the New Bridge Agent.

 

“New Bridge Debt” means, collectively, the New Money Loans and the Roll Up Loans made by the New Bridge Lenders and incurred by Borrower pursuant to the New Bridge Credit Agreement, including interest, fees and expenses payable under the New Bridge Credit Agreement that have been capitalized and added to the outstanding principal amount of the New Bridge Debt, in accordance with the terms of the New Bridge Credit Agreement.

 

“New Bridge Intercreditor Agreement” means that certain Subordination Agreement, dated November 8, 2018, among New Bridge Lenders and Lender , as amended, supplemented or otherwise modified from time to time.

 

“New Bridge Lenders” means each of (i) 1992 MSF International Ltd., (ii) 1992 Tactical Credit Master Fund, L.P., (iii) Athyrium Opportunities II Acquisition, LP, and (iv) Athyrium Opportunities III Acquisition, LP, and each of their respective successors and assigns, in all cases, each in its capacity as a lender under the New Bridge Credit Agreement.

 

“New Money Debt” means the term loans made by the New Bridge Lenders to Borrower in an aggregate principal amount of $50,000,000 (excluding capitalized interest, fees and expenses) pursuant to the New Bridge Credit Agreement and which are senior in priority to the Term Loans under this Agreement pursuant to the New Bridge Intercreditor Agreement.

 

“Novelion” means Novelion Therapeutics Inc., a British Columbia corporation.

 

“Novelion Services” means Novelion Services USA, Inc., a Delaware corporation.

 

Obligations ” are Borrower’s each Loan Party’s obligations to pay when due any debts, principal, interest, Lender Expenses and other amounts Borrower any Loan Party owes Lender now or later, whether now existing or hereafter arising under this Agreement, the other Loan Documents, or

 

41


 

otherwise (including, for the avoidance of doubt, Guarantee Obligations) , including, without limitation, any interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower assigned to Lender, and the performance of Borrower’s duties under the Loan Documents.

 

Offshore Accounts ” are deposit and/or operating accounts maintained by Borrower and/or its Related Entities any Loan Party with foreign financial institutions for ordinary necessary operating expenses of Borrower and/or its Related Entities any Loan Party , provided further that the aggregate balance of all such accounts does not exceed Ten Million Dollars ($10,000,000) in the aggregate at any time.

 

Organizational Documents ” shall mean, with respect to any Person, any charter, articles or certificate of incorporation, certificate of organization, registration or formation, certificate of partnership or limited partnership, bylaws, operating agreement, limited liability company agreement, or partnership agreement of such Person and any and all other applicable documents relating to such Person’s formation, organization or entity governance matters (including any shareholders’ or equity holders’ agreement or voting trust agreement), in each case as amended, modified, supplemented, renewed, restated or replaced, and specifically includes, without limitation, any certificates of designation for preferred stock or other forms of preferred equity.

 

Original Loan Agreement ” is defined in Section 2.1.

 

Other Connection Taxes ” means, with respect to Lender, Taxes imposed as a result of a present or former connection between such Lender and the jurisdiction imposing such Tax (other than connections arising solely from (and that would not have existed but for) such Lender having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document).

 

Other Taxes ” means all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment, grant of a participation, designation of a new office for receiving payments by or on account of Borrower or other transfer (other than an assignment or designation of a new office made by Lender).

 

Participants ” is defined in Section 12.2.2.

 

Participant Register ” is defined in Section 12.2.2.

 

Patents ” means all patents, patent applications and like protections including without limitation improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of the same.

 

“Payment Block” is defined in Section 2.4.

 

Payment Date ” is the last calendar day of each fiscal quarter.

 

Perfection Certificate ” is defined in Section 5.1.

 

42


 

“Permitted Affiliate Services Payments” means payments by the Borrower to Novelion consisting of reimbursements for shared services and other expenses to the extent set forth as a separate line item in the Budget approved by “Required Lenders” (as defined in the New Bridge Credit Agreement).

 

“Permitted Designated Licensing Transaction” has the meaning set forth on Annex D to the First Amendment (subject to the terms and conditions set forth in the New Bridge Intercreditor Agreement).

 

“Permitted Designated Licensing Transaction Amount” has the meaning set forth on Annex D to the First Amendment.

 

Permitted Indebtedness ” is:

 

(a)                                  Borrower’s Indebtedness to Lender under this Agreement and the other Loan Documents;

 

(b)                                  Indebtedness existing on the First Amendment Effective Date and shown on the Perfection Certificate;

 

(c)                                   unsecured intercompany Indebtedness permitted pursuant to clause (i) of the definition of Permitted Investments;

 

(d)                                  unsecured Indebtedness to trade creditors incurred in the ordinary course of business;

 

(e)                                   Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business;

 

(f)                                    Indebtedness secured by Liens permitted under clauses (a) and (c) of the definition of “Permitted Liens” hereunder;

 

(g)                                   extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a) through (f) above, provided that the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon Borrower or its Subsidiaries, as the case may be;

 

(h)                                  reimbursement obligations owed to the banks and financial institutions set forth in the Perfection Certificate with respect to credit card services in an aggregate amount not to exceed Two Hundred Thousand Dollars ($200,000);

 

(i)                                      Indebtedness of the Borrower represented by obligations under a lease that is required to be capitalized and set forth in the Perfection Certificate in an aggregate amount not to exceed One Hundred Thousand Dollars ($100,000) at any time;

 

(j)            Borrower’s Indebtedness to the Subordinated Lender pursuant to the Subordinated Loan Agreement and the other Loan Documents (as defined in the Subordinated Loan Agreement) not to exceed an aggregate principal amount of (i) an initial principal amount of $20,000,000, plus (ii) paid-in-kind interest capitalized pursuant to the Subordinated Loan Agreement, as in effect on the date hereof and as modified in accordance with the terms of the Subordination Agreement; and

 

43


 

(j)                                     (k)  the Indebtedness outstanding under the Convertible Notes as of the Restatement First Amendment Effective Date . ;

 

(k)                                  the New Bridge Debt in a principal amount not to exceed $72,500,000 and subject to the New Bridge Intercreditor Agreement; provided that aggregate principal amount of the New Money Bridge Debt shall not exceed $50,000,000 and the aggregate principal amount of the Roll Up Loans shall not exceed $22,500,000, excluding, in each case paid-in-kind interest, fees and expenses and subject to the terms of the New Bridge Intercreditor Agreement; provided, further , that no Subsidiaries of the Borrower shall guaranty such Indebtedness unless such Subsidiaries also guaranty the Obligations;

 

(l)                                      Indebtedness consisting of accounts payable incurred in the ordinary course of business past due for more than one hundred twenty (120) days after its stated due date (except for accounts payable contested in good faith) which do not in the aggregate exceed $750,000;

 

(m)                              other unsecured Indebtedness in an aggregate principal amount not to exceed $250,000 at any time outstanding;

 

(n)                                  Indebtedness in respect of performance of bids, trade contracts, governmental contracts and leases (other than Indebtedness for borrowed money), statutory obligations, surety, stay, indemnity, customs and appeal bonds, performance bonds and other obligations of a like nature (including those to secure health, safety and environmental obligations), and, in each case, letters of credit in respect thereof, incurred in the ordinary course of business;

 

(o)                                  non-recourse Indebtedness incurred by the Borrower or any of its Subsidiaries to finance the payment of insurance premiums of such Person; and

 

(p)                                  Indebtedness owed to any Person providing worker’s compensation, unemployment insurance and other social security legislation, health, disability or other employee benefits or property, casualty or liability insurance to the Borrower or any of its Subsidiaries incurred in connection with such Person providing such benefits or insurance pursuant to customary reimbursement or indemnification obligations to such Person.

 

Permitted Investments ” are:

 

(a)                                  Investments (including, without limitation, Subsidiaries) existing on the First Amendment Effective Date and shown on the Perfection Certificate ; , and Investments consisting of any modification, replacement, renewal, reinvestment or extension of any such Investment; provided, that the amount of any Investment permitted pursuant to this clause (a) is not increased from the amount of such Investment on the First Amendment Effective Date;

 

(b)                                  Investments consisting of Cash Equivalents;

 

(c)                                   Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of Borrower Borrower’s or Guarantor’s business ;

 

(d)                                  Investments consisting of Collateral Accounts, provided that any such Collateral Account is subject to a Control Agreement to the extent required hereunder;

 

(e)                                   Investments accepted in connection with Transfers permitted by Section 7.1;

 

44


 

(f)                                    Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the ordinary course of business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee stock purchase plans or agreements approved by Borrower’s Board of Directors ;

 

(g)                                   Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business;

 

(h)                                  Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the ordinary course of business; provided that this paragraph (h) shall not apply to Investments of Borrower or Guarantor in any Subsidiary; and

 

(i)                                      other Investments by Borrower in any of its Subsidiaries for current, ordinary and necessary made (i) by any Subsidiary that is not a Loan Party in any other Subsidiary that is not a Loan Party, (ii) by any Loan Party in any Foreign Subsidiary for operating expenses in Latin America, Europe, Middle East and Africa and operating expenses and manufacturing costs of inventory in the United Kingdom in each case consistent with past practices and in the ordinary course of business and to the extent set forth in the Budget for such Investments in Foreign Subsidiaries in an aggregate amount and not to exceed Forty Million Dollars ($40,000,000) $25,000,000 in the aggregate per fiscal year, provided no Event of Default has occurred and is continuing or would result from such Investment . during the term of this Agreement and (iii) by any Subsidiary that is not a Loan Party in any Person to the extent not exceeding $100,000 outstanding at any one time.; and

 

(j)                                     so long as immediately before and after giving effect to any such Investment, no Default has occurred and is continuing , other Investments that do not exceed $ 250,000 in the aggregate (net of any return or distribution of capital or repayments of principal in respect thereof) to the extent expressly set forth in the Budget.

 

Permitted Liens ” are:

 

(a)                                  Liens existing on the Effective Date and shown on the Perfection Certificate or arising under this Agreement and the other Loan Documents, in each case as amended, modified, supplemented, renewed, restated or replaced from time to time; provided that (i) the Lien does not extend to any additional property or additional Indebtedness (except with respect to paid-in-kind obligations pursuant to the terms of such Indebtedness as in effect on the First Amendment Effective Date) other than (A) after-acquired property that is affixed or incorporated into the property covered by such Lien or financed by Permitted Indebtedness, and (B) proceeds and products thereof; and (ii) the renewal, extension or refinancing of the obligations secured or benefited by such Liens is permitted under Section 7.4;

 

(b)                                  Liens for taxes, fees, assessments or other government charges or levies, either (i) not due and payable overdue for a period of more than thirty (30) days or (ii) being contested in good faith and by appropriate proceedings and for which Borrower or Guarantor, as applicable, maintains adequate reserves , provided that no notice of any such Lien has been filed or recorded under the Internal Revenue Code of 1986, as amended, and the Treasury Regulations adopted thereunder; with respect thereto on its books to the extent required in accordance with GAAP;

 

45


 

(c)                                   purchase money Liens or capital leases (i) on Equipment acquired or held by Borrower incurred for financing the acquisition of the Equipment securing no more than Seven Hundred and Fifty Thousand Dollars ($750,000) in the aggregate amount outstanding, or (ii) existing on Equipment when acquired, if any such Lien is confined to such property, improvements , replacements and the proceeds and the products thereof and customary security deposits ;

 

(d)                                  Liens incurred in the extension, renewal or refinancing of the indebtedness secured by Liens described in ( b a ) and (c); provided, that any such extension, renewal or replacement replacements Lien shall be limited to the property encumbered by the existing Lien with respect thereto and the principal amount of the indebtedness Indebtedness secured thereby shall not increase;

 

(e)                                   Liens in favor of other financial institutions arising in connection with Borrower’s or Guarantor’s deposit and/or securities accounts held at such institutions, provided that the Lender has a perfected security interest in the amounts held in such deposit and/or securities accounts;

 

(f)                                    statutory or common law Liens of landlords, carriers, warehousemen, mechanics, materialmen, repairmen, suppliers, construction contractors or other like Liens arising in the ordinary course of business which secure amounts not to exceed $50,000 and not overdue for a period of more than thirty (30) days or if more than thirty (30) days overdue, are unfiled (or if filed have been discharged or stayed) and no other action has been taken to enforce such Lien or which are being contested in good faith, if adequate reserves with respect thereto are maintained on the books of the applicable Person to the extent required in accordance with GAAP;

 

(g)                                   [reserved];

 

(f)  Liens of carriers, warehousemen, suppliers, or other Persons that are possessory in nature arising in the ordinary course of business so long as such Liens attach only to inventory, securing liabilities in the aggregate amount not to exceed Fifty Thousand Dollars ($50,000) and which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto;

 

(g)  Liens to secure payment of workers’ compensation, employment insurance, old-age pensions, social security and other like obligations incurred in the ordinary course of business (other than Liens imposed by ERISA);

 

(h)                                  (i) to the extent constituting a Lien and permitted under Section 7.1 non-exclusive license of Intellectual Property granted to third parties in the ordinary course of business, and licenses of Intellectual Property that would not result and set forth in the Perfection Certificate and other non-exclusive licenses after the First Amendment Effective Date, in each case to the extent not resulting in a legal transfer of title of the licensed property that may be exclusive in respects other than territory and that may be exclusive as to territory only as to discreet geographical areas outside of Intellectual Property and in the ordinary course of business, subject to exclusivity on territory aside from the United States and (ii)  any licenses or sublicenses existing as of the date hereof granted to third parties or Affiliates under the Intellectual Property or Europe ;

 

(i)  Liens arising from attachments or judgments, orders, or decrees in circumstances not constituting an Event of Default under Sections 8.4 and 8.7;

 

46


 

(i)                                      judgment Liens in existence for less than thirty (30) days after the entry thereof, or with respect to which execution has been stayed or the payment of which is covered in full by insurance maintained with responsible insurance companies, or which judgment Liens do not otherwise result in an Event of Default under Section 8.7;

 

(j)                                     Liens on cash deposits not to exceed two hundred thousand Dollars ($200,000) securing the obligations of Borrower in connection with the Indebtedness described in permitted under clause (h) of the definition of Permitted Indebtedness , provided that the aggregate amount of cash deposits subject to such Liens shall not exceed Three Hundred Thousand Dollars ($300,000) ;

 

(k)                                  [reserved];

 

(l)                                      [reserved];

 

(m)                              Liens granted to the New Bridge Lenders and Subordinated Lenders pursuant to the terms and conditions of the New Bridge Credit Agreement which are subject to the New Bridge Intercreditor Agreement (provided, for the avoidance of doubt, that any liens of the Subordinated Lenders securing obligations in connection with the Roll Up Loans shall at all times be junior and subordinate to the Liens of the Lender in accordance with the New Bridge Intercreditor Agreement);

 

(n)                                  (k)  Liens consisting of deposits or letters of credit to secure obligations of the Borrower made in connection with the Indebtedness described in clause (i) of the definition of the types permitted under clauses (n) and (p)  of Permitted Indebtedness ; provided, that the aggregate amount thereof shall not exceed One Hundred Thousand Dollars ($100,000); and (in each case, other than for borrowed money) entered into in the ordinary course of business or to secure the obligations otherwise permitted;

 

(l) Liens granted to the Subordinated Lenders pursuant to the terms of the Subordinated Loan Agreement which are subject to the Subordination Agreement.

 

“Permitted Myalept Spin-Out Transaction” is defined in Section 7.2

 

(o)                                  easements, rights-of-way, covenants, conditions, restrictions, encroachments, and other survey defects protrusions and other similar encumbrances and minor title defects affecting real property which were not incurred in connection with Indebtedness and do not in any case materially and adversely interfere with the use of the property encumbered thereby for its intended purposes;

 

(p)                                  Liens arising by virtue of any contractual, statutory or common law provision relating to banker’s Liens, rights of set-off or similar rights and remedies (i) relating to the establishment of depository relations with banks or other financial institutions not given in connection with the incurrence of Indebtedness, (ii) relating to pooled deposit or sweep accounts of the Borrower or any Subsidiary that is a Guarantor (so long as such Subsidiary remains a Guarantor) to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business of the Borrower or such Subsidiary Guarantor or (iii) relating to purchase orders and other agreements entered into with customers of the Borrower or any of its Subsidiaries in the ordinary course of business;

 

47


 

(q)                                  Liens arising from precautionary Code financing statement filings regarding leases entered into by the Borrower and its Subsidiaries in the ordinary course of business;

 

(r)                                     any zoning, land-use or similar law or right reserved to or vested in any Governmental Authority to control or regulate the use of any real property;

 

(s)                                    any interest or title of a lessor, licensor or sublessor under any lease, license or sublease entered into by the Borrower or any of its Subsidiaries in the ordinary course of its business and covering only the assets so leased, or subleased;

 

(t)                                     other Liens not on borrowed money with respect to which the aggregate amount of the obligations secured thereby does not exceed $100,000 at any time outstanding; provided, that no such Liens shall be on Equity Interests of the Borrower or any of its direct or indirect Subsidiaries;

 

(u)                                  to the extent constituting Liens and permitted under Section 7.1, any leases, subleases, licenses, or sublicenses (other than licenses of Intellectual Property) granted to third parties that do not materially interfere with the Loan Parties’ ordinary course of business;

 

(v)                                  (i) pledges and deposits in the ordinary course of business securing liability for reimbursement or indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the benefit of) insurance carriers providing property, casualty or liability insurance to the Borrower or any Subsidiary and (ii) Liens securing the financing of insurance premiums (to the extent such Liens extend to the unearned premiums for such insurance) in the ordinary course of business; and

 

(w)                                nonconsensual statutory Liens arising after the First Amendment Effective Date.

 

Person ” is any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.

 

PIK Interest ” is defined in Section 2.2(d).

 

“Professionals” is defined in Section 2.3(b).

 

Quarterly Financial Statements ” is defined in Section 6.2(a),

 

Register ” is defined in Section 12.2.1.

 

Registered Organization ” is any “ registered organization ” as defined in the Code with such additions to such term as may hereafter be made.

 

“Requirement of Law” means, as to any Person, any law (including common law), statute, ordinance, treaty, rule, regulation, order, decree, judgment, writ, injunction or settlement agreement, requirement or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.

 

48


 

Responsible Officer ” is any of the President, Vice President, Treasurer or , Secretary or Assistant Secretary of Borrower or Guarantor, as applicable .

 

Restatement Effective Date ” is the first date on which all the conditions precedent in Section 3.1 are satisfied or waived in accordance with Section  12.7 12.6 .

 

Restricted License ” is any material license or other agreement with respect to which Borrower or Guarantor is the licensee (a) that prohibits or otherwise restricts Borrower from granting a security interest in Borrower’s or Guarantor’s interest in such license or agreement or any other property, or (b)  for which a default under or termination of which could interfere with the Lender’s right to exercise its remedies with respect to any Collateral reasonably be expected to result in a Material Adverse Change or otherwise result in liabilities in excess of $500,000 .

 

“Roll Up Loans” means the $22,500,000 in principal amount (excluding capitalized interest, fees and expenses) of the Convertible Notes held by the New Bridge Lenders on the First Amendment Effective Date, which , for the avoidance of doubt, shall be deemed loans outstanding and shall be junior in priority to the Term Loans under this Agreement pursuant to the New Bridge Intercreditor Agreement.

 

SEC ” means the Securities and Exchange Commission, any successor thereto, and any analogous Governmental Authority.

 

Securities Account ” is any “securities account” as defined in the Code with such additions to such term as may hereafter be made.

 

“Subordinated Lenders” means the holders of Roll Up Loans.

 

“Subordinated Lenders” shall mean Broadfin Healthcare Master Fund Ltd., Sarissa Capital Management Offshore Master Fund LP, Sarissa Capital Catapult Fund LLC, and their respective successors and assigns, in all cases, each in its capacity as a lender under the Subordinated Loan Agreement.

 

“Subordinated Loan Agreement” means that certain Loan and Security Agreement, dated as of March 15, 2018 between the Borrower and the Subordinated Lender, as amended, supplemented or otherwise modified in accordance with the terms of the Subordination Agreement.

 

“Subordinated Loan Agent” means Wilmington Savings Fund Society FSB , in its capacity as agent under the Subordinated Loan Agreement and related loan documents, together with its successors and assigns in such capacity.  Any referent to the Subordinated Lenders shall mean, be an include a reference to the Subordinated Loan Agent in its capacity as agent of the Subordinated Lenders.

 

Subordinated Debt ” means indebtedness incurred by Borrower subordinated to Borrower’s now or hereafter indebtedness to Lender (pursuant to a subordination, intercreditor, or other similar agreement in form and substance satisfactory to Lender entered into between Lender and the other creditor(s)), on terms acceptable to Lender.  As of the Restatement First Amendment Effective Date the outstanding Subordinated Debt is the indebtedness outstanding under the Subordinated Loan Agreement Indebtedness of Borrower in connection with the Roll Up Loans .

 

“Subordination Agreement” means the Subordination Agreement, dated as of the Restatement Effective Date, among Lender, Borrower and the Subordinated Lenders , as amended, supplemented or otherwise modified from time to time.

 

49


 

Subsidiary ” is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person.  Unless the context otherwise requires, each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower.

 

“Successor Company ” has the meaning set forth in the definition of Myalept Spin-Out Transaction.

 

“Tax Distributions” means, distributions from the Borrower to Novelion Services in the aggregate amount necessary to permit Novelion Services to pay all or a portion of the U.S. federal, state and local income tax liabilities which are then due and payable and directly attributable to the income of the Borrower; provided that such amounts are used by such Person for such purpose and the amount of such distributions in any taxable period shall not exceed with respect to any taxable period in which the Borrower files a consolidated, combined, unitary or similar type income tax return with Novelion Services or any direct or indirect parent of Novelion Services as the common parent of such group, the amount of U.S. federal, state and local income tax the Borrower and its Subsidiaries would be required to pay with respect to such taxable period if they filed as a separate consolidated, combined, unitary or other similar group for income tax purposes with the Borrower as the common parent of such group.

 

Taxes ” means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.

 

Term Loans ” is defined in Section 2.1 hereof and shall include any PIK Interest.

 

Term Loan Maturity Date ” is the earlier to occur of (i) July 1, 2019 and (ii) such earlier date on which all Obligations become immediately due and payable pursuant to Section 9 of this Agreement.

 

Trademarks ” means any trademark and servicemark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of Borrower or Guarantor, as applicable, connected with and symbolized by such trademarks.

 

“Trade Secrets” means any trade secrets, know-how, show-how or other confidential or proprietary information, including technical and business information, methods, process, discoveries, improvements, technology, databases, supplier lists and customer lists, in each instance not generally known or easily ascertainable, and all rights in the foregoing.

 

Transfer ” is defined in Section 7.1.

 

[Signature page follows.]

 

50


 

IN WITNESS WHEREOF , the parties hereto have caused this Agreement to be executed as of the Restatement Effective Date.

 

 

AEGERION PHARMACEUTICALS, INC.

 

 

 

By:

 

 

Name:

Barbara Chan

 

Title:

President

 

 

 

NOVELION THERAPEUTICS INC.

 

 

 

By:

 

 

Name:

Michael Price

 

Title:

Chief Financial Officer

 

Loan and Security Agreement — Signature Page

 


 

EXHIBIT A - COLLATERAL DESCRIPTION

 

Collateral ” shall mean and include all right, title and interest of the Borrower or Guarantor, as applicable, in all of the following property and assets of the Borrower or Guarantor, as applicable , in each case whether now existing or hereafter arising or created and whether now owned or hereafter acquired and wherever located:

 

(a)                                  all Accounts and all supporting obligations relating thereto;

 

(b)                                  all Equipment and fixtures;

 

(c)                                   all general intangibles (including all payment intangibles and all software) and all supporting obligations related thereto;

 

(d)                                  all Intellectual Property (excluding any non-material lease, license, contract or agreement to which the Borrower or Guarantor, as applicable, is a party, and any of its rights or interests thereunder, if and to the extent that a security interest therein is prohibited by or in violation of (i) any applicable law, or (ii) a term, provision or condition of any such lease, license, contract or agreement (unless in each case, such applicable law, term, provision or condition would be rendered ineffective with respect to the creation of such security interest pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the Code (or any successor provision or provisions) of any relevant jurisdiction or any other applicable law or principles of equity), provided , however , that the foregoing shall cease to be excluded (and shall constitute Collateral) immediately at such time as the contractual or legal prohibition shall no longer be applicable and to the extent severable, such security interest shall attach immediately to any portion of such lease, license, contract or agreement not subject to the prohibitions specified in clauses (i) or (ii) above, provided , further that such excluded Intellectual Property shall not include any proceeds of any such lease, license, contract or agreement or any goodwill of the Borrower’s or Guarantor’s business , as applicable, associated therewith or attributable thereto);

 

(e)                                   all Inventory;

 

(f)                                    all equity interests, securities, Investment Property, and financial assets (excluding equity interests constituting an amount greater than 65% of the total equity interests of any first-tier foreign Subsidiary);

 

(g)                                   all contract rights, rights of payment which have been earned under any contract rights, chattel paper (including electronic chattel paper and tangible chattel paper), commercial tort claims (whether now existing or hereafter arising); documents (including all warehouse receipts and bills of lading), deposit accounts, goods, instruments (including promissory notes), letters of credit (whether or not the respective letter of credit is evidenced by a writing) and letter-of-credit rights, cash, certificates of deposit, insurance proceeds (including hazard, flood and credit insurance), security agreements, eminent domain proceeds, condemnation proceeds, tort claim proceeds and all supporting obligations;

 

(h)                                  all ledger sheets, ledger cards, files, correspondence, records, books of account, business papers, computers, computer software (owned by the Borrower or Guarantor, as applicable, or in which it has an interest), computer programs, tapes, disks and documents, including all of such property relating to the property described in clauses (a) through and including (h) of this definition; and

 

(i)                                      all proceeds and products of the property described in clauses (a) through and including (i) of this definition, in whatever form . ;

 


 

provided, however, that notwithstanding anything to the contrary in this Agreement, this Agreement shall not constitute a grant of a security interest in, and each reference to Collateral or to any relevant type or item of property constituting Collateral shall be deemed to exclude, the following (“Excluded Collateral”): (a) any “intent-to-use” applications for trademark or service mark registrations filed pursuant to Section 1(b) of the Lanham Act, 15 U.S.C. § 1051, unless and until an Amendment to Allege Use or a Statement of Use under Sections 1(c) and 1(d) of the Lanham Act has been filed and accepted; (b) any governmental licenses or state or local franchises, charters and authorizations to the extent a security interest in such licenses, franchises, charters or authorizations is prohibited or restricted thereby (other than to the extent that any such prohibition would be rendered ineffective pursuant to any other applicable requirements of law, including pursuant to Section 9-406, 9-407, 9-408 or 9-409 of the Code) or any other applicable anti-assignment provisions of the Code; (c)  Equipment or other personal property subject to any Lien securing purchase money Indebtedness or a capital lease that is permitted under clause (f) of the definition of Permitted Indebtedness to the extent the contract or other agreement in which such Lien is granted (or the documentation providing for such capital lease) expressly prohibits the creation of any other Lien on such Equipment or other personal property ; (d) any Equity Interests (x) constituting an amount greater than 65% of the voting Equity Interests of any “first tier” Foreign Subsidiary or (y) of Aegerion Securities Corporation, a Massachusetts security corporation ; and (e)  any segregated deposits that constitute Permitted Liens and are prohibited from being subject to other Liens .

 

53


 

Schedule 1 — Guarantors

 

Aegerion Pharmaceuticals Holdings, Inc., a Delaware corporation

 


 

ANNEX B

 

Bridge Credit Agreement

 

[Filed Separately]

 


 

ANNEX C

 

Form of Guaranty

 


 

GUARANTY

 

GUARANTY dated as of [ · ], 2018 (this “ Guaranty ”), by AEGERION PHARMACEUTICALS HOLDINGS, INC. (“ Aegerion Pharmaceuticals Holdings ”), a Delaware corporation, each Subsidiary that may from time to time become a party hereto (together with Aegerion Pharmaceuticals Holdings, each, a “ Guarantor ” and collectively, the “ Guarantors ”) in favor of NOVELION THERAPEUTICS INC., a corporation incorporated under the laws of British Columbia (“ Lender ”).

 

Reference is made to the Amended and Restated Loan and Security Agreement dated as of March 15, 2018 (as amended, restated, supplemented, waived or otherwise modified from time to time, the “ Credit Agreement ”; capitalized terms used herein and not otherwise defined herein have the respective meanings assigned thereto in the Credit Agreement), among AEGERION PHARMACEUTICALS, INC., a Delaware corporation (the “ Borrower ”), the Guarantor, and the Lender.

 

The Lender has agreed to extend credit to the Borrower subject to the terms and conditions set forth in the Credit Agreement. The obligations of the Lender to extend such credit are conditioned upon, among other things, the execution and delivery of this Guaranty. The Guarantor is a Subsidiary of the Borrower and will derive substantial benefits from the extension of credit to the Borrower pursuant to the Credit Agreement and is willing to execute and deliver this Guaranty in order to induce the Lender to extend such credit. Accordingly, the parties hereto agree as follows:

 

ARTICLE I

 

GUARANTY

 

Section 1.01.         Guaranty . Each Guarantor unconditionally guarantees, jointly with the other Guarantors and severally, to the Lender, as a primary obligor and not merely as a surety, the due and punctual payment and performance of the Obligations. Each Guarantor further agrees that the Obligations may be extended or renewed, in whole or in part, or amended or modified, in each case, in accordance with the terms of the Loan Documents, without notice to or further assent from such Guarantor, and that such Guarantor will remain bound upon its guarantee hereunder notwithstanding any extension or renewal, or amendment or modification, of any Obligation.  Each Guarantor waives promptness, presentment to, demand of payment from and protest to the Borrower or any other Loan Party of any of the Obligations, and also waives notice of acceptance of its guarantee and notice of protest for nonpayment.

 

Section 1.02.         Guaranty of Payment and Performance; Continuing Guaranty . Each Guarantor further agrees that its guarantee hereunder constitutes a guarantee of payment and performance when due (whether at the stated maturity, by acceleration or otherwise) and not merely of collection, and waives any right to require that any resort be had by the Lender to any security held for the payment of any of the Obligations or to any balance of any deposit account or credit on the books of the Lender in favor of any Loan Party or any other person. The obligations of each Guarantor hereunder are independent of the obligations of the Borrower or any other Guarantor, and a separate action or actions may be brought and prosecuted against

 

1


 

each Guarantor whether or not action is brought against the Borrower or any other Guarantor and whether or not the Borrower or any other Guarantor is joined in any such action or actions. Each Guarantor agrees that its guarantee hereunder is continuing in nature and applies to all of the Obligations, whether currently existing or hereafter incurred.

 

Section 1.03.         No Limitations, Etc . (a) Except for termination of a Guarantor’s obligations in accordance herewith and except as provided in Section 1.07, the obligations of each Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense or setoff, counterclaim, recoupment or termination whatsoever by reason of the invalidity, illegality or unenforceability of any of the Obligations, any impossibility in the performance of any of the Obligations or otherwise. Without limiting the generality of the foregoing, except for termination or release of a Guarantor’s obligations hereunder (but without prejudice to Section 1.04), the obligations of each Guarantor hereunder, to the fullest extent permitted by applicable law, shall not be discharged or impaired or otherwise affected by, and each Guarantor hereby waives any defense to the enforcement hereof by reason of:

 

(i)            the failure of the Lender to assert any claim or demand or to exercise or enforce any right or remedy under the provisions of any Loan Document or otherwise;

 

(ii)           any rescission, waiver, amendment or modification of, or any release from any of the terms or provisions of, any Loan Document or any other agreement, including with respect to any other Guarantor under this Guaranty;

 

(iii)          the failure to perfect any security interest in, the impairment of or the release of, any of the Collateral held by or on behalf of the Lender for the Obligations;

 

(iv)          any default, failure or delay, willful or otherwise, in the performance of the Obligations;

 

(v)           any other act or omission that may in any manner or to any extent vary the risk of any Guarantor or otherwise operate as a discharge of any Guarantor as a matter of law or equity;

 

(vi)          any illegality, lack of validity or enforceability of any Obligation or any Loan Document;

 

(vii)         any change in the corporate existence, structure or ownership of any Loan Party, or any insolvency, bankruptcy, reorganization or similar proceeding affecting any Loan Party or its assets or any resulting release or discharge of any of the Obligations;

 

(viii)        the existence of any claim, set-off or other rights that any Guarantor may have at any time against the Borrower, the Lender or any other

 

2


 

person, whether in connection herewith, the other Loan Documents or any unrelated transactions;

 

(ix)          this Guaranty having been determined (on whatsoever grounds) to be invalid, non-binding or unenforceable against any other Guarantor ab initio or at any time after the date hereof;

 

(x)           the fact that any person that, pursuant to the Loan Documents, was required to become a party hereto may not have executed or is not effectually bound by this Guaranty, whether or not this fact is known to the Lender;

 

(xi)          any action permitted or authorized hereunder;

 

(xii)         any other circumstance (including any statute of limitations) or any act or omission that may in any manner or to any extent vary the risk of any Guarantor or otherwise operate as a defense to, or a legal or equitable discharge of, the Borrower or any Guarantor or any other guarantor or surety (other than the payment in full in cash or immediately available funds of the Obligations (without prejudice to Section 1.04)); or

 

(xiii)        any extension, renewal, settlement, compromise, waiver or release in respect of any obligation of the Borrower, any other Guarantor or any other person under any Loan Document, by operation of law or otherwise.

 

Each Guarantor expressly authorizes the Lender to take and hold security for the payment and performance of the Obligations, to exchange, waive or release any or all such security (with or without consideration), to enforce or apply such security and direct the order and manner of any sale thereof in their sole discretion or to release or substitute any one or more other guarantors or obligors upon or in respect of the Obligations or take any other actions permitted by the Loan Documents, all without affecting the obligations of any Guarantor hereunder.

 

(b)           To the fullest extent permitted by applicable law and except for termination or release of a Guarantor’s obligations hereunder (but without prejudice to Section 1.04), each Guarantor waives any defense based on or arising out of any defense of any other Loan Party or the unenforceability of the Obligations or any part thereof from any cause, or the cessation from any cause of the liability of any other Loan Party, other than, after all Commitments have been terminated, the payment in full in cash or immediately available funds of all the Obligations (other than contingent indemnification and reimbursement obligations that are not yet due and payable and for which no claim has been asserted) (but without prejudice to Section 1.04). The Lender may, at its election, exercise any right or remedy available to it against any other Loan Party pursuant to this Guaranty or the other Loan Documents, without affecting or impairing in any way the liability of any Guarantor hereunder except to the extent that after giving effect thereto all Obligations have been terminated and paid in full (other than contingent indemnification and reimbursement obligations that are not yet due and payable and for which no claim has been asserted) (but without prejudice to Section 1.04). To the fullest extent permitted by applicable law, each Guarantor waives any defense arising out of any such election even though such election operates, pursuant to applicable law, to impair or to extinguish any right of

 

3


 

reimbursement or subrogation or other right or remedy of such Guarantor against any other Loan Party, or any security. To the fullest extent permitted by applicable law, each Guarantor waives any all suretyship defenses.

 

Section 1.04.         Reinstatement . Each Guarantor agrees that its guarantee hereunder shall continue to be effective or be reinstated, as the case may be, if, at any time payment, or any part thereof, of any Obligation is rescinded or must otherwise be restored by the Lender upon the bankruptcy or reorganization (or analogous proceeding in any jurisdiction) of the Borrower or any other Loan Party or otherwise. The provisions of this Section 1.04 shall survive the termination of this Guaranty.

 

Section 1.05.         Agreement To Pay; Contribution; Subrogation . In furtherance of the foregoing and not in limitation of any other right that the Lender has at law or in equity against any Guarantor by virtue hereof, upon the failure of any Loan Party to pay any Obligation when and as the same shall become due, whether an amortization payment, at maturity, by acceleration, after notice of prepayment or otherwise, each Guarantor hereby promises to and will forthwith pay, or cause to be paid, to the Lender in cash or other immediately available funds the amount of such unpaid Obligation. Subject to the foregoing, to the extent that any Guarantor shall, under this Guaranty or the Credit Agreement as a joint and several obligor, repay any of the Obligations constituting Loans or other advances made to or reimbursement obligations owed by another Loan Party under the Credit Agreement (an “ Accommodation Payment ”), then the Guarantor making such Accommodation Payment shall be entitled to contribution and indemnification from, and be reimbursed by, each of the other Guarantors in an amount equal to a fraction of such Accommodation Payment, the numerator of which fraction is such other Guarantor’s Allocable Amount and the denominator of which is the sum of the Allocable Amounts of all of the Guarantors; provided that such rights of contribution and indemnification shall be subordinated to the discharge of Obligations. As of any date of determination, the “ Allocable Amount ” of each Guarantor shall be equal to the maximum amount of liability for Accommodation Payments which could be asserted against such Guarantor hereunder and under the Credit Agreement without (a) rendering such Guarantor “insolvent” within the meaning of Section 101 (31) of the Bankruptcy Code of the United States, Section 2 of the Uniform Fraudulent Transfer Act (“ UFTA ”) or Section 2 of the Uniform Fraudulent Conveyance Act (“ UFCA ”), (b) leaving such Guarantor with unreasonably small capital or assets, within the meaning of Section 548 of the Bankruptcy Code of the United States, Section 4 of the UFTA, or Section 5 of the UFCA, or (c) leaving such Guarantor unable to pay its debts as they become due within the meaning of Section 548 of the Bankruptcy Code of the United States or Section 4 of the UFTA, or Section 5 of the UFCA. Upon payment by any Guarantor of any sums to the Lender as provided above, all rights of such Guarantor against the Borrower, any other Loan Party or any other Guarantor arising as a result thereof by way of right of subrogation, contribution, reimbursement, indemnity or otherwise shall in all respects be subject to Article II.

 

Section 1.06.         Information . Each Guarantor assumes all responsibility for being and keeping itself informed of the financial condition and assets of the Borrower and each other Loan Party and of all other circumstances bearing upon the risk of nonpayment of the Obligations and the nature, scope and extent of the risks that such Guarantor assumes and incurs hereunder, and

 

4


 

agrees that the Lender will not have any duty to advise such Guarantor of information known to it or any of them regarding such circumstances or risks.

 

Section 1.07.         Maximum Liability . Each Guarantor, and by its acceptance of this Guaranty, the Lender hereby confirms that it is the intention of all such persons that this Guaranty and the Obligations of each Guarantor hereunder not constitute a fraudulent transfer or conveyance for purposes of the U.S. Bankruptcy Code or any other federal, state or foreign bankruptcy, insolvency, receivership or similar law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar foreign, federal or state law to the extent applicable to this Guaranty and the Obligations of each Guarantor hereunder. To effectuate the foregoing intention, the Lender and the Guarantors hereby irrevocably agree that the Obligations of Guarantor under this Guaranty at any time shall be limited to the maximum amount as will result in the Obligations of such Guarantor under this Guaranty not being void or voidable under applicable law, including under Section 548 of the U.S. Bankruptcy Code or any comparable provisions under any other applicable law.

 

Section 1.08.         Taxes . The provisions of Sections 2.5 of the Credit Agreement shall apply to each Guarantor mutatis mutandis .

 

ARTICLE II

 

INDEMNITY, SUBROGATION AND SUBORDINATION

 

Section 2.01.         Indemnity . In addition to all such rights of indemnity and subrogation as the Guarantors may have under applicable law (but subject to Section 2.03 hereof), the Borrower agrees that (a) in the event a payment shall be made by any Guarantor under this Guaranty in respect of any Obligation of the Borrower, the Borrower shall indemnify such Guarantor for the full amount of such payment and such Guarantor shall be subrogated to the rights of the person to whom such payment shall have been made to the extent of such payment and (b) in the event any assets of any Guarantor shall be sold pursuant to the Credit Agreement or any other Loan Document to satisfy in whole or in part an Obligation of the Borrower, the Borrower shall indemnify such Guarantor in an amount equal to the greater of the book value or the fair market value of the assets so sold.

 

Section 2.02.         Contribution and Subrogation . Subject to Section 1.07, each Guarantor (a “ Contributing Guarantor ”) agrees (subject to Section 2.03 hereof) that, in the event a payment shall be made by any other Guarantor hereunder in respect of any Obligation or assets of any other Guarantor (other than the Borrower) shall be sold pursuant to any Loan Document to satisfy any Obligation owed to the Lender and such other Guarantor (the “ Claiming Guarantor ”) shall not have been fully indemnified by the Borrower as provided in Section 2.01 hereof, the Contributing Guarantor shall indemnify the Claiming Guarantor in an amount equal to the amount of such payment or the greater of the book value or the fair market value of such assets, as applicable, in each case multiplied by a fraction of which the numerator shall be the net worth of such Contributing Guarantor on the date hereof and the denominator shall be the aggregate net worth of all the Guarantors on the date hereof (or, in the case of any Guarantor subsequently becoming a party hereto, the date of the joinder of such Guarantor hereto). Any Contributing Guarantor making any payment to a Claiming Guarantor pursuant to this Section 2.02 shall be

 

5


 

subrogated to the rights of such Claiming Guarantor under Section 2.01 hereof to the extent of such payment.

 

Section 2.03.         Subordination . (a) Notwithstanding any provision of this Guaranty to the contrary, all rights of the Guarantors under Sections 2.01 and 2.02 hereof and all other rights of indemnity, contribution or subrogation of the Guarantors under applicable law or otherwise shall be fully subordinated to the payment in full in cash or immediately available funds of the Obligations until such time as this Guaranty has been terminated in accordance with the terms hereof. No failure on the part of the Borrower or any Guarantor to make the payments required by Sections 2.01 and 2.02 hereof (or any other payments required under applicable law or otherwise) shall in any respect limit the obligations and liabilities of the Borrower with respect to the Obligations or any Guarantor with respect to its obligations hereunder, and the Borrower shall remain liable for the full amount of the Obligations and each Guarantor shall remain liable for the full amount of its obligations hereunder.

 

The Borrower and each Guarantor hereby agree that all Indebtedness and other monetary obligations owed by it to the Borrower, any other Guarantor or any Subsidiary shall be fully subordinated to the payment in full in cash or immediately available funds of the Obligations, until such time as this Guaranty has been terminated in accordance with the terms hereof.

 

ARTICLE III

 

MISCELLANEOUS

 

Section 3.01.         Notices . All communications and notices hereunder shall (except as otherwise permitted herein) be in writing and given as provided in Section 10 of the Credit Agreement.

 

Section 3.02.         Limitation By Law . All rights, remedies and powers provided in this Guaranty may be exercised only to the extent that the exercise thereof does not violate any applicable provision of law, and all the provisions of this Guaranty are intended to be subject to all applicable mandatory provisions of law that may be controlling and to be limited to the extent necessary so that they shall not render this Guaranty invalid, unenforceable, in whole or in part, or not entitled to be recorded, registered or filed under the provisions of any applicable law.

 

Section 3.03.         Counterparts . This Guaranty may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one agreement.

 

Section 3.04.         Successors and Assigns . This Guaranty binds and is for the benefit of the successors and permitted assigns of each party.  No Guarantor may assign this Guaranty or any rights or obligations under it without Lender’s prior written consent (which may be granted or withheld in Lender’s discretion).  Lender has the right to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, Lender’s obligations, rights, and benefits under this Guaranty and the other Loan Documents, subject to Sections 12.1 and 12.2  of the Credit Agreement (including any consent rights of the Borrower thereunder).

 

6


 

Section 3.05.         CHOICE OF LAW, VENUE AND JURY TRIAL WAIVER . THE PROVISIONS OF SECTION 11 OF THE CREDIT AGREEMENT ARE INCORPORATED BY REFERENCE HEREIN AND APPLY MUTATIS MUTANDIS.

 

Section 3.06.         Severability . Each provision of this Guaranty is severable from every other provision in determining the enforceability of any provision.

 

Section 3.07.         Counterparts . This Guaranty may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one agreement. Delivery of an executed counterpart to this Guaranty by facsimile or other electronic transmission (including “.pdf” or “.tif”) shall be as effective as delivery of a manually signed original.

 

Section 3.08.         Headings . Article and Section headings used herein are for convenience of reference only, are not part of this Guaranty and are not to affect the construction of, or to be taken into consideration in interpreting, this Guaranty.

 

Section 3.09.         Termination . This Guaranty, the guarantees made herein and all other interests granted hereby shall terminate and be released automatically when all Obligations (other than contingent indemnification and reimbursement obligations that are not yet due and payable and for which no claim has been asserted) have been paid in full in cash or immediately available funds and the Lender has no further commitment to extend credit under the Credit Agreement.  In connection with any such termination or release, Lender shall execute and deliver to Borrower, at Borrower’s expense, all documents reasonably requested to evidence such termination or release.

 

[Signature Pages Follow]

 

7


 

IN WITNESS WHEREOF, the parties hereto have duly executed this Guaranty as of the day and year first above written.

 

 

AEGERION PHARMACEUTICALS HOLDINGS, INC., as Guarantor

 

 

 

 

By:

 

 

 

Name:

 

 

Title:

 

Signature Page to Guaranty

 


 

 

NOVELION THERAPEUTICS INC., as Lender

 

 

 

 

By:

 

 

 

Name

 

 

Title

 

Signature Page to Guaranty

 


 

ANNEX D

 

Certain Definitions

 

Permitted Designated Licensing Transaction ” means the sale, license or other transfer to a third party of rights to and in Juxtapid; provided , the aggregate “Net Cash Proceeds” (as defined in the Bridge Credit Agreement) received at the closing of such transaction shall be no less than $20,000,000.

 

Permitted Designated Licensing Transaction Amount ” means the amount permitted to be delivered to Lender pursuant to Section 7.05 of the Bridge Credit Agreement in accordance with Section 1.01 thereof, as in effect on the First Amendment Effective Date, from the “Net Cash Proceeds” (as defined in the Bridge Credit Agreement) of the Permitted Designated Licensing Transaction; provided , that such “Net Cash Proceeds” received from any Permitted Designated Licensing Transaction in excess of $15,000,000 shall be applied to prepay (x) “New Money Loans” (as defined in the Bridge Credit Agreement) and (y) the portion of the Term Loans that the Bridge Lenders agree not to challenge pursuant to the Bridge Subordination Agreement, on a 58% and 42% basis, respectively.

 

Certain Proceeds Reinvestment Budget ” means a budget approved by the “Required Lenders” (as defined in the Bridge Credit Agreement) detailing the use of up to $12,000,000 of retained sale proceeds with respect to the “Disposition” (as defined in the Bridge Credit Agreement) under Section 7.05(i) of the Bridge Credit Agreement.

 


 

ANNEX E

 

FORM OF
COMPLIANCE CERTIFICATE

 

To:                              Novelion Therapeutics Inc.

c/o Norton Rose Fulbright

1800 - 510 West Georgia Street, Vancouver, BC V6B 0M3 Canada

Attn: Ben Harshbarger, General Counsel

Email: ben.harshbarger@novelion.com

 

Ladies and Gentlemen:

 

This Compliance Certificate is being delivered pursuant to Section 6.2(d)  of the Amended and Restated Loan and Security Agreement dated as of March 15, 2018 (as amended, restated, supplemented or otherwise modified from time to time, the “ Loan Agreement ”) among Aegerion Pharmaceuticals, Inc. (the “ Borrower ”), Novelion Therapeutics Inc., corporation incorporated under the laws of British Columbia (“ Lender ”).  All capitalized terms used and not defined herein have the meanings ascribed thereto in the Loan Agreement.

 

(a)                                  This Certificate is delivered in conjunction with [the unaudited internally prepared balance sheet and related unaudited internally prepared consolidated statements of income or operations and cash flows of the Borrower and its Subsidiaries for the fiscal quarter of the Borrower ended as of [     ] (the “ Financials Date ”).  Such financial statements fairly present, in all material respects, the financial condition, results of operations and cash flows of the Borrower and its Subsidiaries in accordance with GAAP, subject to year-end adjustments.][internally prepared financial statements consisting of a consolidated balance sheet and income statement and cash flows covering the operations of the Borrower and its Subsidiaries for the fiscal year of the Borrower ended as of [     ] (the “ Financials Date ”). Such financial statements were prepared in a manner consistent with GAAP and with prior practices, and is complete and correct in all material respects, subject to normal year-end adjustments that, in the aggregate, are not material to the Borrower’s business operations.]

 

(b)                                  The Borrower hereby certifies, represents and warrants that, as of the Financials Date and the date hereof, no Event of Default has occurred and is continuing [other than as follows:].

 

(c)                                   [Attached hereto as Annex I is a supplement to Sections 3 and 4(b) and Schedules II, III and IV of the Perfection Certificate, updating the information set forth in Sections 3 and 4(b) and Schedules II and III of the Perfection Certificate as of the date hereof.][The Borrower hereby certifies, represents and warrants that there has been no material change in the information set forth in Sections 3 and 4(b) and Schedules II and III of the Perfection Certificate since the First Amendment Effective Date or the latest supplement to Sections 3 and 4(b) and Schedules II, III and IV of the Perfection Certificate delivered to the Lender.]

 


 

IN WITNESS WHEREOF, the undersigned has caused this Compliance Certificate to be executed and delivered by a duly authorized Responsible Officer on this [   ] day of [      ], 20[  ].

 

 

AEGERION PHARMACEUTICALS, INC.

 

 

 

 

By:

 

 

 

Name:

 

 

Title:

 


Exhibit 10.3

 

EXECUTION VERSION

 

SUBORDINATION AGREEMENT

 

This Subordination Agreement (the “ Agreement ”) is made as of November 8, 2018, by and between CANTOR FITZGERALD SECURITIES, as administrative agent and collateral agent for the New Lenders (in such capacities, together with any successor administrative agent and collateral agent, “ Senior Agent ”), the signatories hereto under the heading “NEW LENDERS” (each a “ New Lender ” and each in its capacity as a holder of New Senior Debt and the Roll Up Debt, as applicable, together with the Senior Agent, collectively, the “ Senior Lenders ”), and NOVELION THERAPEUTICS INC., a corporation organized under the laws of British Columbia (“ Novelion ”) and NOVELION SERVICES USA, INC., a Delaware corporation (“ Novelion USA ” and together with Novelion, solely in their respective capacities as creditors of the Borrower (as defined below) and/or any Subsidiary of the Borrower (but, for the avoidance of doubt, not in any capacity as an equity holder of the Borrower), the “ Junior Creditor ”).

 

Recitals

 

A.                                     Aegerion Pharmaceuticals, Inc., a Delaware corporation (“ Borrower ”) has obtained certain loans or other credit accommodations from the Senior Lenders that are secured by assets and property of Borrower.

 

B.                                     The Junior Creditor has previously extended loans or other credit accommodations to Borrower.

 

C.                                     To induce the New Lenders to extend new credit to Borrower and to make such other accommodations to or for the account of Borrower as to such new credit, or to grant such renewals or extension of any such loan, extension of credit, purchase, or other accommodation as the Senior Lenders may deem advisable, the Junior Creditor is willing to subordinate: (i) all of Borrower’s indebtedness and obligations to the Junior Creditor (including, without limitation, principal, premium (if any), interest, fees, charges, expenses, costs, professional fees and expenses, and reimbursement obligations, and all obligations and indebtedness of Borrower to the Junior Creditor) under, pursuant to, or in connection with, that certain Amended and Restated Loan and Security Agreement, dated as of March 15, 2018, between the Junior Creditor and Borrower (as amended by Amendment No. 1 and Consent, dated as of the date hereof (the “ Existing Debt Consent ”) and as further amended, modified, restated, replaced or supplemented from time to time, the “ Existing Loan Agreement ”) and the other “Loan Documents” as therein defined, respectively (together with the Existing Loan Agreement and as amended, modified, restated, replaced or supplemented from time to time, the “ Existing Loan Documents ”), whether presently existing or arising in the future pursuant to the Existing Loan Documents (the “ Existing Debt ”) or any other documentation providing for any payment obligation of Borrower or any Subsidiary of Borrower to the Junior Creditor or any affiliate thereof, including, without limitation, under that certain (x) Master Service Agreement, dated as of December 1, 2016, between Borrower and Novelion, (y) Master Service Agreement, dated as of December 1, 2016, between Borrower and Novelion USA, and (z) Master Service Agreement, dated as of December 1, 2016, between Borrower and Novelion (together with the Existing Debt, the “ Subordinated Obligations ”) to all of Borrower’s indebtedness and obligations to the Senior Lenders constituting New Senior Debt (as defined below); and (ii) all of the Junior Creditor’s Liens (as

 


 

defined below) in the Collateral (as defined below) to all of the Senior Lenders’ Liens in the Collateral securing the New Senior Debt.

 

NOW, THEREFORE, THE PARTIES AGREE AS FOLLOWS:

 

Section 1.                                            New Senior Debt Subordination; Priority .

 

1.1                                Any Lien on the Collateral securing any Subordinated Obligation or any other obligations or liabilities under the Existing Loan Documents, as the case may be, now or hereafter held by or on behalf of the Junior Creditor or any agent or trustee therefor, in each case, regardless of how acquired, whether by grant, possession, statute, operation of law or court order, subrogation or otherwise, shall be subordinated in all respects to any Lien on the Collateral securing any New Senior Debt, under the New Money Loan Documents (as defined below), as the case may be, now or hereafter held by or on behalf of any of the Senior Lenders, but not, for the avoidance of doubt, to any Lien on any Collateral securing Roll Up Debt (as defined below).  Notwithstanding the respective dates of attachment or perfection of the Liens of the Junior Creditor and the Liens of the Senior Lenders, all now existing and hereafter arising Liens granted to, or purported to be granted to any or all of the Senior Lenders on account of the New Senior Debt (but not the Roll Up Debt) in any property of Borrower and its Subsidiaries and all proceeds thereof to secure any New Senior Debt, including, without limitation, the “Collateral”, as defined in that certain Bridge Credit Agreement, dated as of the date hereof (as amended and restated, amended, modified, restated, replaced or supplemented from time to time in accordance with this Agreement, the “ New Money Loan Agreement ”) and the other “Loan Documents” (collectively, together with the New Money Loan Agreement and, in each case, as amended, modified, restated, replaced or supplemented from time to time, the “ New Money Loan Documents ”) (the “ Collateral ”), shall at all times be senior to the Liens of the Junior Creditor granted under any of the Existing Loan Documents.  The Junior Creditor hereby (a) acknowledges and consents to (i) Borrower and its Subsidiaries granting to the Senior Lenders a Lien in the Collateral to secure the New Obligations (as defined below), (ii) the Senior Lenders filing any and all financing statements and other documents as deemed necessary by the Senior Lenders in order to perfect their Lien in the Collateral to secure the New Obligations, and (iii) the entering into of the New Money Loan Agreement and other New Money Loan Documents by Borrower and its Subsidiaries, (b) acknowledges and agrees that the New Senior Debt and the Roll Up Debt (together, the “ New Obligations ”), the entry into the New Money Loan Agreement in the form existing on the date hereof and all other New Money Loan Documents by Borrower and its Subsidiaries, and the Liens granted, or purported to be granted, by Borrower and its Subsidiaries to the Senior Lenders in the Collateral to secure the New Obligations shall be permitted under the provisions of the Existing Loan Documents (notwithstanding any provision of the Existing Loan Documents to the contrary), (c) acknowledges, agrees and covenants that the Junior Creditor shall not contest, challenge or dispute the validity, attachment, perfection, priority (to the extent securing New Senior Debt, or lack of priority, with respect to the Liens securing the Roll Up Debt) or enforceability of the Senior Lenders’ Lien in the Collateral, or the validity, priority (or lack of priority, with respect to the Roll Up Debt) or enforceability of the New Obligations, (d) acknowledges, agrees and covenants that the Junior Creditor shall not contest, challenge or dispute the validity of that certain Loan and Security Agreement, dated as of March 15, 2018, between Borrower, Wilmington Savings Fund Society FSB, and the lenders party thereto , or the obligations of Borrower arising thereunder, or any refinancing thereof

 

2


 

pursuant to the New Money Loan Agreement, and (e) acknowledges and agrees that the provisions of this Agreement will apply fully and unconditionally even in the event that the Senior Lenders’ Lien in the Collateral to secure the New Obligations (or any portion thereof) shall be unperfected or otherwise avoidable.  Each of the Senior Lenders hereby (a) acknowledges and consents to (i) Borrower’s and its Subsidiaries’ continuing grant to the Junior Creditor of a Lien in the Collateral, and (ii) the Junior Creditor filing any and all financing statements and other documents as deemed necessary by the Junior Creditor in order to perfect or maintain the perfection of its Lien in the Collateral, provided that such filings are made in accordance with the terms hereof, and (b)  acknowledges and agrees that the Existing Debt outstanding as of the date hereof, the Existing Loan Documents as in effect on the date hereof, and the Liens previously granted by Borrower and its Subsidiaries to the Junior Creditor in the Collateral are permitted under the provisions of the New Money Loan Documents (notwithstanding any provision of the New Money Loan Documents to the contrary).

 

1.2                                All Subordinated Obligations are subordinated in right of payment to all obligations and liabilities of Borrower and its Subsidiaries to the Senior Lenders now existing or hereafter arising under, pursuant to or in connection with the New Money Loan Agreement other than the Roll Up Debt, including, without limitation, the Obligations (as defined in the New Money Loan Agreement) in respect of or arising in connection with the New Money Debt (and for the avoidance of doubt, other than the Obligations relating to or arising in connection with the Roll Up Debt), together with all reasonable and documented costs of collecting such Obligations in respect of or arising in connection with the New Money Debt (including attorneys’ fees for one primary and one local counsel and one financial advisor to the Senior Lenders, and one primary and one local counsel to the Senior Agent (for all its capacities, including as agent with respect to Roll Up Debt)) and all interest, reasonable and documented costs and expenses, and all of the Senior Lenders’ post-petition claims against Borrower and the estate of Borrower that constitute Obligations under New Money Loan Agreement, accruing or incurred thereon or in connection therewith after the commencement by or against Borrower and its Subsidiaries of any bankruptcy, reorganization or similar proceeding (regardless of whether such interest, costs, expenses, or post-petition claims are allowable in such proceeding and even if any such interest, costs and expenses are disallowed in such proceeding), but excluding the Roll Up Debt (and also excluding, for the avoidance of doubt, Obligations relating to or arising in connection with the Roll Up Debt) (such obligations, collectively, the “ New Senior Debt ”), which for the avoidance of doubt includes, prior to the Payment in Full of the New Senior Debt Obligations, all reasonable costs and expenses of collecting the Roll Up Loan (including attorneys’ fees) (but excluding any costs and expenses of defending any cause of action challenging the validity of the Roll Up Debt or the Liens securing the Roll Up Debt, which such costs and expenses shall constitute Roll Up Debt); provided that, in no event shall the principal amount of the New Senior Debt exceed the New Senior Debt Cap (as defined below) (which, for the avoidance of doubt is exclusive of fees and paid-in-kind interest compounded and added to the principal amount of New Senior Debt pursuant to the New Money Loan Agreement and reasonable and documented fees and expenses, including reasonable fees and expenses of one primary and one local counsel and one financial advisor to the Senior Lenders, and one primary and one local counsel to the Senior Agent (for all its capacities, including as agent with respect to Roll Up Debt), in accordance with the terms of the New Money Loan Agreement).

 

3


 

1.3                                Other than (a) Permitted Junior Securities, (b) regularly scheduled payments of payment-in-kind interest (including at the stated default rate, if applicable), (c) the Permitted Uses (as defined, as of the date hereof, in the New Money Loan Agreement), (d) the Permitted Affiliate Services Payments (as defined in the New Money Loan Agreement), (e) the reasonable and documented fees and expenses of one local and one primary counsel solely in connection with the documentation of this Agreement, the Existing Debt Consent, the New Money Loan Documents and the transactions to be contemplated thereunder on the closing date of the New Money Loan Agreement, (f) the prepayments on the Existing Debt (i) to be made on the closing date of the New Money Loan Agreement in an amount equal to $3.5 million which shall be applied to the partial prepayment of $3.5 million in principal of the Existing Debt comprising the Non-Contested Novelion Intercompany Loan Amount (as defined below) and (ii) from a portion of the proceeds of the Permitted Licensing Transaction (as defined, as of the date hereof, in the New Money Loan Agreement), if and when consummated, in the amount as set forth, as of the date hereof, in Schedule 1.01 of the New Money Loan Agreement, which such amount shall be applied first to the remaining Existing Debt comprising the Non-Contested Novelion Intercompany Loan Amount and second, if any such proceeds remain, to prepay in part the remaining principal amount of the Existing Debt, (g) the payment in kind of a consent fee of 0.50% of the outstanding principal of the Existing Debt on the closing date of the New Money Loan Agreement, after giving effect to the prepayment contemplated under the preceding clause (f)(i) (which shall be compounded and added to the principal amount of the Existing Debt), and (h) as provided in Sections 1.6 and 1.9 of this Agreement; in each case, which the Junior Creditor may receive and Borrower and its Subsidiaries may make in accordance with the terms of this Agreement and the Existing Loan Documents, the Junior Creditor will not demand (except to accelerate the Existing Debt solely in accordance with Section 1.10 ) or receive from Borrower or any Subsidiary thereof (and Borrower will not pay, or permit any of its Subsidiaries to pay, to the Junior Creditor) all or any part of the Subordinated Obligations, by way of payment, prepayment, setoff, lawsuit or otherwise, nor will the Junior Creditor exercise any remedy with respect to any property of Borrower or any Subsidiary, nor will the Junior Creditor, except as otherwise permitted pursuant to Section 1.10 hereof, take any Enforcement Action (as hereinafter defined), unless and until, and subject to the terms of the Existing Loan Documents, the earliest of (i) the Senior Lenders notify in writing Borrower and the Junior Creditor that such payment may be made to and received by the Junior Creditor, (ii) (1) the New Senior Debt has been paid in full in cash, (2) the Senior Lenders have no commitment or obligation to lend any further funds to Borrower, and (3) all financing agreements between the Senior Lenders (other than with respect to the Roll Up Debt) and Borrower pursuant to which the Senior Lenders could be required to advance funds to or for the benefit of Borrower are terminated with respect to the Senior Lenders, including the payment in full of any debtor-in-possession financing to the extent permitted by the terms of this Agreement, the adequate protection claims to the extent not contrary to the terms of this Agreement (regardless of whether such financing or claims are allowable in such proceeding and even if any such financing and/or claims are disallowed in such proceeding) (the date on which each of subparts (1), (2) and (3) above have occurred is hereinafter the “ Payment in Full of the New Senior Debt Obligations ”), or (iii) the expiration of the Junior Standstill Period (defined below).  For the avoidance of doubt, until the Payment in Full of the New Senior Debt Obligations, the Borrower shall continue to elect that interest payable under the Existing Loan Agreement be paid in kind pursuant to Section 2.2(d) of the Existing Loan Agreement.  In the event that the Junior Creditor receives any such payment that

 

4


 

is not otherwise permitted under this Section 1.3 , Section 1.6 or Section 1.9 , the provisions of Section 1.5 hereof shall apply.  Nothing in this Section 1.3 shall prohibit the Junior Creditor from converting all or any part of the Existing Debt into equity securities of Borrower, provided that, if such securities have any call, put or other conversion features that would obligate Borrower to declare or pay dividends, make distributions, or otherwise pay any money or deliver any other securities or consideration to the holder, the Junior Creditor hereby agrees that Borrower may not declare, pay or make such dividends, distributions or other payments with respect to such other securities or consideration to such Junior Creditor, and such Junior Creditor shall not accept any such dividends, distributions or other payments with respect to such other securities or consideration.

 

1.4                                Nothing in Sections 1.2 or 1.3 hereof shall prohibit the Junior Creditor from receiving Permitted Junior Securities in exchange or satisfaction for all or any part of the Subordinated Obligations, in accordance with the terms and conditions of the Existing Loan Documents as in effect on the date hereof.  “ Permitted Junior Securities ” means securities distributed in any Insolvency Proceeding (as defined below), consisting of debt securities or equity securities that are subordinated in right of payment to the New Senior Debt (or any debt securities issued in respect thereof), and in the case of debt securities secured by Liens, such Liens shall be subordinated to the Liens securing the New Senior Debt (or any debt securities issued in respect thereof), in each case, to the same extent as set forth in this Agreement.

 

1.5                                The Junior Creditor shall promptly deliver to the Senior Agent in the form received (except for endorsement or assignment by the Junior Creditor where required by the Senior Lenders) for application to the New Senior Debt any payment, distribution, security or proceeds received by such Junior Creditor with respect to the Subordinated Obligations other than in accordance with this Agreement including, without limitation the provisions of Section 1.3 ; provided , however , that any such payment, distribution, security or proceeds shall not be deemed applied to the New Senior Debt unless and until it has been reduced to cash, which reduction to cash the Senior Lenders shall use commercially reasonable efforts to accomplish promptly after receipt of such non-cash distribution.

 

1.6                                In the event of the commencement of any case or proceeding under any bankruptcy or insolvency law or laws relating to the relief of debtors, including, without limitation, any voluntary or involuntary bankruptcy, insolvency, receivership or other similar statutory or common law proceeding or arrangement involving Borrower or any Subsidiary, the readjustment of its liabilities, any assignment for the benefit of any creditor or any marshalling of its assets or liabilities (each, an “ Insolvency Proceeding ”), (a) this Agreement shall remain in full force and effect and enforceable in accordance with Section 510(a) of Title 11 of the United States Code (as amended, the “ United States Bankruptcy Code ”), (b) the Collateral shall include, without limitation, all Collateral arising during or after any such Insolvency Proceeding, and (c) no payment may be made to the Junior Creditor on account of the Subordinated Obligations (other than Permitted Junior Securities, payment-in-kind interest (including at the stated default rate, if applicable), and adequate protection payments approved by the applicable bankruptcy court overseeing the Insolvency Proceeding paid in kind, except for out of pocket fees and expenses of counsel and one financial advisor to the Junior Creditor (or its counsel), which may be paid in cash) until the Payment in Full of the New Senior Debt Obligations has occurred.

 

5


 

1.7                                The Junior Creditor shall, simultaneously with giving any notice of default to Borrower, provide the Senior Lenders with a copy of any notice of default given to Borrower.  The Junior Creditor acknowledges and agrees that any event of default under the Existing Loan Documents shall be deemed to be a default and an event of default under the New Money Loan Documents.  Each Senior Lender shall, simultaneously with giving any notice of default to Borrower, provide the Junior Creditor with a copy of any notice of default given to Borrower.  Each Senior Lender acknowledges and agrees that any event of default under the New Money Loan Documents shall be deemed to be a default and an event of default under the Existing Loan Documents.

 

1.8                                Prior to Payment in Full of the New Senior Debt Obligations, the Junior Creditor agrees: (a) to execute, verify, deliver and file any proofs of claim in respect of the Subordinated Obligations requested by the Senior Lenders in connection with any such Insolvency Proceeding and hereby irrevocably authorizes, empowers and appoints the Senior Lenders its agent and attorney-in-fact to prepare, execute, verify, deliver and file proofs of claim on account of the Existing Debt upon the failure of the Junior Creditor to promptly do so (in any event prior to twenty (20) days before the expiration of the time to file such proof of claim); provided that the Senior Lenders shall have no obligation to execute, verify, deliver and/or file any such proof of claim and/or vote any such claim; and (b) that the Junior Creditor will not (1) propose or support in any way any plan of reorganization in an Insolvency Proceeding that does not provide for the Payment in Full of the New Senior Debt Obligations or (2) propose or support in any manner any filing, argument, motion or any action that challenges, directly or indirectly, the validity, priority, perfection or enforceability of the New Obligations, the Liens securing the New Obligations or otherwise, or the priority of the New Obligations.

 

1.9                                In addition to and without limiting the foregoing: (x) until Payment in Full of the New Senior Debt Obligations, the Junior Creditor shall not commence or join in any involuntary bankruptcy petition or similar judicial proceeding against Borrower and its Subsidiaries, and (y) if an Insolvency Proceeding occurs, until Payment in Full of the New Senior Debt Obligations has occurred (i) without seeking or obtaining the consent of any Junior Creditor, the Senior Lenders may consent to the use of cash collateral and may provide debtor-in-possession financing, and any third party, with the consent of the Senior Lenders, may provide debtor-in-possession financing on such terms as are consistent with and do not violate this Agreement, including the relative rights hereunder of the Junior Creditor and the Senior Lender with respect to the Roll Up Debt hereunder, in an amount no greater than $30,000,000, as the Senior Lenders and the Borrower shall in good faith determine, (ii) if use of cash collateral by Borrower, or the provision of debtor-in-possession financing is consented to by the Senior Lenders not in violation of this Agreement, the Junior Creditor shall not oppose such use of cash collateral or such debtor-in-possession financing on the basis that the Junior Creditor’s interest in the Collateral (if any) is impaired by such use or financing or inadequately protected by such use or financing, provided that the Liens securing the Subordinated Obligations shall be subordinate to the Liens securing such debtor-in-possession financing in the same priorities as in place prior to the borrowing of such debtor-in-possession financing and the Junior Creditor is permitted to seek, and the Senior Lenders shall not oppose, the adequate protection described in clauses (D) and (E) of the next sentence of this Section 1.9 , (iii) the Junior Creditor shall not object to, or oppose, any sale or other disposition of any assets comprising all or part of the Collateral, free and clear of Liens and claims of any party, including the Junior Creditor, under Section 363 of

 

6


 

the United States Bankruptcy Code or otherwise, on the basis that the interest of the Junior Creditor in the Collateral (if any) is impaired by such sale or inadequately protected as a result of such sale, and the Junior Creditor, solely in its capacity as a junior secured lender, waives its rights under Section 363 of the United States Bankruptcy Code (excluding the right for the Junior Creditor to credit bid so long as such credit bid results in the Payment in Full of the New Senior Debt Obligations at closing) and shall be deemed to have consented to such sale or other disposition of such assets in its capacity as a secured creditor, if the Senior Lenders have consented to, or support, such sale or disposition; provided the Junior Creditor shall retain any objection rights in its capacity as an unsecured creditor or shareholder subject to the terms of this Agreement; provided further that Liens of the parties hereto attach to the proceeds of such sale, and the proceeds of such sale are used to pay the Obligations of the parties hereto, in each case, in accordance with the relative priorities of such obligations, (iv) the Junior Creditor shall not object to, protest or oppose, and shall be deemed to consent to, any adequate protection that the Senior Lenders may seek in respect of the New Senior Debt, and (v) the Junior Creditor shall not propose or provide, or join, direct, support or encourage a third party in proposing or providing, any debtor-in-possession financing that does not result, upon any initial borrowing thereunder, in Payment in Full of the New Senior Debt Obligations and payment in full in cash of the Roll Up Debt; provided , however , that so long as the Junior Creditor does not otherwise join, direct, support or encourage any third party in providing debtor-in-possession financing that results in Payment in Full of the New Senior Debt obligations and Payment in Full of the Junior Obligations (subject to customary challenge rights) and primes the Roll Up Debt (and Senior Lenders expressly reserve all of their rights to oppose any such debtor-in-possession financing), the Junior Creditor’s receipt of such Payment in Full of Junior Obligations, in and of itself, shall not constitute a breach of this clause (v); provided , further that the Senior Lenders shall retain any objection rights in their capacity as unsecured creditors subject to the terms of this Agreement.  Consistent with the terms of this Agreement and acting in accordance with the terms of this Agreement, the Junior Creditor shall be entitled (A) to file any necessary responsive or defensive pleadings in opposition to any motion, claim, adversary proceeding or other pleading made by any person objecting to, or otherwise seeking the disallowance of, or the treatment of, the claims of the Junior Creditor, including without limitation any claims secured by the Collateral, or challenging the perfection, enforceability or unavoidability of any Lien of the Junior Creditor, (B) file a proof of claim, vote on a plan of reorganization and make other filings, arguments and motions with respect to the Subordinated Obligations in accordance with this Agreement, (C) exercise any right or remedy available to an unsecured creditor unless such exercise violates this Agreement, (D) if the Senior Lenders (or any subset thereof) are granted adequate protection in the form of a Lien on additional or replacement collateral and/or a superpriority administrative claim in connection with any debtor-in-possession financing or use of cash collateral under Section 363 or 364 of the United States Bankruptcy Code or any similar provision of law applicable in an Insolvency Proceeding, then the Junior Creditor may seek or request adequate protection in the form of a Lien on such additional or replacement collateral and/or a superpriority administrative claim (as applicable), which Lien and/or superpriority administrative claim is subordinated to the Liens (including any replacement Liens) securing, and claims with respect to, all New Senior Debt and such debtor-in-possession financing (and all obligations relating thereto) on the same basis as the other Liens securing, and claims with respect to, the Subordinated Obligations are so subordinated to the Liens securing New Senior Debt under this Agreement, and (E) to the extent that the Senior Lenders are granted adequate

 

7


 

protection in the form of payments in the amount of current post-petition reasonable and documented fees, expenses, and/or other cash payments, then the Junior Creditor shall not be prohibited from seeking and accepting adequate protection in the form of payments in the amount of its reasonable and documented fees and expenses and/or cash payments (as applicable), provided any such adequate protection, other than with regards to out of pocket fees and expenses of counsel and one financial advisor to the Junior Creditor, shall not be paid in cash until the Payment in Full of the New Senior Obligations.  Furthermore, in the event that the Junior Creditor actually receives any payment of (or through) adequate protection in any Insolvency Proceeding (including any payment in respect of a claim granted under Section 507(b) of the United States Bankruptcy Code, but excluding out of pocket fees and expenses of Junior Creditor’s counsel and financial advisor), the same shall be segregated and held in trust and promptly paid over to the Senior Agent, in the same form as received, with any necessary endorsements, to be held or applied by the Senior Agent in accordance with the terms of the New Money Loan Documents until the Payment in Full of the New Senior Debt Obligations shall have occurred and all of the Senior Lenders’ post-petition claims against Borrower and the estate of Borrower, or any Subsidiary and its estate, shall be indefeasibly paid in full in cash, and any financing commitments of the Senior Lenders shall have been terminated before any of the same may be retained by the Junior Creditor.  The Junior Creditor irrevocably authorizes, empowers and directs any debtor, debtor in possession, receiver, trustee, liquidator, custodian, conservator or other Person having authority to pay or otherwise deliver all such payments to the Senior Lenders.

 

1.10                         Until the Payment in Full of the New Senior Debt Obligations, the Junior Creditor agrees not to take any Enforcement Action during any Junior Standstill Period, except that: (A) the Junior Creditor may accelerate the Existing Debt if the Senior Lenders have accelerated the New Senior Debt or if an Insolvency Proceeding is pending (but if the Senior Lenders rescind such acceleration by the Senior Lenders, then the Junior Creditor, as applicable, shall also rescind their acceleration); (B) the Junior Creditor may join (but not exercise control over) a judicial foreclosure or Lien enforcement proceeding with respect to the Collateral initiated by the Senior Lenders, to the extent such action could not reasonably be expected to interfere materially with the actions of the Senior Lenders; (C) the Junior Creditor may bid for or purchase Collateral at any public, private or judicial foreclosure upon any Collateral initiated by the Senior Lenders or any sale of Collateral during an Insolvency Proceeding, provided such bid provides for the Payment in Full of the New Senior Debt Obligations at closing, and (D) enforce this Agreement and the rights granted hereunder.

 

Section 2.                                            Roll Up Lien Priority .

 

2.1                                For the avoidance of doubt, (i) the Liens on the Collateral securing the Roll Up Debt under the New Money Loan Agreement shall be junior in priority to the Liens held by or on behalf of the Junior Creditor, or any agent or trustee therefor, securing the Existing Loan Documents (subject to Section 2.5 of this Agreement), but (ii) the Roll Up Debt shall not be subordinated in right of payment to the Subordinated Obligations.

 

2.2                                Other than (a) Permitted Junior Roll Up Securities and (b) regularly scheduled payments of payment-in-kind interest (including at the stated default rate, if applicable) and the accrual of fees and expenses with respect to the Roll Up Debt; in each case, which the New

 

8


 

Lenders may receive on account of the Roll Up Debt and Borrower may make in accordance with the terms hereof, following the Payment in Full of the New Senior Debt Obligations, the New Lenders will not demand or receive from Borrower or any Subsidiary (and Borrower will not pay, or cause any Subsidiary to pay, to any Senior Lender) any Collateral, distributions in respect thereof or proceeds thereof, including any such Collateral constituting proceeds, in each case with respect to the Roll Up Debt, by way of payment, prepayment, setoff, lawsuit or otherwise, nor will any New Lender exercise any remedy with respect to any property of Borrower and its Subsidiaries in respect of the Roll Up Debt, nor will any New Lender, as the holder of any Roll Up Debt, except as otherwise permitted pursuant to Section 2.8 hereof, take any Enforcement Action (as hereinafter defined) against any Collateral in respect of the Roll Up Debt, unless and until the earliest of (i) the Junior Creditor notifies in writing Borrower and the New Lenders that such payment may be made to and received by the New Lenders, or (ii) (1) the obligations comprising Existing Debt, if any, have been paid in full in cash other than any amounts that have been adjudicated not to be valid, binding and enforceable by a final order of a court of competent jurisdiction, (2) the Junior Creditor has no commitment or obligation to lend any further funds to Borrower, and (3) all financing agreements between the Junior Creditor and Borrower pursuant to which the Junior Creditor could be required to advance funds to or for the benefit of Borrower are terminated and all of the Junior Creditor’s post-petition claims against Borrower and the estate of Borrower that constitute Obligations under Existing Loan Documents, accruing or incurred thereon or in connection therewith after the commencement by or against Borrower and its Subsidiaries of any bankruptcy, reorganization or similar proceeding (regardless of whether such interest, costs, expenses, or post-petition claims are allowable in such proceeding and even if any such interest, costs and expenses are disallowed in such proceeding) are paid (the date on which each of subparts (1), (2) and (3) above have occurred is hereinafter the “ Payment in Full of the Junior Obligations ”).  In the event that any New Lender receives any Collateral or proceeds of Collateral on account of the Roll Up Debt in connection with the exercise of rights or remedies against the Collateral or otherwise in violation of this Agreement following Payment in Full of the New Senior Debt Obligations and prior to Payment in Full of the Junior Obligations that is not otherwise permitted under this Section 2.2 , the provisions of Section 2.4 hereof shall apply.  Nothing in this Section 2.2 shall prohibit any New Lender from converting all or any part of the Roll Up Debt into equity securities of Borrower, provided that, if such securities have any call, put or other conversion features that would obligate Borrower to declare or pay dividends, make distributions, or otherwise pay any money or deliver any other securities or consideration to the holder, each New Lender hereby agrees that Borrower may not declare, pay or make such dividends, distributions or other payments to such New Lender, and such New Lender shall not accept any such dividends, distributions or other payments until the Payment in Full of the Junior Obligations.

 

2.3                                Nothing in Sections 2.1 or 2.2 hereof shall prohibit any New Lender from receiving Permitted Junior Roll Up Securities in exchange or satisfaction for all or any part of the Roll Up Debt, in accordance with the terms and conditions of the New Money Loan Documents as in effect on the date hereof.  “ Permitted Junior Roll Up Securities ” means securities distributed in any Insolvency Proceeding, consisting of debt securities or equity securities that are subordinated to the Existing Debt (or any debt securities issued in respect thereof), and in the case of debt securities secured by Liens, such Liens shall be subordinated to the Liens securing the Existing Debt (or any debt securities issued in respect thereof), in each case, to the same extent as set forth in this Agreement.

 

9


 

2.4                                If the New Lenders receive distributions with respect to the Roll Up Debt before the Payment in Full of the New Senior Debt Obligations, such amounts will be deemed applied to the New Senior Debt until the Payment in Full of the New Senior Debt Obligations.  Following Payment in Full of the New Senior Debt Obligations and solely until Payment in Full of the Junior Obligations, each New Lender shall promptly deliver to the Junior Lenders in the form received (except for endorsement or assignment by the Junior Creditor where required by the New Lenders) for application to the Existing Debt any Collateral, distributions in respect thereof or proceeds thereof, including any such Collateral constituting proceeds, received by such New Lender with respect to the Roll Up Debt in connection with the exercise of any right or remedy (including any right of set-off or recoupment) against the Collateral or in violation of this Agreement.  Furthermore, in the event that any New Lender actually receives any payment of (or through) adequate protection in any Insolvency Proceeding (including any payment in respect of a claim granted under Section 507(b) of the United States Bankruptcy Code) with respect to the Roll Up Debt following the Payment in Full of the New Senior Debt Obligations, the same shall be segregated and held in trust and promptly paid over to the Junior Creditor, in the same form as received, with any necessary endorsements, to be held or applied by the Junior Creditor in accordance with the terms of the Existing Loan Documents until the Payment in Full of the Junior Obligations shall have occurred before any of the same may be retained by one or more of the New Lenders.  Each New Lender irrevocably authorizes, empowers and directs any debtor, debtor in possession, receiver, trustee, liquidator, custodian, conservator or other Person having authority to pay or otherwise deliver all such payments to the Junior Creditor.

 

2.5                                Consistent with the terms of this Agreement, in each case acting in accordance with the terms of this Agreement, the New Lenders in respect of the Roll Up Debt shall be entitled (A) to file any necessary responsive or defensive pleadings in opposition to any motion, claim, adversary proceeding or other pleading made by any person objecting to, or otherwise seeking the disallowance of, the claims of the New Lenders, including without limitation any claims secured by the Collateral, or challenging the perfection, enforceability or unavoidability of the Lien of the New Lenders, (B) file a proof of claim, vote on a plan of reorganization and make other filings, arguments and motions with respect to the Roll Up Debt in accordance with this Agreement, and (C) exercise any rights and remedies that may be exercised by an unsecured creditor.  For the avoidance of doubt, the Senior Lenders, whether as a secured or unsecured creditor or in any other capacity, may challenge the validity and/or enforceability of the Existing Debt including, without limitation, asserting that such Existing Debt is subject to recharacterization, setoff, subordination, defense or any similar legal or equitable argument, and nothing in this Agreement shall modify or otherwise affect the right of the New Lenders, in any capacity, to do so; provided , in no event shall the New Lenders (in any capacity including as a member of any official committee or ad hoc committee of creditors or as a decision maker for any trust established in an Insolvency Proceeding) challenge, join, direct, support or encourage any other party in challenging or seeking to challenge, Existing Debt incurred under the Existing Loan Agreement and outstanding as of the date hereof in the aggregate amount of $25 million (the “ Non-Contested Novelion Intercompany Loan Amount ”), or contest the validity and/or enforceability of such amount (or any payments received by Novelion on account of the Non-Contested Novelion Intercompany Loan Amount in accordance with this Agreement); provided nothing herein shall prevent or restrict the New Lenders from voting in favor of a plan of reorganization in an Insolvency Proceeding proposed by the Borrower or a third party, for which plan the New Lenders shall neither be a plan sponsor or plan proponent, which contemplates,

 

10


 

provides for, or reserves the right for any other party to, challenge or contest the validity of the Non-Contested Intercompany Loan Amount, provided further, that the New Lenders shall not direct or otherwise instruct The Bank of New York Mellon Trust Company, N.A., as trustee for holders of the Convertible Notes (as defined in the Existing Loan Agreement), in their capacity as holders of Convertible Notes to pursue any challenge to the validity or enforceability of the Non-Contested Novelion Intercompany Loan Amount (including any payments received by Novelion on account of the Non-Contested Novelion Intercompany Amount).

 

2.6                                Until the Payment in Full of the Junior Obligations, the Senior Lenders agree not to take any Enforcement Action against the Collateral in respect of the Roll Up Debt during any Roll Up Standstill Period, except that: (A) the Senior Lenders, as holders of Roll Up Debt, may join (but not exercise control over) a judicial foreclosure or Lien enforcement proceeding with respect to the Collateral initiated by the Junior Creditor, to the extent such action could not reasonably be expected to interfere materially with the actions of the Junior Creditor; and (B) the Senior Lenders, as holders of Roll Up Debt, may bid for or purchase Collateral at any public, private or judicial foreclosure upon any Collateral initiated by the Junior Creditor or any sale of Collateral during an Insolvency Proceeding.  For avoidance of doubt, and notwithstanding anything to the contrary herein, the Senior Lenders, as holders of Roll Up Debt, may exercise any right or remedy available to an unsecured creditor and may take any Enforcement Action that does not constitute the exercise of a right or remedy against any Collateral unless such exercise violates this Agreement.

 

2.7                                From and after the Payment in Full of the New Senior Debt Obligations, Senior Lenders shall promptly deliver to the Junior Creditor in the form received (except for endorsement or assignment by the relevant Senior Lender where required by the Junior Creditor) for application to the Existing Debt any payment, distribution, security  or proceeds from any Collateral received by such Senior Lender with respect to the Roll Up Debt other than in accordance with this Agreement; provided, however, that any such payment, distribution, security or proceeds shall not be deemed applied to the Existing Debt unless and until it has been reduced to cash, which reduction to cash the Junior Creditor shall use commercially reasonable efforts to accomplish promptly after receipt of such non-cash distribution.

 

Section 3.                                            Definitions .  As used herein the following terms have the following meanings:

 

Enforcement Action ” means any action to accelerate maturity, commence or join in any action or proceeding to recover any amounts due, commence or join in, or encourage others to file, any involuntary bankruptcy petition or similar judicial proceeding against Borrower or any Subsidiary, or commence any litigation against Borrower or any Subsidiary for enforcement of any rights or remedies, or collect, take possession of, sell any property or assets of, foreclose upon, or exercise any other rights or remedies with respect to, the Collateral, judicially or non-judicially, or attempt to do any of the foregoing.

 

Junior Standstill Period ” means a period commencing on the date of any default or event of default under any documents, instruments or agreements evidencing or relating to the Existing Debt (a “ Subordinated Default ”), and ending one hundred (100) days after written notice has been given by the Junior Creditor, as applicable, to the Senior Lenders that such Subordinated Default has occurred; provided that , notwithstanding any of the foregoing

 

11


 

provisions, the Junior Standstill Period shall be extended during any period that the Senior Lenders are diligently pursuing any Enforcement Action with respect to the New Senior Debt.

 

Lien ” means, with respect to any asset, any security interest, mortgage, pledge, hypothecation, assignment, deposit arrangement, encumbrance, lien (statutory or otherwise), charge, or preference, priority or other security interest or preferential arrangement in the nature of a security interest of any kind or nature whatsoever (including any conditional sale or other title retention agreement, any easement, right of way or other encumbrance on title to real property, and any financing lease having substantially the same economic effect as any of the foregoing).

 

Roll Up Debt ” means the Roll Up Loans (as defined in the New Money Loan Agreement) in the principal amount as of the date of this Agreement and any interest thereon and all fees payable with respect thereto (if any), together with, solely following the Payment in Full of the New Senior Debt Obligations, all costs and expenses of collecting the Roll Up Loans (including attorneys’ fees), and also including, without limitation, all interest, costs and expenses accruing or incurred in respect of the Roll Up Debt (and not in respect of the New Senior Debt) after the commencement by or against Borrower or any Subsidiary of any bankruptcy, reorganization or similar proceeding (regardless of whether such interest, costs and expenses are allowable in such proceeding and even if any such interest, costs and expenses are disallowed in such proceeding).

 

Roll Up Standstill Period ” means a period commencing on the date of any default or event of default under any documents, instruments or agreements evidencing or relating to the Roll Up Debt (a “ Roll Up Default ”), and ending one hundred and fifty (150) days after written notice has been given by a Senior Lender to the Junior Creditor that such Roll up Default has occurred; provided that , notwithstanding any of the foregoing provisions, the Roll Up Standstill Period shall be extended during any period that the Junior Creditor is diligently pursuing any Enforcement Action against the Collateral with respect to the Existing Debt in accordance with the terms hereof.

 

Section 4.                                            The Junior Creditor represents and warrants that such Junior Creditor has provided the Senior Lenders with true and correct copies of all of the documents evidencing the Subordinated Obligations.  The Junior Creditor further represents and warrants that on the date hereof, the Junior Creditor is the collective current owners and holders of the Existing Debt and all other Existing Loan Documents.  The Junior Creditor shall immediately affix a legend to the instruments evidencing the Existing Debt stating that the instruments are subject to the terms of this Agreement.  By the execution of this Agreement, the Junior Creditor agrees to amend any financing statements filed by such Junior Creditor against Borrower as follows: “In accordance with a certain Subordination Agreement by and among the Secured Party, the Debtor and the Senior Lenders (as defined therein), the Secured Party has subordinated any security interest that Secured Party may have in any property of the Debtor to the security interest of the Senior Lenders in all assets of the Debtor, notwithstanding the respective dates of attachment or perfection of the security interest of the Secured Party and the Senior Lenders to the extent set forth in such Subordination Agreement.”

 

12


 

Section 5.                                            Each Senior Lender represents and warrants that such Senior Lender has provided the Junior Creditor with true and correct copies of all of the documents evidencing the New Obligations.  Each Senior Lender further represents and warrants that on the date hereof, the Senior Lenders party hereto are the collective current owners and holders of the New Obligations and all other New Money Loan Documents.  The Senior Lenders shall immediately affix a legend to the instruments evidencing the Roll Up Debt stating that the instruments are subject to the terms of this Agreement.  By the execution of this Agreement, the Senior Lenders agree to amend any financing statements filed by such Senior Lender against Borrower as follows: “In accordance with a certain Subordination Agreement by and among the Secured Party, the Debtor and the Junior Creditor (as defined therein), the Secured Party has subordinated any security interest that Secured Party may have in any property of the Debtor to the security interest of the Junior Creditor in all assets of the Debtor, notwithstanding the respective dates of attachment or perfection of the security interest of the Secured Party and the Junior Creditor to the extent set forth in such Subordination Agreement.”

 

Section 6.                                            If the Junior Creditor has any Collateral in its possession or control for which possession or control thereof is taken to perfect a Lien thereon under the UCC or other applicable law, then the Junior Creditor will promptly notify the Senior Agent of its possession or control of such Collateral and if requested by the Senior Agent, deliver or transfer such Collateral in its possession or control, together with any necessary endorsements (which endorsements will be without recourse and without any representation or warranty), to the Senior Agent in such manner as the Senior Agent shall reasonably direct.  Until such transfer, the Junior Creditor agrees to hold or control that part of the Collateral that is in its possession or control (or in the possession or control of its agents or bailees) to the extent that possession or control thereof is taken to perfect a Lien thereon under the UCC or other applicable law as collateral agent for the Senior Lenders and any assignee thereof solely for the purpose of perfecting any security interest granted under the New Money Loan Agreement.  The Junior Creditor shall have no obligation whatsoever to the Senior Lenders to assure that the Collateral is genuine or owned by any of the Borrower or its Subsidiaries or to preserve rights or benefits of any Person except as expressly set forth in this Section 6 .  The duties or responsibilities of the Junior Creditor under this Section 6 shall be limited solely to holding the Collateral as bailee and agent for and on behalf of the Senior Lenders for purposes of perfecting the Lien held by such Senior Lenders.

 

Section 7.

 

7.1                                No amendment of the documents evidencing or relating to the Subordinated Obligations shall directly or indirectly modify the provisions of this Agreement in any manner which might terminate or impair the subordination of the Subordinated Obligations or the subordination of the Liens that the Junior Creditor may have in any property of Borrower, or which would increase the principal amount of the Existing Debt (excluding the payment of paid-in-kind interest, which amounts are or will be compounded and added to the principal amount of the Existing Debt).  By way of example, such instruments shall not be amended to (a) increase the rate of interest with respect to the Existing Debt (or to provide for the payment of any interest in cash), (b) other than certain prepayments of the Existing Debt on the closing date of the New Money Loan Agreement and from the potential proceeds of the permitted Permitted Licensing Transaction (as defined, as of the date hereof, in the New Money Loan Agreement), each as provided in Section 1.3 , accelerate the payment of the principal or interest or any other portion of

 

13


 

the Existing Debt, (c) other than as in effect on the date of this Agreement, charge any additional fees to be earned by the Junior Creditor thereunder (including any consent or amendment fee) unless the Senior Lenders shall charge additional fees for similar accommodations, in which case, Junior Creditor may pursue matching fees on an appropriate basis, (d) prohibit or limit the granting of, or perfecting of, any Lien in favor of the Senior Lenders, or (e) prohibit, limit or derogate (or purport to prohibit, limit or derogate) any right of the Senior Lenders under the New Money Loan Documents.  Until the Payment in Full of the New Senior Debt Obligations and subject to applicable law, the Senior Lenders shall have the sole and exclusive right relative to the Junior Creditor to restrict or permit, or approve or disapprove, the sale, transfer or other disposition of property of Borrower.  Upon written notice from the Senior Lenders to the Junior Creditor of the Senior Lenders’ agreement to release its Lien on all or any portion of the Collateral in connection with the sale, transfer or other disposition thereof by the Senior Lenders (or by Borrower or any Subsidiary with consent of the Senior Lenders), the Junior Creditor shall be deemed to have also, automatically and simultaneously, released its Lien on the Collateral, and the Junior Creditor shall, upon written request by the Senior Lenders, immediately take such action as shall be necessary or appropriate to evidence and confirm such release; provided that , other than with respect to a portion of the potential proceeds of the Permitted Licensing Transaction (as set forth, as of the date hereof, in Schedule 1.01 of the New Money Loan Agreement), all proceeds resulting from any such sale, transfer or other disposition shall be applied first to the New Senior Debt until Payment in Full of the New Senior Debt Obligations, with the balance, if any, to the Existing Debt, if any, until Payment in Full of the Junior Debt, with the balance, if any, applied to the Roll Up Debt, or to any other entitled party.  If the Junior Creditor fails to release any Lien as required hereunder, the Junior Creditor hereby appoints the Senior Lenders as attorney in fact with full power of substitution to release the Junior Creditor’s Liens, as applicable, as provided hereunder.  Such power of attorney being coupled with an interest shall be irrevocable.  The Parties intend that the Collateral securing the Existing Debt also secure the New Senior Debt and the parties hereto agree that, so long as the Payment in Full of New Senior Debt Obligations has not occurred, the Borrower shall not, and shall not permit any of its Subsidiaries to, grant or permit any Liens on any asset or property of the Borrower or any of its Subsidiaries to secure any Existing Debt unless it has granted, or substantially concurrently therewith grants, a Lien on such asset or property of such Obligor to secure the New Senior Debt (unless with respect to any New Senior Debt, the Senior Agent has elected in writing not to receive such lien).  Unless the Senior Agent has elected not to receive such lien, if the Junior Creditor shall hold any Lien on any assets or property of Borrower or any Subsidiary securing any Junior Debt that are not also subject to the first-priority Liens securing all New Senior Debt, Junior Creditor (i) shall notify the Senior Agent promptly upon becoming aware thereof and, until such Borrower or Subsidiary grants a similar Lien on such assets or property to Senior Agent as security for the New Senior Debt, shall be deemed to hold and have held such Lien for the benefit of Senior Agent and the Senior Lenders as security for the New Senior Debt.  To the extent that the provisions of the immediately preceding sentence are not complied with for any reason, without limiting any other right or remedy available to Senior Agent or any Senior Lender, Junior Creditor agrees that any amounts received by or distributed to Junior Creditor pursuant to or as a result of any Lien held or granted in contravention of this Section 7.1 shall be subject to Section 1.5 .

 

7.2                                The Parties intend that the Collateral securing the Roll Up Debt also secure the Existing Debt and the parties hereto agree that, if the Payment in Full of New Senior Debt

 

14


 

Obligations has occurred, the Borrower shall not, and shall not permit any of its Subsidiaries to, grant or permit any Liens on any asset or property of the Borrower or any of its Subsidiaries to secure any Roll Up Debt unless it has granted, or substantially concurrently therewith grants, a Lien on such asset or property of such Obligor to secure the Existing Debt (unless with respect to any Existing Debt, the Junior Creditor has elected in writing not to receive such lien).  If the Payment in Full of New Senior Debt Obligations has occurred, unless the Junior Creditor has elected not to receive such lien, if the New Lenders shall hold any Lien on any assets or property of Borrower or any Subsidiary securing any Roll Up Debt that are not also subject to the first-priority Liens securing all the Existing Debt, the New Lenders (i) shall notify the Junior Creditor promptly upon becoming aware thereof and, until such Borrower or Subsidiary grants a similar Lien on such assets or property to Junior Creditor as security for the Existing Debt, shall be deemed to hold and have held such Lien for the benefit of Junior Creditor and the New Lenders as security for the Existing Debt.  To the extent that the provisions of the immediately preceding sentence are not complied with for any reason, without limiting any other right or remedy available to Junior Creditor, the New Lenders agree that any amounts received by or distributed to Senior Lenders pursuant to or as a result of any Lien held or granted in contravention of this Section 7.2 shall be subject to Section 2.7.

 

Section 8.                                            All necessary actions on the part of the Junior Creditor, its respective officers, directors, partners, members and shareholders, as applicable, necessary for the authorization of this Agreement and the performance of all obligations of the Junior Creditor hereunder has been taken.  This Agreement constitutes the legal, valid and binding obligation of the Junior Creditor, enforceable against the Junior Creditor in accordance with its terms.  The execution, delivery and performance of and compliance with this Agreement by the Junior Creditor will not (a) result in any material violation or default of any term of the Junior Creditor’s charter, formation or other organizational documents (such as Articles or Certificate of Incorporation, bylaws, partnership agreement, operating agreement, etc.) or (b) violate any material applicable law, rule or regulation.  All necessary actions on the part of the New Lenders, their respective officers, directors, partners, members and shareholders, as applicable, necessary for the authorization of this Agreement and the performance of all obligations of each New Lender hereunder has been taken.  This Agreement constitutes the legal, valid and binding obligation of each New Lender, enforceable against each New Lender in accordance with its terms.  The execution, delivery and performance of and compliance with this Agreement by the New Lenders will not (a) result in any material violation or default of any term of any New Lenders’ charter, formation or other organizational documents (such as Articles or Certificate of Incorporation, bylaws, partnership agreement, operating agreement, etc.) or (b) violate any material applicable law, rule or regulation.

 

Section 9.                                            If, at any time any payments of the New Senior Debt must be disgorged by the Senior Lenders for any reason (including, without limitation, any Insolvency Proceeding), this Agreement and the relative rights and priorities set forth herein shall be reinstated as to all such disgorged payments as though such payments had not been made and the Junior Creditor shall immediately pay over to the Senior Lenders all payments received with respect to the Existing Debt to the extent that such payments would have been prohibited hereunder.  If, at any time any payments of the enforceable Existing Debt must be disgorged by the Junior Creditor for any reason (including, without limitation, any Insolvency Proceeding), this Agreement and the relative rights and priorities set forth herein shall be reinstated as to all such disgorged payments

 

15


 

as though such payments had not been made and the New Lenders shall immediately pay over to the Junior Creditor for application to the enforceable Existing Debt all payments received with respect to the Roll Up Debt to the extent that such payments would have been prohibited hereunder.

 

Section 10.                                     At any time and from time to time, without notice to the Junior Creditor, the Senior Lenders may take such actions with respect to the New Senior Debt as the Senior Lenders, in their sole discretion, may deem appropriate, including, without limitation, terminating advances to Borrower, increasing the principal amount (provided, that the initial principal amount of the New Senior Debt shall not exceed $50,000,000 (the “ New Senior Debt Cap ”) and for avoidance of doubt the New Senior Debt Cap shall not apply to any paid in kind interest or any fees, costs and expenses that may be added to principal form time to time) or creating an additional tranche of debt under the New Money Loan Agreement (provided that all tranches of New Senior Debt shall be treated as a single class for purposes of voting on any plan in an Insolvency Proceeding) without the prior written consent of the Junior Creditor), extending the time of payment, increasing applicable interest rates (provided such increase is not 300 basis points greater than the rate applicable on the date hereof), renewing, compromising or otherwise amending the terms of any documents affecting the New Senior Debt and any Collateral securing the New Senior Debt, and enforcing or failing to enforce any rights against Borrower, any Subsidiary or any other person; provided that no modification of the New Money Loan Documents shall (a) prohibit, release or limit the granting of, or perfecting of, any Lien in favor of the Junior Creditor to the extent permitted by this Agreement, (b) prohibit, limit or derogate (or purport to prohibit, limit or derogate) any right of the Junior Creditor under the Existing Loan Documents except as set forth herein or under any document governing any other Subordinated Obligations, or (c) prohibit, limit or derogate (or purport to prohibit, limit or derogate) any right of the Junior Creditor under this Agreement, including without limitation, the right to receive the payments provided under Section 1 of this Agreement.

 

Section 11.                                     Miscellaneous .

 

11.1                         This Agreement shall bind any successor or permitted assignee of the Junior Creditor and shall benefit any successors or assigns of the New Lenders; provided, however , each Junior Creditor agrees that, prior to, and as conditions precedent to, the Junior Creditor assigning all or any portion of the Existing Debt: (a) Junior Creditor shall give the New Lenders prior written notice of such assignment, and (b) such successor or assignee, as applicable, shall execute a written agreement whereby such successor or assignee expressly agrees to assume and be bound by all terms and conditions of this Agreement, and any assignment that fails to comply with the foregoing requirements shall be void ab initio .  This Agreement shall bind any successors or assignees of each New Lender and shall benefit any successors or permitted assigns of the Junior Creditor; provided, however, each New Lender agrees that, prior to, and as conditions precedent to, any New Lender assigning all or any portion of the New Obligations: (a) such New Lender shall give the Junior Creditor prior written notice of such assignment, and (b) such successor or assignee, as applicable, shall execute a written agreement whereby such successor or assignee expressly agrees to assume and be bound by all terms and conditions of this Agreement, and any assignment that fails to comply with the foregoing requirements shall be void ab initio.

 

16


 

11.2                         This Agreement shall (i) remain effective with respect to the New Senior Debt until terminated in writing by each of the New Lenders or, if earlier, Payment in Full of the New Senior Debt Obligations and (ii) remain effective with respect to the Roll Up Debt until terminated in writing by the Junior Creditor or, if earlier, Payment in Full of the Junior Obligations.  This Agreement is solely for the benefit of the New Lenders, and the Junior Creditor, and not for the benefit of Borrower or any other party.  The Junior Creditor further agrees that if Borrower is in the process of refinancing any portion of the New Senior Debt with a new lender, and if the New Lenders make a request of the Junior Creditor, the Junior Creditor shall agree to enter into a new subordination agreement with the new lender on substantially the terms and conditions of this Agreement, but no less favorable to the Junior Creditor than this Agreement.

 

11.3                         The Existing Loan Agreement and each other Existing Loan Document evidencing a payment obligation with respect to the Existing Debt shall bear the following legend (or a substantially similar legend):  “THE INDEBTEDNESS AND OTHER OBLIGATIONS OF AEGERION PHARMACEUTICALS, INC. (“BORROWER”) UNDER OR EVIDENCED HEREBY AND THE LIENS AND SECURITY INTERESTS SECURING SAME ARE SUBORDINATED AND SUBJECT TO THE TERMS AND CONDITIONS OF THE SUBORDINATION AGREEMENT, DATED AS OF NOVEMBER 8, 2018, AMONG BORROWER, NOVELION THERAPEUTICS INC., AND THE NEW LENDERS.”  The Junior Creditor hereby agrees to execute such documents and/or take such further action as the Senior Lenders may at any time or times reasonably request (at the Borrower’s sole cost and expense) in order to carry out the provisions and intent of this Agreement, including, without limitation, ratifications and confirmations of this Agreement from time to time hereafter, as and when requested by the Senior Lenders.

 

11.4                         The New Money Loan Agreement and each other New Money Loan Document evidencing a payment obligation with respect to the Roll Up Debt shall bear the following legend (or a substantially similar legend):  “THE INDEBTEDNESS AND OTHER OBLIGATIONS OF AEGERION PHARMACEUTICALS, INC. (“BORROWER”) UNDER OR EVIDENCED HEREBY AND THE LIENS AND SECURITY INTERESTS SECURING SAME ARE SUBORDINATED AND SUBJECT TO THE TERMS AND CONDITIONS OF THE SUBORDINATION AGREEMENT, DATED AS OF NOVEMBER 8, 2018, AMONG BORROWER, NOVELION THERAPEUTICS INC., AND THE NEW LENDERS.”  Each New Lender hereby agrees to execute such documents and/or take such further action as the Junior Creditor may at any time or times reasonably request (at the Borrower’s sole cost and expense) in order to carry out the provisions and intent of this Agreement, including, without limitation, ratifications and confirmations of this Agreement from time to time hereafter, as and when requested by the Junior Creditor.

 

11.5                         This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.

 

11.6                         This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to conflicts of laws principles.  The Junior Creditor and the New Lenders submit to the exclusive jurisdiction of the state and federal courts located in New York, New York in any action, suit, or proceeding of any kind, against it which

 

17


 

arises out of or by reason of this Agreement, provided, however, after the commencement of a case under the United States Bankruptcy Code by Borrower or any Subsidiary, the Junior Creditor and the New Lenders acknowledge and agree that the applicable bankruptcy court shall have the jurisdiction for resolving disputes or matters arising out of this Agreement.  THE NEW LENDERS AND THE JUNIOR CREDITOR WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREIN.

 

11.7                         This Agreement represents the entire agreement with respect to the subject matter hereof, and supersedes all prior negotiations, agreements and commitments.  No Junior Creditor is relying on any representations by the New Lenders or Borrower in entering into this Agreement, and the Junior Creditor has kept and will continue to keep itself fully apprised of the financial and other condition of Borrower.  No New Lender is relying on any representations by the Junior Creditor or Borrower in entering into this Agreement, and each Senior Lender has kept and will continue to keep itself fully apprised of the financial and other condition of Borrower.  This Agreement may be amended only by written instrument signed by each New Lender, the Junior Creditor and Borrower.

 

11.8                         All notices, consents, requests, approvals, demands, or other communication by any party to this Agreement must be in writing and shall be deemed to have been validly served, given, or delivered: (a) upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid; (b) upon transmission, when sent by electronic mail; (c) one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address, facsimile number, or email address indicated below.  Any of the New Lenders, the Junior Creditor or Borrower may change its mailing or electronic mail address or facsimile number by giving the other party written notice thereof in accordance with the terms of this Section 11.8 .

 

If to the Senior Lenders:      Cantor Fitzgerald Securities

1801 N. Military Trail, Suite 202

Boca Raton, FL 33431

Telecopier: (646) 219-1180

Attention: N. Horning (Aegerion)

E-mail: NHorning@cantor.com

 

and

 

Cantor Fitzgerald Securities

900 West Trade Street, Suite 725

Charlotte, North Carolina 28202

Phone: (747) 374-0574

Telecopier: (646) 390-1764

Attention: B. Young (Aegerion)

E-mail: BYoung@cantor.com

 

18


 

with a copy (that shall not constitute notice) to:

 

Shipman & Goodwin LLP

One Constitution Plaza

Hartford, CT 06103

Attention: Nathan Plotkin

E-mail: NPlotkin@goodwin.com

 

If to the Junior Creditor:     Novelion Therapeutics Inc.

c/o Norton Rose Fulbright

1800 - 510 West Georgia Street, Vancouver, BC

V6B 0M3 Canada

Attn: Ben Harshbarger

Email: ben.harshbarger@novelion.com

 

with a copy to:                     Goodwin Procter LLP

100 Northern Avenue

Boston, MA 02210

Attn: Anna Dodson and Greg Fox

Email: adodson@goodwinlaw.com and gfox@goodwinlaw.com

 

11.9                         Cantor Fitzgerald Securities is executing and delivering this Agreement solely in its capacity as “Administrative Agent” under the New Money Loan Agreement and when acting hereunder shall be entitled to all of the rights, privileges and immunities granted to it under the Bridge Loan Agreement.

 

[ Signature pages follows ]

 

19


 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

 

 

CANTOR FITZGERALD SECURITIES, as Administrative Agent

 

 

 

 

 

 

By:

/s/ James Buccola

 

Name:

James Buccola

 

Title:

Head of Fixed Income

 

[Signature Page to Subordination Agreement – Aegerion Pharmaceuticals]

 


 

 

1992 MSF INTERNATIONAL LTD., as a NEW LENDER

 

 

 

 

 

 

By:

/s/ Jonathan Segal

 

Name:

Jonathan Segal

 

Title:

Managing Director

 

 

 

 

 

 

1992 TACTICAL CREDIT MASTER FUND, L.P., as a NEW LENDER

 

 

 

 

 

 

 

By:

/s/ Jonathan Segal

 

Name:

Jonathan Segal

 

Title:

Managing Director

 

[Signature Page to Subordination Agreement]

 


 

 

ATHYRIUM OPPORTUNITIES II ACQUISITION, LP, as a NEW LENDER

 

 

 

By:

Athyrium Opportunities II LP, its general partner

 

 

 

 

By:

Athyrium GP Holdings LLC, its general partner

 

 

 

 

 

 

 

By:

/s/ Andrew C. Hyman

 

Name:

Andrew C. Hyman

 

Title:

Authorized Signatory

 

 

 

 

 

 

ATHYRIUM OPPORTUNITIES III ACQUISITION, LP, as a NEW LENDER

 

 

 

 

By:

Athyrium Opportunities III LP, its general partner

 

 

 

 

By:

Athyrium Opportunities III GP LLC, its general partner

 

 

 

 

 

 

 

By:

/s/ Andrew C. Hyman

 

Name:

Andrew C. Hyman

 

Title:

Authorized Signatory

 

[Signature Page to Subordination Agreement]

 


 

 

NOVELION THERAPEUTICS INC.

 

 

 

 

 

 

By:

/s/ Benjamin S. Harshbarger

 

Name:

Benjamin S. Harshbarger

 

Title:

General Counsel and Secretary

 

 

 

 

 

 

NOVELION SERVICES USA, INC.

 

 

 

 

 

 

 

By:

/s/ Benjamin S. Harshbarger

 

Name:

Benjamin S. Harshbarger

 

Title:

Secretary

 

[Signature Page to Subordination Agreement]

 


Exhibit 99.1

 

 

Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update

 

·      New Aegerion loan facility, provided by existing bondholders, strengthens balance sheet and is expected to provide bridge to a potential comprehensive long-term capital restructuring

 

·      Company expects to achieve positive cash flow at Aegerion level by 2Q 2019 on full-year net product sales of between $145 and $160 million

 

·      Financial advisors retained to advise on strategic process and capital structure review

 

Vancouver, British Columbia, November 8, 2018  —  Novelion Therapeutics Inc.  (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases (“Novelion”), announced that its subsidiary, Aegerion Pharmaceuticals, Inc. (“Aegerion”), after soliciting third party lenders, has entered into a new secured financing facility with certain funds managed by Athyrium Capital Management (Athyrium) and Highbridge Capital Management, LLC (Highbridge) (the “New Lenders”).

 

The facility consists of $50.0 million in new secured first lien term loans that were funded to Aegerion in cash and $22.5 million of new secured term loans that were used, on behalf of Aegerion, to retire an equal amount of Aegerion’s 2% convertible notes due August 2019, at par, held by certain funds managed by each of Athyrium and Highbridge. Additionally, approximately $21.2 million of the proceeds from the financing facility were used by Aegerion to repay in full the indebtedness outstanding under a secured loan facility entered into in March 2018, and $3.5 million of the proceeds from the financing facility were used to repay, in part, the existing secured loan facility made by Novelion to Aegerion. The remaining proceeds of approximately $25.3 million from the new secured financing facility, less approximately $3.5 million in fees and expenses required to be paid by Aegerion in connection with such facility, will be available to Aegerion for general corporate purposes.

 

Jeff Hackman, Interim Chief Executive Officer, said, “The operational improvement and cost reduction initiatives that we executed throughout 2018 have made an impact on the stability of our business, and position Aegerion to become cash flow positive by the second quarter of 2019. This financing, which was sized to provide adequate runway to bridge to cash generation at the Aegerion level, also sets us on a path to a more comprehensive capital restructuring - our primary near-term goal.  We are encouraged by an ongoing productive dialogue with Aegerion’s convertible debtholders to help us meet this goal, and are pleased that some of our largest bondholders showed further support for the Company by providing us with this new capital. As always, we will strive to continue to serve our patients and ensure that our important therapies continue to be made available to those in need.”

 


 

Hondo Sen, a Partner at Athyrium, said, “We believe that with a portfolio of important rare disease therapies there is a fundamental business opportunity to pursue.”

 

Jonathan Segal, Managing Director and Portfolio Manager at Highbridge, added, “We believe  that through this financing we can help bridge the Company to a comprehensive long-term capital restructuring and allow it to take advantage of that business opportunity.”

 

Aegerion has engaged Moelis & Company LLC and AlixPartners, both of whom advised on the capital raise, to continue the comprehensive review of Aegerion’s capital structure. Novelion and Aegerion have also engaged Evercore and Moelis & Company, respectively, to explore and advise the companies on all available financial and strategic options, such as a restructuring of Aegerion’s outstanding convertible notes (including a restructuring that would likely involve a debt for equity swap), a possible sale or merger of Novelion or Aegerion, or the sale or other disposition of certain businesses or assets, including territorial licensing deals. The New Lenders engaged Ducera Securities LLC to advise on the capital raise.

 

The new facility has a maturity date of February 15, 2019, however, the maturity date may be extended, at Aegerion’s option, to June 30, 2019 subject to the payment of a fee to the New Lenders under the new facility, the delivery to such lenders of a term sheet contemplating a sale of Aegerion or its assets that may be acceptable to Aegerion and its board of directors, the bring-down of certain representations and warranties of Aegerion, and the satisfaction of certain other conditions.  While the funds received from the new facility allow the Company to meet its immediate operational needs and obligations, Aegerion may not be able to successfully refinance its approximately $36.8 million secured loan from Novelion, its remaining approximately $302.5 million principal amount of 2.0% convertible senior notes due August 15, 2019, or the new facility with an aggregate principal amount of $72.5 million.  Effecting such a refinancing, or other wholesale recapitalization or other strategic alternative (and some of these alternatives could potentially lead Novelion and/or Aegerion to seek certain protections afforded under law, including U.S. or Canadian bankruptcy codes ) will be critical for us to continue to execute on our commercial strategy and pursue our goals and objectives, and we may not be successful in doing so.

 

The new facility was unanimously approved by the members of the board of directors of Novelion, all of whom are independent, and a special committee of Aegerion’s board of directors, comprised solely of independent directors, each of which received advice from separate legal and financial advisors.

 

Financial Update

 

·                   Novelion expects total net product sales in 2018 to be between $130 and $140 million and total net product sales in 2019 to be between $145 and $160 million, with blended cash gross margins of approximately 80% when adjusted for certain non-cash items, such as amortization of intangible assets and inventory fair value step up (non-GAAP). Following the operational expense cuts announced in August 2018, including a 36% reduction in workforce which included open or on-hold positions, Novelion expects Aegerion to achieve positive cash flow by the

 

2


 

second quarter of 2019, and positive EBITDA in 2019, in each case, excluding any restructuring charges and when adjusted for certain non-cash items, such as amortization of intangible assets and debt discount and inventory fair value step up.

 

·                   As of September 30, 2018, Novelion had approximately $27.4 million in cash on a consolidated basis, including $13.7 million at Novelion and $13.7 million at the Aegerion subsidiary level.  After giving effect to the consummation of the new secured financing by Aegerion as described above and the application of proceeds from such financing and the payment of related fees and expenses, Novelion and Aegerion are anticipated to have approximately $15.7 million and $37.5 million, respectively, of cash as of November 8, 2018.

 

Commercial Update

 

MYALEPT ® /MYALEPTA ®  (metreleptin)

 

Jeff Hackman, Interim Chief Executive Officer, continued, “Metreleptin remains the standard-of-care in the treatment of generalized lipodystrophy (GL) as the only therapy that addresses the underlying cause of this rare and serious genetic disorder. Aegerion is focused on making this important therapy more broadly available to this underserved patient population, including in the EU. Aegerion is also working to expand into new indications and markets, with a top near-term priority of pursuing FDA approval of partial lipodystrophy (PL). With the recent EU approval of MYALEPTA in this indication, Aegerion believes that it has compelling data to support a potential U.S. label expansion, which, if approved, would significantly increase the size of MYALEPT’s addressable U.S. market.”

 

In addition:

 

·                   Aegerion plans to engage in dialogue with the U.S. Food and Drug Administration (FDA) on a potential metreleptin sBLA filing for PL in the U.S.

 

·                   In July 2018, the European Commission (EC) granted marketing authorization for MYALEPTA (metreleptin). MYALEPTA is the first and only licensed treatment in Europe indicated as an adjunct to diet as a replacement therapy to treat the complications of leptin deficiency in LD patients (which includes GL and PL).  Aegerion is pursuing pricing and reimbursement negotiations with healthcare authorities on a country-by-country basis.

 

·                   Currently there are approximately 100 patients being treated through expanded access programs and named patient sales in Europe, the substantial majority of which have GL or PL. Upon, and subject to, receipt of reimbursement approvals, Aegerion plans to convert patients to commercial therapy, where possible.

 

·                   Metreleptin is also currently being sold in certain Latin American countries via the named patient supply process, where allowed, and Aegerion intends to pursue additional marketing approvals for GL and PL in certain countries, including Brazil, in 2019.  The Latin American markets represent a potential growth opportunity, with a number of GL and PL patients already identified.

 

3


 

JUXTAPID ®  (lomitapide)

 

Mr. Hackman continued, “With cash gross margins in excess of 90% and positive cash flow, JUXTAPID continues to be an important asset for Aegerion, and Aegerion is very pleased with its improved commercial performance. Most notably, sales in the U.S. appear to have stabilized, as some adult HoFH patients who have failed to adequately respond to PCSK9 inhibitors return to JUXTAPID due to its novel mechanism of action. In addition, Aegerion expects sales growth from international markets, primarily Japan, as Aegerion continues to execute on our commercial strategy.”

 

In addition:

 

·                   Aegerion continues to expect growth in Japan, where there are approximately 46 homozygous familial hypercholesterolemia (HoFH) patients on therapy, and more than 200 HoFH patients registered in the List of Intractable Diseases.

 

·                   Aegerion has filed for marketing authorization in Brazil for HoFH in August 2018 and anticipates approval in the first half of 2019. In addition, we are currently preparing for commercial launch in Argentina, where JUXTAPID has been approved.  In the meantime, Aegerion continues to provide therapy to HoFH patients via the named patient supply process, where allowed.

 

Research and Clinical Development Update

 

Lomitapide

 

·                   Aegerion is evaluating the possibility of developing lomitapide for the potential treatment of familial chylomicronemia syndrome (FCS) given recent developments in the FCS market.  FCS is a rare genetic disease that Aegerion believes affects approximately one to two individuals per million.  In 2011, the FDA granted Orphan Drug Designation to lomitapide for the treatment of FCS, and in 2012, the FDA indicated support of a potential filing based on a single Phase 3 placebo-controlled study. Aegerion plans to re-engage with FDA on a proposed development plan for FCS.

 

·                   Aegerion also believes there may be an opportunity to develop lomitapide for the treatment of severe heterozygous familial hypercholesterolemia (HeFH). JUXTAPID is currently only indicated as an adjunct therapy for HoFH.

 

Metreleptin

 

·                   Metreleptin has potential clinical utility across a wide range of indications associated with hypoleptinemic metabolic disorder (HMD), including low-leptin obesity, hypoleptinemic nonalcoholic steatohepatitis (PL NASH), and infertility associated with hypothalamic amenorrhea. HMD is a spectrum of metabolic sequelae secondary to underlying leptin deficiency.  HMD patients differ from epidemic “lifestyle” diseases such as common obesity, type 2 diabetes mellitus/insulin resistance and dyslipidemia, in that low leptin is the driver of the metabolic dysfunction.

 

·                   Clinical data from a metreleptin study assessing weight loss in overweight and obese adults with low leptin levels was featured in a poster presentation at the American Diabetes Association’s

 

4


 

(ADA) 78th Scientific Sessions and showed that leptin replacement therapy sustainably decreased weight over time in patients with low baseline leptin levels.

 

Novelion and Aegerion’s ability to pursue these clinical development activities, and to conduct a clinical trial of metreleptin for PL, if required by the FDA as a requirement to seeking approval of PL in the U.S., will require additional funding, which, as noted above, may not be available.

 

Pro Forma Debt Outstanding of Aegerion

 

After giving effect to the closing of the new secured financing facility described above, as of November 8, 2018, Aegerion has outstanding a total of approximately $411.8 million of debt for borrowed money.  This debt consists of $50.0 million of first lien loans owing to certain funds managed by the New Lenders that accrue interest at a per annum rate of 11% and mature on February 15, 2019 subject to extension to June 30, 2019 as described above, $36.8 million of loans owing to Novelion that accrue interest at a per annum rate of 8.0% (8.5% beginning January 1, 2019) and mature on July 1, 2019, $22.5 million of loans owing to certain funds managed by the New Lenders that accrue interest at a per annum rate of 2% and mature on February 15, 2019 subject to extension to June 30, 2019 as described above, and $302.5 million of convertible notes that accrue interest at a per annum rate of 2% and mature on August 15, 2019.  Interest on all of the outstanding debt of Aegerion (other than the convertible notes) is payable in kind, and the next cash interest payment date for the convertible notes is February 15, 2019.

 

Investor Presentation

 

As part of the business update, Novelion has posted an updated investor presentation on its website at https://ir.novelion.com/events-and-presentations.

 

About Novelion Therapeutics

 

Novelion, through Aegerion, is a global biopharmaceutical company dedicated to developing and commercializing therapies that deliver new standards of care for people living with rare and underserved metabolic diseases. Our goal is to develop and bring to market transformational therapies that have the potential to significantly change the treatment paradigm for patients affected by a variety of rare and metabolic diseases, including diseases associated with low leptin, such as low-leptin associated obesity. With a global footprint and an established commercial portfolio, including MYALEPT ®  (metreleptin) and JUXTAPID ®  (lomitapide), our business is supported by differentiated treatments that treat severe and rare diseases.

 

Novelion is the parent company of Aegerion, our operating subsidiary.  References to “we,” “our” and the “Company” refer to the entire enterprise, whose assets and operations reside at Aegerion.

 

5


 

Non-GAAP (“pro forma”) Results

 

The non-GAAP results in this press release, including, without limitation, blended cash gross margins, are provided as a complement to results provided in accordance with GAAP because management believes, when considered together with the GAAP information, these non-GAAP financial measures help indicate underlying trends in the Company’s business, are important in comparing current results with prior period results and provide additional information regarding the Company’s financial performance. Management also uses these non-GAAP financial measures to establish budgets and operational goals that are communicated internally and externally, and to manage the Company’s business and evaluate its performance. The non-GAAP financial measures have no standardized meaning under GAAP and therefore may not be comparable to similar measures presented by other companies. The non-GAAP financial measures are not intended to be considered in isolation or as a substitute for, or superior to, the financial measures prepared and presented in accordance with GAAP and should be reviewed in conjunction with the relevant GAAP financial measures.

 

Forward Looking Statements

 

Certain statements in this press release constitute “forward-looking statements” within the meaning of applicable laws and regulations and constitute “forward-looking information” within the meaning of applicable Canadian securities laws.  Any statements contained herein which do not describe historical facts, including statements regarding beliefs that the new Aegerion loan facility strengthens the balance sheet; expectations that the new Aegerion loan facility will provide a bridge to a potential comprehensive long-term capital restructuring; statements about the terms of the new financing and expectations regarding use of such funds and the opportunity it provides; beliefs about the impact of our cost reduction measures and the stability of our business; expectations regarding Novelion’s and Aegerion’s review of financial and strategic alternatives, including a restructuring of Aegerion and a potential debt for equity swap; beliefs about our operational improvement and cost-reduction initiatives, and as to the ability of Novelion or Aegerion to execute on our commercial strategy and goals; expectations for engagement with Aegerion’s convertible note holders; beliefs about product sales, blended cash gross margins, cash flow and EBITDA, including the timing for achieving positive cash flow and EBITDA (and that positive cash flow and EBITDA are achievable); commercial plans for Myalept and Juxtapid, including market expansion, U.S. and ex-U.S. regulatory filings and milestones, commercial launch preparations overseas, pricing and reimbursement negotiations and patient conversion initiatives; expectations that the Latin American markets represent a potential growth opportunity for Myalept; plans for research and development initiatives for lomitapide and metreleptin, including development plans and beliefs for FCS and severe HeFH for lomitapide, as well as plans and beliefs for HMD and the clinical utility of metreleptin across a wide range of indications associated with HMD; beliefs about data, including that Aegerion has compelling data to support a potential U.S. label expansion for Myalept, and development plans based lomitapide FCS data; beliefs about the market and market opportunities for Myalept and Juxtapid; beliefs that Juxtapid sales have stabilized; expected international sales growth for Juxtapid, including in Japan; and beliefs about the FCS market are forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. Such risks and uncertainties include, among others, Novelion’s and Aegerion’s ability to meet immediate operational needs and obligations, as well as long-term obligations; the possibility that the terms of the new loan facility and its restrictions could have a negative impact on our business and our shareholders (whose interests may not be aligned with those of Aegerion’s bond holders); whether Novelion and/or Aegerion will be able to undertake a wholesale recapitalization, which is likely to include a debt for equity swap, and Novelion

 

6


 

and/ or Aegerion may be forced to use the protections of the bankruptcy code to effectuate such recapitalization or other alternative; Novelion’s and Aegerion’s ability to identify, pursue and consummate any financial or strategic alternatives; Novelion’s ability to maintain its listing status on Nasdaq; Novelion’s and Aegerion’s ability to continue as a going concern; the risks inherent in the development and commercialization of pharmaceutical products; as well as those risks identified in Novelion’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including under the heading “Risk Factors” in our Annual Report on Form 10-K filed on March 16, 2018, and subsequent filings, with the SEC (including Novelion’s upcoming Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 and Novelion’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018), available on the SEC’s website at www.sec.gov.  Any such risks and uncertainties could materially and adversely affect our results of operations, cash flows, and our ability to maintain our operations, any of which would have a significant and adverse impact on our stock price. We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. Except as required by law, we undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

 

This press release also contains “forward-looking information” that constitutes “financial outlooks” within the meaning of applicable Canadian securities laws. This information is provided to give investors general guidance on management’s current expectations of certain factors affecting our business, including our financial results. Given the uncertainties, assumptions and risk factors associated with this type of information, including those described above, investors are cautioned that the information may not be an appropriate subject of reliance for other purposes.

 

Investors and others should note that we communicate with our investors and the public using our company website www.novelion.com, including, but not limited to, company disclosures, investor presentations and FAQs, SEC filings, press releases, public conference calls transcripts and webcast transcripts. The information that we post on this website could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

 

CONTACT:

 

Amanda Murphy, Director, Investor Relations & Corporate Communications

Novelion Therapeutics

857-242-5024

amanda.murphy@novelion.com

 

7


Exhibit 99.2

 

Business Update November 2018 Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved.

GRAPHIC

 

Special Cautionary Statements about this Presentation This presentation includes statements about Novelion’s and Aegerion’s future plans and opportunities. Readers are cautioned that Novelion’s and Aegerion’s ability to pursue and execute on such plans and opportunities is subject to, among other things (including the risks discussed below), Aegerion’s ability to successfully refinance its approximately $36.8 million secured loan from Novelion, its approximately $302.5 million principal amount of 2.0% convertible senior notes due August 15, 2019, and the new $72.5 million facility described herein, which is scheduled to mature on February 15, 2019 but which may be extended, at Aegerion’s option, to June 30, 2019 if certain conditions are satisfied. Effecting such a refinancing, or other wholesale recapitalization or other strategic alternative (which is highly speculative) will be critical for Novelion and Aegerion to continue to execute on the commercial strategy, goals and objectives described in this presentation. Novelion is the parent company of Aegerion, our operating subsidiary. References to “we,” “our” and the “Company” refer to the entire enterprise, whose assets and operations reside at Aegerion, and whose interests may not always be aligned with those of Novelion or its shareholders. The non-GAAP results in this presentation, including, without limitation, blended cash gross margins, are provided as a complement to results provided in accordance with GAAP because management believes, when considered together with the GAAP information, these non-GAAP financial measures help indicate underlying trends in the Company's business, are important in comparing current results with prior period results and provide additional information regarding the Company’s financial performance. Management also uses these non-GAAP financial measures to establish budgets and operational goals that are communicated internally and externally, and to manage the Company's business and evaluate its performance. The non-GAAP financial measures have no standardized meaning under GAAP and therefore may not be comparable to similar measures presented by other companies. The non-GAAP financial measures are not intended to be considered in isolation or as a substitute for, or superior to, the financial measures prepared and presented in accordance with GAAP and should be reviewed in conjunction with the relevant GAAP financial measures. Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. 1

GRAPHIC

 

Forward Looking Statements Certain statements in this presentation constitute “forward-looking statements” of Novelion and Aegerion and “forward-looking information” within the meaning of U.S. federal securities laws and applicable Canadian securities laws, including statements regarding the terms of the new financing and expectations regarding use of such funds; expectations regarding Novelion’s and Aegerion’s review of financial and strategic alternatives (which could include a potential debt for equity swap); beliefs about our operational improvement and cost-reduction initiatives, and that Novelion or Aegerion will be able to execute on our commercial strategy and goals; forecasted sales; beliefs about product positioning, including for sales growth and potential pipeline expansion; beliefs about progress of Juxtapid in Japan and growth potential, including significant and rapid international growth potential; beliefs about payor coverage and reimbursement strength for Juxtapid; beliefs that Myalept sales are growing and the potential for a large opportunity in Latin America; expectations for potential new indications for Myalept, such as HMD, and indications of a founder effect and higher prevalence of GL in the Middle East; beliefs about the reimbursement landscape for Myalept, including impact on sales, plans to launch in Germany in November 2018 and expectations for EU published prices; expectations for the growth opportunity for Myalept in Europe; plans to pursue the PL indication in the United States and expectations as to the growth opportunity; expectations, including timing, regarding approval of broader label in Latin America and Canada; beliefs about the efficacy, and level of tolerance, of Myalept and Juxtapid; beliefs about pipeline opportunities for metreleptin; beliefs about product sales, blended cash gross margins, cash flow and EBITDA, including the timing for achieving positive cash flow and EBITDA; commercial plans for Myalept and Juxtapid, including market expansion, U.S. and ex-U.S. regulatory filings and milestones, commercial launch preparations overseas, pricing and reimbursement negotiations and patient conversion initiatives; plans for research and development initiatives for lomitapide and metreleptin, including development plans and beliefs for FCS and HeFH for lomitapide, as well as plans and beliefs for HMD and the clinical utility of metreleptin across a wide range of indications associated with HMD; beliefs about data, including that Aegerion has compelling data to support a potential U.S. label expansion for Myalept, and development plans based lomitapide FCS data; beliefs about the market and market opportunities for Myalept and Juxtapid; beliefs that Juxtapid sales have stabilized; and beliefs about the FCS market are forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. Such risks and uncertainties include, among others, Novelion’s and Aegerion’s ability to meet immediate operational needs and obligations, as well as long-term obligations; the possibility that the restrictions in and other terms of the new loan facility and the related documents could have a negative impact on Novelion’s business and its shareholders (whose interests may not be aligned with those of Aegerion’s holders of Convertible Notes and other lenders); whether Novelion and/or Aegerion will be able to undertake a wholesale recapitalization, which is likely to include a debt for equity swap, and Novelion and/ or Aegerion may be forced to use the protections of the bankruptcy code to effectuate such recapitalization or other alternative; Novelion’s and Aegerion’s ability to identify, pursue and consummate any financial or strategic alternatives; Novelion’s ability to maintain its listing status on Nasdaq; Novelion’s and Aegerion’s ability to continue as a going concern; the risks inherent in the development and commercialization of pharmaceutical products, as well as those identified in Novelion’s filings with the U.S. Securities and Exchange Commission (the “Commission”), including under the heading “Risk Factors” in Novelion’s Annual Report on Form 10-K filed on March 16, 2018 and subsequent filings with the Commission (including Novelion’s upcoming Quarterly Report on Form 10-Q and Novelion’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018), available on the Commission’s website at www.sec.gov. Any such risks and uncertainties could materially and adversely affect our results of operations, cash flows, and our ability to maintain our operations, any of which would have a significant and adverse impact on our stock price. We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. Except as required by law, we undertake no obligation to update or revise the information contained in this presentation, whether as a result of new information, future events or circumstances or otherwise. This presentation also contains “forward-looking information” that constitutes “financial outlooks” within the meaning of applicable Canadian securities laws. This information is provided to give investors general guidance on management’s current expectations of certain factors affecting our business, including our financial results. Given the uncertainties, assumptions and risk factors associated with this type of information, including those described above, investors are cautioned that the information may not be an appropriate subject of reliance for other purposes. Investors and others should note that we communicate with our investors and the public using our company website, www.novelion.com, including, but not limited to, company disclosures, investor presentations and FAQs, SEC filings, press releases, public conference call transcripts and webcast transcripts. The information that we post on this website could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104)

GRAPHIC

 

Novelion Therapeutics Inc. (Novelion) is the publicly listed (NASDAQ: NVLN) parent of Aegerion Pharmaceuticals, Inc. (Aegerion). Aegerion is a rare disease pharmaceutical company which develops and commercializes prescription drugs to treat rare metabolic diseases with significant unmet need Aegerion’s main operations are in Cambridge, Massachusetts Approximately 125 employees as of October 2018 Recently implemented significant operational improvements, including a 36% reduction in global workforce and other significant cost reduction efforts, intended to result in sustainability and facilitate the achievement of the Company’s cash flow positive goal Two clinically differentiated on-market products commercialized by Aegerion Juxtapid MTP inhibitor for the treatment for patients with homozygous familial hypercholesterolemia (HoFH) Myalept Leptin hormone replacement therapy, approved in the U.S. for Generalized Lipodystrophy (GL), and in Europe recently for GL & Partial Lipodystrophy (PL) on July 31st, 2018 with EU data and label to be referenced for potential GL and PL approvals in LatAm and Canada Plan to pursue an indication for PL in the U.S.; submission to be made to FDA in near-term Operations in the U.S., Canada, Latin America, Europe and Japan Company at a Glance Company Overview Commercial Products Geographical Coverage 3 Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved.

GRAPHIC

 

Two on-market, high-margin rare disease products positioned for sales growth and potential pipeline expansion - Approved in U.S., Canada, Colombia, Argentina, Japan, EU Stabilized sales, despite continued competitive pressure from PCSK9s Majority of HoFH patients lack functional LDL receptor, and thus are unlikely to adequately respond to LDL receptor-targeted PCSK9s and could benefit from Juxtapid treatment Launch in Japan progressing well and is expected to provide medium to long-term growth Filed for approval in Brazil in August 2018 Plan to revisit the possibility of developing lomitapide, which carries orphan drug designation in U.S. and EU, for the potential treatment of Familial Chylomicronemia Syndrome (FCS) given recent developments in FCS market FCS prevalence estimated to be 1:1,000,000 to 2:1,000,000 Discussion with FDA in 2012 supports a potential filing based on single Phase 3 placebo-controlled study; plan to re-engage with FDA to align on path forward Also revisiting plans to evaluate the development of lomitapide for severe heterozygous FH Growth Potential DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 4 Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved.

GRAPHIC

 

- FDA and EMA Approved Only agent that treats the consequences of low leptin, the underlying cause of lipodystrophies GL and PL received European Commission (EC) approval on July 31, 2018; approved for GL in U.S., plan to pursue an indication for PL in the U.S.; submission to be made to FDA in near-term Plan to submit EU dossier for approval in Brazil in H1 2019 Pipeline / Other Leptin Analogs Leptin has the potential to mediate multiple disease states A number of additional potential indications have been identified as possible development candidates Growth Potential DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 5 Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved.

GRAPHIC

 

Pipeline Overview 6 Discovery Preclinical Phase I Phase II Phase III U.S. PL CLD HMD* NASH* HA* Metreleptin Commentary Lomitapide: Plan to evaluate the development of lomitapide for the treatment of Familial Chylomicronemia Syndrome (FCS) and severe Heterozygous Familial Hypercholesterolemia (HeFH) Metreleptin: In addition to the U.S. PL opportunity, metreleptin has the potential to address multiple disease states based on the treatment of leptin deficiency; we may be required to conduct a placebo-controlled trial prior to filing for approval of PL in the U.S. Next Generation Leptin Opportunities

GRAPHIC

 

($ in millions) FY 2017A FY 2018E FY 2019E MYALEPT Net Sales $66.3 Gross Margin After Royalties2 77% GAAP Gross Margin 23% JUXTAPID1 Net Sales $72.1 Gross Margin After Royalties2 90% GAAP Gross Margin 64% Total Net Sales $138.4 $130-$140 $145-160 After proceeds from financing and payment of related fees and expenses, Novelion and Aegerion have approximately $15.7 million and $37.5 million respectively, as of November 8, 2018. 2017A Myalept Revenue 2017A Juxtapid Revenue M J Liquidity Revenue & Financial Summary Note: Regional revenue split from FY 2017; Myalept and Juxtapid are sold and distributed by Aegerion Pharmaceuticals, an indirect subsidiary of Novelion Includes $2.2 million in Juxtapid royalties from Amryt for 2017A Cash gross margin, inclusive of all royalties owed, but excludes non-cash charges like intangible asset amortization and inventory fair value step up as well as E&O reserves 7  Ex-U.S.  U.S.  Ex-U.S.  U.S. Expect Aegerion to achieve positive cash flow in Q2’19, excluding restructuring charges Liquidity 64% 36% 77% 23%

GRAPHIC

 

Aegerion Term Loan Agreement & Capital Structure Review New term loan facility with certain funds managed by Highbridge Capital Management and Athyrium Capital Management $50.0 million of new secured first lien loans funded to Aegerion in cash $22.5 million of new secured loans funded to repurchase and retire an equal amount of Aegerion’s 2% convertible notes due August 2019, at par, held by affiliates of Highbridge Capital Management and Athyrium Capital Management ~$21.2 million of proceeds used to repay in full indebtedness under March 2018 secured loan facility with affiliates of Broadfin Capital and Sarissa Capital $3.5 million of the proceeds from the loan facility used to repay, in part, secured loan facility made by Novelion to Aegerion Remaining proceeds of approximately $25.3 million from new secured financing facility, less approximately $3.5 million in fees and expenses required to be paid by Aegerion in connection with loan, will be available to Aegerion for general corporate purposes Aegerion engaged Moelis & Company and AlixPartners to undertake a comprehensive review of Aegerion’s capital structure Novelion and Aegerion also engaged Evercore and Moelis, respectively, to explore and advise the companies on all available financial and strategic options, such as a restructuring of Aegerion’s outstanding convertible notes, a sale or merger of Novelion or Aegerion, or the sale or other disposition of certain businesses or assets, including territorial licensing deals Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. 8

GRAPHIC

 

Pro Forma Aegerion Debt Outstanding $50.0 million first lien term loan owed to affiliates of Highbridge Capital Management and Athyrium Capital Management, maturing February 15, 2019 subject to extension to June 30, 2019 if certain conditions are satisfied $36.8 million loan owed to Novelion, maturing July 1, 2019 $22.5 million loan owed to affiliates of Highbridge Capital Management and Athyrium Capital Management, maturing February 15, 2019 subject to extension to June 30, 2019 if certain conditions are satisfied $302.5 million convertible notes issued by Aegerion, maturing August 15, 2019 Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. 9 Does not include $32.8 million outstanding DoJ/SEC settlement payment on Balance Sheet as of September 30, 2018

GRAPHIC

 

Portfolio Overview: Juxtapid II Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 10

GRAPHIC

 

Homozygous Familial Hypercholesterolemia Homozygous Familial Hypercholesterolemia (HoFH) HoFH is a serious, rare genetic disease that impairs the function of the receptor responsible for removing LDL-C (“bad” cholesterol) from the blood. An impairment of low density lipoprotein receptor (“LDL-R”) function results in significant elevation of blood cholesterol levels1 Based on epidemiological data, there are expected to be anywhere from 300-2,000 patients in the U.S. It is typically inherited from both parents1 The significantly elevated LDL-C levels in patients with HoFH may lead to premature and progressive atherosclerosis2 Cuchel M et al. Eur Heart J. 2014;35(32):2146-2157. Goldberg AC et al. J Clin Lipidol. 2011;5(3 Suppl):S1-S8. Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 11

GRAPHIC

 

Cash generating product with stabilizing sales and ~90% gross margins(1) (63.9% GAAP gross margins) Due to lomitapide’s MOA, adult HoFH patients are being prescribed lomitapide in greater frequency after using PCSK9s due to the failure of such patients to respond adequately to PCSK9s LOWER patient registry provides 5+ years of long-term efficacy and safety data Potential for significant international growth opportunities with already identified patients and opportunity to launch in several countries DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 12 Stabilizing sales as the third-line agent of choice HoFH null receptor patients do not adequately respond to PCSK9s Opportunity to pick up mipomersen patients following withdrawal from market U.S. Source: Company filings; Management Projections (1) Before non-cash amortization/costs Juxtapid Highlights Partnership with Amryt Reimbursed in Italy, the Netherlands Recently approved for reimbursement by the NHS in the UK Making progress on reimbursement in other EU countries E.U. Rapid growth in Japan with 202 HoFH patients identified Favorable placement in JAS guidelines Approved and preparing to launch in Argentina (Q4 2018) Filed in Brazil in August 2018, expect approval in 1H:2019 Japan / Other Int’l Patent life expected through 2027 Potential new uses (FCS and severe HeFH) Other

GRAPHIC

 

JUXTAPID®: Important Adjunct Treatment Option for Adult HoFH The effect of JUXTAPID on cardiovascular morbidity and mortality has not been established. Current company expectation for therapeutic applicability; subject to FDA approval. Newly Diagnosed 1st Line Treatment New therapies will be introduced 2nd Line Treatment 1st line failures Tolerability Issues 3rd Line Treatment Low Dose Statins, Ezetimibe, Bile Acid Sequestrants High-Dose Statins or PCSK9s JUXTAPID® (Daily Capsule) Mipomersen (Withdrawn from Market) Apheresis JUXTAPID is approved as an adjunct treatment with diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce LDL-C in adult HoFH patients. Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 13

GRAPHIC

 

Important Safety Information CONTRAINDICATIONS Pregnancy Concomitant administration of moderate or strong CYP3A4 inhibitors Moderate or severe hepatic impairment or active liver disease including unexplained persistent elevations of serum transaminases WARNINGS AND PRECAUTIONS JUXTAPID can cause elevations in transaminases and hepatic steatosis. Although cases of hepatic failure have not been reported, there is concern that JUXTAPID could induce steatohepatitis, which can progress to cirrhosis over several years. Modify the dose of JUXTAPID if elevations of transaminases are observed and discontinue JUXTAPID for persistent or clinically significant elevations. If transaminase elevations are accompanied by clinical symptoms of liver injury, such as nausea, vomiting, abdominal pain, fever, jaundice, lethargy, flu-like-symptoms, increases in bilirubin 2x ULN, or active liver disease, discontinue treatment with JUXTAPID and identify the probable cause. Use JUXTAPID with caution when co-administered with agents known to be hepatotoxic. Alcohol may increase levels of hepatic fat and induce or exacerbate liver injury. Measure ALT, AST, alkaline phosphatase, and total bilirubin before initiating treatment. During the first year, measure liver-related tests (ALT and AST, at a minimum) prior to each increase in dose or monthly, whichever occurs first. After the first year, do these tests at least every 3 months and before any increase in dose. Females of reproductive potential should have a negative pregnancy test before starting JUXTAPID and should use effective contraception during therapy with JUXTAPID. Given its mechanism of action in the small intestine, JUXTAPID may reduce the absorption of fat-soluble nutrients. Patients treated with JUXTAPID should take daily supplements that contain 400 international units vitamin E and at least 200 mg linoleic acid, 210 mg alpha-linolenic acid (ALA), 110 mg eicosapentaenoic acid (EPA), and 80 mg docosahexaenoic acid (DHA). Gastrointestinal adverse reactions are common and may lead to treatment discontinuation. To reduce the risk of gastrointestinal adverse reactions, patients should adhere to a low-fat diet supplying less than 20% of energy from fat and the dosage of JUXTAPID should be increased gradually. Combination with CYP3A4 inhibitors increases exposure to lomitapide. Strong and moderate CYP3A4 inhibitors should not be used with JUXTAPID. JUXTAPID dosage should not exceed 30 mg daily when used concomitantly with weak CYP3A4 inhibitors. Due to risk of myopathy associated with simvastatin or lovastatin, doses of these agents should be limited when co-administered with JUXTAPID. JUXTAPID increases the plasma concentrations of warfarin. Increases or decreases in the dose of JUXTAPID may lead to supra- or subtherapeutic anticoagulation, respectively. Patients taking warfarin should undergo regular monitoring of the INR, especially after any changes in JUXTAPID dosage. Avoid use of JUXTAPID in patients with rare hereditary disorders of galactose intolerance. Juxtapid: Important Safety Information and Boxed Warning WARNING: RISK OF HEPATOTOXICITY JUXTAPID can cause elevations in transaminases. In the JUXTAPID clinical trial, 10 (34%) of the 29 patients treated with JUXTAPID had at least one elevation in alanine aminotransferase (ALT) or aspartate aminotransferase (AST) 3x upper limit of normal (ULN). There were no concomitant clinically meaningful elevations of total bilirubin, international normalized ratio (INR), or alkaline phosphatase. JUXTAPID also increases hepatic fat, with or without concomitant increases in transaminases. The median absolute increase in hepatic fat was 6% after both 26 and 78 weeks of treatment, from 1% at baseline, measured by magnetic resonance spectroscopy. Hepatic steatosis associated with JUXTAPID treatment may be a risk factor for progressive liver disease, including steatohepatitis and cirrhosis. Measure ALT, AST, alkaline phosphatase, and total bilirubin before initiating treatment and then ALT and AST regularly as recommended. During treatment, adjust the dose of JUXTAPID if the ALT or AST are 3x ULN. Boxed Warning Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 14

GRAPHIC

 

Juxtapid: Reimbursement Landscape Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 15 Strong payor coverage in the U.S. and ex-U.S. ~58% of current US paid patients covered by commercial insurers, 42% covered by government payors Largely overcome third-line step-edit reimbursement issues in the U.S. Continued progress with payors in the EU Lojuxta® recently approved for funding by NHS England (NICE) Mandated reimbursement in Japan, where the product is approved Japanese HoFH Patients registered in the Intractable Diseases List (Nanbyo) receive 100% reimbursement Strong reimbursement in LATAM, where the product is approved or in registration in the markets where we operate Payors in Colombia provide reimbursement for Lomitapide In Brazil and Argentina, the product is purchased by the local payors on a named-patient basis; plan to launch in Argentina in Q4 2018

GRAPHIC

 

Juxtapid: Launch in Japan Represents Potential Growth Engine 202 HoFH patients registered across Japan Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 16 Population: 127.6M (74M Adult Population) HoFH listed as one of the 256 Intractable Diseases (Nanbyo – National Program on Rare and Intractable Diseases) Registered patients receive government-mandated reimbursement Currently, there are now 202 HoFH patients registered in the List of Intractable Diseases; approximately 46 patients on therapy More rigorous genetic testing favors Juxtapid use among diagnosed patients JUXTAPID® included in updated Japanese Atherosclerosis Society (JAS) guidelines in July 2017 Competitive landscape includes 2 launched PCSK9 inhibitors: Amgen/Astellas’ Repatha indicated for FH & HoFH and Sanofi’s Praluent for FH Both launched prior to Juxtapid approval Phase 3 Efficacy and safety study in Japanese subjects consistent with U.S. efficacy and safety data (n=9) Juxtapid is commercialized through the Aegerion Japan subsidiary with an outsourced salesforce

GRAPHIC

 

I Portfolio Overview: Myalept III Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 17

GRAPHIC

 

Generalized and Partial Lipodystrophy GL & PL result in abnormal or degenerative conditions of the body's adipose tissue; can be inherited or acquired (resulting in the following sub-categories: AGL, CGL, APL & CPL) Serious progressive diseases: Loss of subcutaneous fat Ectopic deposition of lipid (liver, muscle) Hyperphagia and significant fatigue Metabolic abnormalities often refractory to conventional therapies: Severe insulin resistance Diabetes mellitus Severe hypertriglyceridemia Hepatic steatosis or fatty liver Associated with life altering organ damage if uncontrolled Reduced life expectancy in severe forms GL estimated prevalence = ~ 1:1,000,000 PL estimated prevalence = ~ 3:1,000,000 Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 18

GRAPHIC

 

Source: National Organization for Rare Disorders (NORD), company estimates; Quality of life and benefits of leptin replacement. Ali O et al ADA abstract 1331P 2018 Loss of adipose tissue Relative leptin deficiency Ectopic fat deposition in liver and muscle Impaired fat oxidation Increased appetite Hyperphagia NAS (incl. NASH Cirrhosis Insulin resistance Accelerated microvascular complications from uncontrolled diabetes Accelerated microvascular complications Cardiovascular disease Renal disease Acute pancreatitis Diabetes Hypertriglyceridemia M M M M = Potential opportunity for use of Myalept as leptin replacement therapy* Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. Downstream Complications of Lipodystrophy DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 19

GRAPHIC

 

Metreleptin is the standard-of-care in the treatment of GL Only agent that treats the underlying cause of lipodystrophies that is low leptin Growing sales with ~70% gross margins(1) (~23% on a GAAP basis) Support NPS in pre-approval countries where permitted Immunogenicity plans agreed with FDA (PMR4) and EU (post approval study) – antibody response has not impacted clinical effect Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 20 Approved for GL; opportunity to greatly expand addressable population with a PL approval; plan to request meeting with FDA on PL Market exclusivity through 2026 Method of use patent expires in July 2027 U.S. Source: Company filings; Management Projections (1) Before non-cash amortization/costs; The time-based royalty rate ranges from mid-single digits to low double digits, increasing annually in years 2016 to 2019 from rates in the low single digits to low double digits, peaking in years 2019 to 2020 at a rate in the low double digits before decreasing in years 2022 through 2025 to rates in the high single digits to mid-single digits. Myalept Highlights GL & PL approval received in July 2018 ~100 patients currently treated on Expanded Access Programs, a majority of which have PL and GL Label includes treatment of patients with GL and PL; estimated ~1,000 addressable patients Market exclusivity in EU to August 2028 E.U. Large potential LATAM opportunity (200+ patients identified for GL with additional for PL) 120+ GL patients identified in Brazil alone Possible founder effect evidenced by large GL patient base EU Label will be basis for filings LATAM / Other Areas Potential new indications, such as HMD A relatively large number of GL patients in the Middle East may indicate a founder effect and support higher prevalence Other

GRAPHIC

 

Improve: Glycemic control TG levels Liver function Diabetes mellitus Hypertriglyceridemia Fatty liver Euglycemia Normal TG level Normal liver MYALEPT (metreleptin for injection) is a recombinant analogue of human leptin Regulates energy homeostasis and metabolic function Metreleptin is indicated as an adjunct to diet as replacement therapy to treat complications of leptin deficiency in patients with GL Studies have shown that metreleptin has the potential to dramatically improve conditions such as hyperglycemia, hyperphagia, hypertriglyceridemia and hepatomegaly Clinical observations suggest a potential to positively impact on the quality of life of affected patients MYALEPT is the only agent to treat the underlying cause of lipodystrophies (low leptin) and therefore halt the progression of the disease which effects organ damage and outcome compared to other agents which only tackle the symptoms of hyperglycemia and hypertriglyceridemia Overview of MYALEPT Effect of MYALEPT(1) (1) Source: Kyoto University Faculty of Medicine website Healthy Lipodystrophy Myalept Injection Adipose Tissue Blood Leptin Leptin Leptin Appetite suppression Energy expenditure Insulin sensitizing Improve: Appetite suppression Energy expenditure Insulin sensitizing Hyperphagia Low energy exp. Insulin resistance Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. Metreleptin: The Only Product Approved in the U.S. for the Treatment of GL DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 21

GRAPHIC

 

Metreleptin Safety Profile and Limitations of Use < 10% discontinuation due to ADRs, and < 1% due to drug-related ADRs Common adverse drug reactions (ADRs) in >10% of all 113 patients: Weight decreased (15%) Hypoglycemia (13%) Less common ADRs (in < 4% of patients): Injection site reaction, neutralizing antibodies, Decreased appetite, nausea, alopecia Presence of neutralizing antibodies in a small minority of patients did not result in clearly identified clinical sequelae Anaplastic large-cell lymphoma, n = 1; Peripheral T-cell lymphoma, n = 2 Evidence of pre-existing lymphoma and/or bone marrow/hematologic abnormalities in both lymphomas Lymphoma also reported in patients with acquired LD not treated with metreleptin, likely related to underlying predisposition to autoimmune conditions WARNING: RISK OF ANTI-METRELEPTIN ANTIBODIES WITH NEUTRALIZING ACTIVITY AND RISK OF LYMPHOMA MYALEPT® is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the MYALEPT® REMS PROGRAM See www.Myalept.com for full prescribing information U.S. Prescribing Information Boxed Warning for MYALEPT® Limitations of Use The safety and effectiveness of MYALEPT for the treatment of complications of partial lipodystrophy have not been established. The safety and effectiveness of MYALEPT for the treatment of liver disease, including nonalcoholic steatohepatitis (NASH), have not been established. MYALEPT is not indicated for use in patients with HIV-related lipodystrophy. MYALEPT is not indicated for use in patients with metabolic disease, including diabetes mellitus and hypertriglyceridemia, without concurrent evidence of congenital or acquired generalized lipodystrophy. Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 22

GRAPHIC

 

Myalept: Reimbursement Landscape Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 23 Broad payor coverage in the U.S. for GL ~55% of current US paid patients covered by commercial insurers, ~45% covered by Medicaid/Medicare Significant pre-approval/pre-launch unsolicited sales in LATAM, Turkey and certain EU countries (i.e. France and Italy) on a named-patient basis where permitted by applicable laws EU Pricing and Reimbursement (P&R) payor discussions are ongoing Plan to launch in Germany in November 2018 Expect EU published prices to be consistent with orphan drug analogs with comparable market size

GRAPHIC

 

Recent European Approval a Growth Opportunity for Myalept MYALEPTA is indicated as an adjunct to diet as a replacement therapy to treat the complications of leptin deficiency in lipodystrophy (LD) patients with: Confirmed congenital generalised LD (Berardinelli-Seip syndrome) or acquired generalised LD (Lawrence syndrome) in adults and children 2 years of age and above Confirmed familial partial LD or acquired partial LD (Barraquer-Simons syndrome), in adults and children 12 years of age and above for whom standard treatments have failed to achieve adequate metabolic control 24 EU label includes both GL (CGL & AGL) and PL indications (FPL & APL) ~100 patients currently on EAP, with a majority of EAP patients having GL or PL EMEA opportunity of ~1000 treatable patients based on estimated prevalence rates for GL & PL Estimated prevalence rate for GL & PL assumed to be 4 patients/million population (1/M GL & 3/M PL) Concentration of likely prescribers in Centers of Excellence enables Aegerion to commercialize MYALEPTA with relatively small EU team EU Opportunity EU Indication Source: Management Projections

GRAPHIC

 

BLA for Metreleptin was filed on April 3rd, 2012, by BMS & Amylin, which was later acquired by BMS in August 2012 Myalept® was approved by the FDA on February 25th, 2014. The FDA concluded that the BLA was approvable in Generalized Lipodystrophy (GL) patients but that its efficacy and safety was not established in PL patients BLA was transferred from BMS to AstraZeneca as part of the acquisition of the diabetes alliance assets, including MYALEPT and Amylin Pharmaceuticals, which was completed in February 2014 Myalept® was approved only for GL when Aegerion acquired the asset in 2014 While clinical data from the same studies were submitted to the EMA, the EMA had more safety data from AE reports and overall determined that Myalept was an effective treatment for patients with both GL and PL As part of the approval in Europe, the following are required: Pediatric GL study Immunogenicity study PL post-approval study Maintain a registry called MEASURE Anticipated applications for approval in LATAM (and possibly Canada) are expected to be based on the broader EMA submission After the approval of Myalepta in PL in Europe, plan to pursue PL indication in the U.S.; briefing documents to be submitted in near-term Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. Partial Lipodystrophy (PL) Growth Opportunity Regulatory History in the U.S. Europe LATAM & Canada Future U.S. Opportunity 25

GRAPHIC

 

Metreleptin Efficacy in PL Patients Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 26 PL patients experienced a clinically and statistically significant response to Metreleptin after a year of therapy Source: CHMP Oral Explanation, 2/21/2018 Note: PL Subgroup are patients from NIH having TG >5.65 mmol/l and Hba1c >6.5% and leptin <12ng/ml

GRAPHIC

 

Metreleptin is Generally Well Tolerated in PL Patients PL subgroup n=25(%) PL overall N=73 (%) GL overall N=75 (%) Adverse Drug Reactions Hypoglycemia 4 (16%) 3 (15%) 8 (13%) Fatigue 3 (12%) 4 (5%) 4 (5%) Nausea 1 (4%) 8 (11%) 1 (1%) Headache 0 (0%) 3 (4%) 1( 1%) Weight decrease 1 (4%) 2 (3%) 16 (21%) Blocking activity NAb n=38 5 (26%) 13 (27%) 25 (47%) AE leading to discontinuation N=148 1 (4%) 4 (5%) 6 (8%) Immunogenicity in NAb positive PL Subgroup patients (n=5): Positive clinical outcomes in all except one patient (901-051) death due to anoxic encephalopathy (multiple other pre-existing comorbidities) No related SAE or related severe AE reported in this group No indication of negative impact on NAbs on endogenous leptin in PL patients Metreleptin was generally well tolerated There was no difference in safety profile in <4ng/ml vs >4 ng/ml groups (data not shown) In conclusion, the safety and immunogenicity of metreleptin was the same in PL Subgroup patients across all leptin levels 27 Source: Phase 3 study Note: PL Subgroup are patients from NIH having TG >5.65 mmol/l and Hba1c >6.5% and leptin <12ng/ml Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved.

GRAPHIC

 

I Metreleptin Pipeline Opportunities IV Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 28

GRAPHIC

 

Metreleptin – Potential Pipeline in a Product DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 29 GL ~700 pts PL ~700 - 2100 pts HA ~70,000 pts HL-NASH ~70,000 pts HMD >700,000 pts (U.S. only) Generalized Lipodystrophy Partial Lipodystrophy Infertility Assoc. with Hypothalamic Amenorrhea Hypoleptinemic Nonalcoholic Steatohepatitis Hypoleptinemic Metabolic Disorder Severe Hypoleptinemias Hypoleptinemias U.S. & EU Prevalence Estimated Aleptinemia Congenital Leptin Deficiency Degree of Hypoleptinemia Approved (GL, U.S. and GL & PL in EU) CLD ~30 pts Areas of Potential Future Focus for Pipeline Current Commercial Operations and Potential Growth Pipeline & Future Leptin Opportunities Pursuing PL in U.S.

GRAPHIC

 

I Summary V Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) 30

GRAPHIC

 

Current Patent & Exclusivity Portfolio in Key Markets Proprietary and confidential. Copyright © 2017 Novelion Therapeutics Inc. All rights reserved. 31 2019 JUXTAPID® Orphan Drug Exclusivity (U.S.) 12/2019 JUXTAPID® COM Patent (U.S.) 2/2020 7/2023 2/2026 8/2027 2020 2023 2026 2027 MYALEPTA® Market/Orphan Drug Exclusivity (EU) 7/2028 MYALEPT® Market Exclusivity (U.S.) JUXTAPID® Market Exclusivity (Japan) 2026 2028 MYALEPT® Method of Use (U.S.) JUXTAPID® Dosing Patent (U.S.) LOJUXTA Marketing Exclusivity (EU) 7/2027 In March 2011, Aegerion was granted orphan drug designation from the U.S. FDA Office of Orphan Product Development for lomitapide for the treatment of familial chylomicronemia syndrome (FCS)

GRAPHIC

 

Corporate Infrastructure U.S. G&A 3 S&M 23 R&D 6 Total 32 LATAM & Other INT’L G&A 2 S&M 6 R&D 3 Total 11 EMEA G&A 4 S&M 11 R&D 12 Total 27 JAPAN G&A - S&M 3 R&D 6 Total 9 Established global commercial infrastructure, including sales force, medical affairs and support functions in key geographic areas, with a total of ~126 FTEs (79 commercial business FTEs) plus contract sales force in Japan Non-Commercial Corporate (G&A) 18 R&D and Operations 29 Total 47 Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. 32 Approximate data as of October 2018

GRAPHIC

 

Commercial Business Snapshot DO NOT DELETE Color Palette (246/105/38) (29/167/157) (211/222/229) (0/126/178) Font (104/104/104) Highlights Growth Other Juxtapid U.S. provides a high margin revenue stream that appears to be stabilizing after PCSK9 impact Ongoing Japan and international expansion opportunities provide for potential continued upside with a large number of identified patients Fulfilled regulatory requirements in Argentina through local testing; estimated launch in Q4 2018 Orphan drug legislation in effect since February 2018 in Brazil supported filing of Juxtapid in August 2018 Potential new uses such as for severe HeFH and familial chylomicronemia syndrome Opportunity to capture further share of adult HoFH market with withdrawal of Kynamro in the U.S. and globally Myalept is the standard-of-care in the treatment of GL Significant growth expected in the EU and other international countries High-margin product with expected market exclusivity through 2026/27 Potential upside if PL indication is approved in US Significant opportunity in Europe and other ex-U.S. markets with indications in GL and PL U.S. opportunity to expand label to PL Large LATAM opportunity (200+ patients identified for GL with additional for PL) A relatively large number of GL patients in the Middle East may indicate a founder effect and support higher prevalence Potential to get CLD indication Potential to pursue new indications leveraging existing clinical data 33 Juxtapid Myalept Stable high-margin rare disease products positioned for potential growth * Currently no development being conducted other than for metreleptin in PL and CLD.

GRAPHIC

 

Michael Price Executive Vice President & Chief Financial Officer Served since November 2017 following a role as CFO for Noven Pharmaceuticals, Inc where he executed commercial scaling strategies. Mr. Price is a Certified Public Accountant and holds a Masters of Business Administration from Florida State University Geographical Coverage Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. Leadership Team Jeffrey Hackman Chief Operating Officer / Acting CEO Served since November 2017 following a role as head of U.S. Internal Medicine & Oncology for Shire. Prior to joining Shire, Mr. Hackman was region head for North America at Baxalta. He holds a Bachelor of Arts in communications from Lycoming College Ben Harshbarger Global General Counsel Served since November 2016 following a similar role at Aegerion. Also served in legal roles at Cubist Pharmaceuticals, ViaCell and Biogen/Biogen Idec. Mr. Harshbarger served at the law firm of Mintz Levin and holds a J.D. from Boston College and a B.A. from the University of Richmond (VA) Linda Buono Senior Vice President, Human Resources Served since November 2016 following a similar role at Aegerion and more than 25 years at Immunogen where she held a variety of leadership positions in Human Resources Roger Louis Global Chief Compliance Officer Served since November 2016 following a similar role at Aegerion. Also served in compliance and risk management roles at Cubist Pharmaceuticals and Genzyme. Mr. Louis began his legal career at Hale & Dorr and received his J.D. and B.A. from the University of Chicago and Tufts University respectively 34

GRAPHIC

 

ADA Meeting: Pipeline HMD Poster Q2 2018 Recent Accomplishments and Upcoming Potential Milestones 2016 2017 2018 Closing of QLT & Aegerion Merger and Private Placement Q4 2016 Launch of Juxtapid in Japan Q4 2016 Metreleptin MAA Filing With EMA Q4 2016 35 Metreleptin GL / PL Filing in Other Countries 2019 Pre-2016: 2006: Aegerion’s licensing of Lomitapide global rights from UPenn 2013: Launch of Juxtapid in the US and EU 2015: Aegerion’s acquisition of Myalept from AstraZeneca Licensing of Juxtapid EU to Amryt Q4 2016 Announced Cost Reduction Plans, Capital Structure Review and Finalization of DOJ/SEC Settlement Q1 2018 Strengthening of Key Leadership Q3/Q4 2017 Metreleptin EMA Positive CHMP Opinion Q2 2018 Brazil Filed for Juxtapid Q3 2018 2019 Metreleptin EMA Approval Q3 2018 Metreleptin US PL FDA meeting Q1 2019 Proprietary and Confidential. Copyright © 2018 Novelion Therapeutics Inc. All rights reserved. Announced Cost Reduction Initiative Q3 2018

GRAPHIC